Possible input of diabetes and smoking cigarettes in confirmation of AMI diagnosis by Domazetovska, Saska et al.
XXVII. BALKAN KLİNİK 
LABORATUVAR FEDERASYONU 
KONGRESİ BCLF 2019 
XXX. TÜRK BİYOKİMYA 
DERNEĞİ ULUSAL BİYOKİMYA 
KONGRESİ TBD 2019
27-31 Ekim 2019, Antalya, Türkiye
XXVII. BALKAN CLINICAL 
LABORATORY FEDERATION 
MEETING BCLF 2019 
XXX. NATIONAL CONGRESS OF 
THE TURKISH BIOCHEMICAL 
SOCIETY TBS 2019
27-31 October 2019, Antalya, Turkey
2019
Cilt [Volume] 44
Ek Sayı [Supplement] 3
Türk Biyokimya Derneği’nin yayın organıdır.
[Published by the Turkish Biochemical Society]
YER ALDIĞI 
İNDEKSLER 
[INDEXED BY]
SCI Expanded,
Journal Citation
Reports/Science
Edition, Chemical
Abstracts, Index
Copernicus,
Embase, Scopus,
Ulakbim Türk
Tıp Dizini,
Ulrich’s Periodical
Directory, EBSCO,
Türkiye Atıf Dizini
27-31 October 2019Turkish Journal of Biochemistry, 2019
XXVII. Balkan Clinical Laboratory Federation Meeting BCLF 2019 
XXX. National Congress of the Turkish Biochemical Society TBS 2019
Turk J Biochem, 2019; 44 (S3) http://www.TurkJBiochem.com2
Vice eDiTors 
[yarDimci eDiTÖrler]
Aylin Sepici Dinçel, Ankara, TR
Merve Sibel Güngören, Ankara, TR
Oytun Portakal, Ankara, TR
Muhittin Serdar, Ankara, TR
Mehmet Şeneş, Ankara, TR
associaTe eDiTors 
[BÖlÜm eDİTÖrlerİ]
Sedat Abuşoğlu, Konya, TR 
Ebubekir Bakan, Erzurum, TR
Sreeparna Banerjee, Ankara, TR
Emine Bayraktar, Ankara, TR
Ebru Bodur, Ankara, TR
Murat Bolayırlı, İstanbul, TR
Abdurrahman Coşkun, İstanbul, TR
Özlem Dalmızrak, Nicosia, TRNC
Birsen Can Demirdöğen, Ankara, TR
2019 · VOluME 44 · SUPPLEMENT ISSUE 2
Turkish Journal 
of BiochemisTry 
TÜRK BİYOKİMYA 
DERGİSİ
 Official JOurnal Of the turkish BiOchemical sOciety
eDiTor in chief [BaŞ eDİTÖr]
Doğan Yücel, Ankara, TR
Serenay Elgün Ülkar, Ankara, TR
Suat Erdoğan, Edirne, TR
Uzay Görmüş, Solna, SE
Levent Kayrın, Kyrenia , TRNC
Semra Koçtürk, İzmir, TR
Işıl Aksun Kurnaz, Kocaeli, TR
Melek Özkan, Kocaeli, TR
Yeşim Özkan, Ankara, TR
Ebru Saatçi, Kayseri, TR
Çağdaş Son, Ankara, TR
Alaattin Şen, Denizli, TR
Ajlan Tükün, Ankara,TR
Hamdi Uysal, Ankara, TR
Serenay Elgün Ülkar, Ankara, TR
Süha Yalçın, İstanbul, TR
İlhan Yaylım, İstanbul, TR
Fatma Meriç Yılmaz, Ankara, TR
Meral Yüksel, Istanbul, TR
sTaTisTics eDiTors  
[İsTaTİsTİk eDİTÖrlerİ] 
Erdal Coşgun, Redmond, WA, USA
Sevilay Karahan, Ankara, TR
Jale Karakaya, Ankara, TR
Technical eDiTors 
(Teknİk eDİTÖrler) 
Tülin Bayrak, Ordu, TR
Birsen Can Demirdöğen, Ankara, TR
Merve Sibel Güngören, Ankara, TR 
Elvan Laleli Şahin, Dallas, USA
Duygu Şahin, Istanbul, TR  
Z. Onur Uygun, İzmir, TR
Oğuzhan Zengi, İstanbul, TR
corresPonDence [yaZi İŞlerİ]
Nermin Şahan, Ankara, TR
Unauthenticated
Download Date | 9/27/19 10:30 AM
 . LU   . PPLEMENT ISSUE 3
EDITORIAL BOARD 
[EDİTÖRLER KURULU]
N. Leyla Açan, Ankara, TR
A. Kevser Pişkin Özden, Ankara, TR
Ergun Karaağaoğlu, Ankara, TR
Sreeparna Banerjee, Ankara, TR
Emine Bayraktar , Ankara, TR
Serenay Elgün Ülkar, Ankara, TR
Çetin Kocaefe, Ankara, TR
Muhittin Serdar , Ankara, TR
Aylin Sepici Dinçel, Ankara, TR
SECTION EDITORS 
[BÖLÜM EDİTÖRLERİ]
Biochemistry [Biyokimya]
N. Leyla Açan , Ankara, TR
Ebru Bodur, Ankara, TR
Özlem Dalmızrak , Nicosia, TRNC
Aylin Sepici Dinçel, Ankara, TR
Semra Koçtürk , İzmir, TR
Ebru Saatçi , Kayseri, TR
Alaattin Şen, Denizli, TR
Önder Şirikçi , İstanbul, TR
Hamdi Uysal , Ankara, TR
Serenay Elgün Ülkar, Ankara, TR
Süha Yalçın , İstanbul, TR
20 SPECIA  ISSUE 1
URKISH OURNAL
OF IOCHEMIS RY
RK BİYOKİMYA  
ERGİS
 FFICIAL J URNAL OF THE TURKISH BI CHEMICAL SOCIETY
EDITOR IN CHIEF [BAŞ EDİTÖR]
Yahya Laleli, Ankara, TR
Clinical Biochemistry 
[Klinik Biyokimya]
Murat Bolayırlı, İstanbul, TR
Ergun Karaağaoğlu, Ankara, TR
Yahya Laleli, Ankara, TR  
Gül Saydam, Ankara, TR
Muhittin Serdar, Ankara, TR
Doğan Yücel, Ankara, TR
Molecular Genetics (Medical) 
[Moleküler Genetik (Tıbbi)]
Ajlan Tükün , Ankara, TR
Cell and Molecular Biology
[Hücre Biyolojisi ve Moleküler 
Biyoloji]
A. Kevser Pişkin Özden, Ankara, TR
Sreeparna Banerjee, Ankara, TR
Çetin Kocaefe, Ankara, TR
Biotechnology [Biyoteknoloji]
Emine Bayraktar, Ankara, TR
Melek Özkan, Gebze, TR
Bioinformatics [Biyoinformatik]
Çağdaş Son, Ankara, TR
Ayşe Ergüven, Ankara, TR
STATISTICS EDITORS  
[İSTATİSTİK EDİTÖRLERİ] 
Erdal Coşgun, Redmond, WA, USA  
Ergun Karaağaoğlu, Ankara, TR  
Sevilay K arahan , Ankara, TR
Jale Karakaya , Ankara, TR
LANGUAGE EDITORS  
(DİL EDİTÖRLERİ) 
Tülin Bayrak, Ordu, TR
Birsen Can Demirdö ğen, Ankara, TR  
Elvan Laleli Şahin , Dallas, US
Z.  Onur Uygun , İzmir, TR
CORRESPONDENCE [YAZI İŞLERİ] 
Nermin Şahan, Ankara, TR
Unauthenticated
Download Date | 5/1/18 10:50 PM
Vice eDiTors 
[yarDimci eDiTÖrler]
Aylin Sepici Dinçel, Ankara, TR
Mer e Sibel Güngören, A r , 
Oytun Portakal, Ankara, TR
Muhittin Serdar, Ankar , TR
Mehmet Şeneş, Ankar , TR
associ Te eDiTors 
[BÖlÜm eDİTÖrlerİ]
Sedat Abuşoğlu, Konya, TR 
Ebubekir Bakan, Erzurum, TR
Sreeparna Banerjee, Ankara, TR
Emine Bayraktar, Ankara, TR
Ebru Bodur, Ankara, TR
Murat Bolayırlı, İstanbul, TR
Abdurrahman Coşkun, İstanbul, TR
Özlem Dalmızrak, Nicosia, TRNC
Birsen Can Demirdöğen, Ankara, TR
2019 · VOluME 44 · SUPPLEMENT ISSUE 2
Turkish Journal 
of BiochemisTry 
TÜRK BİYOKİMYA 
DERGİSİ
 Official JOurnal Of the turkish BiOchemical sOciety
eDiTor in chief [BaŞ eDİTÖr]
Doğan Yücel, Ankara, TR
Serenay Elgün Ülkar, Ankara, TR
Suat Erdoğ n, Edirne, TR
Uzay Görmüş, Soln  SE
Levent K yrın, Kyrenia , TRNC
Semra Koçtürk, İzmir, TR
Işıl Aksun Kur az, Kocaeli, TR
Melek Özkan, Kocaeli, TR
Yeşim Özkan, Ankara, TR
Ebru Saatçi, Kayseri, TR
Çağdaş So , 
Alaattin Şen, Denizli, TR
Ajlan Tükün, Ank a,TR
amdi Uysal, Ankara, TR
Serenay Elgün Ülkar, Ankara, TR
Süha Yalçın, İstanbul, TR
İlhan Yaylım, İstanbul, TR
Fatma Meriç Yılmaz, Ankara, TR
Meral Yüksel, Istanbul, TR
sT TisTics eDiT rs  
[İsTaTİsTİk eDİTÖrlerİ] 
Erdal Coşgun, Redmond WA, USA
Sevilay Karahan, Ankara, TR
Jale Karakaya, Ankara, TR
Technical eDiTors 
(Teknİk eDİTÖrler) 
Tülin Bayrak, Ordu, TR
Birsen Can Demirdöğen, Ankara, TR
Merve Sibel Güngören, Ankara, TR 
Elvan Laleli Şahin, Dallas, USA
Duygu Şahin, Istanbul, TR  
Z. Onur Uygu , İzmir, TR
Oğuzhan Zengi, İstanbul, TR
corresPonDence [yaZi İŞlerİ]
Nermin Şahan, Ankara, TR
Unauthenticated
Download Date | 9/27/19 10:30 AM
SUPPLEMENET ISSUE EDITORS
[EK SAYI EDİTÖRLERİ]
Ferhan G. S ğın, İzmir,TR
Doğan Yüc l, Ankara, TR
27-31 October 2019Turkish Journal of Biochemistry, 2019
XXVII. Balkan Clinical Laboratory Federation Meeting BCLF 2019 
XXX. National Congress of the Turkish Biochemical Society TBS 2019
Turk J Biochem, 2019; 44 (S3) http://www.TurkJBiochem.com3
eDiTorial BoarD  
[eDİTÖrler kurulu]
Khosrow Adeli, Molecular Medicine, Research Institute, The Hospital 
for Sick Children, University of Toronto, Toronto, Ontario, CANADA
Diler Aslan, Department of Biochemistry, Faculty of Medicine, 
Pamukkale University, Denizli, TURKEY
Cumhur Bilgi, Özel Koru Hastaneleri, Department of Biochemistry, 
Ankara, TURKEY
Anyla Bulo-Kasneci, Laboratory Department, University Hospital 
Center “Mother Teresa”, Tirana, ALBANIA
Orhan Değer, Department of Medical Biochemistry, Faculty of 
Medicine, Karadeniz Technical University, Trabzon, TURKEY
Elif Demirkan, Department of Biology, Faculty of Arts & Sciences, 
Uludağ University, Bursa, TURKEY
Z. Günnur Dikmen, Department of Biochemistry, Faculty of Medicine, 
Hacettepe University, Ankara, TURKEY
Miral Dizdaroğlu, National Institute of Standards and Technology, 
Gaithersburg, MD, USA
Mustafa B. A. Djamgoz, Department of Life Sciences,  Faculty of 
Natural Sciences, Imperial College, London, UNITED KINGDOM
Figen Erkoç, Department of Biology Education, Faculty of Gazi 
Education, Gazi University, Ankara, TURKEY
Gökhan Hotamişlıgil, Department of Genetics and Complex Diseases, 
Harvard School of Public Healt, Boston, USA
Mehmet Kesimer, Department of Pathology and Laboratory Medicine, 
Marsico Lung Institute, University of North Carolina at Chapel Hill, 
NC, USA
İrfan Küfrevioğlu, Department of Chemistry, Faculty of Art & Sciences, 
Atatürk University, Erzurum, TURKEY
Nada Majkic-Singh, Institute of Medical Biochemistry, Pharmaceutical 
Faculty and Clinical Centre of Serbia, Belgrade, SERBIA
Gülgün Oktay, Department of Medical Biochemistry, Faculty of 
Medicine, University of Dokuz Eylül, İzmir, TR
İ. Hamdi Öğüş, Department of Medical Biochemistry, Faculty of 
Medicine, Near East University, Nicosia, TRNC 
Turkish Journal of Biochemistry (TJB), official journal of Turkish Biochemical Society, is issued electronically every 2 months. Research articles, reviews, short communi-
cations, technical reports, case presentations, opinions, and letters to the editor, that have not published elsewhere, on biochemistry, clinical biochemistry, molecular biology, 
molecular genetics, biotechnology, bioinformatics, bioengineering, and their educational disciplines are published in the journal.
The main aim of the journal is to support the research and publishing culture by ensuring that every published manuscript has an added value and thus providing international 
acceptance of the “readability” of the manuscripts published in the journal.
e-ISSN 1303-829X
All information regarding notes for contributors, subscriptions, Open access, back volumes and orders is available online at 
www.degruyter.com/view/j/tjb.
resPonsiBle eDiTor Doğan Yücel PhD, Assoc Professor of Biochemistry, Department of Medical Biochemistry, Ankara Training and Research Hospital, University 
of Health Sciences, 06340, Ankara, Turkey, Tel: +90312 595 321, Email: doyucel@yahoo.com
Journal manager Alexander Görlt, De Gruyter, Genthiner Straße 13, 10785 Berlin, Germany. Tel.: +49 (0) 30 260 05–234,  
Fax: +49 (0) 30 260 05–250, Email: alexander.goerlt@degruyter.com
resPonsiBle for aDVerTisemenTs Claudia Neumann, De Gruyter, Genthiner Straße 13, 10785 Berlin, Germany. Tel.: +49 (0) 30 260 05–226,  
Fax: +49 (0) 30 260 05–264, Email: anzeigen@degruyter.com
TyPeseTTing Compuscript Limited, Shannon, Ireland
© 2019 Walter de Gruyter GmbH, Berlin / Boston
Yeşim Özarda, Department of Medical Biochemistry, Faculty of 
Medicine, Uludağ University, Bursa, TURKEY
Tomris Özben, Department of Medical Biochemistry, Faculty of 
Medicine, Akdeniz University, Antalya, TURKEY
Nazmi Özer, Department of Medical Biochemistry, Faculty of Medicine, 
Near East University, Nicosia, TRNC 
İsrael Pecht, Department of Immunology, Weizmann Institute of 
Science, Rehovot, ISRAEL
Mario Plebani, Department of Medical Sciences, University of Padova, 
Padova, ITALY 
Demetrios Rizos, Hormonal and Biochemical Laboratory, Aretaieio 
Hospital, University of Athens, Athens, GREECE
George Russev, Bulgarian Academy of Sciences, Institute of Molecular 
Biology, Sofia, BULGARIA
Fahri Saatçioğlu, Department of Biosciences, University of Oslo, Oslo, 
NORWAY
Ferhan Girgin Sağın, Department of Medical Biochemistry, Faculty of 
Medicine, Ege University, İzmir, TURKEY
Aziz Sancar, Department of Biochemistry and Biophysics, University of 
North Carolina School of Medicine, Chapel Hill, NC, USA
Praveen Sharma, All India Institute of Medical Sciences, Jodhpur, 
INDIA  
Emin Sofic, Department of Chemistry, Faculty of Science, Sarajevo 
University, Sarajevo, BOSNIA AND HERZEGOVIA
Eser Sözmen, Department of Medical Biochemistry, Faculty of 
Medicine, University of Ege, İzmir, TR
Abdullah Tuli, Department of Medical Biochemistry, Faculty of 
Medicine, Çukurova University, Adana, TURKEY
Ali Ünlü, Department of Biochemistry, Faculty of Medicine,  Selçuk 
University, Konya, TURKEY
Sedef Yenice, Department of Clinical Chemistry, Group Florence 
Nightingale Hospitals, İstanbul, TURKEY
Unauthenticated
Download Date | 9/27/19 10:30 AM
27-31 October 2019Turkish Journal of Biochemistry, 2019
XXVII. Balkan Clinical Laboratory Federation Meeting BCLF 2019 
XXX. National Congress of the Turkish Biochemical Society TBS 2019
Turk J Biochem, 2019; 44 (S3) http://www.TurkJBiochem.com4
CONTENTS
• BCLF Welcome Letter....................................................................................5
• TBS Welcome Letter ........................................................................................6
• Scientific Program ...............................................................................................7
 26  October 2019, Saturday ...............................................................7
 27 October 2019, Sunday .....................................................................7
 28 October 2019, Monday ...................................................................8
 29 October 2019, Tuesday ................................................................11
 30 October 2019, Wednesday .......................................................14
 31 October 2019, Thursday .............................................................17
• Invited Speakers Abstracts ......................................................................18
• Congress Course Abstracts .....................................................................37
• Industry Sponsored Symposium Abstracts ...........................39
• Oral Presentations Abstracts .................................................................40
• Poster Presentation Abstracts  .............................................................69
• Full-Text Articles from Oral Presentations ...................... 113
27-31 October 2019Turkish Journal of Biochemistry, 2019
XXVII. Balkan Clinical Laboratory Federation Meeting BCLF 2019 
XXX. National Congress of the Turkish Biochemical Society TBS 2019
Turk J Biochem, 2019; 44 (S3) http://www.TurkJBiochem.com5
BCLF WELCOME LETTER
Dear friends and colleagues,
On behalf of Balkan Clinical Laboratory Federation it is my great pleasure to invite you to take part on this great scientific event to be 
held on 27-31 October 2019 in Antalya - Turkey.
Gear up for an exciting and informative 27th Balkan Clinical Laboratory Federation Meeting that will enable You to refresh your 
knowledge base, explore innovations, exchange ideas, meet other researches, friends and colleagues as well as sponsors and exibitors.
The Meeting will cover all the scientific and technological aspects of Laboratory Medicine. Ideal location to participate to very 
advanced scientific presentations combined with well balanced programme of oral and poster presentations, and dedicated workshops, 
will guarantee an efficient exchange of ideas and allow productive discussions.
These are exciting times in the world of laboratory medicine and I am sure that 27th BCLF Meeting will be a rewarding and unforgettable 
experience for all participants.
I look forward to meeting you all in beautiful Turkey.
Jozo Coric
BCLF President
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TBS WELCOME LETTER 
Dear Colleagues, Dear Friends,
On behalf of the Turkish Biochemical Society (TBS), it is a great pleasure to welcome you to Antalya and to the Joint Meeting of 27th Balkan 
Clinical Laboratory Federation Congress and 30th  National Biochemistry Congress of TBS.
Formerly, TBS held a lot of joint international congresses with the collaboration of international organisations and BCLF. This BCLF Congress 
is the fifth in Turkey. The last one was in Istanbul, embedded within the Worldlab 2014.   
In general, the BCLF congresses are held at the beginning of September. But we asked the colleagues from the EB of BCLF if the congress 
could be held at the end of October. Because we organize national biochemistry congresses every year at the end of October covering 29th 
October which is the anniversary of the foundation of Turkish Republic. So we celebrate this special day in our congresses every year with a 
greate gratefulness to Mustafa Kemal, the founder of TR. And, I am pleased that all the BCLF EB members approved our proposal. I would 
like to thank to all colleagues from the BCLF EB. 
The scientific program of the Congress is powerful. As you know, former IFCC President Prof. Howard Morris would come to the Congress for the 
opening lecture. But it is our deep sorrow that he passed away due to a heart attack in April. We commemorate him with our deepest respect. 
There are many top keynote speakers in the program such as Khosrow Adeli (the newly elected president of IFCC, on behalf of IFCC, 
Canada), Mario Plebani (opening lecturer, on behalf of IFCC, Italy), Sverre Sandberg (EFLM past-president, on behalf of EFLM, Norway), 
Elvar Theodorsson (Sweden), Christa Cobbaert (on behalf of IFCC, Netherland), Jerca Dumic (on behalf of FEBS, Croatia), Hassan 
Bayat (Iran), Alexander Haliassos (Greece), and Tomris Ozben (IFCC Treasurer and newly elected president of EFLM). Of course, there 
are a lot of foreign and Turkish outstanding scientists, difficult to name one by one, as a speaker or chair on interesting and hot topics of 
biochemistry / clinical biochemistry, and laboratory medicine. As total there are more than 50 speakers at the Congress.
In the scientific program, due to the high demand, we could open wide space for oral presentations. There are 116 oral presentations now. And, 
as usual, there are numerous (more than 200) poster presentations. 
Additionally, the courses/workshops performed before or will be held during the Congress are remarkable. Two of them, the EFLM scientific 
writing course and the miRNA Course were successfully completed today, just before the opening. I would like to highlight the workshops 
during the Congress on basic and advanced mass spec and Six Sigma application for analytical performance. Another important workshop 
prepared by National Metrology Institute of Turkey on the traceability in laboratory medicine. Diagnostic companies also support the 
scientific program by their satellite symposia. Every Congress day, there are one or two industrial satellite symposia with interesting topics.
There is an important session also on 30th of October on Nazmi Ozer Science Award. Two young scientsits who won the awards last year will 
present their studies in this session. And the new award winners of this year will be announced. 
Dear colleagues, geographically and culturally Turkey is a “bridge” between Europe and Asia. Therefore, and I am pleased to say that there is a 
greater participation to Congress than I expected with a total of >600 attendees. About 130 of them from essentially Balkan countries and other 
European countries such as Germany, Sweden, Norway and Croatia, but there are participants from Iran, Iraq, Syria, Pakistan, Azerbaijan etc. 
The young scientists have revealed a great interest to the Congress. There are too many young scientists actively attending to the Congress 
with a presentation. As usual, we tried to respond to this interest by giving registration bursary to these young persons (We gave registration 
bursary to more than 60 young colleagues). We also gave young colleagues (<35 years old) an opportunity to free participation in two days 
EFLM scientific writing course. We are proud to be able to give this support. I hope, active participation in this Congress will prove greatly 
beneficial to their continuing professional development. 
Dear Colleagues, historically or politically, there might be some conflicts between some of these countries in this huge region, but 
science means peace or science is a means of peace at the same time, I think. So, this meeting will contribute not only to the scientific 
development in lab med but also contribute to lasting and sustainable peace in this region.  
I would like to highlight once again that all abstracts presented at the Congress will be published in the Turkish Journal of Biochemistry, the 
official journal of TBS and listed by SCI-E. This is also valuable for especially young colleagues, I think.
Finally, I would like to thank to all speakers, attendees, our sponsors, and the PCO, Kenes. 
Dear Collegues, the Congress venue and accomodation conditions are well, the weather of Antalya is also excellent for this season. I hope all 
attendees will enjoy the meeting. 
I wish you a successful and fruitful Congress. 
Thank you for coming…
With my best regards,
Dr. Dogan Yucel
Chair of TBS and Congress 
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SCIENTIFIC PROGRAM
26 October 2019, Saturday   
TIME HALL B
09:00-17:00 EFLM Course:
 How to write a good scientific and professional article?
 Sverre Sandberg, Noklus, Norway - Elvar Theodorsson, Ike/Klinisk Kemi, Sweden
27 October 2019, Sunday    
TIME HALL B
09:00-17:00 EFLM Course:                                                                                                                                
 How to write a good scientific and professional article?
 Sverre Sandberg, Noklus, Norway - Elvar Theodorsson, Ike/Klinisk Kemi, Sweden
TIME HALL C
09:00-17:00 COURSE: miRNA isolation and expression training program
 Aylin Sepici Dincel, Gazi University, Turkey  - Oytun Portakal, Hacettepe University, Turkey                                                                                         
TIME HALL A
17:00-17:30 Opening Ceremony 
	 Doğan	Yücel											
 TBS President 
 Congress President
 Tomris Ozben
 Congress Co-President 
 BCLF Past-President and Representative of TBS 
 EFLM President-Elect
 IFCC Treasurer
 IFCC Foundation for Emerging Nations (FEN), Board of Directors
 Jozo Coric
 BCLF President
 Sverre Sandberg
 EFLM Past-President
 Khosrow Adeli        
 IFCC President-Elect
17:30-18:30 Opening Lecture                                                                          
 Quality and patient safety in laboratory medicine 
 Mario Plebani, University Of Padova, Italy
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SCIENTIFIC PROGRAM
28 October 2019, Monday        
Time HALL A
08:30-10:00 SESSION 1
	 Moderators:	Diler	Aslan,	Turkey	-	Süleyman	Demir,	Turkey
08:30-09:00 eApps and medical diagnostics data management 
 Khosrow Adeli, University Of Toronto, Canada
09:00-09:30 The statistical principles of laboratory data analysis
 Muhittin Serdar, Acibadem University, Turkey
09:30-10:00 Evaluating the performance of autoverification processes using Six Sigma approach
 Abdurrahman Coskun, Acibadem University, Turkey
10:00-10:30 Coffee Break
10:30-11:15 Plenary Lecture: 
 Moderator: Tomris Ozben, Turkey
 Uncertainty in laboratory medicine             
 Mario Plebani, University Of Padova, Italy
11:15-12:00 Industry Sponsored Symposium 1 (Beckman Coulter)
 Moderator: Abdurrahman Coskun, Turkey
 The role of auto-verification in postanalytical process improvement
 Speaker: Ozlem Gulbahar
12:00-13:15 Lunch Break
13:15-14:00 Industry Sponsored Symposium 2 (Snibe) 
 Moderator: Mehmet Senes, Turkey
 The clinical performance of Maglumi AMH, 17-OH progesterone and B2 microglobulin
 Speaker: Pinar Eker
14:00-14:45 Plenary Lecture:  
 Moderator: Nazmi Ozer, Turkey
 Harmonisation in clinical laboratories and the harmonisation activities of EFLM
 Sverre Sandberg, Noklus, Norway
14:45-16:30 SESSION 2
 Moderators: Erdinc Devrim, Turkey - Aylin Sepici Dincel, Turkey
14:45-15:15 Adding value in thyroid cancer diagnostic: thyroglobulin and calcitonin measurement in fine needle aspirate washout
 Andra Caragheorgheopol, C.I.Parhon National Institute of Endocrinology, Romania
15:15-15:45 Mass spectrometry achieving prominence in clinical medicine 
 Dobrin Svinarov, Alexander Hospital, Medical University Of Sofia, Bulgaria
15:45-16:00 SignificancAnflammatory response to obese and nonobese subjects, facts and promises
 Driton Sopa, Universitary Clinical Center Of Kosova, Kosovo
16:15-16:25 O-019 Evaluation of inflammatory status with procalcitonin and neopterin in healthy overweight and obese adults 
 based on waist hip ratio
 Cigdem Sonmez, University of Health Sciences, Turkey
16:30-17:00 Coffee Break
17:00-18:00 Oral Presentations 1
 Moderators: Cumhur Bilgi, Turkey - Oytun Portakal, Turkey
17:00-17:15 Assessment of vitamin D status deficiency in Albanian pregnant women
 Ersida Kapllani, University Hospital Centre Mother Teresa, Albania
17:15-17:30 Anti müllerian hormone: new roles for an established biomarker of ovarian reserve
 Demetrios Rizos, National And Kapodistrian University Of Athens, Greece
17:30-17:45 Evidence of HbC disease in Albania.  Clinical heterogeneity related to combination with other hemoglobin disorders
 Etleva Refatllari, University Hospital Center Mother Teresa, Albania
17:45-18:00  
  
18:00-19:00 APLUSTBD EXTERNAL QUALITY ASSESSMENT SCHEME
	 Moderator:	Dogan	Yucel,	Turkey
 Why APLUSTBD EQAS?
	 Dogan	Yucel,	Turkey
 The IFCC committee on EQA and Proficiency Testing (IFCC C-PT) Major programs and new projects.
 Alexander Haliassos, Greece 
 A new approach to EQA and APLUSTBD 
 Mujdat Aytekin, Turkey
 Being consistently wrong is no longer acceptable
 David Seccombe, Canada
21:00-22:00 Yesterday, today, and tomorrow of medical laboratory services in Turkey: a discussion
	 Moderator:	Dogan	Yucel,	Turkey	
 Ferzane Mercan, Turkey
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SCIENTIFIC PROGRAM
28 October 2019, Monday        
Time HALL B
08:30-10:00 Oral Presentations 2
 Moderators: Halef Okan Dogan, Turkey - Dilek Iren Emekli, Turkey
08:30-08:40 O-001 Thymoquinone and Sorafenib as a therapeutic combination in liver cancer: In vitro and in vivo
 Eray Metin Guler, Bezmialem Vakif University, Turkey
08:40-08:50 O-002 Investigation of type I collagen and MMP-2 changes in mandibular bone tissue in natural development
 Velid Unsal, Artuklu University Mardin, Turkey
08:50-09:00 O-003 Induction of APAF-1 and TRAIL by bilberry tea in HCT-116 colon cancer cell line
 Burak Durmaz, Ege University, Turkey
09:00-09:10 O-004 Induction of apoptosis and cell cycle arrest by pomegranate extract and tangeretin in the rat mammary carcinogenesis
 Huseyin Fatih Gul, Kafkas University, Turkey
09:10-09:20 O-005 Preparation of magnetic nanoparticle coated glutaraldehyde to reduce toxic effects of idarubicin and its effect on 
 HL60 cell line
 Hasan Ulusal, Gaziantep University, Turkey
09:20-09:30 O-006 The effects of overexpression of acetylcholinesterase on amyloid precursor protein and β-secretase-1 levels in Hs766T cells
 Kevser Biberoglu, Hacettepe University, Turkey
09:30-09:40 O-007 Genome-wide CRISPR-Cas9 screening for identification of cancer essential genes in malignant pleural mesothelioma
 Ece Cakiroglu, Dokuz Eylul University, Izmir, Turkey; Izmir Biomedicine and Genome Center, Izmir, Turkey
09:40-09:50 O-008 The importance of serum hyaluronidase measurement in discrimination of patients with prostate cancer and   
 benign prostatic hyperplasia
	 Zeynep	Adıyaman	Koçer,	University	of	Health	Sciences,		Turkey
09:50-10:00 O-009 Antioxidant and anti-denaturation activities of asparagus horridus grows in North Cyprus
 Duygu Gencalp, Eastern Mediterranean University, North Cyprus
10:00-10:30 Coffee Break
14:45-18:15 COURSE: Applying six sigma to analytical performance in the medical laboratories 
 Hassan Bayat, Sina Medical Laboratory (Qaem Shahr), Iran 
16:30-17:00 Coffee Break
14:45-18:15 COURSE: Applying six sigma to analytical performance in the medical laboratories 
 Hassan Bayat, Sina Medical Laboratory (Qaem Shahr), Iran 
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28 October 2019, Monday        
Time HALL C
08:30-10:00 Oral Presentations 3
	 Moderators:	Yasemin	Ucal,	Turkey	-	Neval	Aksoy,	Turkey
08:30-08:40 O-010 CA125 test request ratio in male patients
	 Huriye	Erbak	Yilmaz,	İzmir	Atatürk	Education	and	Research	Hospital,	Turkey
08:40-08:50 O-011 Evaluation of tumor marker tests in a hospital setting
 Muzaffer Katar,  Tokat Gaziosmanpasa University, Turkey
08:50-09:00 O-012 Detection of preanalytical errors in blood gas analysis
 Hayat Ozkanay Yoruk, Izmir Katip Çelebi University, Turkey
09:00-09:10 O-013 The effect of hemolysis and storage conditions on insulin stability
 Didem Barlak Keti, Erciyes University, Turkey
09:10-09:20 O-014 Falsely low levels of unconjugated estriol: A case series of interference by anti-ALP antibodies
 Merve Sibel Gungoren, Duzen Laboratories Group, Turkey
09:20-09:30 O-015 What if all is well except insulin? A macroinsulin case report
 Cevdet Zungun, Duzen Laboratories Group, Turkey
09:30-09:40 O-016 Comparison of biochemical analytes in different blood collection tubes and evaluation of stability
 Fatma Demet Arslan, University of Health Sciences, Turkey
09:40-09:50 O-017 Elevated high sensitivity troponin in the absence of coronary artery disease: a case report
	 Feyza	Yagmur	Tekeli,	Antalya	Education	and	Research	Hospital,	Turkey
09:50-10:00 O-018 Serum separation problem on gel tubes: is it a problem or a clue of some clinical conditions?
 Ahmet Ozsoy, University of Health Sciences, Turkey
10:00-10:30 Coffee Break
14:45-16:30 Oral Presentations 4
 Moderators: Guzin Aykal, Turkey - Oguzhan Zengi, Turkey
14:45-14:55  
14:55-15:05 O-021 Simultaneous determination, quantitation and validation of the most used benzodiazepines in urine
 Cigdem Karakukcu, Kayseri City Hospital, Turkey
15:05-15:15 O-022 Association of Nucb2/Nesfatin-1 gene polymorphism with obstructive sleep apnea severity
 Deniz Mihcioglu, SANKO University, Turkey
15:15-15:25 O-023 The effect of lycopene on autophagy in fluoride toxicity in kidney cells
	 Ayşe	Usta,	Van	Yuzuncu	Yil	University,	Turkey
15:25-15:35  
15:35-15:45 O-025 The relationship between WNT signaling activity and organ attitudes in scleroderma disease sub-groups
 Ayse Kocak, Dokuz Eylul University, Turkey
15:45-15:55 O-096 Reelin enzyme levels in emergency service suicide or self harm attempt patients
	 Turgut	Dolanbay,	Kafkas	University	Health	Research	and	Application	Hospital,	Turkey
15:55-16:05 O-027 Towards the clinical implementation of pharmacogenetics in cardiology: Serbian experience
 Sanja Stankovic, Clinical Center of Serbia, Serbia; Business Academy University Novi Sad, Serbia
16:05-16:15 
16:15-16:25 
16:30-17:00 Coffee Break
17:00-18:00 Oral Presentations 5
 Moderators: Murat Cihan, Turkey - Mine Erguven, Turkey
17:00-17:10 O-030 Inhibitory effect of glyphosate on butyrylcholinesterase and acetylcholinesterase activity
 Ayse Ulusoy, Cukurova University, Turkey
17:10-17:20 O-031 Evaluation of Roche Accu-Chek Inform II glucose test strip system in the hospital setting
 Settar Kosova, Caycuma/Zonguldak State Hospital, Turkey
17:20-17:30 O-032 Evaluation of urine drug screening test results between 2016-2018 years in Kanuni Education and Research Hospital Laboratory
	 Nazime	Cebi,	University	of	Health	Sciences,	Kanuni	Education	and	Research	Hospital	Laboratory,	Turkey
17:30-17:40 O-033 Pregabalin substance abuse
	 Salı̇ha Aksun, Izmir Katip Celebi University, Turkey
17:40-17:50 O-034 The protein supplements and its inhibition of liver enzymes at athletes
 Nafija Serdarevic, University of Sarajevo, Bosnia and Herzegovina
17:50-18:00 O-035 Effect of bariatric surgery on ghrelin-hepatosteatosis interaction: The Selcuk University Faculty of Medicine example
 Hakan Vatansev, Necmettin Erbakan University, Turkey
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29 October 2019, Tuesday 
Time HALL A
08:30-10:00 SESSION 3
 Moderators: Ebubekir Bakan, Turkey - Berrin Bercik Inal, Turkey
08:30-09:00 Analytical performance goals
 Hassan Bayat, Sina Medical Laboratory (Qaem Shahr), Iran
09:00-09:30 Quality management: illuminating the path to ISO 15189 accreditation. A view from the Republic of North Macedonia
 Katerina Tosheska-Trajkovska, Medical Faculty/Institute Of Medical And Experimental Biochemistry, Macedonia
09:30-10:00 Quality control in research laboratory: The need for standardization
	 Yasemin	Ucal,	Acibadem	Mehmet	Ali	Aydinlar	University,	Turkey
10:00-10:30 Coffee Break
10:30-11:15 Plenary Lecture:
	 Moderator:	Jozo	Čorić,	Bosnia	and	Herzegovina
 Bias in clinical chemistry
 Elvar Theodorsson, Ike/Klinisk Kemi, Sweden
11:15-12:00 Industry Sponsored Sympoisum 3 (Roche)
 Moderator: Cem Öcal, Turkey
 Automation solutions in laboratories 
 Speaker: Cigdem Karakukcu
12:00-13:15 Lunch Break
13:30-14:15 Industry Sponsored Sympoisum 4 (Mindray)
 Moderator: Muhittin Serdar, Turkey
 Clinical utility of Reticulocyte Hemoglobin and Hypochromic erythrocytes reported by Mindray BC6800 Plus   
 hematology analyzer in the study of erythropoiesis
 Speaker: Eloísa Urrechaga
 Senior Consultant for Clinical Laboratory 
14:15-15:00 Plenary Lecture:
 Moderator: Nada Majkic-Singh, Serbia
 Value and impact of laboratory medicine in healthcare delivery 
 Khosrow Adeli, University Of Toronto, Canada
15:00-16:45 SESSION 4
 Moderators: Ali Unlu, Turkey - Ebru Sezer, Turkey
15:00-15:30 Lipid guidelines: emerging evidence on importance of non-fasting and postprandial lipids
 Khosrow Adeli, University Of Toronto, Canada,
15:30-16:00 Apolipoprotein profiling for addressing residual cardiovascular risk: in search of a personalized and 
 metrologically sound answer to the latest dyslipidemia guidelines
 Christa Cobbaert, Lumc, The Netherlands 
16:00-16:30 The importance of cholesterol synthesis and absorption markers determination in healthy subjects and patients 
 with ischemic heart disease
 Tamara Gojkovic, University Of Belgrade, Serbia
16:30-16:45 Impact of redox imbalance and inflammation on activity of paraoxonase 1 and its distribution in high density 
 lipoprotein in polycystic ovary syndrome
	 Iva	Perović	Blagojević,	KBC	Dr	Dragiša	Mišović	-	Dedinje,	Serbia
16:45-17:15 Coffee Break
17:15-18:15 Oral Presentations 6
 Moderators: Anyla Bulo Kasneci, Albania - Alexander Haliassos, Greece
17:15-17:30 Sensitive assessment of white blood cell functionality by novel hematological parameters
 Milena Velizarova, Medical University- Sofia, Bulgaria; Alexander University, Bulgaria
17:30-17:45 The future of cytometry in Europe
 Georgios Markopoulos, University of Ioannina, Greece
17:45-18:00 Significance of the determination of biomarkers of bone resorption and formation in patients with end 
 stage renal disease
	 Neda	Milinković,	University	of	Belgrade,	Serbia
18:00-18:15 CEA monitoring in colorectal carcinoma - to the limit of the guidelines and beyond
	 Yana	Bocheva,	Medical	University-	Varna,	Bulgaria
20:00-23:00  29 October, Republic Day Celebration & Networking Event       
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29 October 2019, Tuesday 
Time HALL B
08:30-13:00 COURSE: 
 Mass spectrometre use in clinical laboratory practice 
 (Basic Course)
 Ali Unlu, Selcuk University, Turkey - Muhittin Serdar, Acibadem University, Turkey - Sedat Abusoglu, Selcuk 
 University Faculty of Medicine, Turkey
14:50-18:00 Workshop: 
 TUBITAK UME (National Metrology Institute of TURKEY) - 
 Elements of Metrological Traceability for Laboratory Medicine
14:50-15:10 Traceability in laboratory medicine and IVD directives
 Tomris Ozben, Akdeniz University, Turkey
15:10-15:30 Introduction of the European Metrology Network on Traceability in Laboratory Medicine
 Muslum Akgoz, TUBITAK, Turkey
15:30-15:50 Amino acid and organic acid CRMs for newborn screening
 Simay Gunduz, TUBITAK, Turkey
15:50-16:10 ID-MS based reference measurement method for small analytes: vitamin D, creatinine, glucose, cholesterol, amino acids
 Mine Bilsel, TUBITAK, Turkey
16:10-16:30 Reference methods for quantification of peptides & proteins: β-amyloid in CSF (ReMIND Project), human C-peptide,   
 oxytocin, HbA1c, insulin, human growth hormone
 Merve Oztug, TUBITAK, Turkey
16:45-17:15 Coffee Break
17:00-17:20 Latest developments on NMR; reference method for purity determination of small analytes and peptides: 17β-estradiol, 
 folic acid, human C-peptide, oxytocin, HbA1c
 Ilker Un, TUBITAK, Turkey
17:20-17:40 Development of a reference method for transferrin quantification in serum
 F. Gonca Coskun, TUBITAK, Turkey
17:40-18:00 A Reference method for genetic mutation quantification of KRAS
 Muslum Akgoz, TUBITAK, Turkey
20:00-23:00  29 October, Republic Day Celebration & Networking Event      
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29 October 2019, Tuesday 
Time HALL C
08:30-10:00 Oral Presentations 7
	 Moderators:	Banu	İsbilen	Basok,	Turkey	-	Settar	Kosova,	Turkey
08:30-08:40 O-036 The results in two different provinces in Black Sea Region where thalassemia screening was implemented:a rare 
 hemoglobin variant
	 Durmus	Ayan,		Amasya	University	Sabuncuoglu	Serefeddin	Research	and	Training	Hospital,	Amasya,	Turkey
08:40-08:50 O-037 First observation of hemoglobin Hamilton [β11(A8)Val→Ile] in Turkey
 Irem Yildiz, Cukurova University, Turkey
08:50-09:00 O-038 Glanzmann thrombasthenia: a case report
	 Aylin	Haklıgor,	University	of	Health	Sciences,	Turkey
09:00-09:10 O-080 Evaluation of analytical process performance by six sigma methods in laboratories 
 Dilek Iren Emekli, Erbayraktar Private Medical Laboratories, Turkey 
09:10-09:20 O-040 Determination of electrochemical behaviour of glucose-6-phosphate dehydrogenase by biosensor
	 Basak	Gunaşti,		Cukurova	University,	Turkey
09:20-09:30 O-041 Investigation of the effect of glyphosate on G6PD activity in in vitro conditions
 Kezban Kartlasmis,  Cukurova University, Turkey
09:30-09:40 O-042 The evaluation of microtubes’ compatibility to automated process for complete blood count
	 Ahmet	Erkin	Bozdemir,	Health	Sciences	University	Tepecik	Training	and	Research	Hospital,	Turkey
09:40-09:50 O-043 Design of a new biosensor for the determination of ferric iron in blood
 Ahmet Ilhan, University of Cukurova, Turkey
09:50-10:00 O-044 Correlation Between LUC % and Thyroid Function Tests
 Arzu Kosem, Ankara City Hospital, Turkey
10:00-10:30 Coffee Break
14:45-16:30 Oral Presentations 8
 Moderators: Sevil Kurban, Turkey - Emre Avci, Turkey
14:45-14:55 O-045 The effect of Rhamnetine against to ischemia-reperfusion injury in the kidney
 Mustafa Nisari, University of Nuh Naci Yazgan, Turkey
14:55-15:05 O-046 The protective effect of resveratrol against cyclosporine A-induced oxidative stress and hepatotoxicity
 Ilknur Bingul, Istanbul University, Turkey
15:05-15:15 O-047 Thiol/Disulphide balance and Ischemia-modified albumin levels in female with iron deficiency anemia
 Emre Avci, Hitit University, Turkey
15:15-15:25 O-048 Effect of hibernation on oxidative equilibrium in ground squirrels
 Tulay Pekmez, Hitit University, Turkey
15:25-15:35 O-049 Cellular protection by Phlomis Species in H2O2-induced oxidative Stress
	 Derviş	Birim,	Ege	University,	Turkey
15:35-15:45 O-050 Neuroprotection by optimized system extracts of Morus nigra L. Fruits in L-DOPA-induced toxicity
 Gizem Kaftan, Ege University, Turkey
15:45-15:55 O-051 Dynamic thiol-disulphide balance and thioredoxin reductase enyzme levels in patients with chronic kidney disease
 Huseyin Erdal,  Hatay Mustafa Kemal University, Turkey
15:55-16:05 O-052 Protective role of lycopene in experimental heart ischemia reperfusion model
 Busra Citil, Sutcu Imam University, Turkey
16:05-16:15 O-053 
16:15-16:25 O-054 
16:45-17:15 Coffee Break
17:00-18:00 Oral Presentations 9
 Moderators: Bahadir Ozturk, Turkey - Aylin Hakligor, Turkey
17:00-17:10 O-055 Oxidative status in degenerated painful ıntervertebral disc samples: variability with respect to duration of 
 symptoms and type of disease
 Hatice Kopar, Sutcu Imam University, Turkey
17:10-17:20 O-056 The effect of turmeric on GPER1 and oxidative/nitrosative stress biomarkers in cardiac ischemia reperfusion
	 Seda	Ikı̇kardeş,	Sutcu	Imam	University,	Turkey
17:20-17:30 O-057 The impact of acupuncture treatment on dynamic thiol–disulphide homeostasis and ischemia-modified   
 albumin levels to assess
 Yasemin Gunduztepe, Gazi University, Turkey
17:30-17:40 O-058 Effect of N-acetylcysteine on cisplatin induced apoptosis in rat kidney
 Seyda Seydel, Nigde Omer University, Turkey
17:40-17:50 
17:50-18:00 O-060 Thiol-disulfide homeostasis in diabetic microvascular complications
 Cuma Mertoglu, Erzincan University, Turkey
20:00-23:00  29 October, Republic Day Celebration & Networking Event      
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Time HALL A
08:30-10:00 SESSION 5
 Moderators: Z. Gunnur Dikmen, Turkey - Sabahattin Muhtaroglu, Turkey
08:30-09:00 IFCC, C-RIDL; The current concept and future plans for reference intervals and decision limits
	 Yesim	Ozarda,	Uludag	University,	Turkey
09:00-09:30 Developing a roadmap for laboratory test utilization management program
	 Sedef	Yenice,	G	Florence	Nightingale	Hospital,	Turkey
09:30-10:00 Threat of chemical weapons in Syria conflict and its impact on Balkan region along with the health and laboratory 
 management system
 Levent Kenar, University Of Health Sciences, Turkey
10:00-10:30 Coffee Break
10:30-11:15 Plenary lecture: 
 Moderator: Muslum Akgoz, Turkey
 The new IVD regulation 2017/746 and consequences for laboratory medicine
 Christa Cobbaert, Lumc, The Netherlands 
11:15-12:00 Industry Sponsored Symposium V (Archem)
 Moderator: Mujdat Aytekin, Turkey
 HbA1c immunoturbidimetric test: CRM concept, standardization and interference studies
 Speaker: Mehmet Salih Uca
12:00-13:15 Lunch Break
13:15-14:00 Oral Presentations 10
	 Moderators:	Ali	Unlu,	Turkey	-	İlhan	Yaylım,	Turkey
13:15-13:25 O-061 Biological variation in clinical practice: bridge between laboratorians and clinicians
 Fatma Hande Karpuzoglu, Acibadem Labmed, Turkey
13:25-13:35 O-062 Using the  model of quality indicators: a pilot study
 Oguzhan Zengi, Bagcilar Research and Training Hospital, Turkey
13:35-13:45 O-063 National guidelines for the preparation, distribution and testing of purified water for clinical laboratories
 Oytun Portakal, Hacettepe University, Turkey
13:45-13:55 O-064 Evaluation of CKD-EPI Pakistan equation for estimated glomerular filtration rate (eGFR) in Pakistan
 Sibtain Ahmed, The Aga Khan University, Karachi Pakistan
14:00-14:45 Plenary Lecture: 
 Moderator: Ferhan Sagin, Turkey
 Galectin-3: from molecule to biomarker and back 
 Jerka Dumic, University of Zagreb Faculty of Pharmacy and Biochemistry, Croatia 
 ‘The FEBS National Lecturer’ 
14:45-16:30 SESSION 6
 Moderators: Fatma Taneli, Turkey - Sedat Abusoglu, Turkey
14:45-15:15 Serum non-coding RNA profiling as a promising diagnostic approach
 Christos Tsatsanis, University Of Crete Medical School, Greece
15:15 - 15:45  Ethical challanges in (pharmaco) genetics
 Marija Hiljadnikova-Bajro, Ss Cyril And Methodius University, Macedonia  
15:45 - 16:00  The relationship between adiposity parameters and hsC-reactive protein values in overweight and obese women
 Aleksandra Atanasova Boshku, University Clinic For Gynecology And Obstetrics, Macedonia  
16:00-16:10  O-113 Transcriptomic meta-analysis in pancreatic ductal adenocarcinoma reveals therapeutic targets and diagnostic biomarkers
 Sevcan Atay, Ege University, Turkey  
16:30-17:00 Coffee Break
17:00-18:00 Oral Presentations 11
	 Moderators:	Ferhan	Sagin,	Turkey	-	Dogan	Yucel,	Turkey
	 Yasemin	Aksoy,	Turkey	-	Ozlem	Dalmizrak,	Turkey
17:00-17:15 2018 Nazmi Ozer Award Recipient Presentation                   
 Molecular demultiplexer as a terminator automaton
	 Gurcan	Gunaydın,	Turkey
17:15-17:30 2018 Nazmi Ozer Award Recipient Presentation                                            
 Photodynamic activity properties of novel BODIPY compound against colorectal cancer cell line
 Burak Barut, Karadeniz Technical University, Turkey
17:30-17:45 2019 Nazmi Ozer Awards
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Time HALL B
08:30-13:00 COURSE: 
 Mass spectrometre use in clinical laboratory practice (Advance Course)                                                                                         
 Ali Unlu, Selcuk University, Turkey - Muhittin Serdar, Acibadem University, Turkey - 
 Sedat Abusoglu, Selcuk University Faculty of Medicine, Turkey 
13:15-14:00 Oral Presentations 12
	 Moderators:	Fatma	Demet	Arslan,	Turkey	-	Muammer	Yucel,	Turkey
13:15-13:25 O-065 The local technical validation of Barricor™ tube that uses a mechanical separator
 Kamil Taha Ucar, Istanbul Gaziosmanpasa Taksim Training and Research Hospital, Turkey
13:25-13:35 O-066 The utility of preanalytical quality indicators: a Turkish survey study
 Hikmet Can Cubukcu, Erzurum Maresal Cakmak Devlet Hastanesi, Turkey
13:35-13:45 O-067 A web-based application for management of quality control data
	 Deniz	Ilhan	Topcu,	Başkent	University,	Turkey
13:45-13:55 O-068 Quality control application for CBC parameters by ‘Average of Normals’ method
 Ilknur Alkan Kusabbi, Health Sciences University, Turkey
14:45-16:35 Oral Presentations 13
	 Moderator:	Meral	Yuksel,	Turkey	
14:45-14:55 O-069 Evaluation of the most common rejection reasons in the preanalytical process at our laboratory using six sigma analysis
 Mehmet Akif Bozdayi, Gaziantep University, Turkey
14:55-15:05 O-070 
15:05-15:15 O-071 Analytical performance of Cobas 6500 for predicting urinary tract infection 
 Esra Firat Oguz, Ankara City Hospital, Turkey
15:15-15:25 O-072 A comparison of Sysmex UF-5000 flow cytometer and Fuchs-Rosenthal Chamber in urine sediment analysis
 Ozlem Unay Demirel, Bahcesehir University, Turkey
15:25-15:35 O-073  Determination of serum carbamazepine by tandem mass spectrometry
 Duygu Eryavuz Onmaz, Selcuk University, Turkey
15:35-15:45 O-074 3D placental barrier models: a novel cryogel based method
 Aysun Kilic Suloglu, Hacettepe University, Turkey
15:45-15:55 O-075 Antioxidant effects of flavonoid neoeriocitrin on streptozotocin-induced INS-1E cell diabetic model
 Elif Karacaoglu, Hacettepe University, Turkey
15:55-16:05 O-076 In vitro investigation of Argiope bruennichi derived spider silk materials
 Secil Karahisar Turan, Hacettepe University, Turkey
16:05-16:15 O-077 MicroRNAs in patients with type 2 diabetic nephropathy
 Kadriye Akpinar, Pamukkale University, Turkey
16:15-16:25 O-078 Differentiation of Osteopetrotic IPSC to Osteoclasts:Comparision of Osteopetrotic&Healthy Osteoclast
 Inci Cevher, Hacettepe University, Turkey
16:25-16:35 O-079 Monodisperse-porous metal oxide microspheres with peroxidase/oxidase mimetic activity as a new tool for 
 biomolecule determination
 Sevim Eda Ogut, Hacettepe University, Turkey
16:30-17:00 Coffee Break
18:00-19:00  Oral Presentations 14
 Moderators: Oguzhan Zengi , Turkey - Deniz Ilhan Topcu, Turkey  
18:10-18:20  O-081 Evaluation of analytical quality of cardiac biomarkers in the emergency laboratory by sigma metrics
 Saadet Kader, Karapinar State Hospital, Turkey  
18:20-18:30  O-083 Automated vitamin D immunoassay comparison with LC-MS/MS method
 Ercan Saruhan, Mugla Sitki Kocman University, Turkey  
18:30-18:40  O-084 Calculation of measurement uncertainty of three different biochemistry parameters
 Seren Orhan, Gaziantep University, Turkey  
18:40-18:50  O-085 Development of a LC/MSMS method for quantification of adrenal-derived 11-oxygenated 19-carbon steroids
	 Ali	Yaman,	Marmara	University,	Turkey		
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Time HALL C
08:30-10:00 Oral Presentations 15
 Moderators: Ercan Saruhan, Turkey - Bagnu Orhan, Turkey
08:30-08:40 O-086 Structural bioinformatics approach in bioactive peptide research: tomato vicilin case study
 Burcu Kaplan Turkoz, Ege University, Turkey
08:40-08:50 O-087 In silico prediction of antidepressant-binding sites on human glutathione reductase
 Kerem Terali, Near East University, Cyprus
08:50-09:00 O-088 Smart approval service for biochemical tests
 Ali Ozen Akyurek, Ventura Software Inc., Ankara, Turkey
09:00-09:10 O-089 Evaluation of saliva kallikrein-8 levels related with stress
	 Rabia	Semsı̇, Gazi University, Turkey
09:10-09:20 O-090 The evaluation of ADAMTS-1 and ADAMTS-13 levels at coronary collateral circulation
 Abdulhakim Hasan Gul, Onsekiz Mart University, Turkey
09:20-09:30 O-091 Apelin and other adipokines as potential biomarkers in myocardial ischemia
 Mehmet Ali Gul,  Ataturk University, Turkey
09:30-09:40 O-092 Relationship between platelet activating factor acetylhydrolase and cardiac valvular calcification in dialysis patients
 Serkan Bolat, University of Health Sciences, Turkey
09:40-09:50 O-093 Determination of ADMA and ghrelin levels as a marker of endothelial dysfunction in asthma patients
	 Burcu	Baba,	Yüksek	İhtisas	University,	Turkey
09:50-10:00 O-094 Antimicrobial and antioxidant activities of Lactarius deliciosus
 Elif Sevinc, Hitit University, Turkey
10:00-10:30 Coffee Break
13:15-14:00 Oral Presentations 16
 Moderators: Aysegul Cort, Turkey - Aysun Kilic Suloglu, Turkey
13:15-13:25 O-095 Telmisartan and irbesartan alleviate methylglyoxal-induced elevation of MG-H1 in VSMCs
 Mustafa Kirca, Kutahya Health Sciences University, Turkey
13:25-13:35 O-116 Drug-induced (quinine) acute hepatitis with high level of serum vitamin B12
 Ozlem Ozun, University of Health Sciences Suat Seren Chest Diseases and Surgery Training and Research Hospital, Turkey
13:35-13:45 O-097 Relationship between lipoprotein(a) and other lipids in children
 Fatime Merdan, Child Health and Diseases Training and Research Hospital, Turkey
13:45-13:55 O-098 Relationship between B-HCG and LUC% levels
 Funda Eren, Ankara City Hospital, Turkey
14:45-16:35 Oral Presentations 17
 Moderators: Cigdem Sonmez, Turkey - Burak Barut, Turkey
14:45-14:55 O-099 Biological variation of beta-trace protein, a novel marker for eGFR along with traditional markers
 Banu Isbilen Basok, Health Sciences University, Turkey
14:55-15:05 O-100 Calculation of APTTandPT reference intervals from patient data and evaluation of preoperative test utilisation in  
 surgicalpatients 
 Neslihan Cihan, Ankara Health Research and Training Hospital, Turkey
15:05-15:15 O-101 ICD code specific normal ranges are needed, particularly in total bilirubin in this case
 Ozgur Aydin, Kepez Public Hospital, Turkey
15:15-15:25 O-102 Pending laboratory tests at discharge in emergency department
 Murat Alisik, Polatli State Hospital, Turkey
15:25-15:35 O-103 The effect of blood lactate levels on mortality in patients with sepsis
	 Kamile	Yucel,	KTO	Karatay	University	School	of	Health	Sciences,	Turkey
15:35-15:45 O-104 The anti-inflammatory effects of orexin receptor antagonist on endotoxemia induced sepsis model
 Evren Kilinc, Acibadem Mehmet Ali Aydinlar University, Turkey
15:45-15:55 O-105 Correlation of CRP with blood-based inflammatory markers; large cohort study
 Sibel Soylemez, Gazi University, Turkey
15:55-16:05 O-106 Serum cytokine and complement levels in ALS and their association with LRP antibody positivity
 Murat Giris, Istanbul University, Turkey
16:05-16:15 O-107 The relationship between standard sedo-analgesia implementation and serum procalcitonin levels in intensive care unit
	 Yesim	Guvenc	Demiragci,	Manisa	Celal	Bayar	University,	Turkey
16:15-16:25 O-108 Midkine can not be accepted as a new biomarker for the diagnosis and the treatment of unexplained female infertility
	 Mine	Erguven,	İstanbul	Aydın	University,	Turkey
16:25-16:35 O-109 Perspective of C-peptide from diabetes window
 Saadet Kader, Selcuk University, Turkey
16:30-17:00 Coffee Break
18:00-19:00  Oral Presentations 18
	 Moderators:	Berrin	Bercik	Inal,	Turkey	-	Feyza	Yagmur	Tekeli,	Turkey		
18:00-18:10  O-110 Development and validation of a biosensor for measurement of serum hypoxia-inducible factor-1
 Zihni Onur Uygun, Ege University, Turkey  
18:10-18:20  O-111 A fast and convenient UPLC - MSMS Method for routine analysis of GALT activity from dried blood spot
	 Muhammet	Topbaş,	Ege	University,	Turkey		
18:20-18:30  O-112 Magnetic bead based electrochemical food and enzyme activity analysis by using SPE dependent immunosensors
 Ebru Saatci, Erciyes University, Turkey  
18:30-18:40   
18:40-18:50  O-114 Assessment of vitamin D levels in Şanlıurfa region
 Oruc Aslan, Harran University Medical School, Turkey  
18:50-19:00  O-115 The role of HDL-associated MPO and PON-1 for coronary artery disease in Hashimoto thyroiditis
 Gizem Uncu, Hitit University, Turkey  
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31 October 2019, Thursday  
Time HALL A
09:00-10:30 SESSION 7
	 Moderators:	Gultekin	Yucel,	Turkey	-	Güzin	Aykal,	Turkey
09:00-09:30 Clinical and laboratory approach to inborn errors of metabolism
 Ali Dursun, Hacettepe University, Turkey
09:30-10:00 Metabolomics and biomarkers in inborn errors of metabolism
 Incilay Lay, Hacettepe University, Turkey
10:00-10:30 Genetic technologies in inborn errors of metabolism
	 Didem	Yucel	Yılmaz,	Hacettepe	University,	Turkey
10:30-11:00 Coffee Break
11:00-11:30 CLOSING CEREMONY OF THE CONGRESS 
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INVITED SPEAKERS ABSTRACTS 
Quality and patient safety in laboratory medicine
Mario Plebani
University of Padova-Department of Laboratory Medicine, Italy
The path leading to quality and patient safety in laboratory medicine is infinite, 
since it must be ensured that each and every step in the total testing process (TTP) 
is correctly performed, thus guaranteeing a valuable medical decision making 
process and effective patient care. Laboratory-associated error has a completely 
different meaning today than it did a century ago. At that time the term referred 
to defects in the analytical performance of the test itself, the so-called analytic 
phase. The new millennium has hailed a formidable improvement in the 
analytical phase with a 100-fold reduction in error rates, thanks to an improved 
standardization of analytic techniques and reagents, advances in instrumentation 
and information technologies, as well as to the availability of more qualified and 
better trained staff. In addition, this achievement is due to the development and 
introduction of reliable quality indicators (QIs) and quality specifications for 
the effective management of analytical procedures by adopting internal quality 
control programs and attending external quality assurance (EQA/PT) schemes. 
According to recent evidence, most errors fall outside the analytical phase, in 
fact, the extra-analytical steps (both pre- and post-analytical) have been found to 
be more vulnerable to the risk of error. It needs, therefore, to evaluate all the steps 
in TTP, whether or not they fall under the direct control of laboratory personnel, 
with the ultimate goal being to improve, first and foremost, quality and safety 
for patients. Quality indicators (QIs) are fundamental tools for enabling users to 
quantify the quality of all operational processes by comparing it against a defined 
criterion. According to the International Standard for medical laboratories 
accreditation, the laboratory shall establish and periodically review QIs to 
monitor and evaluate performance throughout critical aspects of pre-, intra-, 
and post-analytical processes. A consensual agreement on a possible list of QIs 
has been recently achieved after revising the model of quality indicators (MQI) 
developed by the Working Group on “Laboratory Errors and Patient Safety” of the 
International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) 
in two Consensus Conferences organized in 2013 and 2016. The consensually 
accepted list of QIs, which takes into consideration both their importance and 
applicability, should be tested by all potentially interested clinical laboratories 
to identify further steps in the harmonization project. The data collected in 
the last few years, have already allowed us to establish tentative performance 
specification for extra-analytical phases and to demonstrate that error rates may 
decrease after QIs monitoring and performing appropriate corrective actions.
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Electronic apps and medical diagnostics data management
Khosrow Adeli PhD, FCACB, DABCC
Clinical Biochemistry, 
The Hospital for Sick Children, University of Toronto, Toronto, ON, Canada
Laboratory medicine is a domain which offers a unique opportunity to analyze 
objective patient laboratory data and enable ready communication to both 
healthcare workers as well as patients. In recent years, an increasing number 
of web-based and mobile applications has been developed to improve access to 
laboratory test information and test result interpretation. They range from simple 
apps that provide reference lab value information to complex medical diagnostics 
data management. As examples, the “eLab” developed by Tru-Solutions Inc. is 
a comprehensive medical diagnostic center and lab management software that 
provides a user friendly interface  and access control. It is linked iMedDx.com 
to allow flexible patient search and selection and includes an eLab Dashboard on 
mobile/tablet, allowing patients and labs/hospitals access to lab reports online. 
The Davis’s Laboratory & Diagnostic Tests medical app provides another useful 
app with a wide-breadth of tests, as well as guidance on how to counsel and 
collect tests. The app is available on multiple platforms including the iPhone/
iPad, Android and Blackberry. The “LabGear” is a medical lab reference app 
providing a pocket tool for medical laboratory test and is integrated with 
MedCalc with normal lab value reference information for over 200+ lab tests. 
There are several other medical apps that provide reference lab values including 
CALIPER, MedRef, Normal Lab Values, and Lab Tests. The CALIPER App 
has been developed in our laboratory for paediatricians, family physicians, 
and other healthcare workers worldwide. It is a user friendly and easy tool to 
assess a child’s laboratory test results using the latest reference value database 
developed based on a study of thousands of healthy children and adolescents. The 
CALIPER apps allow pediatricians & family physicians to interpret laboratory 
test results for over 170 medical laboratory tests in children and adolescents using 
a comprehensive database of pediatric data
 
The statistical principles of laboratory data analysis
Muhittin A. Serdar, Prof. Dr.
Acibadem University, Turkey
The majority of scientists (app 70%) are often afraid of statistics. Because most 
scientists do not fully understand statistics, they tend to either overestimate 
or underestimate. Unless concepts of statistics are thoroughly understood and 
comprehended, critical evaluation of scientific research will hardly be adequate 
and efficient.
Statistics, as defined by the American Statistical Association, is “the science 
of learning from data, and of measuring, controlling and communicating 
uncertainty”. Briefly, statistics is the science concerned with developing and 
studying methods for collecting, analyzing, interpreting, and presenting empirical 
data. In this lecture, we will briefly discuss the statistics from the laboratory 
specialist’s point of view.
Descriptive (table, figure, etc.) and inferential statistics (group comparison, 
correlation, regression, etc.) are two broad categories in the field of statistics. A 
third group, especially useful for Laboratory Specialists is “specific statistics”, 
which consists of methods for validation, verification, reference intervals, 
biological variation, quality control statistics, etc.
One of the difficulties in understanding statistics is the “p-value”. A lower p-value 
is generally interpreted as a stronger relationship or differences between two 
and all variables. Nevertheless, statistical significance means that, it is unlikely 
that the null hypothesis is correct. To understand the strength of the difference 
between two groups (control vs. experimental) a researcher needs to calculate 
the effect size. 
The concept of “effect size” enables the readers to understand the magnitude of 
differences found; however, statistical significance examines the probability of 
an outcome to occur by chance alone.
The words ‘‘data’’, ‘‘information’’ and ‘‘knowledge’’ are sometimes used 
interchangeably. It is essential to understand how ‘‘knowledge’’ differs from 
‘‘data’’ and ‘‘information’’, and to understand what ‘‘knowledge management’’ 
can add to clinical practice. 
Data Science refers to the umbrella of techniques by which, one is trying to 
extract information and insights from data.
Data mining (DM) is the process of analyzing unknown patterns of data according 
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to different points of view for categorization into valuable information, which is 
collected in common areas, for example, data warehouses, for efficient analysis, 
data mining algorithms, facilitation decision making, and other information 
requirements to cut costs and increase revenue ultimately. DM is also known as 
data discovery and knowledge discovery.
DM  and Big Data (BD) are two different concepts. BD is a term, which refers to 
a large amount of data whereas DM refers to deep drive into the data to extract 
the critical knowledge from a small or large amount of data.
Data Mining and Big Data are essential for clinical laboratories. A medium-sized 
laboratory can generate 3 to 4 million patient test results a year and also, each 
one of those results has related data that never make it to the chart. Our goal in 
analyzing these laboratory and clinical data is to see whether we can uncover 
ways to improve not only laboratory practice, but clinical practice all together. 
That is, in addition to ensuring the accuracy, precision, and turnaround times of 
laboratory results. 
There are lots of softwares for laboratory statistics; some of which we will be 
investigating during this course. These are Ep Evaluator, Analyse-It, MedCalc, 
XLSTAT, QI Macros, Minitab, SPSS, Stata, SAS, R.  All of them, except for 
“R”, are usually expensive commercial softwares. When analyzed in terms of 
laboratory statistics, it is observed that Analyze It, Ep Evaluator and sometimes 
MedCalc are more convenient than others. While it may not be the ideal software 
for advanced statistics and Data Mining studies; Analyze It appears to be the most 
user-friendly software for basic laboratory statistics. Being an open-source and 
free software, that enables considerable flexibility; “R” definitely stands out as an 
advantageous software among the others. However, it is not as user-friendly, and 
certainly requires significant experience. 
As a result;
· The problem of fear of statistics should be overcome. 
· It is important not to confuse statistical significance with clinical significance.
· A clear understanding of various information technology tools (computer, 
software, LIMS, HIMS) will enable appropriate and efficient analysis.
· Each specialist must be able to make and evaluate basic statistics and laboratory 
statistics. Laboratory scientists should learn to apply statistical tools correctly, 
interpret the findings correctly and get an idea about the possibilities of analyzing 
research questions using statistics.
· A single software cannot solve all our problems. Sufficient comprehension 
of and substantial experience in Microsoft Excel and SPSS (or other general 
software) is a must. Where possible, data mining should also be carried out.
· Big data and data mining are critically important to us. However, it is important 
to note that analysis of the Big Data alone will not guarantee better outcomes. 
Overwhelming the clinicians with unrestrained volumes of data bears the risk of 
complicating the separation of signal from the noise.
Evaluation the Performance of Autoverification Processes Using Six Sigma 
Approach
Abdurrahman Coskun
Acibadem Mehmet Ali Aydınlar University, School of Medicine, Department of 
Medical Biochemistry, Istanbul, Turkey
One of the main objectives of the quality is to minimize the error rates to a 
negligible level. The literature of laboratory errors goes back to 1950s (1,2). In 
1999 the report of Institute of Medicine (US) ‘To Err is Human: Building a Safer 
Health System’ broke the silence on medical errors, and created awareness in the 
public and healthcare sector. Later in 1915 we learned that the big picture was 
worse and medical error is the third leading cause of death in US (3). In total testing 
process (TTP), the error rates are higher in the phases where human interventions 
are higher such as pre-pre and post-post analytical phases. To decrease error rates 
of each phases of TTP, we should decrease human interventions and implement 
laboratory automation and artificial intelligence. 
Autoverification (AV) of test results decrease error rate and increase the 
efficiency of laboratory and patients’ safety. In addition to verification test results, 
a well-designed AV system use patient-related clinical information, instrumental 
messages and flags to help physicians to interpret test results correctly and 
consequently decrease the error rate in post-post analytical phase. 
Six Sigma methodology has been evolved from total quality management and 
created a revolution in quality management in new millennium. It is not only a 
statistical tool but also provide problem solving methods by using the approach 
of define, measure, analyze, improve and control (DMAIC) cycle. In each phase 
of this approach statistical procedures are used to evaluate the performance of 
the phase and help us to take the corrective actions. In addition to DMAIC, the 
performance of a process can be measured objectively using sigma metric (SM). 
SM denotes the number of standard deviations (SD) of the process fit between the 
target and upper/lower tolerance limits. 6 sigma represents the world class quality 
and in this process only 3.4 errors or defects occur per million opportunities 
(DPMO). SM can be converted to DPMO and inversely DPMO can be converted 
to SM. This flexibility enabled the application of the Six Sigma Methodology to 
a broad area such as industry, business, healthcare sector etc.. 
It has been shown that applying the principles of Six Sigma methodology 
(DMAIC) to AV systems improved turn-around time and reduced time for manual 
verification (4). For the ideal AV system, DMAIC principles should be taken into 
consideration while developing a suitable system compatible with the realities of 
the laboratory, and an objective criteria such as SM should be used to measure the 
performance of the system. A detailed data analysis using fishbone diagram and 
Pareto chart can be used to evaluate the performance of AV systems. 
In conclusion, AV systems designed on the principles of Six Sigma methodology 
will increase the performance of laboratory, decrease error rate and contribute 
patients’ safety significantly. Additionally, the performance of AV systems should 
be measured using an objective criteria such as SM.
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Uncertainty in laboratory medicine
Mario Plebani
University of Padova, Deparment of Laboratory Medicine, Italy
Medical laboratories should guarantee that their measurement procedures (MPs) 
results are fit for clinical purposes, and this requirement calls for the long-
term monitoring of the quality and reliability of results. Since its inception, the 
International Standard ISO 15189 for medical laboratory accreditation has called 
for the calculation of measurement uncertainty (MU) to be included in each MP. 
Interestingly, because MPs are used to describe the whole measurement process, 
including the specific analytical procedure, all processes which contribute to 
uncertainty in the test results should be considered when calculating MU. The 
international vocabulary of metrology (VIM) has defined MU as a “nonnegative 
quantity that characterizes the dispersion of the values that could reasonably 
be attributed to the measurand”. For a given test result, MU thus represents the 
interval associated with a defined probability in which the true result should lie. 
In addition, this interval should fall within limits which guarantee fitness for 
the clinical purpose of the tests in question. Measurement uncertainty goals for 
defining fitness-for-purpose limits  may be based on clinical outcome studies, 
biological variation, state of the art, recommendations from an expert group or 
professional opinions. The components which require consideration in calculating 
MU are systematic error (bias) and random errors. Bias is inversely related to the 
degree of trueness of a measurement, while random error represents imprecision 
and is defined as the standard deviation of a series of measurements. I would 
like to provide some usable practical procedures regarding the MU estimation 
for a series of MPs, routinely used in medical laboratories. In particular, for 
imprecision component its estimation appears to be a reliable estimation of MU 
if the correct interpretation of the lab test result is guaranteed on the basis of its 
clinical purpose. For the bias component, the development of a practical solution 
for including bias in MU estimation allowed us to derive a standardized approach 
that considers the source of the bias reference and whether and how bias can be 
calculated. 
In addition, MU is an important information to improve the appropriate 
interpretation of laboratory results and reduce the risk of errors. In fact, diagnostic 
uncertainty may derive from incomplete information in laboratory reports, 
leading to an increased risk of inappropriate interpretation of laboratory data.
Therefore, MU has two intended uses: for laboratory professionals, it gives 
information about the quality of measurements, providing evidence of the 
compliance
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with analytical performance characteristics; for physicians (and patients) it 
may help in interpretation of measurement results, especially when values are 
compared with reference intervals or clinical decision limits, providing objective 
information.
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Harmonisation in clinical laboratories and the harmonisation activities of 
EFLM 
Sverre Sandberg 
Organisation for Quality Improvement of Laboratory Examinations (Noklus), 
Haraldsplass Deaconess Hospital, Bergen, Norway 
Harmonisation is likely to be an important contributor to ensure high quality 
laboratory testing, thus potentially improving patient outcome. Efforts for 
harmonisation must be made in the total testing process, from test requesting 
to communication of the laboratory test results and its consequences to the 
patient. In this article, suggestions are given about what level of harmonisation 
is possible at the various steps of the testing process, who could be responsible 
for facilitating and monitoring the effects of harmonisation, and what are likely 
barriers to achieving harmonisation. Harmonisation can be achieved at local, 
national and international levels, and will be most challenging when it involves 
more than one profession as in the extra-analytical phases. Key facilitators will 
be laboratory associations, regulatory bodies and accreditation systems, whereas 
barriers are likely to be reimbursement systems or economic factors, opinion 
leaders and manufacturers. A challenge is to try to turn barriers into facilitators. 
Harmonisation effects can in most settings be monitored by external quality 
assurance organisations provided that schemes are expanded to cover all relevant 
steps and phases. We must combine our efforts, both within our profession as 
well as in cooperation with others, to achieve harmonisation of the total testing 
process, in the best interests of the patient. The European Federation of Clinical 
Chemistry and Laboratory Medicine (EFLM) has initiated many harmonization 
activities in all phases of the examination process. The EFLM is dealing with 
both the scien- tific and the educational aspects of harmonization, with the 
intention of disseminating best practice in laboratory medicine throughout 
Europe. Priorities have been given (1) to establish a standard for conducting 
and assessing biological variation studies and to construct an evidence based 
EFLM webpage on biological variation data, (2) to harmonize preanalytical 
procedures by producing European guidelines, (3) to improve test ordering and 
interpretation, (4) to produce other common European guidelines for laboratory 
medicine and play an active part in development of clinical guidelines, (5) to 
establish a common basis for communicating laboratory results to patients, 
(6) to harmonize units of measurement throughout Europe, (7) to harmonize 
preanalytical procedures in molecular diagnostics and (8) to harmonize and 
optimize test evaluation procedures. The EFLM has launched a new database 
for biological variation study (www.eflm.eu) and also the 5th version of the 
European Syllabus to help the education of European Specialists in Laboratory 
Medicine (EuSpLM).
Adding value in thyroid cancer diagnostic: thyroglobulin and calcitonin 
measurement in fine needle aspirate washout
Andra Caragheorgheopol1,2, Catalina Poalelungi1,3, Adriana Padure1, 
Suzana Vladoiu1, Liliana Parvu1, Dumitru Ioachim1, Dan Niculescu1,2, 
Dana Manda1, Ruxandra Dobrescu1,2 
1C.I.Parhon National Institute of Endocrinology, Bucharest, Romania
2Carol Davila University of Medicine and Pharmacy, Bucharest, Romania
3University of Bucharest, Romania 
The diagnostic approach to thyroid cancer (TC) is one of the most challenging 
issues in the oncology of the endocrine system because of its growing incidence, 
the difficulty in distinguishing benign from malignant non-functional thyroid 
nodules and in accurately establishing cervical lymph node involvement during 
preoperative staging, as well as identifying later recurrences. 
Neoplastic transformation can occur in either the follicular cells of the thyroid, 
generating differentiated tumors (papillary thyroid carcinomas (PTCs), 
follicular thyroid carcinomas (FTCs), Hürthle cell carcinomas), or rarely, poorly 
differentiated and anaplastic thyroid carcinomas, or in the parafollicular cells of 
the gland, producing medullary thyroid carcinomas (MTCs).
Accurate selection for surgery of thyroid nodules at risk for malignancy, as well 
as avoiding the adverse effects of overdiagnosis and overtreatment it is of critical 
clinical importance. Optimal diagnosis and stratification of TCs needs less-
invasive, specific, reliable and clinically relevant biomarkers.
Fine-needle aspiration biopsy (FNAB) of thyroid nodules or lymph nodes is a 
useful and safe tool and it is considered the gold-standard method in TC diagnosis 
and monitoring. Despite its high accuracy, in 10-30% of the cases the cytology is 
inconclusive. Measurement of biochemical tumor markers (thyroglobulin (Tg), 
calcitonin (Ct), recently CYFRA 21-1) in washout fluids from FNAB of lymph 
nodes or thyroid nodules is recommended as an ancillary tool for the management 
of TC patients. 
In differentiated thyroid cancer (DTC) Tg measurement in FNAB washout 
(FNAB-Tg) of a suspect lymph node may increase the diagnostic sensitivity 
and specificity particularly in those cases in which the lymph nodes are cystic, 
cytological  evaluation of the lymph node is indeterminate, or the cytological and 
sonographic evaluations are divergent (i.e., normal cytological biopsy of a large 
lymph node with microcalcifications).The diagnostic performance of Tg-FNAB 
compares favorably with cytology, having superior results in athyreotic patients.
For the diagnosis of MTC  the recommendations of the American Thyroid 
Association (2016) is that FNAB inconclusive results should be followed-up 
by Calcitonin (Ct) measurement in the FNAB washout fluid (FNAB-Ct), in 
addition to IHC staining of the FNAB sample for several tumor markers (Ct, 
chromogranin, CEA).
However, the lack of standardization of FNAB-biomarkers measurements (patient 
selection, technique of sampling, standardization of the analytical methods - e.g. 
washout matrix, samples processing and storage, assays, antibodies and/or biotin 
interferences, cut-off values) rises potential difficulties in interpreting data and 
have an important impact on clinical decision.
We evaluated the analytical performance of FNAB-Tg and FNAB-Ct 
immunoassays in our laboratory. For both determinations the washout was 
performed by rinsing the needle with 1 ml saline solution 0.9% immediately after 
the biopsy’s cellular component was expelled for the cytological examination. No 
matrix interference was demonstrated with saline solution either for Tg, or for Ct 
(LOB = 0.04 ng/ml/<0.5 pg/ml, LOD = 0.046 ng/ml/0.55 pg/ml, respectively), when 
measured with an immunoelectrochemiluminiscent method. Validation parameters 
(accuracy, precision, reproducibility, recovery, dilution linearity) fulfilled the 
acceptance criteria.
Besides analytical validation, studies for the clinical validation are ongoing, in the 
attempt to identify the best cut-offs for FNAB-Tg and FNAB-Ct. 
Our experience so far confirms that a reflex strategy would be most cost-effective: 
negative or non-diagnostic or indeterminate cytology cases should be reflexed to 
FNAB-Tg/Ct, while positive cytology cases do not need measurement of tumor 
markers in FNAB.
The management of TC patient may be improved by a genomic approach, various 
diagnostic and prognostic molecular markers (BRAF, PAX8/PPRG, RAS, TP53, 
TERT promoter, mutations and RET/PTC rearrangements) being available; the 
benefit of the extent of their analysis in FNAB samples should be further evaluated.
A generally accepted standardization of tumor markers measurement in FNAB 
is required and the results should be integrated in the context of the full clinical, 
imagistic and histological picture.
Key words: Thyroid cancer, FNAB, thyroglobulin, calcitonin
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Mass spectrometry achieving prominence in clinical medicine
Dobrin Svinarov, 
Alexander University Hospital, Faculty of Medicine, Medical University of 
Sofia, Bulgaria 
There is an extraordinary flood of new technologies in medicine nowadays  - 
sophisticated diagnostics based on mass spectrometry, genome assays and cell 
sorting platforms are driving the technological transfer and promote the entrance 
of individualized patient management in clinical practice. Mass spectrometry 
(MS) could be viewed as one of the major tools that achieve prominence in clinical 
medicine. GC-MS was the starting of MS for biochemical research and clinical 
analysis, and still remains a working horse for clinical toxicology. LC-MS/MS 
(QQQ) is the today’s most utilized analytical platform, but high-resolution MS 
systems are also employed to resolve challenging analytical demands. MALDI-
TOF platforms are routine instruments in medical microbiology laboratories 
from over 10 years now, which revolutionize diagnostics of infectious 
diseases, achieving ultimate speed and accuracy. Orbitrap and tandem TOF MS 
systems transfer proteomic and peptidomic research into clinical diagnostics 
with unprecedented incite and data to understand deepest pathobiochemical 
mechanisms of many illnesses. The great technological advance of LC-MS/MS 
resulted in the introduction of methods with extreme sensitivity, specificity and 
extended linearity range, which are simpler to use in the medical laboratories, 
and are based on the current reference analytical principles. Further, the ability to 
perform panel profiling with simultaneous measurement of bioactive compounds, 
their precursors and metabolites in a single sample, enormously amplifies the 
informative value of results, with significant improvement of patient care. 
Typical examples include new born screening, TDM, toxicology, endocrinology 
and others. There is an ultimate demand for clear differentiation of the discovery 
stages, selection and validation of newer biomarkers, as well as analytical method 
development and validation of MS techniques that are standardized to meet criteria 
for clinical use with post validation routine proficiency testing assessment: CLSI 
has issued guidance for validation and performance characteristics of LC-MS/MS 
methods for clinical use, which is much more stringent, compared to industrial 
requirements. Currently, MS is the preferred technique in central laboratories, 
where the expertise and the larger sample workload provide cost-effectiveness 
and reliability in applications. Clinical MS will flourish in the near future, with 
the introduction of certified commercial LC-MS assay kits, and automated 
analytical platforms closely resembling routine clinical chemistry analyzers. 
In addition, clinical MS will meet and get together chemical and anatomical 
pathology: MS imaging and I-knife-MS guidance in surgery, although still in 
research phase, open new horizons for personalized treatment and individualized 
patient care, with ultimate impact on precision medicine. Precision medicine 
(also referred to as personalized medicine), employs patient’s genotype and 
phenotype investigation to establish individually tailored drug treatment. 
While genetic testing allows the physician to choose appropriate medicine, the 
performance of MS assays provides the patient’s actual phenotype, with all of 
the environmental, pharmacological and pathological variables. Therefore, MS is 
essentially important technology for personalized patient management.
Significance of systemic inflammatory markers in patients with systemic 
diseases
Gramos Begolli 1, 2, Driton Sopa1, 3, Shemsi Veseli1, 2, Norma Budima1, 
Greta Begolli4
1 University Clinical Center of Kosova,  
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Systemic diseases are generally an interdisciplinary challenge in clinical practice. 
Systemic diseases are able to induce tissue damage in different organs with 
ongoing duration of the illness. The heart and the circulation are important targets 
in systemic diseases. 
A wide variety of systemic diseases may affect the heart by a number of different 
mechanisms, including increasing demands on the heart, causing arrhythmias, 
affecting the structure of the heart or promoting cardiovascular disease and 
therefore coronary heart disease.
Coronary artery disease (CAD) also known as atherosclerotic heart disease, 
coronary heart disease or ischemic heart disease (IHD), has been defined as a 
progressive disease process that causes focal thickening of large- to medium–
seized muscular and large elastic arteries. Atherosclerotic vascular diseases 
are the number one cause of death globally, accounting for 30% of all deaths 
worldwide
New scientific evidence from the last two decades including epidemiological, in 
vivo and in vitro assays support the notion that the immune system significantly 
contributes in the development and progression of atherosclerosis
This new theory proposes that any potential noxious challenge to the host immune 
response could be related to the pathogenesis of atherosclerosis
Traditional risk factors for atherosclerosis and consequent CAD, such as 
hypertension, hypercholesterolemia, diabetes mellitus, marked obesity, smoking 
and physical inactivity, do not account for fully half of all cases of atherosclerosis. 
Inflammation and the systemic immune response are believed to play a central 
role in the initiation and progression of atherosclerosis.
Inflammatory response and cytokine elaboration are integral components of the 
host response to the tissue injury and an active role after myocardial infarction.
Elevated values of circulating inflammatory markers such as CRP, serum 
amyloid A, IL-6, and IL-1 receptor antagonist commonly accompany CAD. Such 
elevations correlate with in-hospital and short-term adverse prognosis and may 
reflect not only a high prevalence of myocardial necrosis, ischemia-reperfusion 
damage, or severe coronary atherosclerosis but also a primary inflammatory 
instigator of coronary instability.
The acute-phase response is a non-specific process that may occur in the 
initial host response to injures, infections, ischemic necrosis or malignancy. It 
is initiated by the activation of local macrophages and other cells leading the 
release of mediators such as TNF-alpha, interleukin-6 and interleukin-1 beta. 
These in turn cause systemic changes including hepatic release of a range of 
plasma proteins, including CRP, activation of complement proteins and various 
of metabolic changes. IL-6 also promotes induction of fibrinogen, haptogloblin, 
α1-	antitrypsin	and	α	2	macrogloblin	among	others.
The purpose of our study was to assess the serum levels of high-sensitivity C 
reactive protein (hs-CRP), interleukin-1 beta (IL-1β), interleukin-6 (IL-6) and 
tumor necrosis factor-alpha (TNF-α) between patients with and without coronary 
heart disease.
These results demonstrated that inflammatory markers are significantly higher 
in patients with coronary heart disease compared with healthy group, especially 
for hs-CRP.
CRP is the best studied of the inflammatory biomarkers in CAD. CRP is not only 
a powerful inflammatory marker, but increasing evidence suggests that CRP may 
also directly participate in the inflammatory process of atherogenesis.
Keywords: inflammatory markers, systemic diseases, CAD
Low grade inflammatory response to obese and non-obese subjects, facts 
and promises.
Driton Sopa1,2, Antonino De Lorenzo1, Laura Di Renzo1, Gramoz Begolli2
1 University of Rome “Tor Vergata”,Department of Biomedicine and Prevention, 
Division of Clinical Nutrition and Nutrigenomics, Rome, Italy. 
2Universitary clinical center of Kosova ,Department  of clinical biochemistry.
While researched the inflammatory response induced by diet, we have come across 
two terminologies that describe it. Generally they are the two most commonly 
used as, chronic inflammation and  Low-grade inflammation response, but the 
latter is more appropriate for conception and preferred. 
It is generally known that there is a greater presence of inflammatory elements 
in obese individuals, but how could be readouts in term of a ‘low grade of 
inflammation’ compered to non-obese subjects  ,we tried to find out  in this study 
review.
Many inflammatory mediators are released by adipose tissue,more expressed 
at obese subjects. Many of inflammatory markers are present at obese people 
in higher concentrations of lean people do. Infiltrations of macrophages in fatty 
tissue of the obese people seem to be a clear relation between obesity and pro 
inflammatory tendency. Therefore, it is believed that many of these mediators 
of inflammation are the trigger of many metabolic diseases, which begin as 
reactions at the cellular level and until the onset of metabolic syndrome where its 
insulin-resistance and the appearance of diabetes are at its center. 
Likewise, hours following the consumption of a meal, there is an elevation 
in the concentrations of inflammatory mediators in the bloodstream which 
is exaggerated in obese subjects and in type 2 diabetics although this is quite 
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difficult to differentiate when other chronic inflammatory situations occur.
Low grade inflammation response  is induced mostly by high-fat, high-glucose 
meals and  high meal content of advanced glycation end products (AGE), too. 
It has been proven that involvement of certain antioxidants or antioxidant-
containing foods within the meal has greatly mitigated their adverse effects. The 
most known of healthy diet  component are vegetables and fruits , whole grains 
, fish, PUFA(polyunsaturated fatty acids), especially long-chain n-3 PUFA, 
are all associated with lower inflammation or anti-inflammatory effects, while 
meal content AGE ,SFA(saturated fatty acids)  ,trans-MUFA (monounsaturated 
fatty acids) are associated with inflammation and  enhanced oxidative 
stress thus creating all the prerequisites for metabolic syndrome. The  best 
monitoring of  low grade inflammatory response  is through pro-inflammatory 
and anti-inflammatory mediators concentrations acute-phase proteins, pro-
inflammatory cytokines,chemokines, soluble adhesion molecules,adipokines 
(TNF,Interleucines,MCP1 ,IFN,.),etc. .It is generally accepted that a consider 
amount  of  these mediators produced are adipocytes and macrophages infiltrated 
therein. 
Main focus in this review was to analyze the literature regarding the presence of 
typical inflammatory mediators in obese and healthy individuals in some in some 
cross-section studies, selected according to the purpose of this paper. We used 
sources in PubMed databases. 
In general, the low grade inflammation response, although being influenced by 
the type of diet  and the modifiers of inflammatory markers, nevertheless of their 
mixed effects there is a clear trend of low grade inflammation, expressed through 
higher values of inflammation mediators in obese versus non-obese.
Studies targeting the obese population group with a well-defined diet according 
to a calorie and ingredients report and identifying or excluding of inflammatory 
modifiers, would be the best approaches to differentiate a diet with less 
inflammatory effect on the obese population.
Such a diet would create all the prerequisites for a reduction in obesity as well as 
a reduction of low grade inflammatory response.
Keywords: Obesity, Inflammation, Metabolic syndrome, Low-grade 
inflammation, Postprandial inflammatory response, Pro- and anti- inflammatory 
mediators, Pro- and anti- inflammatory diet.
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There are many evidences suggesting that vitamin D deficiency is related 
with mother problems during pregnancy such as pre-eclampsia, gestational 
diabetes mellitus, metabolic disorders, increased risk for caesarean section and 
also with fetal complications such as impaired fetal growth, lower bone mineral 
density, respiratory infections, small size for gestational age, etc. 
Serum levels of 25-hydroxyvitamin D (25-OH-D) were evaluated in 185 
Albanian healthy pregnant women aged 18-47 years old, which are presented 
at the National Blood Transfusion Centre during the period from July to 
December 2018. A general information form was completed for each pregnant 
woman included in the study. In this form, for every pregnant woman, were 
collected general demographic data (self-reported) regarding age (in years), 
weeks of pregnancy, place of residence, number of pregnancy, education, use 
of multivitamins and/or vitamin D, smoking, alcohol etc. All participants with 
a history of chronic diseases were excluded from the study. The gestational age 
of the participants was a 3-41 week. 25-OH-D levels were evaluated on a blood 
sample obtained by venepuncture in a plain tube. Serum level of 25-OH-D was 
measured using the CMIA method in Abbott Architect i2000 platform. We used 
the Endocrine Society recommendation cut-off of 25-OH-D to define vitamin D 
status: <20 ng/mL deficiency; 20-30 ng/ml insufficiency; 31-50 ng/mL adequate 
Vitamin D status. 
Of 185 Albanian pregnant women participating in our study we found that: 9 
(4.9%) participants result with vitamin D severe deficiency <10 ng/mL as cut 
off (95%CI, 5.71-8.42 ng/mL) ; 66 (35.6%) participants result with vitamin D 
deficiency 10-20 ng/mL (95%CI, 14.7-16.22 ng/mL) ;  62 (33.5%) participants 
result with vitamin D insufficiency 20-30 ng/mL (95%CI, 24.38-25.95 ng/mL) 
and only 48 (26%) of them had optimal levels of vitamin D (>30 ng/mL as 
cut off). High percentage (74%) of pregnant women had vitamin D levels  ≤30 
ng / mL (75nmol / L) and only 26% had normal levels >30ng/mL (75nmol / 
L). It is important to note that the factors affecting vitamin D levels in our 
study are: Season: the prevalence of vitamin D deficiency is higher in winter 
(100%) and decreases towards summer (62%); Age: with age increases, 
the prevalence of vitamin D deficiency decreases; Gestational age: the prevalence 
of vitamin D  deficiency is lower in the third trimester of pregnancy; Vitamin 
D levels increase with increasing intake of multivitamin and/or vitamin D 
supplements. While the least important factors resulted, engagement at work, 
education level, number of pregnancies. 
Vitamin D deficiency in Albanian pregnant women is in significant percentage, up 
to 40.5 % are vitamin D deficient and 74% had vitamin D levels  ≤30 ng/ml. It 
is necessary to elaborate a national screening and treatment strategy to detect 
vitamin D status, especially in high-risk groups such as pregnant women.   
Anti Müllerian Hormone: New roles for an established biomarker 
of ovarian reserve
Demetrios Rizos, PhD, EuSpLM
Assoc. Prof. of Clinical Chemistry, Medical School, National and Kapodistrian 
University of Athens, Director of Hormone Laboratory, “Aretaieion” Hospital, 
Athens Greece
Anti Müllerian Hormone (AMH) is a homodimeric glycoprotein that belongs to 
transforming growth factor b (TGF-b) superfamily. In females, AMH is secreted 
by primary, secondary, pre-antral and small antral follicles (<7 mm). Since its 
serum concentration is strongly correlated with the ultrasound marker antral 
follicle count (AFC), AMH represents a reliable biomarker of ovarian function, 
having also the advantage of low variation within and between cycles. In our 
days, AMH plays an increasing role in the forecasting of reproductive lifespan, 
the prediction of menopause onset, ovarian response to stimulation in ART 
techniques, iatrogenic amenorrhea due to ovarian surgery or gonadotoxic cancer 
treatment, and has also proposed as a marker of Polycystic Ovary Syndrome 
(PCOS).
In serum, AMH is found in different forms: an inactive non-cleaved form 
known as pro-AMH and a cleaved, biologically active form AMH composed by 
N- and C-terminal fragments. Both Pro-AMH and active AMH are detected by 
immunometric assays.  Until recently, enzyme-immunoassays (mainly Beckman 
Gen II, EIA/AMH Immunotech, and Anshlab assays: Ultrasensitive (Al-105i) and 
Pico-AMH) were used for the determination of AMH concentrations. Since 2014, 
automated techniques have been developed (Roche Elecsys AMH and Beckman 
Coulter Access AMH) and have improved the sensitivity and reproducibility of 
AMH measurements showing 15% to 20% lower values compared to manual 
assays.  
In normo-ovulatory women, a peak of AMH secretion is observed between 20-25 
years of age with AMH values decline thereafter until menopause. It is estimated 
that 34% of total AMH variation is due to age. A recent study suggested median 
age-specific values of AMH for normo-ovulating women with Elecsys assays: 
4/3.31/2.81/2/0.882 and 0.071 ng/mL for age ranges respectively: 20–24/25–
29/30–34/35–39/40–44 and 45–50 years. Similar median AMH values were also 
found in our study with Roche Cobas e411: 6.7/3.9/2.3/1.6/0.84/0.11 for the same 
age ranges.
The estimated age of menopause is important for women seeking fertility 
individualized counselling, or oocyte preservation. So far, no marker enough 
reliable exists to assess the onset of menopause. AMH may be a more effective 
marker than FSH, menstrual irregularities, or maternal age alone. AMH levels 
decrease from 5.6% per year, and become undetectable during the 3–5 years 
before menopause onset. A meta-analysis showed that AMH associated to age 
was more effective in the prediction of early menopause than age alone. However, 
a specific AMH threshold for menopause is still under debate.  
Treatments such as chemotherapy (CT), radiotherapy, ovarian surgery are known 
to have detrimental effects on female fertility. Recent studies have suggested that 
AMH could be used to predict ovarian follicle loss for CT patients. In a large 
prospective study, mean basal AMH levels were 4.19 ng/mL and 4 months after 
CT completion, AMH levels were of 0.78 ng/mL. Moreover, a prognostic score 
to estimate the time to recovery of ovarian function following chemotherapy was 
developed based on age, AMH and BMI.
It remains unclear whether low AMH levels are predictive of lower spontaneous 
fertility. A prospective study conducted on patients aged from 30 to 44 years 
old found lower fertility rates in patients with AMH levels under 0.7 ng/mL. 
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Conversely, by measuring biomarkers of ovarian reserve (AMH, FSH and Inhibin 
B), another study showed that women with low AMH levels (<0.7 ng/mL) did 
not have a significantly different predicted probability of conceiving compared to 
other women, after 6 or 12 cycles.  
AMH appears to be a weak independent predictor of qualitative outcomes of 
assisted reproductive technology (ART) such as implantation, pregnancy, and 
live birth. Meta-analysis has shown that the predictive accuracy of AMH on live 
birth in women undergoing IVF was poor. Although different AMH values (from 
0,3 to 1 ng/mL) have been proposed, no clear AMH threshold exists to conclude 
on a low, normal or increased ovarian reserve, nor on the chances of a future 
pregnancy.
Since AMH is associated with AFC, may be the best predictive marker of hyper 
or hypo-response to ovarian stimulation. Since 2013, dosing AMH before IVF 
is recommended by ESHRE (European Society of Human Reproduction and 
Embryology) and NICE (National Institute of Excellence for Health and Care) to 
individualize strategies for ovarian stimulation. 
Concerning 5 to 10% of women, PCOS is the most common cause of chronic 
anovulation and hyperandrogenism in young women. Since a solid correlation 
exists between AMH and AFC, AMH may play a role in the diagnosis of PCOS. 
Its use is yet not recognized in clinical practice. In vitro, AMH production by 
granulosa cells was found to be 4-fold higher in normo ovulatory PCOS and 75-
fold higher in anovulatory PCOS compared to normal ovaries, suggesting that 
AMH in PCOS women is not only explained by the increase of pre-antral and 
small antral follicles. However, no AMH threshold exists to define PCOS. Despite 
this absence, American Association of Clinical Endocrinologists proposed that 
AMH might be an interesting alternative, while the new ESHRE guidelines do 
not recommend the use of serum AMH levels as an alternative for the detection 
of PCOM, nor as a single test for the diagnosis of PCOS.
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Evidence of HbC disease in Albania - Clinical heterogeneity related to 
combination with other haemoglobin disorders
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Albania is one of the Mediterranean countries where inherited hemoglobin 
disorders (thalassemia and hemoglobinophaties) are considerably widespread 
and constitute a major concern for public health even today. Screening studies 
have noted a high frequency of β- thalassemia carriers in the western lowland 
areas. Besides the β-thalassemia, all screening studies conducted on the 
Albanian population have found a high presence of another hemoglobin disorder, 
hemoglobin S (sickle cell disease), in various areas of the country. The frequency 
of HbS has been found to be particularly high (up to 12%) in the central areas 
of the western lowland. Studies have also identified carriers of Hb O-Arab, Hb 
Lepore, double heterozygotes HbS/β-thalasaemia and some carriers of   alpha 
thalasaemia. 
In this presentation we report our data about the presence of haemoglobin C 
variant in Albanian population and we describe some of the distinctive clinical 
features of the disease related to the combination with other haemoglobin 
disorders. 
A retrospective study was conducted. Data were collected from the results of the 
anemia screening and diagnosis unit of the Laboratory Department, University 
Hospital Center “Mother Teresa” between 2006 and 2018. Clinical data relating 
to geographical origin, place of birth, age, disease onset, comorbidity, and past 
and ongoing treatments were collected. 
Laboratory tests were performed as part of a routine diagnostic evaluation. 
CBC (complete blood count) and biochemical parameters were determined by 
automated routine procedures. Hemoglobin electrophoresis was performed in 
alkaline and acid agarose gel using Hyrys Hydrasys SEBIA system. 
From 2006 to 2018 we have identified 15 cases with presence of HbC. 80% of our 
patients were women and 20% were man. Only 1 patient was in pediatric age. The 
median age was 33 years (range 10-52).  14 patients were Albanian from central 
and south areas of western lowland. 1 patient was from Nigeria. 
53% of our patients (8 cases) result with HbC trait. We have found 5 cases with Hb 
SC disease, 1 case with Hb C homozygote and 1 case with HbC/β+ thalassaemia. 
Clinical picture for our HbC trait patients was nonspecific anemia. In this group, 
general hematological findings didn’t reveal any important or evident change. 
Painful crisis, acute chest syndrome, cholelithiasis with icterus, pain and fever 
were the main clinical features in our Hb SC disease cases. Our patient with 
HbC/β+ thalassaemia was followed-up for several years in the Hematology 
Department of our University Hospital for anemia symptoms with splenomegaly, 
abdominal pain crises and recurrent weakness.
The presence of HbC is a rare event in Europe and Mediterranean region where 
thalassemia and HbS are more frequently encountered. The rarely diagnosed 
cases are linked with the migration of people from West-Central Africa and their 
movements in the trade routes that connected these areas with Europe in centuries. 
The subjects found in our population do not refer any descent indicative for 
mutation migration. An additional reason for HbC presence in Albania might also 
be the past presence of malaria. Until the mid-twentieth century, malaria has been 
the principal medical and social cause influencing the reduction of the number of 
the Albanian population. This disease was endemic in western lowlands, which 
was the origin of the above mentioned patients.
The clinical presentation, as also confirmed in our suspected and diagnosed cases 
at an adult age, is discrete and unclear. HbC carriers might never be diagnosed 
because they are asymptomatic. The most serious clinical presentation belongs 
to HbC/HbS forms where sickling phenomenon might lead to pulmonary 
complications, cholelythiasis, retinal phenomena, osteonecrosis, etc. From 
morbidity and mortality point of view, HbC presence, particularly when 
combined with HbS or thalassemia, is problematic during gestation, especially 
in the perinatal period. 
The correct diagnosis of HbC presence can’t be confirmed with standard methods 
used for the screening of thalassemia and sickle cell disease in our country. In 
literature is emphasized that hematological changes might be absent or to 
a degree that is not an indication for diagnosis. The changes in the peripheral 
blood smear, although characteristic, do not confirm the diagnosis because they 
can also be encountered in other forms of hemoglobinopathy. The common 
electrophoresis in alkaline pH gives information only about the presence 
of a band that migrates in A2 position which can be HbC, HbO-Arab or HbE. 
Electrophoresis at acidic pH confirms the diagnosis because not only identifies 
HbC but gives exact data on the relative percentage of HbC and the other 
fractions of the patient. In cases where it is suspected the combination of HbC 
with alpha or beta-thalassemia, the diagnosis confirmation can be achieved only 
by molecular biology methods. Chromatography is also a method of choice to 
correctly diagnose hemoglobinopathies including HbC presence, due to the short 
time of examination and comparable cost regarding to other methods.
HbC seems to be a hemoglobin variant widespreed in areas reported as endemic 
of hemoglobinopathies in Albania. Due to the morbidity and complications it 
may manifest in patients, it is necessary the application of neonatal screening 
programs for HbC and HbS, at least for the subjects whose origin is from the 
areas with high prevalence of thalassemia and hemoglobinopaties.
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Analytical performance goals
Hassan Bayat Sina Medical Laboratory (Qaem Shahr), Iran
Quality laboratory results are one of the factors involved in patient safety. 
Discussing performance specifications has a long history of more than 70 years 
in the laboratory medicine because it is long realized that it is impossible, and 
rather non-productive, to discuss quality in laboratory medicine unless analytical 
quality specifications (quality goals, analytical goals, or analytical performance 
goals) are set a priori. 
Analytical performance specifications are required for many purposes, including: 
1) to assist laboratorians in choosing and evaluating new assay methods; 2) 
to assist the organizers of EQA/PT schemes; 3) to help the manufacturers 
of instruments and reagents, in design, construction and marketing; and 4) 
to encourage laboratories to decide which particular examinations require 
improvement.
First universal initiative to harmonize goal setting was reflected in the 1999 
Stockholm Consensus statement in which a 5-level hierarchy was proposed. 
In 2014, in the Milan Congress, the Stockholm hierarchy was reduced to three 
models based on: 1) clinical outcome; 2) biological variation; and 3) state of the 
art.
Depending on how quality of performance is defined, analytical performance 
specifications can be presented as separate goals for bias and imprecision or 
as combined goals in the form of allowable total error. Total error model has 
the advantages of: 1) compatibility with Six Sigma concept, and 2) usability 
in internal and external quality control. Therefore, Even if separate goals are 
preferred, when it comes to QC planning and Six Sigma, allowable total errors 
is needed.
 
Quality management: illuminating the path to ISO 15189 accreditation - 
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In the Republic of North Macedonia the work of the diagnostic medical 
laboratories is regulated by the Law of Health Care. There is an urgent need 
for better development of an evidence-based, scientific, and sustainable national 
strategy for the improvement of health laboratory service. Clear indicators of 
improvement must be established. A key indicator should be the number of 
laboratories that have achieved, and can maintain accreditation.
The Macedonian Society of Medical Biochemistry and Laboratory Medicine 
(MSMBLM) recommends that the quality system established meet the 
requirements of the International Standard for medical laboratories (‘Medical 
laboratories: Requirements for quality and competence ’[EN ISO 15189:2012]), 
which has been accepted as the fundamental standard for the accreditation of 
medical laboratories in European countries. EN ISO 15189 was developed as 
a baseline standard for the Quality Management System (QMS) in medical 
laboratories and is recognised as the connecting standard for all disciplines 
in laboratory medicine. With the acceptance of the ISO standard, the need of 
countries for their own QMS for laboratory medicine no longer existed. 
In 2013, the Standardisation Institute of the Republic of North Macedonia 
accepted the standard as the Macedonian norm for quality assessment of medical 
laboratories (MKS EN ISO 15189:2013). 
MSMBLM, as the professional society of specialists in medical biochemistry, is 
responsible for the translation of international guidelines into national guidelines. 
These guidelines have to be in agreement with the standard EN ISO 15189.  
For that purpose, cooperation between MSMBLM and the National Accreditation 
Body (Institute for accreditation of the Republic of North Macedonia), as well 
as cooperation between international medical laboratory organisations, such as 
International Federation of Clinical Chemistry (IFCC), European Federation of 
Laboratory Medicine (EFLM) and international accreditation bodies, such as 
International Laboratory Accreditation Cooperation (ILAC) is essential. 
The accreditation of Macedonian medical laboratories is not mandatory; the 
decision for accreditation is voluntary. Accreditation is accessible to every client 
submitting an accreditation application to the Institute of Accreditation, which 
has been a member of ILAC since 2008. In 2013, the first medical biochemistry 
laboratory was accredited in the country. So far, nine medical laboratories have 
been accredited according the MKS EN ISO 15189:2013. Four of them are 
public sector laboratories. Flexible scope is not yet started for the ISO 15189 
accreditation process in North Macedonia. The medicalized steps, including test’s 
selection advice and interpretation of results are not included in accreditation 
process.
Diagnostic laboratories of the Institute of pathology, Medical Faculty-Skopje 
and Research Center for Genetic Engineering and Biotechnology “Georgi D. 
Efremov (Macedonian Academy of Sciences and Arts) are also using ISO 17025 
as additional standard.
The low number of accredited laboratories could be the result of the shortage of 
financial resources, poor government attention to laboratory service, the shortage 
of qualified personnel and/or the lack of a national laboratory policy. 
The experiences of laboratory professionals from accredited laboratories, who 
have a high level of knowledge, skills, and competence, are crucially important 
to the process of developing a competent laboratory service within the national 
health system. 
The implementation of the Laboratory Quality Management system (LQMS) 
requires support of laboratories by the MSMBLM and close collaboration 
between specialists in laboratory medicine (medical biochemistry), technical 
assessors, and consultants. Each of them will give a different perspective on what 
should be prioritised. Implementation of a QMS should be a stepwise process but 
it is necessary to start with changes that can be easily accomplished and have the 
biggest impact. All quality essentials must be addressed.  Appropriate laboratory 
facilities, infrastructure, and equipment for each laboratory tier level are essential 
to enable safely and efficient performance. Strong programs supporting quality 
assurance, quality control, and quality improvement should exist. They are 
fundamental for the establishment, maintenance and improvement of laboratory 
quality systems. SOPs must be well-written, understood, and implemented; 
laboratory personnel should routinely perform IQCs; and laboratories must be 
required to participate in EQA or proficiency testing (PT) programmes. 
Future directions: 
The globalisation of markets and migration of health professionals requires 
improving the laboratory diagnostic process. A quality laboratory system 
is the foundation of a strong national health system. Laboratory workforce, 
infrastructure, and quality management system are vital for the delivery of quality 
laboratory services. Coordination with the Ministries of Education and Health is 
essential for maintaining standards of education and levels of knowledge. The 
competency of laboratory professionals has to be maintained through mandatory 
participation in continuous medical education (CME). 
For Government, Ministry of Health, professional association(s) and stakeholders, 
accreditation of medical laboratories according to ISO 15189:2012 should be 
a high priority. They should act together and undertake coordinated efforts to 
integrate accreditation programs into national health policy, planning, and health 
development programmes.
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Quality Control in Research Laboratories: Perspectives on Standardization
Yasemin Ucal, Abdurrahman Coskun, Aysel Ozpinar
Acibadem Mehmet Ali Aydinlar University, School of Medicine, Department of 
Medical Biochemistry, Istanbul-Turkey
Basic or applied research is based on scientific assessments aimed at unraveling 
new facts using new inventions and/or innovations of techniques. The quality 
control (QC) in the routine analysis in clinical laboratories is well established. 
For example, staff training and ongoing competency, maintenance of equipment, 
written document control, and method validation/verification are some of 
the important requirements in clinical laboratories.  However, in research 
laboratories the culture regarding quality is immature although the resulting data 
is substantial. There are limited specific standards for research laboratories (1) and 
implementing the existing standards is difficult due to the peculiar characteristics 
of research laboratories. In a typical research laboratory, quality management 
systems are most commonly not a priority, the professionals’ performances are 
measured on the publications and teaching activities and most of the staff in 
research laboratories are temporary (graduate students and visiting scientists). 
In addition, the costs of quality assurance (QA) might cause a significant loss 
of research time. All the mentioned issues and many other peculiar features of 
research laboratories impede the execution of potential quality management 
systems at research laboratories. 
Despite the problems stated above, there is extensive interest in setting up a concept 
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for QC in research laboratories since it has become increasingly substantial that 
the researchers conduct experiments at the highest standards. In the late 1990s, it 
became recognized that researchers were in need of practical guidance about the 
best way to implement existing QA applications to non-routine analytical work. 
Therefore, a guide was produced by a EUROCHEM working party in order to 
promote QA applications in research and development and non-routine analysis 
(2). According to the guide, basic measurements are conducted in accordance 
with the Valid Analytical Measurement (VAM) (3) and supported by technical 
and operational quality elements. The EUROCHEM’s guide advises controls 
at organizational, technical, and analytical levels (2). The research laboratories 
that implemented QA applications based on EUROCHEM’s guide, had indicated 
some critical factors for achieving success in research laboratories. For example, 
it was suggested that the QA documentation system should be simple, QA system 
should add value to the organization, and be self-sustainable in order to keep the 
maintenance of the QA system due to the presence of temporary staff (graduate 
students and visiting scientists) (1).
As expected, every research process has its own characteristics based on the 
targeted objectives and experimental design. Still, the quality in the research 
process can be divided into three common features that represent key quality 
aspects; namely the quality of the objective, quality of the research approach 
to reach that specific objective, and the quality of the results (4). For example, 
the quality of the objective can be judged by a funding agency according to 
the research proposal in view of the aims, scientific interests, and approaches. 
Similarly, the quality of the results can be evaluated in panels or assessed in 
refereed high-impact journals.  Besides, the assessment of the research approach 
quality is dependent on scientific and technical competence, and the presence 
of a quality system. Importantly, the implementation of QA systems requires a 
certain degree of flexibility, in which the limits determined by standards, in order 
to reach success in research laboratories. The need for flexibility arises from 
the inherent nature of research since observations and approaches in research 
processes cannot be defined and predicted precisely. 
In order to assure effective QC in research laboratories, it is also substantial to 
embrace pre-analytical, analytical, and post-analytical phases just like routine 
measurements in clinical laboratories. In typical basic research practice, the 
storage conditions, the sampling time of the biological material, and sample 
preparation methodologies are major pre-analytical aspect. The analytical phase 
consists of the analytical process itself and other related approaches to obtain 
an analytical result.  In an analytical perspective, the validation of the standard 
operating procedures (SOPs) and protocols represents an important issue in 
research laboratories in order to obtain repeatable results. Using a standardized 
workflow including pre-analytical, analytical, and post-analytical aspects will 
increase the reliability of the data produced in research laboratories. 
Research laboratories have intrinsic quality criteria, namely reliability of data, 
reproducibility of methods, and monitorability of the research process (5), and 
mainly act upon it. However, what is new and necessary in research laboratories 
is to construct structured and pre-planned QA systems. Therefore, there is a 
need for developing specific QA systems for research consisting of national and 
international standards (2). It should be further noted that the acceptance and 
commitment to the potential QA systems are the initial steps for success. These 
systems need to be embedded in an organization’s culture and therefore; it should 
be taught early at the undergraduate and postgraduate levels in universities. 
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Bias in clinical chemistry
Elvar Theodorsson Clinical Chemistry, Linkoping University, Sweden
“Error” of a single measurement result consists of random and systematic 
components. The “error” may be determined by comparison with the result of 
a reference measurement procedure or by participating in proficiency testing, 
but neither the systematic nor random error can be elucidated as such from a 
single measurement result. The average of repeated measurements is needed for 
estimating bias. 
A qualitative concept measurement trueness is the “closeness of agreement 
between the average of an infinite number of replicate measured quantity values 
and a reference quantity value”. It is quantitatively expressed as bias. Another 
qualitative concept measurement accuracy describes the “closeness of agreement 
between a measured quantity value and a true quantity value of a measurand. It 
includes both systematic and random error components. A more accurate result 
has a smaller measurement error. It is on the average more true when the bias is 
small and more precise when the random error is small. Precision is expressed 
quantitatively as its opposite – imprecision using the unit standard deviation or 
relative standard deviation (e.g. %CV).
The reasons for bias in clinical chemistry are numerous and vary between 
measurement methods e.g.:
· Bias when taking samples, e.g. when samples are sometimes taken when the 
patient has been walking around and sometimes when he/she has been lying 
down. When the regulatory systems of the body adapt to gravity, the blood 
plasma volume is reduced to about 10% from a lying to a standing position thus 
increasing the concentration of macromolecules and cells in the blood of the 
patient.
· Instability of the sample during transport or storage, e.g. during transport in 
extremes of heat and cold and mechanical effects on cells and blood gases when 
transporting samples through pneumatic tubes in hospital transport systems.
· Uncorrected loss of measurand at extraction e.g. when preparing samples 
for measurement using high-performance liquid chromatography or mass-
spectrometry. 
· Errors when the calibrator is prepared, including errors in volume measurements 
or in weighing of calibrators in the laboratory
· Using sample matrix which differs from the matrix in the samples e.g. using de-
fatted and lyophilized stable materials for internal quality control or proficiency 
testing programs.
· Interferences in the samples, e.g. the color of hemoglobin and bilirubin in 
hemolytic and icteric samples or the presence of high concentrations of proteins 
or lipids in the sample (myeloma or hyperlipidemia)
· The presence of molecules which specifically interfere with the reagents used 
in the measurement process, e.g. heterophilic antibodies (e.g. human antibodies 
against mouse IgG)
· Specificity for different epitopes in macromolecules of antibodies used in 
immunochemical measurement methods e.g. when measuring macromolecules 
including prostate- specific antigen, troponins and protein- or peptide hormones.
Metrological traceability is a property of a measurement result whereby the 
result can be related to a reference through a documented unbroken chain of 
calibrations, each contributing to the measurement uncertainty. Traceability 
is crucial for standardization of measurement results and for minimizing bias. 
A crucial and frequently underestimated factor in achieving traceability is 
commutability. Commutability is a property of a reference material that expresses 
the closeness of agreement between results for the reference material and results 
for patient samples when measured by two or more measurement procedures. 
Lack of commutability is commonly due to matrix effects which are the combined 
effects on the measurement results of all other molecules than the ones you intend 
to measure.
Automation has substantially reduced repeatability imprecision when measuring 
patient samples in clinical chemistry. Reproducibility	 imprecision has not been 
reduced to the same extent probably since it is more challenging manufacturers 
to improve reproducibility.
The Joint Committee for Traceability in Laboratory Medicine (JCTLM, http://
www.jctlm.org/ ) was established in 2002 in response to the implementation of 
the European Community Directive on in vitro medical devices. Its founding 
organizations are the International Committee of Weights and Mesures (CIPM), 
the International Federation for Clinical Chemistry and Laboratory Medicine 
(IFCC), and the International Laboratory Accreditation Cooperation (ILAC). 
The JCTLM publishes list of higher order reference materials, reference methods 
and reference laboratories. They are joined in this effort by other corresponding 
organizations including the FDA, National Metrological Institutes (NMI) etc. in 
other parts of the world. Though far from easy, through perseverance we are likely 
to see a bountiful harvest of the work done by JCTLM, especially as producers of 
reagents and systems and organizers of proficiency testing programs increasingly 
adopt the facilities that JCTLM brings together.
The American Association of Clinical Chemistry (AACC) in 2010 initiated the 
International	 Consortium	 for	 Harmonization	 of	 Clinical	 Laboratory	 Results 
(ICHCLR, https://www.harmonization.net ) organizing a global effort to 
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harmonize test results especially in the instances where standardisation is not 
feasible. Amongst the activities of the consortium is the publication of a toolbox 
of approaches and procedures to be used when developing a process to achieve 
harmonization for a measurand. 
Further developments in reference measurement systems is likely continue to 
play the major role in minimizing bias in clinical chemistry in the decade ahead. 
Reference measurement systems are, however, unlikely to solve the most complex 
bias issues, e.g. in the fields of immunochemistry. Natural patient samples are 
commutable and in abundant supply in the laboratories of clinical chemistry. 
They represent an asset that is likely to be increasingly used for minimizing bias 
using harmonisation methods which promise to minimize bias and measurement 
uncertainty in clinical chemistry still further.
Value and impact of the clinical laboratory in healthcare
Khosrow Adeli PhD, FCACB, DABCC Clinical Biochemistry,
The Hospital for Sick Children, University of Toronto, Toronto, ON, Canada
Chair, IFCC Communications and Publications Division (2016-2018)
Laboratory medicine is the branch of medicine that provides objective data to 
clinicians and other healthcare workers to guide appropriate clinical decision 
making. Laboratory medicine is integral to many clinical decisions on prevention, 
diagnosis, treatment, and disease management (CLB 2017). It supplies health 
care professionals with evidence-based data necessary to provide high-quality, 
safe, effective and appropriate care to patients. Unfortunately, this critical role 
of laboratory medicine is not widely recognized within healthcare organizations, 
leading to poor visibility both within the field of clinical medicine and externally 
with the public at large. The laboratory is viewed as a black box where patient 
specimens are sent and test results are magically generated. There is very little 
understanding of the laboratory testing process not only with patients but also 
physicians and other healthcare workers. This is in large part due to the low 
visibility of the important work carried out in clinical laboratories and the poor 
recognition of the major developments in laboratory testing technology that 
have contributed to an increasingly vital role in evidence-based clinical decision 
making.
Systematic evidence for the contribution of the clinical laboratory to the overall 
assessment, diagnosis, and management of patients is not readily available. 
Establishing this evidence is vital to all promotional activities by the IFCC and 
other organizations involved in laboratory medicine. There is a critical need for 
both a systematic review of the available evidence in the published literature 
as well as the initiation of new retrospective and prospective studies to more 
clearly establish this crucial evidence. The IFCC established a new taskforce to 
evaluate the published evidence on value and impact of laboratory medicine on 
clinical outcomes and healthcare delivery, and if necessary propose new studies 
to more clearly establish this evidence. I will review the evidence supporting 
the key role of laboratory medicine in clinical management and outcomes and 
identify the gaps requiring new studies. This will be followed by a discussion of 
data demonstrating the value of laboratory testing from a clinical and economical 
perspective. I will also review the key activities of the IFCC in promoting the 
visibility of the field of laboratory medicine among healthcare professionals, 
hospital administrators, governmental regulators and funders, and the general 
public.
 
Lipid guidelines: emerging evidence on importance of non-fasting 
and postprandial lipids
Khosrow Adeli PhD, FCACB, DABCC Clinical Biochemistry, 
The Hospital for Sick Children, University of Toronto, Toronto, ON, Canada
Chair, IFCC Communications and Publications Division (2016-2018)
With the current eating patterns in Western societies, the fed state predominates 
over the course of a day, with the typical individual only in the fasted state for 
a few hours in the early morning. Nevertheless, the fasting lipid profile has 
been a standard assessment of cardiovascular disease (CVD) risk. There are two 
primary reasons for traditionally measuring fasting triglycerides (TG): to reduce 
the variability in TG concentration following meal ingestion and to accurately 
calculate low-density lipoprotein cholesterol (LDL-C) using the Friedewald 
equation. However, nonfasting (i.e. random blood sample measurement 
irrespective of time since last meal) TG levels have been reported to fluctuate 
only modestly within the same individual. Additionally, calculated LDL-C has 
been shown to change minimally after food intake and measured and calculated 
LDL-C are highly correlated between fasting and nonfasting state. As nonfasting 
TG levels are independently associated with cardiovascular event, a paradigm 
shift towards assessing lipid parameters in the nonfasting or postprandial (i.e. 
blood sample measurement at specified time points following a standardized 
meal) state is occurring. In fact, postprandial TG levels obtained after consuming 
a standardized high-fat meal, better predict coronary artery disease compared 
to fasting TG levels. Several clinical guidelines have included nonfasting lipid 
testing in the primary prevention setting, including Denmark in 2009, UK in 2014, 
as well as the European Atherosclerosis Society (EAS) and European Federation 
of Clinical Chemistry and Laboratory Medicine (EFLM) and the Canadian 
Cardiovascular Guidelines in 2016. The nonfasting lipid panel has become the 
clinical standard in Denmark, offering physicians the option to measure fasting 
lipids when TG > 4mmol/L, while in Canada it is recommended to obtain a fasting 
measurement when TG >4.5mmol/L. Furthermore, the EAS/EFLM guidelines 
state that nonfasting and fasting measurements should be complementary and not 
mutually exclusive. The option of nonfasting lipid testing has also been included 
in The 2011 National Heart, Lung, and Blood Institute (NHLBI) Guidelines 
specific for the pediatric population. Assessing the postprandial lipid profile 
can provide a better indication of an individual’s capacity to metabolize lipids 
following a meal, reflecting their metabolic efficiency. 
Apolipoprotein profiling for addressing residual cardiovascular risk: in 
search of a personalized and metrologically sound answer to the latest 
dyslipidaemia guidelines
Christa Cobbaert
Department of Clinical Chemistry and Laboratory Medicine, Leiden University 
Medical Centre, Leiden, the Netherlands
An elevated low-density lipoprotein cholesterol (LDLc) concentration is a 
classical risk factor for cardiovascular disease. This has led to pharmacotherapy 
in patients with atherosclerotic heart disease or high heart disease risk with 
statins to reduce serum LDLc. Even in patients in whom the target levels of 
LDLc are reached, there remains a significant residual cardiovascular risk; this is 
due, in part, to a focus on LDLc alone and neglect of other important aspects of 
lipoprotein metabolism. According to the latest dyslipidaemia guidelines, a more 
refined lipoprotein analysis is advocated, especially for secondary prevention, 
which provides additional information on the accumulation of very low-density 
lipoproteins, intermediate density lipoproteins, chylomicrons, chylomicron-
remnants and Lp(a). Instead of measuring the overall cholesterol and triglyceride 
content of  lipoproteins, measurement of their apolipoproteins is more informative. 
Apolipoproteins are either specific for a particular lipoprotein or for a group of 
lipoproteins. Measurement of apolipoproteins in atherogenic particles is more 
biologically meaningful than the measurement of the cholesterol concentration 
contained in these particles. Applying serum apolipoprotein profiling will not 
only improve characterization of lipoprotein abnormalities, but will also improve 
definition of therapeutic targets. Apolipoprotein profiling aligns with the concept 
of precision medicine by which an individual patient is not treated as ‘average’ 
patient by the average (dose of) therapy. This concept of precision medicine fits 
the unmet clinical need for stratified cardiovascular medicine. The requirements 
for clinical application of proteomics, including apolipoprotein profiling, can 
now be met using robust mass spectrometry technology which offers desirable 
analytical performance and standardization.
Keywords: Dyslipidaemia, mass spectrometry, clinical proteomics, metrological 
traceability, serum apolipoprotein profiling 
The importance of cholesterol synthesis and absorption markers 
determination in healthy subjects and patients with ischemic heart disease
Tamara Gojkovic University Of Belgrade, Serbia
According to the World Health Organization, worldwide incidence of 
cardiovascular diseases (CVDs) is everincreasing, and CVD are among the 
leading causes of morbidity, co-morbidity and mortality. Atherosclerosis is a 
chronic, focal disease of the blood vessel intima. Atherosclerosis is the underlying 
27-31 October 2019Turkish Journal of Biochemistry, 2019
XXVII. Balkan Clinical Laboratory Federation Meeting BCLF 2019 
XXX. National Congress of the Turkish Biochemical Society TBS 2019
Turk J Biochem, 2019; 44 (S3) http://www.TurkJBiochem.com27
cause of the most CVD, including coronary artery disease (CAD). Even though 
many etiological factors are involved in the pathogenesis and progression of 
atherosclerosis, dyslipidemia has the key role in atheroma development. Statins 
represent a hypolipemics of choice in primary and secondary CAD prevention. 
In addition to the inhibitory effect on cholesterol synthesis, statins also have 
numerous pleiotropic effects. Basic lipid parameters are used for diagnosing 
dyslipidemia and monitoring the statin therapy response in clinical practice. 
Elevated plasma total cholesterol (TC), LDL-cholesterol (LDL-C) and triglyceride 
(TG) concentrations and low HDL-cholesterol (HDL-C) concentrations represent 
well-documented risk factors for CVD. However, in order to examine the overall 
cholesterol metabolism and monitor its homeostasis, it is necessary to examine 
the efficiency of cholesterol synthesis and absorption, its distribution between 
lipoprotein particles, and the preservation of the reverse cholesterol transport 
function. Cholesterol homeostasis represents the balance between cholesterol 
synthesis and absorption. Many studies have shown that cholesterol synthesis and 
absorption are in equilibrium. Increased cholesterol synthesis leads to reduced 
absorption and vice versa, in order to maintain balance. Cholesterol synthesis 
is divided into two different pathways, that may be independently regulated 
(80% via the lathosterol - Kandutsch-Russel pathway; 20% via the desmosterol - 
Bloch pathway). Non-cholesterol sterols (NCSs) represent cholesterol synthesis 
precursors (desmosterol and lathosterol) and cholesterol absorption surrogate 
markers (phytosterols - campesterol, stigmasterol and β-sitosterol). Knowing that 
the plant sterols are absorbed in the same way as the intestinal cholesterol, plant 
sterols are used as surrogate markers of cholesterol absorption efficiency. These 
markers can indicate early development of dyslipidemia and predict response 
to statin therapy. NCSs concentrations in plasma are 200–1000 times lower 
compared to cholesterol levels and relatively low NCSs concentrations represent 
a specific problem for their quantification. This represents the additional 
reason to conduct an extensive method validation for NCSs determination, as 
well as to resolve pre-analytical and analytical factors of influence. In order to 
contribute to a better understanding of cholesterol metabolism and the statin 
effects on cholesterol homeostasis, the objectives of this study were: establishing 
and validating the method for NHSs determination; determination of NHSs 
concentrations in healthy subjects (CG) and CAD patients; determination of 
cholesterol homeostasis patterns and their association with basic lipid parameters 
and distribution of low-density lipoprotein subclasses (LDL) in examined groups.
The study included 31 healthy controls (CG), 32 statin-treated patients and 47 
statin-naive CAD patients. Method optimization, validation and stability studies 
were executed in human serum and plasma. Freeze-thaw cycles were done with 
and without antioxidant. Gas chromatography-mass spectrometer (GC-MS) 
was used for NCSs confirmation and plasticizer identification, while GC-flame 
ionization detector (GC-FID) was used for NCSs quantitation. Lipoprotein 
subclasses were separated by gradient gel electrophoresis (GGE). 
The results of this study have shown that both serum and plasma are adequate 
biological materials for NCSs determination. Intra- and inter-assay variabilities 
for all NCSs were 2.75–9.55% and 5.80–7.75% for plasma and 3.10–5.72% 
and 3.05–10.92% for serum, respectively. Recovery studies showed satisfactory 
percentage errors for all NCSs: 93.4–105.7% in plasma and 87.5–106.9 in serum. 
The presented results showed that the derivatization of samples is necessary in 
order to obtain adequate chromatographic NCSs separation.  Derivatized samples 
were stable up to 7 days at −20 °C and derivatization yield was affected by 
presence of plasticizers. Fatty acid amides were identified as interfering plastic 
leachates and our results shown that the use of plastic laboratory consumables 
should be avoided in NCSs analysis. Statistically, different NCSs concentrations 
were observed after the 1st freeze-thaw cycle, in antioxidant-free samples, 
and after the 4th cycle in antioxidant-enriched samples. The concentrations of 
desmosterol and lathosterol were significantly higher in both groups of patients 
compared to CG. Desmosterol absolute values were higher in patients receiving 
no statin treatment compared to patients with statin treatment and controls. 
Desmosterol concentrations showed a negative correlation with the LDL particle 
size in CG (r = -0.459, p = 0.016) and in a statin-naive patients (r = -0.381, p = 
0.012). For the assessment of cholesterol homeostasis, we divided each group of 
participants into four subgroups with good or poor synthesis and good or poor 
absorption (PS/PA, PS/GA, GS/PA and GS/GA) according to desmosterol or 
lathosterol and β-sitosterol median values. Within subgroups, total cholesterol 
levels increased with increasing synthesis and/or absorption. In CG, the GS/
PA subgroup had the highest triglyceride values and the largest proportion of 
small dense LDL particles. In the statin-treated patients, GS/PA subgroup had 
the lowest LDL-cholesterol concentration and the smallest LDL IVB subclasses 
distribution compared to other groups. 
Derivatization, as well as derivatization yield assessment, was shown to be 
necessary in order to accomplish the reliable quantitation of the cholesterol 
precursors. Also, when applying derivatization, special care must be taken 
during the selection of appropriate labware and laboratory consumables. Based 
on NHSs concentrations, it is possible to determinate cholesterol synthesis and 
absorption patterns and identify individuals at high risk for CVD development 
and progression. In addition, determinations of cholesterol homeostasis patterns 
are potentially useful tool for predicting the individual propensity toward 
hypolipidemic therapy response. 
Key words: dyslipidemia, non-cholesterol sterols, cholesterol homeostasis, 
plasticizer
Impact of redox imbalance and inflammation on activity of paraoxonase 
1 and its distribution in high density lipoprotein in polycystic ovary 
syndrome
Iva Perović Blagojević, 
KBC “Dr Dragiša Mišović - Dedinje”,  Serbia
Polycystic ovary syndrome (PCOS) is the most common endocrine disorder in 
women of reproductive age. It is a complex endocrinological condition because 
of its heterogeneity, inconsistency regarding the etiology and difficulty in making 
the diagnosis. Over the years, diagnostic criteria for PCOS have changed. In our 
study, PCOS was defined on the basis of the revised Rotterdam Consensus Criteria 
(2003) by meeting two of the following three criteria: moderate oligo/amenorrhea 
(less than eight menstrual cycles per year), presence of clinical hyperandogenism 
(hirsutism) and/or biochemical hypeandrogenemia and the existence of polycistic 
ovaries confirmed by transvaginal ultrasonography. 
Oxidative stress (OS) is characterised by irreversible damage of practically all 
cellular components (proteins, lipids and DNA) leading to impaired cell function. 
OS is an important link in the pathogenesis of PCOS, but it has not yet been 
determined whether increased levels of OS in PCOS are due to the syndrome 
itself or related to its characteristics (hyperandrogenism, insulin resistance (IR), 
obesity and abdominal obesity that significantly contribute to OS development). 
Chronic low-grade inflammation is an important feature of PCOS (participates in 
its pathogenesis and development). Numerous evidence supports the concept of 
feedback formation, where inflammation induces reactive oxygen species (ROS) 
formation, while OS exacerbates inflammation as described in endothelium and 
adipose tissue.
High-density lipoprotein (HDL) particles are present in the circulation in the 
form of different subclasses that differ in size, density and lipid composition.
The antioxidant/anti-inflammatory role of HDL depends on the presence of 
antioxidant enzymes. Paraoxonase 1 (PON1) is an antioxidant enzyme associated 
with apolipoprotein A1 on HDL particles whose activity and concentration may 
be reduced in OS, further increasing the risk of developing cardiovascular disease 
(CVD). Although there are different opinions about the PON1 distribution between 
HDL 2 and HDL 3 subclasses, PON1 is assumed to follow the reverse cholesterol 
transport.
The study included 114 PCOS patients and 50 healthy females (control group, 
CG), of similar age (18 – 39 years). The CG participants had normal glucose 
metabolism, were non-smokers and zero alcohol consumers with no signs of 
hyperandrogenism.  Patients were analysed during the early follicular phase of the 
menstrual cycle, or at any time if they had severe oligomenorrhea or amenorrhea. 
Systolic and diastolic arterial blood pressure (SBP and DBP), anthropometric, 
biochemical and oxidative stress parameters were determined in all study 
paticipants using standardised assays. Plasma HDL particles were separated 
using a non-denaturing 3-31% polyacrylamide gradient gel electrophoresis 
method, previously described by Rainwater et al. which was optimized in the 
laboratory of the Department of Medical Biochemistry, Faculty of Pharmacy, 
Belgrade. Following HDL lipoprotein electrophoresis, PON1 activity on HDL 
2 and HDL 3 subclasses was determined using the Trinder reaction according to 
Gugliucci et al. 
As we wished to examine the mutual effect of the most important risk factors in 
PCOS patients, we calculated the DOI score as a sum of dyslipidemia, OS and 
inflammatory scores.
High-density lipoprotein cholesterol (HDL-C) was significantly lower in 
patients compared to healthy controls (P<0.01) with no significant differences 
in triglyceride (TG), non-HDL-C concentration and atherogenic index (TG / 
HDL-C) values. Total cholesterol (TC) and low-density lipoprotein cholesterol 
(LDL-C) concentrations were not elevated in women with PCOS. In contrast 
PCOS patients had significantly higher CRP (P<0.001). More pronounced 
oxidative stress markers such as AOPP, TOS, MDA (P<0.001) and PAB (P<0.05) 
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combined with a concomitant reduction in the concentration of total SH-groups and 
lower PON1 antioxidant activity (P<0.001, P<0.05, respectively) were found in 
patients compared to healthy controls. All individual scores: oxy-score (P<0.001), 
dyslipidemia (P<0.05) and inflammation (P<0.001) scores were significantly 
higher in patients compared to healthy controls. Consequently, the DOI score was 
significantly higher in comparison to healthy controls (P<0.001), highlighting the 
significance of this result for assessing cardiometabolic risk in patients.
The analysis of HDL size and HDL subclasses (HDL 2 and HDL 3) distribution 
showed that HDL particle size did not differ between patients and healthy controls. 
However, normal weight patients had significantly higher HDL 2 subclass than 
normal weight and obese controls (P<0.05). HDL particle size analysis within the 
PCOS group showed that obese patients had significantly smaller HDL diameters 
(P<0.05) and a greater HDL 3 subclass than normal weight patients (P<0.05). This 
was consistent with previous findings that showed a decrease in HDL particle size 
in patients with higher CVD risk.
PON1 distribution within HDL subclasses did not differ between patients and healthy 
controls. Obesity had no influence on PON1 distribution within HDL subclasses in 
patients. However, in patients with small LDL particle size the relative proportion 
of PON1 on HDL 2 subclasses was significantly higher (P<0.001) and the relative 
proportion of PON1 on HDL 3 subclasses was significantly lower (P<0.01) than in 
patients with large LDL particle size. As patients had a higher antioxidant score, 
the relative proportion of PON1 on HDL 2 subclasses increased (P<0.01) while the 
total proportion of PON1 in the HDL 3 subclasses decreased (P<0.05). Increased 
oxy-score was accompanied by an increase in the total proportion of PON1 on HDL 
3 subclasses (P<0.05).
The results demonstrate that PCOS women have elevated levels of OS markers i.e. 
products of their action, and decreased values of antioxidant protection parameters. 
Patients have higher OS, dyslipidemia as well as chronic low-grade inflammation 
compared to healthy women that indicates currently low cardiovascular risk. Obese 
PCOS patients have significantly smaller HDL diameters and a higher proportion 
of small HDL 3 subclasses (associated with a high risk for CVD) compared to 
normal weight PCOS patients. Based on this, we can assume that obesity in 
PCOS affects the profile of HDL subclasses, while PCOS itself has no effect on 
the HDL subclasses profile. A comparison of PCOS women, according to the 
LDL particle size, indicated that PON1 activity on small HDL 3 subclasses was 
significantly lower in women with small, denser LDL particles, which is a sign that 
the antioxidant ability of HDL 3 subclasses is decreased in PCOS in conditions of 
increased risk for CVD. 
Sensitive assessment of white blood cell functionality by novel 
hematological parameters
Milena Velizarova Medical University- Sofia, Bulgaria; Alexander University, 
Bulgaria
Cellular and morphological analysis is an integral part of modern haematology 
analyzers. A unique combination of techniques permits to separate cell populations 
based on lipid composition of cell membranes, the fluorochrome RNA labels, cell 
volume and intracellular structure. In addition, the DNA of the nucleus is labeled 
by the fluorescence reagent penetration. The intensity of the fluorescence signal 
is directly proportional to the nucleic acid content and the strongest signals are 
shown by immature and activated cells. Sensitive assessment of cell functionality 
or activation status depends on cholesterol- and glycosphingolipid raft in the 
plasma membranes that play important roles in protein trafficking and cellular 
signalling. The information about membrane lipid rafts and cytoplasmic RNA is 
analyzed with proprietary algorithms that deliver sensitive detection of reactive or 
pathological cells in a blood sample. Modern hematology analyzers are designed 
with improved gating and optimization of leukocyte clusters including immature 
granulocytes (IGs). Moreover, results including the presence and concentration 
of IGs become available within minutes – and are included in the complete 
CBC+DIFF analysis, making it a valuable sixth subpopulation of the white blood 
cells. The measurement of the immature cells, which combine promyelocytes, 
myelocytes and metamyelocytes, is considered clinically useful for the diagnosis 
of infections, especially neonatal sepsis, inflammation, myeloproliferative 
diseases, tissue necrosis and acute transplant rejection at a very early stage. The 
results were excellent considering the low levels of IGs observed and the wellff
known limitations of manual differentials and rare cell events. Modern analyzers 
are much more sensitive than the manual differential counting method in the 
detection of leukemic blasts and they provide more cell population data than the 
manual differential count, including blast lineages. Distribution and appearance 
of lymphocyte population quantify the numbers of all reactive, antibody-
synthesizing and malignant lymphocytes. For instance, several studies showed 
that lymphocyte RE-LYMP and AS-LYMP counts (Sysmex XN series) were 
mainly increased in viral infections. Monocytic population provides information 
for screening and differential diagnosis of malaria and dengue by a calculated 
malaria factor. The modern analyzers are characterized with high sensitivity and 
specificity for detecting atypical cells in the samples and smear reviews can be 
reduced by approximately 20 % in routine laboratory. The possibilities of current 
haematology analyzers for better screening, diagnosis and monitoring of reactive 
and malignant diseases are increased without the need for clinically irrelevant 
follow-up tests.
The future of Cytometry in Europe
Georgios Markopoulos1, Katherina Psarra2
)Laboratory of Biology, Faculty of Medicine, University of Ioannina, Greec
)Department of Immunology - Histocompatibility, Evangelismos Hospital, 
Athens, Greec
The field of Cytometry is a recent discipline which emerged through developments 
in the fields of Physics (optics and fluidics) and Computer Science (electronics 
and informatics). Flow cytometry is today an established field that deals with the 
quantification of cellular characteristics. To envision the future of the field of 
cytometry in Europe we navigate through the past and the present in an effort to 
describe the state of the art on the field, based on the recent advances.
From the dawn of Cytometry during the mid-20th century till today many pioneer 
European cytometrists have largely contributed to the field. Among them, 
Wolfgang Göhde is considered as the founder of European cytometry and is the 
one that developed the first fluorescence-based cytometer. The field has further 
evolved after Kholer and Milstein (Nobel prize in Physiology or Medicine in 
1984) described the development of monoclonal antibodies. During this period 
Flow Cytometry attracted many pioneer scientists from diverse disciplines 
and scientific backgrounds, including: Claude Curties, who applied cytometry 
in oceanographic studies and in discovery of eukaryotic organisms; Andrew 
Ridell, founder of the European Cytometry Network;  Gerd Schmitz, founder of 
EWGCCA (European Working Group on Clinical Cell analysis); Günter Vallet, 
Pioneer of multiparametric flow cytometric analysis and one of the earliest 
promoters and appliers of the current concept of Cytomics and its application 
to Predictive Medicine; Phillip Sansonetty, organizer of the First International 
Workshop on Flow and Image Cytometry. 
The continuous application of novel methodologies widened the scope and 
target audience of Flow Cytometry in both clinical and research laboratories. 
Such developments led to initiatives that resulted in the formation of organized 
Working Groups and Societies in individual Countries and in Europe as a whole. 
First, ISAC (International Society for Advancement of Cytometry) held many of 
its meetings in European countries, while many presidents of ISAC were also of 
European origin. Second, National Societies have been established in European 
Countries and a Network of Quality Control has been working since 1989.  Third, 
a European Cytometry Network has been recently established, as an initiative of 
European Molecular Biology Laboratory EMBL, Heidelberg, 2008, in order to 
establish communication, cooperation, education and promotion of Cytometric 
science and techniques among its members. The European Cytometry Network 
(ECN) has been created with the aim to support modern infrastructure and to 
build up connections between professionals in Cytometry. Euroflow Network 
is also an established network in the field of HematoOncology, by J.J.M. Van 
Dongen (chair) and Alberto Orfao (co-chair), including 19 diagnostic research 
groups and one SME, with a vision to connect experts in the field of flow 
cytometry and molecular diagnostics. The European Working Group on Clinical 
Cell Analysis (EWGCCA) established cooperation and training in Cytometry 
since 1995, including the First European Course in Clinical Cytometry in Athens 
in 2005. As a continuation of EWGCCA activities, European Society for Clinical 
Cell Analysis has been established as a scientific society in 2006. ESCCA holds 
Annual Conferences in collaboration with local societies, annual EuroCourses 
(Education programs), Schools on cytometry (winter, summer, autumn), flow 
events, harmonization and guidelines projects. More recently ESCCA provides 
Certification exams for Cytometry operators and Cytometry specialists and also 
ESCCAbase, an organized database of flow cytometry results and analyses. 
The development of European and local societies, along with the organization 
of Conferences and educational courses have been necessary, based on the rapid 
recent developments of technology and methodologies. During recent years 
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Multiparametric Flow Cytometry made it possible for more cell characteristics 
to be examined from the same cell population leading to the establishment of 
Cytomics. Recent developments in the field also include: Mass Cytometry, a 
combination of flow cytometry and mass spectrometry to interrogate up to 100 
parameters from a single cell; Imaging Flow Cytometry, Using a microscope that 
also analyses cell shape and the relative position of different epitopes (allowing 
for colocalization analysis); Spectral Flow Cytometry, where newly developed 
multichannel detectors allow for the simultaneous analysis of more parameters 
minimizing the problems of spectral overlap.   
The state of the art in the field include Cytometry methodologies that are among 
the standard techniques practiced in both clinical and research laboratories. The 
combined efforts of cytometrists throughout Europe guaranteed the advancement 
of the field up until today. Knowledge and data dissemination are critical 
parameters in the era of information and informatics. Our suggestion is that 
the future of the field should be based on cooperation, openness in knowledge 
sharing and organized cytometry courses for educating the new generation of 
cytometrists.
Significance of the determination of biomarkers of bone resorption and 
formation in patients with end stage renal disease
Neda Milinković
Department of Medical Biochemistry, University of Belgrade-Faculty of 
Pharmacy
End stage renal disease (ESRD) is associated with various mineral and bone 
disorders. Guidelines for improving the quality of life and education of patients 
with ESRD (Kidney Disease Outcomes Quality Initiatives, KDOQI), published 
by the U.S. National Kidney Foundation (NKF), indicate the importance of 
biomarkers of bone metabolism that should be analyzed in ESRD patients. Routine 
parameters that are determined in most laboratories are indirect indicators of bone 
turnover, such as: calcium ions (Ca), inorganic phosphate ions (P), magnesium 
ions (Mg), the total alkaline phosphatase (ALP), an intact parathyroid hormone 
(iPTH) and 25-hydroxy vitamin D (25D). On the other hand, direct indicators of 
bone metabolism are products of bone cells. The activity of osteoblasts, the cells 
responsible for bone formation, is well expressed by the levels of bone alkaline 
phosphatase isoenzymes (BALP), which is highly specific for bone tissue. The 
activity of osteoclasts, the cells responsible for bone resorption, specifically 
reflect levels of tartrate resistant acid phosphatase (TRAP). A good marker of 
bone resorption is the beta-carboxy terminal telopeptide of collagen type I, beta-
CrossLaps (beta-CTx). The aim of this study was to evaluate the usefulness of 
biomarkers of bone resorption and bone formation in ESRD patients. The study 
included 40 predialysis patients (18 women and 22 men) aged 25−79, 114 
patients on continuous ambulatory peritoneal dialysis (CAPD) (49 women and 
65 men) aged 30−84 and 112 patients on hemodialysis (HD) (53 women and 
59 men) aged 25−79. Average duration of the HD and CAPD treatment was 76 
and 35 months, respectively. The analyzed biomarkers of bone formation and 
resorption were determined in the serum of patients on the day of sampling: for 
predialysis and CAPD patients when they came to the routine check-ups, and 
for HD patients immediately before dialysis therapy. To determine the reference 
intervals, analyzed biomarkers were measured in a group of 50 healthy volunteers 
(25 women and 25 men) aged 20−70 years. ALP, TRAP, Ca, P and Mg were 
determined using spectrophotometry (Olympus AU2700 ISE). BALP values 
were determined using zone electrophoresis (SEBIA Hydrasis), beta-CTx and 
iPTH concentrations were determined with ECLIA (Elecsys Rosche) and 25D 
concentrations were determined by HPLC with reversed phase detection (HPLC 
ChromLineR Clinical software Version 4:20). Determination of the analyzed 
biomarkers is considered reliable based on the coefficients of variation (CV) 
obtained by precision testing in the series (CV: 0.6%−3.3%) and from day to 
day (CV: 1.0%−3.6%). We established the normal distribution of the values for 
each of the analyzed biomarkers in predialysis and dialyzed patients. There was 
significant impact of gender on iPTH, P and CaxP values in the all analyzed groups. 
However, the effect of age was observed only on the values of BALP. Duration 
of the dialysis had impact only on the values of ALP and BALP in HD patients 
and on Mg concentrations in CAPD group. BALP values were significantly lower 
(P<0.001), and beta-CTx and TRAP values were significantly higher (P<0.05 
and P<0.01) in ESRD patients, compared to the control group. The effect of the 
dialysis, regardless of the dialysis mode, was confirmed with lower BALP values 
in dialysis patients compared to the predialysis patients (P<0.05). However, we 
obtained much lower beta-CTx concentrations in HD patients as compared to 
predialysis patients (P<0.05). The most significant change considering the iPTH 
concentrations (<150 pg/mL, 150−300 pg/mL and >300 pg/mL) was observed 
in the BALP values in all three groups of patients. There were parallel changes 
in the values of BALP and iPTH in all three groups of the patients. There was 
significant difference in the BALP values, regarding the 25D concentrations 
(<50 nmol/L and >50 nmol/L) in CAPD patients (P<0.05). In order to determine 
diagnostic accuracy of direct and recommended biomarkers in relation to the 
recommended value of the iPTH (<100 pg/mL) for detection of adynamic bone 
disease in ESRD patients, we performed ROC analysis. When we analyzed all 
three studied groups of patients and HD patients separately, we found calcium had 
highest diagnostic value. The areas under the curves (AUC) were significantly 
different in comparison with other biomarkers analyzed (AUC=0.701, P=0.0001 
and AUC=0.651, P=0.007, respectively). In the group of predialysis and CAPD 
patients, the highest diagnostic value had BALP (AUC=0.688 and AUC=0.588), 
although there was a marginal significant difference with other analyzed 
biomarkers (p=0.058 and p=0.053). This study support other reported data, that 
examined biomarkers (BALP, TRAP and beta-CTx) have comparable diagnostic 
accuracy as well as the recommended biomarkers (Ca, P, Mg, ALP, iPTH and 
25D) to determine the level of bone metabolism in ESRD patients. On the basis of 
our results we can conclude that bone markers, generally, may be an appropriate 
alternative to invasive method of bone biopsy.
CEA monitoring in colorectal carcinoma - to the limit of 
the guidelines and beyond
Yana Bocheva1, MD, PhD, Pavel Bochev2, MD, PhD
1Medical University, Varna, Bulgaria
2University Hospital “St. Marin ”, Varna, Bulgaria
Carcinoembryonic antigen (CEA) is a well-established serum tumor marker 
in colorectal cancer. It is used in preoperative prognostication, disease stage 
prediction, immediate post-resection assessment  and , to some extend as an 
adjunct in treatment response monitoring. The diagnostic and screening  value 
of CEA is definitely poor, but the pre-operative determinations of the marker for 
risk stratification in patients with diagnosed colorectal cancer is widely discussed 
in the literature and is considered  to be recommended.  The discussion for the 
preoperative testing is much more connected with the clinical value of the marker, 
i. e. whether  the patients with higher preoperative values to receive adjuvant 
therapy, due to the poorer prognosis, based on these higher values of CEA or 
not. The disease stage prediction, based on CEA is accepted and recommended 
by NCCN and ASCO, but it should be mentioned that the tumor marker values 
must not be considered as an indication for adjuvant therapy, but only for a basis 
for intensive follow-up of patients in high risk of recurrence. The data for   the 
immediate post-resection assessment of CEA is under discussion and although 
there are some research studies that report positive results, the value of the marker 
is not considered proven and is not recommended in the official guidelines. The 
usage of the marker in the recurrence monitoring has a proven influence on the 
surveillance of patients with colorectal cancer. The major role of the marker, 
however, is in the monitoring/follow up of patients with colorectal cancer, treated 
with curative intent. CEA value in follow up of those patients is addressed in 
multiple randomized trials, meta analyses and systemic reviews, reaching the 
highest evidence bases appraisal as a monitoring tool. Although comparatively 
straight-forward, the diagnostic assessment in patients with elevated surveillance 
CEA levels may vary. Generally clinical examination, imaging (CT, MRI) and 
endoscopy (wherever applicable) should follow a confirmed CEA rise. There is 
a specific group of patients, where the so called conventional work up does not 
show a recurrence or fails to do so. In this scenario the clear clinical question 
is whether the increase In CEA levels is a false positive or a true positive for 
recurrence. In those cases more sophisticated diagnostic work-up may be needed 
including FDG PET CT and possibly novel biomarkers.  PET CT shows high 
detection rate in previously not recognized colorectal cancer recurrence with 
rising CEA levels and is the modality of choice in this particular situation. If 
appropriately performed it demonstrates detection rate as high as about 85% 
in rising CEA positive patients, which is in favor of predominantly malignant 
reasons for CEA rise or can also lead to detection of a synchronous/metachronous 
primaries that also produce high CEA levels. Here breast cancer, stomach 
and lung cancer, pancreatic cancer and mesothelioma should be mentioned. 
Metastatic sites that may present as high CEA and could potentially be missed by 
conventional imaging are mostly lymph node metastases, peritoneal spread, local 
recurrence, liver and other rare locations.   The minority of patients with rising 
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CEA levels may occasionally experience a recurrence despite negative results 
from the extensive work-up. Close CEA levels monitoring is essential in this 
scenario with the results going in two directions: those with further rising CEA 
levels almost invariably recur while those with high but stable CEA levels rarely 
experience recurrence. The absolute CEA value is also important with serum 
levels of CEA of more than 10ng/ml being predictive of recurrence in very high 
proportion of patients. However one should bear in mind that CEA levels rise in 
a variety of benign conditions and could reach excessive absolute values without 
a presence of malignancy. The most often and typical benign diseases, connected 
with CEA elevation are chronic hepatitis, cirrhosis, chronic kidney failure, colitis, 
jaundice.  So neither the rise alone nor the absolute value but the trend of rising 
is predictive of recurrence if so-far work up has failed to localize disease. Even 
though guidelines and official recommendations are mostly clear about the role 
of CEA in the monitoring of colorectal cancer patients, treated with curative 
intent and the consecutive conventional and high-end imaging, the management 
of the patients with no recurrence detected is less clear. In these cases combined 
assessment with Ca 19-9 may be attempted, but with the clear idea that Ca 19-9 
performs suboptimal in colorectal cancer and is a subject of broad spectrum of 
non-specificity.  Other problem is that Ca19-9 and CEA may rise simultaneously 
in similar benign processes which limits the use of the combination of markers 
as differential diagnostic tool. In the present era of molecular and genetic 
testing attempts are made to correlate the rising monitoring CEA levels,  such as 
circulating tumor cells, circulating free tumor DNA (cfDNA), methylated DNA 
(e.g septin 9), reporter mRNA etc.  Attempts in this direction have been made 
also in the group of CEA positive FDG negative patients. None of the tests has 
however reached routine clinical use. 
The development of new imaging methods and tests for detecting recurrence in 
patients with colorectal cancer puts on discussion whether and how  underestimated 
is in fact  the positive predictive value of CEA, including the levels below 5 
ng/ml and whether in patients with higher levels of the marker the oncologist 
should make a great effort for clearing the reason, i.e. accepting or rejecting a 
recurrence, or the patient should be followed up using only conventional methods 
till appearance and verification of clinical symptoms of recurrence. 
:Although not perfect in predicting recurrence CEA is still the monitoring tool 
of choice when it comes to colorectal cancer patients. Patients with rising CEA 
levels should be chased to prove recurrence by conventional imaging, endoscopy 
and FDG PET CT. Those with no proof of recurrence should be followed up 
strictly to define any upward trend of CEA values and in case of such should be 
reassessed again.
Traceability in Laboratory Medicine and IVD Directives
Tomris Ozben
Akdeniz University, Medical Faculty, Department of Medical Biochemistr8, 
Antalya, Turkey
A high percentage of clinical decisions are based on data stemming from 
Laboratory Medicine (LM). This responsibility requires delivery of a high-
quality service. Method calibration is a challenge. In vitro Diagnostic (IVD) 
companies mostly produce their ‘own’ calibrators, resulting often in variability 
between methods for the same measurand. Variability between methods may 
cause incorrect patient results leading to wrong diagnosis and treatment, and 
poor clinical outcome. Traceability requires both (certified) reference materials 
and reference measurement procedures (methods) in which they are used. The 
Joint Committee for Traceability in Laboratory Medicine (JCTLM) was formed 
in 2002 by the International Bureau of Weights and Measures (BIPM), IFCC and 
International Laboratory Accreditation Cooperation (ILAC) to enable a global 
response to the IVD Directives. The In Vitro Medical Devices Directive (IVDD) 
98/79/EC, introduced in 1998 was not capable of regulating all new technical 
and medical developments. Several weaknesses in the IVDD were identified: 
new developments regarding genetic testing and companion diagnostic devices 
that are not specifically addressed in the IVDD, the need to better align with 
international guidelines– including a risk-based classification system–and 
the lack of control over high risk “in-house” tests. The new European In Vitro 
Diagnostic Regulation (IVDR) EU/2017/746, published in the Official Journal 
of the European Union on May 5, 2017, entered into force on May 25, 2017. The 
biggest change is the introduction of a risk-based approach to classification in 
combination with increased Notified Body (NB) oversight. The official transition 
period for full implementation is five years. The new EU regulations create a new 
environment for IVD companies in terms of product development, management 
of product lifecycle, and commercialization approach. The new EU regulations 
create a new environment for IVD companies in terms of product development, 
management of product lifecycle, and commercialization approach. 
Introduction of the European Metrology Network on Traceability in 
Laboratory Medicine
Muslum Akgoz, TUBITAK Turkey
The new EURAMET European Metrology Networks (EMNs) were introduced 
with the objective to create sustainable structures in areas of strategic importance 
for the future development of European metrology. The network on Traceability 
in Laboratory Medicine (TraceLabMed) was initiated to build a coordinated 
infrastructure in an area that affects almost every European citizen. In vitro 
diagnostics based laboratory testing is fundamental to healthcare and an 
important factor within the EU economy. The maximum benefit of laboratory 
tests for patients (proper diagnosis, reduced hospital stays, less burden on 
health insurances, etc.) can be achieved with tests that provide accurate results 
irrespective of the laboratory, the test kit, and the instruments used to obtain 
these results. The European regulation on in vitro diagnostic medical devices 
(2017/746/EU) (IVDR), which came into force in May 2017, supports this task, 
among other measures, by requiring metrological traceability of calibrator and 
control material values as well as designated EU reference laboratories. The 
EMN TraceLabMed was established as a central point of contact for calibration 
and reference laboratories and IVD manufacturers to support a coherent strategy 
for a pan-European response to the legal requirements for in vitro diagnostics. 
By facilitating collaboration across Europe, the EMN TraceLabMed will help 
to establish the reliability and consistency of measurement results in laboratory 
medicine, supporting the health of European citizens. The presentation will give 
a brief overview of the status and activities of the EMN TraceLabMed and the 
strategies used to achieve progress. 
Amino Acid and Organic Acid CRMs for Newborn Screening
Simay Gunduz 
TUBITAK National Metrology Institute (UME), Organic Chemistry Laboratory, 
Gebze,/Kocaeli, Turkey 
The Certified Reference Material (CRM) is utilized in chemical measurements 
as a useful tool for proving traceability of measurement result and enhances 
measurement quality. Organic acid and Amino acid concentrations are frequently 
measured for treatment and diagnosis purposes of Inborn error of metabolism 
(IEM) which is a permanent and inherited biochemical disorder generally 
caused by organic acid, amino acid metabolism distortedness. Early diagnosis 
of metabolic diseases is very critical and they should be evaluated through 
reliable screening tests. The use of CRMs is required to ensure the quality of the 
chemical measurements. Particularly, it is important to use CRMs, having the 
same chemical compositions (matrix matched CRM), for the detection of subject 
quantity in the mixtures (matrix), such as body fluids, containing more than one 
metabolite. In this way, through the use of CRM in measurements, metrological 
traceability chain can be ensured.:Production and the certification of the CRMs 
are carried out according to the technical requirements of ISO Guide 35. 
Quality management system based on ISO/IEC 17025 and ISO Guide 34. 
IDMS method was applied as primary method of measurement for the 
characterisation of the materialsS:Amino acid concentrations in lyophilized 
human plasma are certified in UME CRM 1314.
Organic acid concentrations in lyophilized urine are certified in UME CRM 
1315.:Two new certified reference materials were produced and certified to be 
used in newborn screening tests and routine clinical measurements for 32 amino 
acids in human plasma and 47 organic acids in urine.
Keywords: Certified Reference Materials (CRMs), quality control, newborn 
screening, metabolic disorder
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ID-MS based reference measurement method for small analytes: vitamin D, 
creatinine, glucose, cholesterol, amino acids
Mine Bilsel, Hasibe Yılmaz, Gökhan Bilsel, Simay Gündüz, 
Ahmet Ceyhan Gören 
TÜBİTAK-UME, National Metrology Institute, Organic Chemistry Laboratory, 
Gebze-Kocaeli, TurkeY 
Isotope Dilution Mass Spectrometry (IDMS) is a primary method capable of 
providing accurate and precise results directly traceable to the International 
System of units. IDMS is an analytical technique based on the modification of 
the natural isotope composition of compounds after the addition to the sample 
an isotopically labeled form of the analyte. In this study, the use of LC-IDMS in 
analysing Vitamine D, Creatine, Cholesterol, Glucose in serum and amino acids 
in diluted HCL is described.:Certified references materials were provided from 
Nist. Liquid Chromatography- Isotope Dilution Mass Spectrometry method was 
used for quantification.:25-hydroxy vitamin D3 in human serum were ranging 
from 25.84 to 37.82 ng/g with an expanded uncertainty of 1.84 to 2.71 ng/g for 
25-hydroxy vitamin D3.
Creatinine in human serum were ranging from 7.47 to 7.485 µg/g with an 
expanded uncertainty of 7.45E-02 to 7.74E-02 µg/g.
Glucose in human serum were ranging from 1.15 to 1.16 mg/g with an expanded 
uncertainty of 1.23E-02 to 1.39E-02 mg/g.
Cholesterol in human serum were ranging from 2.27 to 2.31 mg/g with an 
expanded uncertainty of 6.19E-02 to 6.59E-02 mg/g.
Phenlalanine, Leucine, Isoleucine and Proline in diluted HCL were 482.59, 
200.64, 218.98 and 47.24 µg/g with an expanded uncertainty of 7.20, 3.24, 7.00 
and 1.62 µg/g respectively.:Primary method techniques are capable of providing 
accurate and precise results.The reliability and performance of the method was 
demonstrated by uncertainty budget and method validation.
Keywords: vitamin D, creatinine, glucose, cholesterol, amino acids
Reference methods for quantification of peptides & proteins: β-amyloid in 
CSF, hCP, oxytocin, HbA1c, insulin, hGH
Merve Oztug, Gonca Altın Yılmazer, Bilgin Vatansever, 
Suleyman Zühtü Can, Muslum Akgoz 
TUBITAK UME, National Metrology Institute ofYTurkey, Gebze, Kocaeli, 
Turkey 
Over the past two decades there have been important developments in the 
diagnosis and treatment of diseases with the increase in the number of 
biomarker molecules. There are now many endogenous peptides and proteins 
used as biomarkers and/or drugs. Amyloid-beta (Aβ) peptide, oxytocin, growth 
hormone, C-peptide, HbA1C are just a few of them. These molecules are used 
for therapeutic purposes as well as reference material for the diagnosis of the 
disease from plasma or serum. The use of certified reference materials (CRM) 
and validation of the measurement methods is a technical and regulatory 
issue deserves close attention.:In TUBITAK UME Laboratories, the peptide 
impurity analysis is performed by PICAA (Peptide Impurity Corrected Amino 
Acid Analysis) method. PICAA analysis involves AAA Isotope Dilution Mass 
Spectrometry (AAA-ID-MS / MS) and the intact peptide analysis using High 
Resolution Liquid Chromatography MS (LC-HR-MS/MS). Impurities from the 
peptide content determined by intact peptide analysis are used to correct the 
results of AAA analysis.:An SI traceable method was developed and validated for 
the impurity determination of several peptides and proteins in our laboratories. 
The analytical run was assessed determining, linearity, within-run accuracy and 
carryover. Matching the acceptance criteria the Correlation coefficient (r) of 
the calibration curve was found more than 0.995. The accuracy of 90% of the 
analyzed Quality Control was between 85.0% and 115.0%.:The PICAA method is 
an alternative method to the Total Mass Balance method used in peptide impurity 
analysis and can be performed with much less peptide/protein.
Keywords: CRM, Quantification, Peptide, Protein, Traceable
Latest developments on NMR; reference method for purity determination 
of small analytes and peptides
Ilker Ün 
TÜBİTAK UME, Kimya Grubu, Organik Kimya Laboratuvarı, Gebze, 
Kocaeli,eTurkey 
Nuclear magnetic resonance spectroscopy (NMR) is a very significant analytical 
method which has been routinely used by chemists for the determination of 
structures of compounds. Besides this, quantitative nuclear magnetic resonance 
spectroscopy (qNMR) has great importance in various fields, such as drug 
industry, manufacturing of reference materials, food analyses and metabolite 
determination in human body fluids. Moreover, applications of quantitative NMR 
involve determination of purity of a compound and amount and concentration 
of a sample inside a matrix. The aim of this study is to determine the purity 
of some small molecules by qNMR method. It is also to obtain very useful 
information to be used with the mass balance method for the purity determination 
of larger molecules such as peptides:The purity assessment of estradiol, folic 
acid, human C-peptide and oxytocin were done by quantitative nuclear magnetic 
resonance (qNMR). Internal standard purity was determined by UME CRM 1301 
chloramphenicol with a certified value of 99.58 ± 0.15% (k=2 (TÜBİTAK UME, 
Gebze, TR) within the traceability chain. All NMR experiments were performed 
at 298.15 K on a Varian VNMRS 600 spectrometer operating at 599.747 MHz for 
proton (1H) resonance frequency equipped with a 5 mm One NMR probe using 
5 mm sample tubes. The softwares VnmrJ 4.2 and MestReNova 11.0.0 were used 
for data acquisition and data processing, respectively.:The purity determination 
studies performed within CCQM comparisons have been successfully completed. 
The results of these comparisons were published in the Metrologia journal and in 
the BIPM key comparison database (kcdb.bipm.org/). The purity of folic acid and 
human C-peptide were reported as 909.78 ± 2.56 mg/g, and 853.15 ± 8.06 mg/g 
respectively by qNMR.:NMR is the unique method, which can determine, with 
one analysis, a small molecule, having a single proton or a peptide possessing 
multiple protons. In this study, the advantages of NMR as a quantitative technique 
are mentioned.
Keywords: qNMR traceability purity
Development of a Reference Method for Transferrin Quantification in 
Serum
Gonca F Coşkun, Süleyman Z Can 
Inorganic Chemistry Laboratory, TUBITAK UME, Kocaeli, Turkey 
Iron is one of the metals that are though to be involved in development of 
Alzheimer’s Disease (AD). Recent developments revealed that metalloproteins 
transport the metals to the brain across the blood-brain barrier. Hence, reliable 
measurement method for determination of transferrin (TRF) in body fluids is 
needed for investigating the influence of TRF in AD development. This study 
aims to develope and validate a reference method for TRF quantification in 
serum.:Triple species-specific HPLC isotope dilution mass spectrometry (SS-
HPLC-IDMS) approach was used for determination of TRF in serum and CSF. 
ERM-DA470k/IFCC (IRMM) and pooled CSF sample were used for method 
development and the method was validated using ERM-DA470k/IFCC. Firstly, 
57Fe-TRF spike was synthesized and characterized. In triple SS-HPLC-IDMS 
approach, two calibration blends were prepared with 56Fe-TRF solution (traceable 
to NIST SRM 3126a) and the synthesised 57Fe-TRF spike solution. The sample 
blend was prepared with 56Fe saturated ERM-DA470k/IFCC and 57Fe-TRF 
spike. The measurement of 56Fe/57Fe ratios in all blends were performed on 
HPLC-ICP-MS system using bracketing sequence. The instruments used for 
the measurements were Agilent 1100 Bioinert HPLC and Agilent 8000 ICP-
MS Triple Quad (Agilent Technologies). MonoQ 5/50 GL column (5 x 50 mm 
i.d., GE Healthcare) is used for separation of TRF sialoforms.:In the validation 
study, 3.0% repeatability has been obtained in measurements of 5 replicate 
measurements of ERM-DA470k/IFCC. The trueness of the method was tested, 
and varying recoveries in the range of 99.8%-105.9% were obtained.:A traceable 
quantification method for TRF in serum was developed and validated.
Keywords: Cerebrospinal fluid, Serum, Transferrin, SS-HPLC-IDMS
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A Reference method for genetic mutation quantification of KRAS
Muslum Akgoz, TUBITAK, Turkey 
The TÜBİTAK National Metrology Institute (UME) is a member of the International 
Bureau of Weights and Measures (BIPM). The aim of the Bioanalysis Laboratory is to 
develop primary measurement methods in the field of biometrology and life sciences, 
to give primary level measurement service, to produce certified reference materials 
and to carry out proficiency testing needed especially in our country. The aim of this 
study is to describe newly developed measurement methods with digital PCR (dPCR: 
Digital Polymerase Chain Reaction) instrument which is a new technology product.
Digital PCR instruments enables the calculation of DNA amount with the help of 
statistics by dividing single tube reaction to thousands to millions of smaller partitions.
In digital PCR method, the copy number concentration of DNA is determined 
without using a certified reference material and it is considered as the reference 
DNA measurements method. Additionally, since calibration graph is not used, 
new measurement methods have much higher accuracy and lower uncertainty 
than Real Time PCR methods. As personalized medicine applications has 
increased, the dPCR device has also been widely used clinically in the screening 
of genetic variants and additionally in the detection of bacteria and viruses. In 
this presentation, examples of research and development studies conducted in 
Bioanalysis Laboratory with dPCR method will be summarized.
IFCC, C-RIDL; The current concept and future plans for reference 
intervals and decision limits
Yesim Ozarda
Uludag University, School of Medicine, Department of Clinical Biochemistry, 
Bursa, Turkey
Chair, The IFCC Committee on Reference Intervals and Decision Limits
From 1987 to 1991, the International Federation of Clinical Chemistry (IFCC) 
published a series of 6 papers, in which it was recommended that each laboratory 
follow defined procedures to produce its own reference intervals (Rıs). Although 
there were very important developments and implementations between the 
1990s and 2008, the C28-A3 guideline, published in 2008 by CLSI and IFCC 
constituted the most significant step in the development of Rıs and updated in 
2010 as EP28-A3c guideline that is still in current use. This guideline entitled 
‘Defining, Establishing, and Verifying Reference Intervals in the Clinical 
Laboratory’ provides the necessary steps mainly for the selection of reference 
individuals, pre-analytical and analytical considerations, analysis of reference 
values for a RI establishment study, transference and verification of the Rıs. The 
recommended process for defining a reference interval is the so-called “direct” 
approach, where subjects representing the reference population are selected and 
sampled and the specimen analyzed for this purpose. The concept of reference 
intervals is now well established and is based on including a fixed percentage of 
a reference population within the interval described by upper and lower reference 
limits. 
Interest has been renewed in the topic as a result of the following regulatory 
initiatives in the last two decades: according to the European Directive 98/79 on in 
vitro diagnostic (IVD) medical devices, diagnostic kit manufacturers are obliged 
to supply their clients with appropriate Rıs for use with their assay platforms 
and reagents, and the International Organization for Standardization (ISO) 15189 
standard for clinical laboratory accreditation states that each laboratory should 
periodically re-evaluate its own Rıs. In the present-day era of evidence-based 
medicine, there is still a big gap between theory and practice with respect to the 
application of Rıs as decision-making tools, despite the mandatory requirements. 
The IFCC, C-RIDL has published two papers including a protocol and 
comprehensive standard operating procedures (SOPs) for multicenter RI studies, 
with an indication of the utility of a panel of sera for the alignment of test results 
among laboratories in multicenter studies. In recent years, the IFCC, C-RIDL has 
coordinated a global multicenter study to establish Rıs and to explore sources 
of variations on reference values across several countries and published the 
results of the global study in two articles in CCA that are accessible through the 
IFCC website. For pediatric and geriatric Rıs, the challenges are even greater 
since samples from reference individuals are difficult to obtain. The alternative 
approaches are recommended especially in these cases in the EP28-A3c guideline.
An alternative approach is the “indirect” approach where results from specimens 
are collected for routine purposes, which have been collected for screening, 
diagnostic or monitoring purposes and are used to determine the reference 
intervals. Last year, a review has been published in CCLM by C-RIDL on 
the use of indirect approaches to establish and verify Rıs from the results of 
routine laboratory testing. The indirect approach has some potential advantages 
compared with direct methods. The processes are faster, cheaper and do not 
involve patient inconvenience, discomfort or the risks associated with generating 
new patient health information. Indirect methods also use the same preanalytical 
and analytical techniques used for patient management and can provide very 
large numbers for assessment. Limitations to the indirect methods include 
possible effects of diseased subpopulations on the derived interval. Currently, the 
Committee is working on the comparison of different statistical techniques for 
indirect methods to establish reference intervals with the existing direct methods.
Another point of discussion is the confusion which arises from Rıs and clinical 
decision limits (CDLs). As the two concepts are sometimes confused, there is a 
need to clarify the differences between these terms and to ensure they are easily 
distinguished, especially because CDLs have a clinical association with specific 
diseases and risks, thereby implying that effective clinical interventions are 
available. It is important to note that, because population-based Rıs are derived 
from the range of values expected in a typical community population, laboratory 
results that fall outside a RI do not necessarily indicate a disease but rather that 
additional medical follow-up and/or treatment may be warranted. In contrast, 
CDLs are associated with a risk of specific adverse outcomes and are commonly 
used to interpret laboratory test results, including lipid parameters, glucose, 
hemoglobin A1c (HbA1c), and tumor markers, to determine the risk of disease, 
to diagnose or to treat. Therefore, C-RIDL aims to emphasize the importance of 
the correct use of both Rıs and CDLs and to encourage laboratories to specify the 
appropriate information to clinicians as needed. 
The aim of this talk is to present the current theory and practice of Rıs together 
with a detailed evaluation of the most recent multicenter studies, an assessment of 
the Rıs of the pediatric and geriatric groups, which is still regarded as a problem 
in this area, a detailed explanation of the advantages and disadvantages of the 
indirect approaches, future possibilities based on the comparison of direct and 
indirect methods for establishing reference intervals and a clarification of the 
confusion which arises from the use of CDLs.
Keywords: IFCC, C-RIDL, reference intervals, multicenter studies, EP28-A3c 
guideline, decision limits,  indirect methods
Developing a roadmap for laboratory test utilization management program
Sedef Yenice Florence Nightingale Hospital, İstanbul, Turkey
Utilization management has been a traditional approach to control costs in clinical 
laboratory services for several decades. Following utilization management, best 
practices results in the highest quality care at the lowest cost, supports Lean and 
Six Sigma initiatives, and saves significant time and money. In fact, appropriate 
utilization reduces patient risk and empowers organizations to provide the 
highest quality of care. While it is good to have an understanding of utilization 
management, IFCC Committee on Clinical Laboratory Management has recently 
conducted an international survey to investigate what does this mean for the 
laboratory leaders and examined the state of medical laboratory test utilization 
management and relevant practices which are country-specific from a laboratory 
leader perspective. The findings of this survey revealed that the recognition of 
test utilization management, current practices, and maturation of those programs 
are significantly diverse among countries. It is relatively well established in 
most developed nations. However, the findings have confirmed that the need to 
develop a roadmap and to construct essential strategies for managing laboratory 
test utilization is a common interest.  With this regard, it is of importance to select 
the right management tool to implement an optimal laboratory test utilization. 
This presentation will address the following key points for implementing 
utilization management initiatives:
· Structure of effective communication 
· Infrastructure to assist implementation
· Establishing a laboratory formulary 
· Gatekeeping mechanisms
· Clinical decision support
· Benchmarking and management metrics
· Consultative and Interpretive services
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Threat of chemical weapons in Syria conflict and its impact on Balkan 
Region along with the health and laboratory management system
Levent Kenar,
Chief of Medical CBRN (Chemical, Biological, Radiological, Nuclear) Defense
University of Health Sciences (formerly Gulhane Military Medical Academy), 
Ankara,/Turkey
The Balkan countries have a special geostrategic importance as they enable the 
passage to the Mediterranean from North and cross region from Asia including 
Middle-East to Europa. Since this region has been one of the targets of various 
States and groups historically, this geographical area is still under the influence 
of terrorist attacks.
As one of such dangers, threat emerging from chemical warfare / terror agents has 
been one of the biggest challenges originated not only from military operations 
but also from terrorist attacks and natural disasters. The threat from chemical 
agents on this dynamic “hot” region is still a great concern necessitating an 
extensive collaboration between the Balkan countries. 
From the beginning of the crisis starting at 2013, chemical weapons have been 
used over 160 times in Syria and at least more than 15000 Syrians have suffered 
from chemical exposure since the beginning of the conflict. Some intelligence 
analysis data reported that Syria had an important chemical weapon capability, 
which included blister agents, like sulfur mustard, and nerve agents, like sarin 
and Vx. The striking event of those which occurred in Syria was the attack of 
chemical weapons used on 21 August 2013 during the ongoing conflict between 
the parties in the Syrian Arab Republic also against civilians, including children, 
on a relatively large scale according to the UN Mission team reports. A high 
number of patients in a short period of time were showing clinical signs, like 
miosis, excessive secretions of rhinorrhea and salivation, shortness of breath and 
convulsions, were consistent with exposure to a nerve agent.
Since this threat has evolved as a great issue in both military and terrorist aspects 
in recent years, an effective medical preparedness against such weapons along 
with the effective health organization is a requirement. Chemical warfare/
terrorism is the intentional use of toxic chemicals such as nerve gases, vesicating 
agents, cyanide, toxic industrail chemicals, smokes, tear gases, cyanide and 
chemicals listed in the Chemical Weapons Convention and toxins to spread life-
threatening diseases in order to incapacitate the population of an area. They are 
used for hostile purposes and planned to cause disease or death in human, animals 
or plants. 
Under the pre-incident preparedness measures, A rapid and coordinated medical 
response should be based on main integrated areas of interest  including training 
and research on preparedness and prevention, 
detection and surveillance system,
 diagnosis and characterization of the agents
 and emergency management involving epidemiologic investigation, medical 
treatment and prophylaxis for affected people and decontamination measures. 
Modern threats of biochemical terrorism lead to development of methods for 
true and fast detection of chemical weapons. Currently, there are many types 
of methods used in this field, from which chromatography techniques can be 
employed for more rapid identification of these agents than conventional 
laboratory analytical methods. However, analysis is often challenging because 
of the limited size, quality, and purity of the biological target for the verification 
of chemical in use. 
Lack of coordination and preparedness at national, regional and international levels 
can have some dramatic consequences. Defense against chemical threat is such a 
complex issue that requires highly qualified experts from various organizations 
including medical units, procurement of protective measures and detection assets 
and being aware of the current treatment approaches accompanied with extensive 
training activities. This is why the medical management involves first responders’ 
organisations (including health experts) in charge of the protection and mitigation 
of the effects of chemicals.
To enhance coordination and effective medical response against regional 
chemical threat, some proposals may include in fields of concern such as: sharing 
medical preparedness plans whic also contain emergency medical and public 
health issues, establishing specialized response teams and a laboratory response 
network, exchange information and publications which are not confidential, 
organizing scientific meetings to increase the awareness amongst medical 
personnel. A Balkan common understanding may play a vital role in coordinating 
and conducting these mentioned measures.         
In this presentation, measures that needs to be taken against biochemical 
terrorism and concepts are to be reviewed from the Turkish medical perspective 
and potential items which are supposed to be roled in this event to be outlined. 
Through this presentation, a table top analytical laboratory exercise following a 
chemical terrorist attack will be simulated, and the response and coordination 
that needs to be developed against such an attack will be summarized within 
this network between the countries through the each national condiserations for 
coordination.    
The new In Vitro Diagnostic Regulation 2017/746 and consequences for 
Laboratory Medicine
Christa Cobbaert
Department of Clinical Chemistry and Laboratory Medicine, Leiden University 
Medical Centre, Leiden, the Netherlands
The new In Vitro Diagnostic Regulation 2017/746 (IVDR) was published May 
2017 and will fully replace Directive 98/79/EC (IVDD) per May 2022.  The aim of 
the IVDR is to further establish a well-regulated and smoothly functioning single 
market for in vitro diagnostic tests (IVDs) within the EU that is better aligned 
with new developments and guidelines. The IVDR introduces scope enlargement 
and a risk-based classification of medical tests. In this era of genetic testing and 
companion diagnostics it was crucial to secure protection of patient safety and 
public health by setting high standards for safety and performance of IVDs. The 
IVDR brings along expanded involvement of notified bodies that have to assess 
the majority (~85%) of IVDs with respect to IVDR compliance (namely for class 
B, C and D tests).  Other key changes are the requirements for evaluation and 
documentation of clinical evidence (i.e. scientific validity, analytical and clinical 
performance of tests); the introduction of a universal device identification code 
system (UDI); the set-up of an EudaMed database for the deposition by IVD-
industry of information about IVDs and lot-specific data; and the establishment 
of ongoing post-market surveillance programs. IVD-manufacturers have to fulfil 
all these IVDR requirements in order to get CE-marking and market access under 
the new IVDR. These changes will translate to a need for additional well-trained 
staff, increased costs and a higher dependence on notified bodies (for class B, C 
and D tests) and expert panels (in case of class D tests) for IVD-manufacturers. 
The replacement also has major consequences for diagnostic labs that use Lab-
Developed-Tests (LDTs).
Keywords: IVDR, IVDD, clinical evidence, notified bodies, expert panels
Galectin-3: from molecule to biomarker and back
Jerka Dumic
University of Zagreb Faculty of Pharmacy and Biochemistry, Department of 
Biochemistry and Molecular Biology, Ante Kovacica 1, HR-10000 Zagreb, Croati
Galectin-3 (Gal-3) is today the most widely studied member of galactoside-
binding lectin family (galectins), but during the first 25 years after it was firstly 
described in 1982 Gal-3 was mainly of interest of a few “glycobiology groups”. 
During that period, a significant amount of knowledge about Gal-3 had been 
collected and Gal-3 was recognised as both a potential diagnostic biomarker 
and a therapeutic target. We learned that Gal-3 can be present intracellularly 
(in the nucleus and cytoplasm) or extracellularly (on the cell surface and in 
the extracellular space), found in a wide range of cells and tissues, but that its 
expression depends on cell/tissue type and maturity, whereas the cells in which it 
is the most abundant are macrophages, epithelial and endothelial cells. Besides, it 
was found that Gal-3 affects numerous biological processes (e.g. cell proliferation, 
differentiation, apoptosis, signalling, cell-cell and cell-matrix interactions, etc.) 
through the specific interactions with a variety of intracellular (protein-protein) 
and extracellular proteins (lectin-sugar). Furthermore, it was identified as an 
important player of many physiological and pathophysiological events such as 
inflammation, fibrosis, angiogenesis, tumorigenesis and metastasis, but still it 
was just a one of thousands molecules “with a great potential”. 
Although Gal-3 was previously recognised as a molecule related to the heart 
failure in animal model, the Copernican turn regarding the interest for Gal-3 
occurred by the study of Kramer’s group in 2008, conducted on end-stage heart 
failure (HF) patients. The study detected elevated Gal-3 plasma concentration in 
those patients immediately and 30 days after application of mechanical circulatory 
support. After this discovery, the interest of scientists and clinicians for Gal-3 
tremendously increased, resulting in more than 600 papers (in PubMed) that 
referred “Gal-3 and heart” in the last 10 years. In 2013, the American College of 
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Cardiology Foundation and the American Heart Association recognized the value 
of Gal-3 testing and included it into the Guideline for the Management of Heart 
Failure, because it has been proven that Gal-3 could provide useful information 
for optimisation of HF patient care decisions. Namely, Gal-3, as a biomarker of 
myocardial fibrosis, is predictive of hospitalization and death and may provide 
incremental prognostic value over natriuretic peptide levels in patients with HF. 
Gal-3 has also been proven as a useful diagnostic marker for the differentiation 
of benign and malignant thyroid nodules, whereas its value for the diagnosis/
prognosis of other malignant and chronic diseases, e.g.  diabetic nephropathy, is 
under intensive investigations. 
Due to its important roles in different pathologies, Gal-3 has also been recognised 
as a potential therapeutic target. However, designing selective Gal-3 inhibitors 
is challenging because of the shared homology of the carbohydrate-recognition 
domains among not only galectins, but also other lectins. Yet, several Gal-
3 agonists, either plan-based (GCS-100, GM-CT-01, GR-MD-02, modified 
citrus pectin) or synthetic (TD139) are in different phases of clinical trials as 
a potential drugs for different chronic diseases, e.g. NASH advanced fibrosis, 
chronic kidney disease, idiopathic pulmonary fibrosis, osteoarthritis, etc. as well 
as malignant diseases, e.g. chronic lymphocytic leukaemia, melanoma, colorectal 
cancer, metastatic melanoma, etc.
Our long-standing interest in Gal-3 has recently been directed on its involvement 
in the adaptation response of cardiovascular system (CVS) to recreational 
SCUBA diving, which represents a special form of physical activity, due 
to the body exposure to low temperature, hyperoxia and elevated pressure. 
Our studies of the effects of single dive and repeated dives on CVS, showed 
significant changes not only in Gal-3 plasma concentration, but also in the levels 
of other CVS biomarkers, such as hs-TnI, NT-proBNP, VEGF, endothelin-1 and 
myoglobin. Although transient, these changes suggest extensive activation of 
adaptation mechanisms, which in some aspects could possibly have a positive 
effect of SCUBA diving on CVS.  
Serum non-coding RNA profiling as a promising diagnostic approach
Christos Tsatsanis
Laboratory of Clinical Chemistry, Medical School, University of Crete, 
and Laboratory of Clinical Chemistry-Biochemistry, University Hospital of 
Heraklion, Heraklio3, Greece
Serum non-coding RNAs (ncRNAs) have been identified as paracrine and 
endocrine messengers of different diseases. It has now been widely acknowledged 
that ncRNAs a new area in the field of biomarkers has emerged. ncRNAs are 
RNA molecules of different sizes that are transcribed as independent genes or as 
part of protein coding genes and are not translated, therefore they do not produce 
proteins. They have been classified according to their size and function and 
include micro RNAs (miRNAs), piwiRNAs (piRNAs), snoRNAs and long non 
coding RNAs (lncRNAs). These non coding RNAs are present in different cell 
compartments participating in multiple cell functions, but they have also been 
identified in biological fluids, also known as cell-free or circulating ncRNAs, 
where they can be detected in exosomes, bound on lipoproteins as well as free 
circulating molecules. The role of circulating ncRNAs is still under investigation 
but are believed to be paracrine or endocrine messengers to systematically deliver 
signals between cells and tissues. Extensive studies have implicated a family of 
ncRNAs, this of miRNAs in disease pathogenesis and their potential as diagnostic 
and prognostic biomarkers of diseases. Recent evidence have identified additional 
families of ncRNAs such as piRNAs or lncRNAs as potential diagnostic tools 
both in the serum and in tissues. Detecting ncRNAs in biological fluids has 
opened a new field in Clinical Chemistry utilizing them as biomarkers of diseases 
or prognostic markers for different pathological conditions. To date, individual 
ncRNAs or groups of ncRNAs are being used to facilitate disease diagnosis. 
Nevertheless, diversity between individuals and pathogenetic mechanisms limits 
their specificity for most conditions. As high throughput analyses are becoming 
wider used and more affordable, ncRNA profiling is emerging as a diagnostic and 
prognostic approach. Profiling utilizes next generation sequencing approaches 
and allows screening  of all ncRNAs in biological fluids or cell extracts, thus 
providing a comprehensive view of the changes in any particular patient. Serum 
ncRNA profiling coupled with bioinformatics analyses that identify targets and 
functions associated with the target genes, provides evidence for a direct impact 
of the circulating ncRNAs on disease pathogenesis. A recent example published 
by our group has shown that ncRNA profiling identified miRNAs and piRNAs 
as biomarkers of male subfertility and associated those with hypogonadism. 
Additional examples in cancer patients have indicated that changes in serum 
ncRNA profiling reflects changes in cancer growth and may predict disease 
outcome. Thus, profiling of ncRNAs will provide a diagnostic tool that allows 
global understanding of changes occurring in diseases. Thus, ncRNA profiling 
coupled with proteomics analyses in patient samples is the foreseeable future in 
diagnostics.
Ethical issues in (pharmaco) genetics
Marija Hiljadnikova-Bajro
University SS Cyril and Methodius, Faculty of Pharmacy, Institute for Applied 
Biochemistry
Mother Theresa Boulevard, 47, Skopje, Republic of North Macedonia
Apart from genetic testing for diagnostic purposes, application of genetics in 
human medicine encompasses genetic interventions and pharmacogenetical testing 
which are becoming more frequently utilized in clinical practice, as well as genetic 
studies employed in the process of research and drug development.
It’s been widely known and accepted that application of a drug in equal dosing 
regimens for treatment of the same diagnosis in different patients, doesn’t produce 
equal results regarding achievement of a therapeutic effect and/or occurrence 
of side effects. Investigating the genetic cause for interindividual variations in 
patients’ drug response and toxicity, pharmacogenetics holds valuable prognostic 
and predictive value in tailoring the pharmacological treatment of various diseases 
accorcing to the principles of precision medicine. 
But, just as any other medical testing, genetic analyses impose ethical risks which in 
this case are even more serious due to the following specific features of these tests and 
the obtained data: the “mutual” ownership of the genetic information by individuals 
from the same family, the lack of precise phenotype-genotype correlation and the 
influence of epigenetic and environmental factors on the phenotypic expression of 
genetic information, the balance between the right of an individual “to know” and 
the right “to not know” as well as the enormous potential for discrimination. The 
rapid advancement of high throughput technologies delivering a mass of detailed 
data on an individual’s genome introduces a lot of advantages in scientific and 
clinical applications, but also threatens with a tremendous risk for misuse of these 
data in various settings.
The lecture discusses the fundamental ethical principles applicable to genetic 
analyses/studies including respect of the individual’s autonomy and privacy and 
commitment to providing confidentiality, beneficence and justice. The informed 
consent as well as the levels of anonymization in genetic testing as measures to 
satisfy the above mentioned principles will be addressed. Special emphasis will be 
placed on the ethical issues regarding orphan and rescued drugs emerging in the 
pharmacogenetical testing within clinical studies in drug research and development.
Philosophers of science claim that science is morally neutral, it is actually the use 
and implementation of science that can have positive or negative impact. Hence, 
it is crucial to understand that achievement of our aim for humane application 
of (pharmaco)genetics can only be accomplished if technological and clinical 
advances in this field advance at a similar rate with the corresponding ethical 
considerations.
The relationship between adiposity parameters and hsC-reactive protein 
values in overweight and obese women   
Aleksandra Atanasova Boshku
Department of Laboratory Diagnostics, University Clinic of Obstetrics and 
Gynecology, Faculty of Medicine, Skopje, Macedonia
Overweight/obesity has become an important health problem in developed 
countries and as a result of the rising epidemic of obesity, understanding body fat 
distribution and its clinical implications is critical to timely treatment. Adipose 
tissue is anatomically distributed in different proportions throughout the human 
body, but the percentage of adipose tissue is higher in women, the elderly 
and overweight individuals. Visceral adipose tissue is a hormonally active 
component of total body fat, which possesses unique biochemical characteristics 
that influence several normal and pathological processes in the human body. It 
has been distinctly linked to several pathological conditions including impaired 
glucose and lipid metabolism, insulin resistance, several malignancies, increased 
incidence of infections and non-infectious complications, and increased mortality 
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in hospital. Visceral obesity itself is an independent component of metabolic 
syndrome and the magnitude of obesity directly relates to the prognosis of this 
condition. It may be related to presence of low-grade inflammation in white 
adipose tissue. Precise mechanisms of chronic inflammation induction in obesity 
as well as the relation between obesity and inflammatory markers are yet to be 
explained. So far, the importance of high sensitive C-reactive protein (hs-CRP), as 
the most versatile inflammatory marker, is still in the spotlight. Hs-CRP outstands 
as independent risk factor, apparent from traditional risk factors such as increased 
total cholesterol, increased levels of glucose and homocysteine, hypertension, age, 
high body mass index (BMI), smoking and physical inactivity. As a hormonally 
active tissue, VAT releases different bioactive molecules and hormones, such as 
adiponectin, leptin, tumor necrosis factor, resistin and interleukin 6 (IL-6). Among 
these hormones, adiponectin is of particular significance owing to its protective 
antiangiogenic activity. In addition, in obese persons, white adipose tissue is 
infiltrated by macrophages with increased local production of proinflammatory 
mediators. These factors promote acute phase reaction and chronic inflammation 
in obese persons. However, some authors proposed the existence of a subgroup 
of obese persons who are metabolically normal (without increased risks of heart 
diseases, type 2 diabetes, hypertension, stroke, cancers, etc.). They hypothesize that 
in this subpopulation obesity seems to be uncomplicated and is characterized by 
early onset, hyper-plasticity of otherwise normal adipocytes, and peripheral type 
of fat distribution. The inflammation in these persons should be absent, and they 
supposed to have normal levels of inflammatory markers. The aim of this study was 
is to investigate the levels of inflammatory marker CRP and adiponectin and their 
relation to standard anthropometric parameters [body mass index (BMI) , waist 
circumference (WC), waist-to-hip ratio (WHR), waist-to-height ratio (WHtR)], in 
population of apparently healthy overweight and obese females. This study enrolled 
76 overweight (BMI between 25 and 29.9 kg/m2 ) and 45 obese (BMI ≥ 30 kg/
m2 ) females, nonsmokers, aged 18–45 years, without any comorbidities, and with 
regular menstrual cycles. Standard anthropometric measurements were performed: 
body weight (BW), body height, WC and hip circumference and followed 
parameters were calculated: BMI [kg/m2 ], waist-to-hip ratio (WHR), waist-to-
height ratio (WHtR). Quantitative determination of hs-CRP was determined using 
particle enhanced turbidimetric assay on the Cobas Integra 400 plus autoanalyser. 
The measuring range of hs-CRP was 0.1–20 mg/L, with a lower detection limit of 
0.1 mg/L. Levels of the total adiponectin were measured by an ELISA competitive 
enzyme immunoassay for quantitative measurement of the human adiponectin, 
using commercially available kits (BV51001 Human Adiponectin). Average hs-
CRP was 5.36 ± 2.43 mg/L, and significantly positively correlated to all investigated 
anthropometric parameters. 
Statistical analysis showed the significant difference between the overweight and 
obese group for all investigated anthropometric parameters, except for the age as 
well as CRP values.
Average adiponectin was 9,88±4,4 and correlated both negatively and significantly 
with the waist circumference, BMI (p<0.001). The major characteristic of our 
results is significant difference observed between overweight and obese subjects in 
almost all important features. Besides the anthropometric differences which were 
expected (BW, BMI), in the overweight group we recorded significantly lower 
values of parameters that reflect the metabolic risk: WC, WHR, WHtR, as well as 
significantly lower values of inflammatory marker CRP. Our results confirmed that 
CRP is a valuable marker of metabolic risk in obese females, and BMI, although 
not so new, is still a reliable parameter of adiposity.  
Photodynamic activity properties of novel BODIPY compound against 
colorectal cancer cell line
Burak Barut1, Can Özgür Yalçın2, Suat Sari3, Özlem Çoban4, Turgut Keleş5, 
Zekeriya Biyiklioglu5, Mahmoud Abudayyak2, Ümit Demirbaş5, Arzu Özel1
1Karadeniz Technical University, Faculty of Pharmacy, Department of 
Biochemistry, Trabzon, Turkey
2Karadeniz Technical University, Faculty of Pharmacy, Department of 
Toxicology, Trabzon, Turkey
3Hacettepe University, Faculty of Pharmacy, Department of Pharmaceutical 
Chemistry, Ankara, Turkey
4Karadeniz Technical University, Faculty of Pharmacy, Department of 
Pharmaceutical Technology, Trabzon, Turkey
5Karadeniz Technical University, Department of Chemistry, Trabzon, Turkey
Colorectal cancer (CRC) is the third most common cancer type and the second 
leading cause of cancer-related mortality worldwide in 2018 according to 
World Health Organization reports. Photodynamic therapy is a well-established 
clinical modality for treating various types of cancers. BODIPY compounds are 
promising molecules for diagnostic and therapy usage in cancer. In this study, 
photodynamic activity potential of water soluble novel BODIPY compound 
bearing pyridine group using different techniques were investigated. The 
photochemical and CT-DNA binding properties of water soluble novel BODIPY 
compound bearing pyridine groups (6a) were investigated absorption titration, 
competitive ethidium bromide and viscosity experiments. The DNA cleavage 
activities and topoisomerase I and II inhibition properties of compounds were 
investigated using pBR322 DNA on agarose gel electrophoresis. The cytotoxic 
and phototoxic effects of the compound were tested against human colorectal 
(HCT-116) cell line using MTT assay and flow cytometer. The singlet oxygen 
quantum yield of 6a was 0.21 in photochemical studies. The DNA binding 
experiments suggested that 6a interacted with DNA via non-covalent modes. 6a 
significantly cleaved pBR322 plasmid DNA forming singlet oxygen with light 
irradiation. The topoisomerases studies suggested that 6a inhibited enzymes 
in a concentration-dependent manner. In the cell culture studies, 6a had lower 
cytotoxic and higher phototoxic effects. In addition it induced apoptosis on 
HCT-116 cells. The results suggested that it was thought that 6a had a promising 
photosensitizer agent for CRC. 
This	 study	 was	 supported	 by	 The	 Research	 Fund	 of	 Karadeniz	 Technical	
University (Grant no: 8134), Trabzon, Turkey.
Metabolomics and biomarkers in inborn errors of metabolism
İncilay Lay
Hacettepe University Faculty of Medicine, Department of Medical Biochemistry; 
Hacettepe University Hospitals, Clinical Pathology Laboratory, Ankara-Turkey
Inborn errors of metabolism are inherited disorders resulting from mutations 
affecting functional proteins such as an enzyme/transport/activator protein in the 
metabolic pathways or organelle function that cause an interruption of protein, fat, 
carbohydrate, sterol, nucleic acid, membrane, neurotransmitter etc. metabolisms. 
To date, over 1000 inborn errors of metabolism have been identified. Although 
they are individually rare disorders, the cumulative incidence is 1/1000 live births. 
Age of presentation can vary from infancy to adolescence with a wide clinical 
spectrum, the more severe forms appearing in early childhood accompanied 
by significant morbidity and mortality. Nowadays, treatment options including 
enzyme replacement, substrate reduction, cell and organ transplantation and 
gene therapies are available and early diagnosis is becoming important for early 
treatment. In recent years, with the development of high-througput technologies, 
metabolomic studies have advanced and new biomarkers have started to emerge 
for early diagnosis and treatment follow-up. Metabolomics is comprehensive 
analysis of metabolites (≤1500Da) in a biological specimen that can enable 
precision medicine at a number of levels, including the characterization of 
metabolic derangements and metabolic phenotypes that underlie disease, 
discovery of new therapeutic targets, and discovery of biomarkers that may be 
used to either diagnose disease or monitor activity of therapeutics. Structural and 
functional information on 247 metabolites associated with 147 inborn errors of 
metabolism and 202 metabolic pathways involved in various inborn errors of 
metabolism have been reported in the human metabolome database (HMDB). 
Nuclear magnetic resonance (NMR) spectroscopy and mass spectrometry (MS)-
based tecnologies are reference methods for extracting comprehensive and 
unbiased chemical information from complex mixtures of metabolites. Both 
targeted and untargeted mass spectrometry-based metabolomic approaches have 
been used to expand the range of disease-associate metabolites. In the targeted 
approach, specific metabolites are detected, quantified and compared to establish 
reference ranges. The untargeted approach consists of analysis of all detectable 
metabolites known and unknown in a single test performed on a biological sample 
to determine any perturbation of single or multiple metabolites and of related 
biochemical pathways. Among the first well-known targeted metabolomic for 
inborn errors of metabolism include acylcarnitine, amino acid and organic acid 
analyses in biological samples for screening of the disorders. Aminoacidopathies, 
organic acidurias and fatty acid oxidation disorders were investigated by using the 
targeted metabolomic analyses. Beside them, analyses of oxysterols (Cholestane-
3β, 5α, 6β triol and 7-ketocholesterol) as biomarkers for Niemann-Pick Type C, 
and bile acids in the diagnosis of hereditary bile acid metabolism defects have been 
performed by targeted mass spectrometry-based analyses in Central Laboratory 
of Hacettepe University Hospitals. Classical bile acids, hydroxylated bile acids, 
3β-hydroxy-Δ5-bile acids, 3-oxo-Δ4-bile acids, short-chain bile acids, long-chain 
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bile acids, differential bile acids can be screened in urine samples by LC-MS/MS. 
An increase in 3-oxo-Δ4-bile acids in Δ4-3-oxo-steroid 5β-reductase deficiency, 
an increase in 3β-monohydroxy-Δ5 bile acids in oxysterol-7α-hydroxylase 
deficiency, an increase in bile acid alcohols in peroxisomal diseases can be 
observed. Decreasing in unusual bile acids can be observed during treatment 
follow-up. With targeted metabolic approaches using MS technology, biomarkers 
for different inborn errors of metabolism can be detected. Beside oxysterols, 
lyso-sphingomyelin-509 for Niemann-Pick Type C, glycosaminoglycans for 
types of Mucopolysaccharidoses, globotriaosylsphingosine (LysoGb3) for Fabry, 
Lyso-Gb1 for Gaucher are examples for biomarkers of some inborn errors of 
metabolism that can be detected by targeted metabolomic analyses. The best 
approach to metabolomic study of complex inborn errors of metabolism may be 
the combination of untargeted approach, that span the breadth of metabolome 
and perform pathways analysis, with targeted approach, that measures specific 
metabolites and establishes their reference intervals. The integration of genomic 
with metabolomic data will improve diagnosis and prognostication of inborn 
errors of metabolism. 
Key words: Metabolomics, mass spectrometry, biomarkers, inborn errors of 
metabolism
Genetic Technologies in Inborn Errors of Metabolism
Didem Yücel Yılmaz
Hacettepe University, Institute of Child Health&Department of Pediatrics, 
Metabolism Unit, Ankara,YTurkey
Inborn errors of metabolism (IEM) are inherited single gene disorders caused 
by a deficiency of an enzyme, its cofactor or a transporter protein in synthesis 
or catabolic pathway of proteins, carbohydrates and fatty acids. Neurometabolic 
diseases, which are also considered as a subgroup of metabolic diseases, result in 
neuronal damage due to inability to synthesize essential biochemical substances, 
abnormal accumulation or formation of toxic metabolites. Although these 
disorders are individually rare, collectively they account for a significant portion 
of childhood genetic disorders. 
The incidence of metabolic / neurometabolic diseases is generally reported as 
1/4 000 - 1/5 000 in the worldwide. The rate of consanguineous marriages in 
Turkey is 21.4% resulting in a population with relatively high frequency of 
metabolic/neurometabolic disorders compared to other countries. Metabolic/ 
neurometabolic disorders are considered rare diseases in other countries however 
these disorders are much more common in Turkey. IEM are quite heterogeneous 
and severe genetic diseases with a variety of overlapping or unspecific clinical 
phenotypes. Even though primary diagnosis of IEM is done by clinical suspicion 
and biochemical tests, genetic investigations play a significant role for appropriate 
patient treatment and genetic counselling as indispensable tool.
Since the sequencing of the first human genome in 2001, genomic technologies 
have made a huge impact across many fields such as medicine, computational and 
information technology, and healthcare. For many years there have been a variety 
of technologies and tools used in genome analysis. However, only in the past 
decade there has been rapid revolutionizing progress and improvement in high-
throughput methods. These methods are ranging from traditional conventional 
laboratory genetic techniques of microscopic cytogenetics, fluorescence in situ 
hybridization (FISH), southern blotting, denaturing gel electrophoresis, single 
stranded conformation, restriction fragment length polymorphism (RFLP), 
mapping and genotyping studies using microsatellite markers and many 
other nonsequencing genetic laboratory methods to more complex systems, 
such as microarrays and next-generation sequencing. Developing these new 
methodologies allow rapid, high specificity and high-throughput and cost-
effective analysis of a large number of samples from small amount of biological 
material. Also, utilization of advanced genetic technologies applications/analysis 
has led to the rapid and accurate diagnosis of the diseases and as a result several 
novel diseases have lately been defined. 
IEM are generally inherited as autosomal recessive although dominant, 
mitochondrial and X-linked types of inheritance are also possible. The 
genetic defects include point mutations, deletions, insertions or chromosomal 
abnormalities that result in loss- or gain-of-function of mutant enzymes or proteins. 
Depending on the variant type and locus, there are numerous different genetic 
methods and tools for the variant detection. For example, due to its simplicity the 
most frequent method for the analysis of a large (>5 Mb) chromosomal aberration 
is karyotype analysis by using the GTG banding technique. Other molecular 
genetic methods, such as microarray-based comparative genomic hybridization 
(aCGH) or fluorescent in situ hybridization (FISH), could be applied for a more 
accurate analysis. Moreover, for detection particular variant another molecular 
genetic methods might be applicable, which include restriction enzyme assay of 
specific DNA sequence. Direct DNA sequencing method (Sanger sequencing) 
is accepted as the “gold standard” for the identification of known as well as 
unspecified variants such as point mutations, small deletions and duplications 
in the genomic DNA. Although the majority of the mutations accounting for 
IEM are point mutations, sometimes, large deletions and insertions and copy 
number changes can be causative. For this purpose, the most commonly used 
technologies are “multiplex ligation-dependent probe amplification (MLPA)” and 
“comparative genomic hybridization (CGH).” High-throughput single-nucleotide 
polymorphism (SNP) microarray is also produces genome-wide results that 
designed for genotyping a patient’s DNA for genome-wide association studies 
(GWAS) and co-segregation studies to determine linkage between a disease 
locus and a chromosomal region These results are very useful in complementing 
the next-generation sequencing results. Furthermore, SNP array platforms may 
now also include a large number of probes specifically for the detection of copy 
number variants. SNP arrays and aCGH arrays also provide accurate tools for 
detecting small deletions and duplications. 
In recent years “next-generation sequencing technologies” have enabled 
investigation of hundreds and thousand of targeted genes, even the whole 
exome and whole genome, at single base pair resolution. Large deletions and 
insertions can also be detected by this technology. The use of whole exome 
sequencing (WES) has facilitated the identification of the many novel genes 
responsible for metabolic/neurometabolic diseases. In terms of rare genetic 
diseases, the identification of the genetic basis of disease is reached in 20 to 
40% of patients using WES. The most important and crucial part of exome and 
genome sequencing, is to find the disease-causing mutation among the thousands 
of variations. The structural or functional effect of the variation on protein or 
enzyme determines whether the nucleotide changes are a mutation that causes 
disease pathology. Base changes that result in amino acid changes (missense 
mutations) are evaluated by software programs including PolyPhen-2, SIFT, 
and Mutation Taster that rate the pathogenicity of the amino acid change. These 
programs estimates of how tightly the base is conserved over evolution, whether 
the amino acid changes charge, size, or conformation, and, sometimes, where 
in the protein the amino acid change reside. Functional studies may be required 
to demonstrate the pathogenic effect of a mutations. Genome databases, disease 
databases, mutation databases can be used to investigate clinical phenotypes 
caused by different mutations. 
Depending on the location and type of mutations, their effects on protein and 
clinical findings in patients may vary widely. Mutations that cause clinical 
phenotype are now being investigated by comprehensive methods including 
collectively evaluating all changes at the genomic level, searching for modifying 
genes, epigenetic changes and genome-wide bioinformatic analysis methods. 
Molecular diagnostic methods are of increasing importance in many medical 
applications such as elucidating the pathophysiology of the disease, identifying 
patients and carriers and providing genetic counseling services, identifying 
asymptomatic individuals, differential diagnosis of atypical patients, and 
developing effective treatment and follow-up for patients.
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CONGRESS COURSE ABSTRACTS 
EFLM Course: How to write a good scientific and professional article?
Sverre Sandberg, Noklus, Norway - Elvar Theodorsson, Ike/Klinisk Kemi, 
Sweden
Introduction
Scientific manuscripts can be written in solitude, but it is commonly more 
productive and more likely to result in better quality if several persons collaborate. 
The present course builds on this premise and on the understanding that mentored 
learning through an intensive work of the participants themselves is the most 
effective method of learning.
The present 48 hours EFLM course in the writing of scientific manuscripts rests 
on four pillars:
The task of turning a scientific study with resulting data that the participants 
get from the outset into a manuscript written in English as when intended for 
publication in an international scientific journal
The participants work closely together in groups of 5-8 persons chosen by the 
mentors. The group work is performed in the participants own mother tongue 
whereas the communication of the group with the mentors and in the written parts 
of manuscript will be in English.
The individual participants are expected to take and maintain the initiative during 
the entire course in creating and maintaining a fruitful working relation in the 
groups and in utilizing their own knowledge and skills and those of the two 
mentors optimally for finishing the task of the group in a fruitful and timely 
manner.
The two mentors will have brief introductory lectures and subsequently rotate 
amongst the groups for advice on request of the members of the groups and for 
making short (about 20 min) presentations.
The tasks of the participants
Maintaining an open mind regarding the knowledge and skills of all other 
members of the group
Contributing all the relevant knowledge and skills of the participants towards the 
common goals of the group
Introductory lectures of about 20 minutes each
Day 1 The study and data that makeup the data for the current manuscript
• The Material and methods part of the manuscript
• The Results part of the manuscript
• The Introduction part of the manuscript
Day 2 The Discussion part of the manuscript
• The Title, index words and Abstract parts of the manuscrip
miRNA isolation and expression training program
Aylin Sepici Dincel, Gazi University, Turkey - Oytun Portakal, Hacettepe 
University, Turkey             
miRNAs regulate various metabolic and cellular pathways that specifically 
control cell proliferation, migration, differentiation and signal transduction by 
negatively affecting the expression of target mRNAs. Numerous microRNAs 
have been identified that play a role in the transcription and translation of 
tumor suppressor genes or oncogenes in many solid tumors and hematologic 
malignancies. The relationship between microRNA expression levels and 
metastasis and survival in cancer patients was investigated. Since microRNAs 
have tissue-specific expression profiles and effective and reliable methods of 
expression quantification can be performed, microRNA-based markers are 
important in cancer diagnosis, prognosis and follow-up of treatment. In addition, 
microRNAs are involved in the regulation of radiotherapy and chemotherapy 
responses of tissues.
Objective
To gain knowledge and ability to detect and evaluate the amount of miRNA 
expression from different samples. The theoretical part of the course will provide 
information on miRNA isolation methods and details, methods for determining 
the amount of miRNA, amplification methods and how to normalize them. 
For the isolation of miRNA, the methods of isolation from classical tissue 
or cell culture as well as direct isolation from plasma will be discussed and 
their effectiveness will be examined. Sources of errors and strategies to avoid 
mistakes will be explained. In the application part, suitable samples prepared 
for miRNA isolation will be used and individual study will be provided. The 
quantification and expression of miRNAs obtained will be discussed with visual 
materials prepared by real-time PCR method. Information will be given about 
normalization. Clinical evaluation of identified up-regulated and down-regulated 
miRNA profiles will be performed.
Learning Objective
To be able to create a different view of these molecules with the recent 
developments in the field of research of miRNAs that attract attention with 
biomarker studies.
At the end of this course participants will:
1. explain and apply miRNA isolation methods from plasma and different tissues
2. be able to quantify miRNA
3. identify miRNA expression profiles
4. apply normalization, basic clinical evaluation issues
Target group
Researchers and postgraduate students and specialists in biochemistry.
Necessary knowledge and skills
Molecular genomic techniques should have a basic level of knowledge.
Applying Six Sigma to analytical performance in the medical laboratories 
Hassan Bayat, Iran
Introduction 
14:45-15:15 
The concepts of Sigma Metric 
The history of the development of this metric 
Definitions of Acceptable Product, Acceptable Performance, the meaning of 
Defects per Million Opportunities (DPMO) 
Two Approaches to Calculating Sigma-metric 
15:15-16:00 
The counting approach vs. statistical approach to determine defect rate 
Statistical approach is appropriate for estimating error rate of analytical phase 
Sigma-metric in Evaluation of Analytical Performance 
16:00—16:45 
The equation to determine the analytical Sigma-metric 
The components necessary to calculate Sigma-metric: TEa, bias and imprecision 
Sigma-metric in QC Planning 
16:45-17:45 
The relation between Sigma and patient risk 
Characteristics of statistical quality control 
Adjusting QC based on Sigma: QC rules, number of QC assays per event, and 
QC frequency 
Q & A 
17:45-18:15 
The audience will present their comments and questions
 
Mass Spectrometer use in clinical laboratory practice (Basic Course)
Prof. Dr. Ali Ünlü, Selçuk University, Konya
Prof. Dr. Muhittin Serdar, Acıbadem University, İstanbul
Doç. Dr. Sedat Abuşoğlu, Selçuk University, Konya
AIM: Mass spectrometric techniques are increasingly used in clinical laboratory. 
The aim of this course is to reach a sufficient level of knowledge about working 
principles, procedures, aspects to be considered and application areas of mass 
spectrometry.
COURSE OUTLINE:
Liquid chromatography principles,
Mass Spectrometer (MS) techniques
Setting up a clinical mass spectrometer lab, calibrator and reagent selection in 
MS methods, quantitative result evaluation.
MS applications in clinical laboratories, comparison with immunassays.
Method validation and verification process in MS
Discussion
PARTICIPANT PORTFOLIO:
Medical biochemistry specialists, PhD, research assistants, graduate students, 
device users.
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Mass spectrometer use in clinical laboratory practice (Advance Course)
Prof. Dr. Ali Ünlü, Selçuk University, Konya
Prof. Dr. Muhittin Serdar, Acıbadem University, İstanbul
Doç. Dr. Sedat Abuşoğlu, Selçuk University, Konya
AIM: Advanced mass spectrometer training course for partially experienced 
specialists who have mass spectrometer in their laboratory and familiar with mass 
spectrometer use.
COURSE OUTLINE:
“In house “method development in mass spectrometer laboratories and 
verification of commercial kits (CLSI 62-A)
Maintenance of mass spectrometry and troubleshooting, maintenance of quality 
in mass spectrometry analysis
Use of MS in metabolism laboratories
Method selection in analytical toxicology
Mass spectrometry use in endocrine laboratories
Discussion
PARTICIPANT PORTFOLIO:
Medical biochemistry specialists, PhD, research assistants, graduate students, 
device users.
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INDUSTRY SPONSORED 
SYMPOSIUM ABSTRACTS
INDUSTRY SPONSORED SYMPOSIUM 1
BECKMAN COULTER
The role of autoverification in postanalitic process improvement
Özlem Gülbahar, Turkey
Today, there is an enhancing workload in clinical biochemistry laboratories 
because of the increase in test volume and variety. However, expectations of 
clinicians are increasing from the laboratory, including faster results. One of the 
solutions to cope with this situation is to use auto-verification (CDSS: Clinical 
Decision Support System). By CDSS, both the probability of human error and 
the turnaround time (TAT) will be shortened. More importantly, more time can 
be devoted to reviewing complex test results that require expert interpretation. 
Thus, it may be possible to develop rational laboratory use applications such 
as reflective testing and consultation. However, all these benefits depend on the 
creation of a suitable and adequate verification algorithm. Basically, an algorithm 
should include evaluation parameters for preanalytical phase (serum index, etc.), 
analytical phase (flags etc.) and postanalytical phase (critical value, delta check, 
etc.). In addition, validation studies must be completed, and reliability should be 
tested before use. The relevant CLSI guidelines (AUTO 10A and AUTO15) can 
be used for CDSS use. The use of CDDS, which is becoming more widespread in 
Europe and the USA, has started to be applied not mandatory in our country and 
its use is controlled by the health authority.
INDUSTRY SPONSORED SYMPOSIUM 2
SNIBE
The clinical performance of Maglumi AMH, 17-OH progesterone and B2 
microglobulin
Pinar Eker, Turkey
After seeing the evaluation of post-analytical phase as laboratory specialists by 
taking the opinions about outcomes of patients regarding the available results 
of 17 OH progesterone, AMH, β2 microglobulin and free testosterone(it will be 
called Maglumi panel in the next), the survey is made which is for clinicians about 
the clinical usefulness of our results especially for diagnosis and monitoring of 
concerning diseases . 
With the help of LIS data, the most frequent test requesting clinicians and the 
clinicians who requested the Maglumi panel tests have been chosen. In this case, 
The questionnaire was prepared and directed to each clinician by an e-survey 
in an electronic environment including the purpose where the results were 
graphically evaluated.
In terms of its contribution to clinical monitoring, positive feedback is received 
from most clinicians. Among all feedback, no less than 92% positive feedback is 
given expect that free testosterone with 84% positive feedback on monitoring, 
however, 92% positive feedback is given on its diagnostics use. 
In conclusion, total testing process may be never ending circle. Communicating 
with clinician is another extra step we need for patient safety.
INDUSTRY SPONSORED SYMPOSIUM 3
ROCHE
Automation solutions in laboratories 
Cigdem Karakukcu
Turkish Ministry of Health, Kayseri City Hospital, Biochemistry Laboratory
XXX. National Congress of the Turkish Biochemical Society TBS 2019 and 
XXVII. Balkan Clinical LaboratoryFederation Meeting BCLF 2019 have been 
hold together on October 27-31, 2019, in Antalya, Turkey. During the congress, 
Mrs. Karakukcu made a satellite symposium about the benefits of the workflow 
automation systems and she shared her experience during the installation and 
re-structure processes of the Biochemistry Laboratory located in the Central 
Laboratory, in the Kayseri City Hospital, one of the biggest hospitals of Turkey, 
with a 1607 bed capacity.
The start and installation of the biochemistry lab was on May 2018 without an 
automation system. During that time, there was 3,400 samples and 33,350 clinical 
chemistry and immunoassay tests daily and rate of Immunoassay testing was 
19.3% of total. Under these conditions, the average Turn Araound Time (TAT) 
was 370 minutes. The whole system and company was changed on October 2018. 
System workflow was rearranged.
After the change in system on October 2018 (just only the change of analyzers 
and workflow, the automation system was not installed yet), daily run test number 
was 36,070. TAT decreased to an average of 114 minutes on January 2019. In this 
period, Immunoassay testing rate was 22.4%.
After the automation system was installed in January 2019, the number of 
laboratory tests reached 40,028 in September 2019. The average TAT was 135 
minutes, although the immunoassay test rate reached 25%.
The addition of an automation system increases the control of the laboratory. It 
also has the effect of improving the workflow and eliminating errors in such high-
volume laboratories.  The contributions of automation to the laboratory can be 
summarized under 3 main pillars: Quality, Flexibility, Short and Predictible TAT.
Sample quality is checked in the first stage with a high resolution camera. In 
case the samples are lipemic, icteric or hemolytic, scenarios are defined and the 
journey of the sample in the laboratory is determined.
Sample loading to the system can be done with a bulk loader module or via a 
separate input module. The centrifuge module can change the rotational speeds 
according to the test contained in the samples. For example, it can be defined as 9 
minutes rotation time for hepatitis tests and 7 minutes for other tests.
Since the carriers which carrying the samples in the automation system are also 
the carriers of the analyzers themselves, the samples are not transferred to another 
carrier while entering the analyzers. Thus, there is no time loss during the transfer 
of the samples.
In the automation system, a post analytical device with a capacity of 27,000 
samples is used to archive and store samples at 4-8°C.  Samples that complete the 
storage period defined as 3 days are sent to waste automatically by the system.
Due to the structure of the City Hospitals, the systems are expected to be quite 
suitable for expansion. The Cobas ® Connection Modules (CCM) system meets 
this expectation quite well. It is possible to replace the analyzers with faster 
models and to add new pre-analytical equipments to the system. In addition, 
the system can be extended to connect not only biochemistry analyzers but also 
hemogram and coagulation analyzers.
INDUSTRY SPONSORED SYMPOSIUM 4
MINDRAY
Clinical utility of Reticulocyte Hemoglobin and Hypochromic erythrocytes 
reported by Mindray BC6800 Plus hematology analyzer in the study of 
erythropoiesis
Eloísa Urrechaga, Senior Consultant for Clinical Laboratory
The hemogram is one of the more required tests by the clinicians, the analysis 
nowadays is totally automated, and the correct interpretation of the results 
requires joining the knowledge about the characteristics of the equipment and the 
clinical meaning of the results. The suppliers contribute innovations, providing 
new parameters that can help the clinicians to make a diagnosis in a fast, cheap, 
and useful manner.
Flow cytometry provides information about individual cell characteristics. This 
is in contrast to previous measurements of MCV, MCH, and MCHC which 
only calculate mean values for the total red cell population. Modern counters 
can provide information about the reticulocyte counts but also about the 
characteristics of these cells (size or Hb content), related to the quality of the 
erythropoiesis, giving information of the current erythropoietic activity of the 
bone marrow.
Mindray (Shenzhen, China) has recently launched a new analyzer 6800 
Plus, which incorporate the RBC extended parameters, RBC subsets and the 
reticulocyte Hb content.
These parameters expand information at a cellular level:
(1) Provide information of the Hb on individual red cells, erythrocytes and 
reticulocytes as well
(2) Can aid in monitoring changes in Hb synthes
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ORAL PRESENTATIONS ABSTRACTS 
O-001
Thymoquinone and Sorafenib as a therapeutic combination in liver cancer: 
In vitro and in vivo
Eray Metin Guler, Abdurrrahim Kocyigit 
Bezmialem Vakif University, School of Medicine, Department of Medical 
Biochemistry, Turkey 
OBJECTIVES:Hepatocellular carcinoma (HSC) is the most common primary 
malignant tumor of the liver originating from hepatocytes.The aim of this study 
is to investigate the antitumor effects of chemotherapeutic agent sorafenib 
and N.sativa’s active substance thymoquinone against in vivo and in vitro 
hepatocellular carcinoma.
MATERIALS and METHODS:Cytotoxicity, genotoxicity, apoptosis, intracellular 
ROS, intracellular glutathione and mitochondrial membrane potential were 
measured in Luc-transfected hepatocellular carcinoma cells. Cells were given to 
nude mices by zenograft method. TQ, sorafenib, and combined therapy reduced 
tumor size after the 4 week treatment. Tumor size were measured with an IVIS 
imaging device and caliper.
RESULTS:In vitro dose-dependent thymoquinone and sorafenib have 
cytotoxic genotoxic, apoptotic and ROS-producing effects, both individually 
and in combination. In vivo study, combine therapy was found to be more 
effective than mono therapies in vivo hepatocellular carcinoma, which 
was formed by the xenographic method. While tumor size, inflammation, 
oxidative stress decreased, While tumor size, inflammation, oxidative 
stress decreased, antioxidantive markers and thiol levels increased. 
CONCLUSIONS:Our results showed that, thymoquinone has anticancer 
properties in vivo and in vitro. It has been shown to be more effective at lower 
doses when used with routine therapy.
Keywords: Thymoquinone, Sorafenib, hepatocellular carcinoma, IVIS 
 
 
O-002
Investigation of type I collagen and MMP-2 changes in mandibular bone 
tissue in natural development
Velid Unsal1, Mustafa Çı̇çek2 
1Department of Nutrition and Dietetics, Faculty of Health Science, Mardin 
Artuklu University, Mardin, Turkey 
2Department of Anatomy, Faculty of Medicine, Kahramanmaras Sütcü Imam 
University, Kahramanmaras, Turkey. 
OBJECTIVES:Mandibular bone, which is a part of the masticatory system, 
changes in histology and molecular structure based on the age and gender of an 
individual. The masticatory system develops with age and it affects all oral and 
temporomandibular joint disorders. In this study, we have aimed to examine the 
effects that aging has on the changes on type I collagen, which exists in the bone 
tissue and provides its matrix and its durability, and matrixmetalloproteinase-2 
(MMP-2).
MATERIALS and METHODS:14 Balb / C species white mice were used in 
the study. Animals were divided into two groups of seven, based on whether 
they are young or old. Mandibular bone tissue homogenate was prepared for 
biochemical analyses and mandibular bone tissue was obtained for histological 
evaluations. After routine histological follow-up, the tissues were embedded in 
paraffin. 4-5 µm thick sections were taken from paraffin-embedded tissues and 
hematoxylin-eosin, Type I collagen and MMP-2 immunohistochemical stainings 
were performed.
RESULTS:Ca+2, ALP ve calcitonin levels were decreased in the aging-based 
bone tissue homojenate analyses that were performed and TNF-α and PTH levels 
were significantly increased. Type I collagen and MMP-2 immunoreactivity in 
elderly mice showed a significant decrease in comparison to young mice.
CONCLUSIONS:As a result, aging causes a decrease in the amount of bone 
formed in the bone reconstruction cycle due to the decrease in the osteoblast 
support and the increases osteoclastic activity
Keywords: Type I collagen, MMP-2, Calcium, Calcitonin, TNF-α
 
 
O-003
Induction of APAF-1 and TRAIL by bilberry tea in HCT-116 colon cancer 
cell line
Burak Durmaz1, Latife Merve Oktay2, Hikmet Memmedov1, Nur Selvi Günel2, 
Hatice Kalkan Yıldırım3, Eser Yıldırım Sözmen1 
1Department of Medical Biochemistry, Ege University Faculty of Medicine, 
İzmir, Turkey 
2Department of Medical Biology, Ege University Faculty of Medicine, İzmir, 
Turkey 
3Department of Food Engineering, Ege University Faculty of Engineering, 
İzmir, Turkey 
OBJECTIVES:In this study, it was aimed to determine the effect of bilberry tea 
samples on the markers of the intrinsic and extrinsic pathways of apoptosis in the 
HCT-116 colon cancer cell.
MATERIALS and METHODS:Bilberry tea in different infusions and boiling (1 min, 
3 min, 5 min, 7 min, 10 min) were prepared and phenolic levels were determined by 
LC MS / MS technique. The highest phenolic content was determined in tea samples 
of seedless fruits for 5 min boiling, so this product was chosen for in vitro study. 
Cytotoxicity and viability tests were performed by adding WST-8 solution. Intrinsic 
and extrinsic pathways of Apoptosis were assessed by determining the TRAIL, 
APAF-1,Cytochrome-c, Caspase -3,-8,-9 levels in HCT-116 colon cancer cell line.
RESULTS:Cytotoxicity studies in cell culture were conducted using 50-10 µg/ml of 
bilberry tea samples which was prepared at a concentration of 5 g/10 ml. The levels of 
APAF-1, TRAIL and Cytochrome-c were significantly higher in bilberry added cell 
culture than the control cells. Other markers (caspase -3, -8, -9 levels) did not show 
any significant change compared to control cells
CONCLUSIONS:It is concluded that bilberries induced TRAIL, APAF-1, 
Cytochrome-c and consequently induced both intrinsic and extrinsic pathways of 
apoptosis.
Keywords: APAF-1, TRAIL, Bilbery, HCT-116, Colon cancer
 
O-004
Induction of apoptosis and cell cycle arrest by pomegranate extract and 
tangeretin in the rat mammary carcinogenesis
Huseyin Fatih Gul1, Necip Ilhan2, Nevin Ilhan2, Ibrahim Hanifi Ozercan3 
1Department of Medical Biochemistry, Faculty of Medicine, Kafkas University, 
Kars, Turkey 
2Department of Medical Biochemistry, Faculty of Medicine, Firat University, 
Elazıg, Turkey 
3Department of Medical Pathology, Faculty of Medicine, Firat University, 
Elazıg, Turkey 
OBJECTIVES:The present study investigated the potential chemoprevention effects 
of Pomegranate extract (P) and Tangeretin (T), both alone and in combination, on the 
apoptosis and cell cycle in 7,12-dimethylbenz [a] anthracene (DMBA)-induced rat 
mammary carcinogenesis.
MATERIALS and METHODS:Sprague Dawley female rats (n=56) were randomly 
divided into 8 groups. Group I was control, Group II, III and IV were treated with 
P, T and P+T respectively. Group V was DMBA-induced (a single dose of 60 mg/
kg body) weight breast cancer-bearing rats. Group VI, VII, VIII were designed as 
the chemopreventive treatment groups and were composed of D+P, D+T, D+P+T 
groups, respectively. The presence of the breast tumour tissue was demonstrated with 
histopathological examinations. In the breast tissue samples, the expressions leves 
of p53, Bax, Bcl-2 and cyclin D1 proteins acting on apoptosis and cell cycle were 
performed by western blot analysis.
RESULTS:According to histopathological evaluations, it was determined 
that most (90%) of the tumours created were invasive ductal carcinoma. 
While p53 and Bax expressions of pro-apoptotic markers significantly decreased in the 
DMBA group compared to the control group, it was observed that Bcl-2 and cyclin 
D1 expressions significantly increased. It was observed that p53 and Bax expressions 
significantly increased in both D+P and D+P+T groups compared to the DMBA group. 
Cyclin D1 expressions were determined to significantly decrease only in the D+T group. 
CONCLUSIONS:Our study results have shown that the combined administration of 
Pomegranate extract and Tangeretin may be more beneficial in preventing breast cancer.
Keywords: Breast cancer, Apoptosis, Cell cycle arrest, Pomegranate extract, 
Tangeretin 
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Preparation of magnetic nanoparticle coated glutaraldehyde to reduce toxic 
effects of idarubicin and its effect on HL60 cell line
Hasan Ulusal1, Fatma Ulusal3, Mehmet Tarakçıoğlu1, Seyithan Taysı1, 
Bilgehan Güzel2 
1Department of Biochemistry, Gaziantep University, Gaziantep, Turkey 
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3Department of Biochemistry, Gaziantep University, Gaziantep, Turkey, 
Department of Chemistry, Cukurova University, Adana, Turkey 
OBJECTIVES:Anthracyclines (doxorubicin, daunorubicin and idarubicin) are 
very effective chemotherapeutic drugs to treat many cancers; however, they 
cannot distinguish between healthy cells and cancer cells and cause serious 
side effects and systemic toxicity. Furthermore, one of the major problems is 
that the drugs which are being used cannot be used efficiently because of their 
low half-life time and low stability. In recent years, studies have focused on 
magnetic nanoparticles (MNP) which are capable of carrying drugs to overcome 
these shortcomings. The aim of this study was to immobilize idarubicin (IDA) 
to glutaraldehyde-coated MNPs, to prepare a drug with high stability and low 
toxicity levels.
MATERIALS and METHODS:MNPs were prepared and coated with 
glutaraldehyde, IDA was immobilized and its activity in HL-60 cell line was 
examined. All of the materials were characterized by various measurements, 
including XRD,TEM, SEM and UV-Vis. Idarubicin loaded MNPs were 
administered to HL60 cell line at different doses, and MTT and ATP cell viability 
analyzes were performed and compared to free idarubicin.
RESULTS:The in-vitro cytotoxicity results showed that the IC50 value of IDA-
MNPs was 13-folds lower than that of free IDA solution in HL60 cell line (IC50: 
0,029μM for IDA-MNPs and 0,396μM for free IDA). In addition, analyzes 
showed that idarubicin was bound to MNP system by 54%.
CONCLUSIONS:The results of this study showed that MNP-induced idarubicin 
is effective in eliminating cancer cells even at doses 13 times lower. So these 
results show promising effects in cancer treatment.
This study was supported by TUBITAK BIDEB 2218.
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The effects of overexpression of acetylcholinesterase on amyloid precursor 
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Kevser Biberoglu, Seda Onder, Ozden Tacal 
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OBJECTIVES:Acetylcholinesterase (AChE) plays a key role in catalytic 
hydrolysis of acetylcholine. It has known that acetylcholine can cause 
angiogenesis, migration and proliferation of cancer cells via activating the 
nicotinic acetylcholine receptor. Intensive research has indicated that AChE-R 
(readthrough isoform) is involved in proliferation, whereas AChE-T (tailed 
isoform) plays a role in apoptosis. A recent study has shown that AChE-T has 
potent anti-tumor effects and causes apoptosis of gastric cancer cells in-vitro 
and in-vivo. With the discovery of non-classical functions of AChE on cancer 
cells, the proteins that interact with AChE have become remarkable. Inhibiting 
the expression of amyloid precursor protein (APP) or β-secretase-1 (BACE1) 
is one of the therapeutic strategies due to their positive effects on cancer cell 
proliferation. In this study, we wonder whether AChE-T has any effects on APP 
and BACE1 expression in Hs766T pancreatic cancer cells.
MATERIALS and METHODS:Hs766T cells were transiently transfected 
with pGS-AChE-T plasmid, using lipofectamine-2000. To check transfection 
efficiency, AChE activity was assayed spectrophotometrically. After 48 hours of 
transfection, the levels of APP and BACE1 in cell lysates were analyzed using 
Western Blot.
RESULTS:We observed a significant decrease in both APP and BACE1 levels 
in transfected cells compared to vehicle-treated cells. Mature and immature 
APP levels were reduced by 60% and 68%, respectively whereas mature and 
immature BACE1 levels were reduced by 30% and 71%, respectively.
CONCLUSIONS: AChE-T reduces the levels of BACE1 and APP in Hs766T 
cells therefore it may show anti-cancer effects.
Supported by a grant from Hacettepe University Scientific Research Projects 
Coordination Unit (HUBAB, TSA-2017-13929)
Keywords: acetylcholinesterase, β-secretase-1, amyloid precursor protein, 
pancreas cancer 
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genes in malignant pleural mesothelioma
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OBJECTIVES:Malignant pleural mesothelioma (MPM), which accounts for 80-
90% of all mesothelioma cases, is a rare cancer with an increasing incidence and 
low survival rates. Existing treatment options are limited to chemotherapy with 
a low success rate. Therefore, novel targeted therapies are needed. In this study, 
we applied genome-wide negative selection CRISPR-Cas9 screening to identify 
cancer cell essential genes in MPM cell lines.
MATERIALS and METHODS:To obtain stable Cas9 expression we transduced 3 
different MPM cancer cell lines and 1 normal epithelial cell line with lentiCas9-
EGFP vector. FACS was performed to obtain and select clonal sublines with 
highest Cas9 expression. Competition assay and T7E1 assay were performed 
for functional characterization of selected clones. Brunello gRNA library was 
amplified and lentiviral particles were produced. Selected clones were transduced 
with Brunello gRNA library at MOI~0.3-0.5 and selected with puromycin and 
were cultured for 14 doublings.
RESULTS:We obtained clonal sublines showing permanent Cas9 nuclease 
expression. Selected clones with highest Cas9 expression were functionally 
characterized and were screened by transducing with whole genome Brunello 
gRNA library. Fold coverage of >400x was achieved following transduction.
CONCLUSIONS:Although whole genome CRISPR-Cas9 screening has some 
challenges due to the usage of high volume of cell cultures. While the risk of skewing 
of the composition of the final recovered DNA is high, CRISPR-Cas9 screening is 
still a powerful tool for obtaining essential genes and druggable targets in cancer. 
This study was supported by the Scientific and Technological Research Council 
of Turkey (TUBITAK) (Project number: 117Z227)
Keywords: CRISPR-Cas9 screening, brunello library, malignant pleural 
mesothelioma 
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The importance of serum hyaluronidase measurement in discrimination of 
patients with prostate cancer and benign prostatic hyperplasia
Zeynep Adıyaman Koçer1, Elmas Öğüş1, Tuba Özgün1, Koray Ağras2, 
Veysel Bayburtluoğlu2, Doğan Yücel1 
1Health Sciences University Ankara Health Application and Research Center, 
Department of Medical Biochemistry, Ankara 
2Health Sciences University Ankara Health Application and Research Center, 
Department of Urology, Ankara 
OBJECTIVES:The aim of this study was to investigate the ability of serum 
HYAL activity and mass concentration to distinguish prostate cancer (PC) from 
benign conditions.
MATERIALS and METHODS:Our study included age-matched 37 newly 
diagnosed PK, 72 benign prostatic hyperplasia (BPH), 53 chronic prostatitis 
(CrP) patients according to biopsy results and 49 control patients. Other cancers, 
liver disease, rheumatologic diseases, collagen tissue disease and dermatological 
disorders that could increase serum HYAL levels were excluded. Morgan-Elson 
colorimetric method was used to measure serum HYAL activity (sHYALa). 
Serum HYAL concentration (sHYALc) was determined by an ELISA method. 
Biopsy results were used for evaluation of clinical performance.
RESULTS:sHYALa, sHYALc and total PSA levels were found to be significantly 
higher in PK patients compared to control and benign patients (p<0.05). In all 
groups, there was a relatively weak positive correlation between sHYALa and 
PSA (rho=0.405, p<0.05, n=141); sHYALc and PSA (rho=0.344, p<0.05, n=88). 
sHYALa and sHYALc was found to be significantly higher in PK patients with 
PSA values in gray zone (4-10 μg/L) compared to other benign patient groups 
(p<0.05). In ROC analysis, AUC for sHYALa, sHYALc and PSA were 0.866; 
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0.826 and 0.813, respectively. Sensitivity and specificity were found for sHYALa, 
sHYALc and PSA as 88%, 71%; %82, %89 and 79%, 71%, respectively.
CONCLUSIONS:Combining sHYALa or sHYALc with PSA, physical 
examination and ultrasonography data may be useful in the evaluation of PK 
patients.
Keywords: Hyaluronidase, Prostate, Cancer 
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OBJECTIVES: Asparagus horridus is an edible plant known as “Ayrelli” in 
North Cyprus. There is a huge information gap in literature about this plant. The 
purpose of the research was to determine the antioxidant and anti-denaturation 
activities of the Asparagus horridus.
MATERIALS and METHODS:In this study, soxhlet extraction was used to 
obtain the extract from air-dried Asparagus horridus plant. We conducted a 
1,1-diphenyl-2-picrylhydrazyl (DPPH), total flavonoid content (TFC),Ferric 
reducing activity and total phenolic content (TPC) tests to determine the 
antioxidant activity with using standard methods. Protein degredation assay 
was performed to determine the anti-denaturation activity of Asparagus horridus 
extract.
RESULTS:The DPPH test of Asparagus horridus methanol extract showed an 
increase of DPPH scavenging activity from 27.71 % (p<0.0001) to 49.69 % 
(p<0.0001) with the extract dose from 15 to 25 mg/ml.Total Phenolic Content 
of the extract was determined as 140.68 (p<0.01) to 167.61 (p<0.01) mg/µg 
equivalent of gallic acid with the extract dose from 15 to 25 mg/ml. Beside 
that Total Flavonoid Content was obtained as 119.72 (p<0.00001) to 273.5 
(p<0.00001) mg/µg equivalent of quercetin with the extract dose from 10 to 25 
mg/ml.Ferric reducing activity varied from 0.36 (p<0.001) to 1.27 (p<0.0001) 
mg/µg equivalent of FeSO4 with the extract dose from 10 to 25 mg/ml. When 
anti-denaturation activity of Asparagus horridus extract was checked, is was 
found that the extract exhibited the highest inhibitory activity at 25 mg/ml as % 
29.41±0.34.
CONCLUSIONS:Consequently, these results showed that the methanol extract 
of Asparagus horridus plant grows North Cyprus has important antioxidant and 
anti-denaturation potential.
Keywords: Asparagus horridus, North Cyprus, antioxidant, anti denaturation 
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CA125 test request ratio in male patients
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OBJECTIVES:Cancer Antigen 125 (CA125) test is one of the most 
commonly studied tumor markers in clinical biochemistry laboratories. 
Low sensitivity and specificity of CA125 restrict the clinical use of it. In 
addition to ovarian cancer, it may increase in tumor-related diseases of 
serous membranes and a number of benign conditions.CA125 test can be 
ordered by all clinicians in our hospital. We examined CA125 test orders 
in detail in the 6-month period and detected unnecessary test orders. 
MATERIALS and METHODS:CA125 test was performed by chemiluminescence 
method on Advia Centaur XPT(Siemens) analyzer in our laboratory. CA125 
which were analyzed between January – July 2019 period were examined from 
laboratory information system (ALIS, Ventura)(Reference Range: 0 - 35 U/mL). 
RESULTS:In the 6-month period, 5,635 CA125 tests were performed 
which 1,356 of them belong to male patients(24%). In those patients, 
144(10%) results of the ordered CA125 were found above the reference 
range(min:36, Max:4,463, median:87.5). Oncology(35%) and Internal 
Medicine(30%) clinics were having most common orders of CA125. 
CONCLUSIONS:Unnecessary tests increase the laboratory workload and high 
costs. The use of tumor markers for screening in patients having no symptoms 
is one of the most common reason of the unnecessary test ordering. The main 
usage of CA125 test is non-mucinous ovarian carcinoma. Therefore, except in 
exceptional cases, it should not recommended for male patients.Department-
based and/or gender-based test ordering restrictions through the hospital 
information system may prevent unnecessary test ordering, such as the order of 
CA125 for male patients. In addition a pop-up message can be created during the 
clinician orderings.
Keywords: CA125, unnecessary test request, tumor markers 
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OBJECTIVES:Early diagnosis and treatment of oncological diseases is 
extremely important. In this study, we aimed to evaluate tumor marker requests 
of our hospital and investigate the presence of improper use.
MATERIALS and METHODS:Evaluation of the tumor markers (CEA, CA 
15-3, CA 19-9 and CA 125 ) performed by the biochemistry laboratory of 
Tokat Gaziosmanpasa Research and Application Hospital between 01.01.2018 
and 31.12.2018 was accomplished. Our parameters were divided into sub-
groups according to being within and above the reference ranges. The clinical 
application of tumor markers can be divided into 4 groups: screening, diagnostic 
confirmation, prognosis, and monitoring of recurrence. Internal Medicine, 
Gastroenterology, Endocrine Diseases, Chest Diseases, General Surgery, 
Gynecology and Obstetrics and Medical Oncology have made requests.
RESULTS:Total requests were 1420 for CEA, 671 for CA15-3, 868 for CA 19-9, 
and 585 for CA 125. A significant difference between genders for CEA and CA 
125 was determined (p <0.001 and p: 0.033, respectively). 312 (22%) of CEA, 
202 (30.1%) of CA 15-3, 204 (23.5%) of CA 19-9, and 113 (19, 3%) of CA 125 
requests were above the reference ranges. Significant positive correlations were 
determined between age and tumor markers of CEA, CA 15-3, and CA 19-9 (r: 
0,262, p<0,001; r: 0,096, p: 0,013; r: 0,090, p: 0,008; respectively). Preliminary 
diagnoses were nonspecific pain, acute vaginitis, anemia, anxiety disorder, 
dyspepsia, neoplasm and thyroid disorders.
CONCLUSIONS:This study shows that many outpatient clinics have made 
excessive amount of tumor marker requests incompatible with preliminary 
diagnosis suggesting overutilization. This situation causes cost and workload.
Keywords: Inappropriate Test Request, Oncology, Neoplasm Tumor Markers 
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Detection of preanalytical errors in blood gas analysis
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OBJECTIVES:Blood gas analysis is an urgent test needs to be studied in a short 
time interval for its preanalytical instability and there is still no consensus about 
the storage temperature. The aim of this study was to determine the effect of air 
bubbles in the blood gas injectors and different temperature conditions on the 
results.
MATERIALS and METHODS:Arterial blood was collected from 20 patients 
in intensive care unit into lithium heparin syringes from their catheter. The 
samples were grouped as; room temperature, room temperature plus air 
bubble, +4 degrees, and +4 degree plus air bubble. Blood gas analyses were 
performed by a potentiometric method using a blood gas analyzer ABL 800 
(Radiometer,Copenhagen,Denmark) within 5 minutes (baseline) and at 30, 60, 90 
and 120 minutes. Results were compared with baseline statistically with paired 
27-31 October 2019Turkish Journal of Biochemistry, 2019
XXVII. Balkan Clinical Laboratory Federation Meeting BCLF 2019 
XXX. National Congress of the Turkish Biochemical Society TBS 2019
Turk J Biochem, 2019; 44 (S3) http://www.TurkJBiochem.com43
samples t-test or Wilcoxon signed rank test with post hoc Bonferroni correction 
(p<0.0125), and evaluated clinically according to the desirable bias.
RESULTS:PCO2 results were increased significantly in all study groups. PO2 
levels were unaffected at room temperature up to 60’, but found as increased at 
30’ when cooled. PH levels were all in acceptable limits. HCO3 was stable up to 
90’, and SaO2 levels were affected less than 1% in all groups.
CONCLUSIONS:Cooling the arterial blood sample in plastic syringe is 
inappropriate for pO2 analysis, however, it was found as stable up to 60’ at room 
temperature. In conclusion, room temperature is better than cooling samples in 
plastic syringes for arterial blood gas analysis.
Keywords: blood gas, preanalytical errors 
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OBJECTIVES:Biochemical or spectrophotometric measurements are known to 
be more affected by hemolysis when compared to immunochemical analysis. 
This situation can often lead to less consideration on immunochemical assays. 
Threshold values at which hemolysis affects immunochemical tests are indicated 
in our kit inserts, but there is no value related to insulin. Therefore, the aim of 
this study is to determine the hemolysis threshold for insulin and the effect of 
storage conditions on serum insulin stability.
MATERIALS and METHODS:Serum pools were formed from the samples 
of the routine laboratory. Serum samples of equal volume were transferred to 
seven tubes. The tubes were designed as only serum in the first tube, serum 
+ assay diluent in the second tube, and serum + hemolysate in the 3-7 tubes 
which correspond to 50,100, 200, 400 and 800, respectively hemolysis index. In 
addition, insulin levels were measured in the patient samples with <20 (n = 10), 
20-50 (n=10), 50-100 (n=10) and 100-200 (n=10) hemolysis index immediately 
and after 8 hours at room temperature.
RESULTS:Negative bias was detected as 10% in the samples with below 200 
mg/dL hemolysis index which were analysed immediately after centrifugation. 
Negative bias was determined as <10%, 27.6% and 29.5% in the samples <20, 
20-50 and 50-100 hemolysis index, respectively which stayed for 8 hours at 
room temperature.
CONCLUSIONS:Hemolysis index should be considered when reporting insulin 
levels. Insulin analysis is not suitable for hemolysed serum samples that have 
waited 8 hours at room temperature.
Keywords: Hemolysis, insulin, stability 
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OBJECTIVES:Interferences are the most serious limitations of immunoassays 
which are one of the most common measurement methods in clinical chemistry. 
According to the measurement principle of immunoassay, sources of interference 
may vary from antibodies, to vitamins, drugs and endogenous molecules. 
Unconjugated estriol (uE3) assay is an important component of second trimester 
screening and negative interference of uE3 assay may lead to false Down 
Syndrome and even Smith Lemli Opitz Syndrome risk. The aim of this case 
report is to present a case series of 70 patients with falsely low uE3 results from 
Beckman Coulter DxI 800 instrument.
MATERIALS and METHODS:Increase in number of low uE3 results (<0.3 
ng/mL) led us to confirm the results. We started to dilute samples ½ and 1/5 
any sample with the result below 0.3 ng/mL. Recovery results above 150% 
were considered as interfered samples. 1500 patient samples were screened 
to detect negative interference in uE3 assay within two years period. Samples 
with suspicion of interference were furtherly investigated in Beckman Coulter 
Laboratories (Marseille, France).
RESULTS:70 samples were found to be confirmed to be affected by interference 
which was cleared by scavenger ALP. Interfered results were below 0.56 ng/mL. 
Recovery results varied from 150 to 600%.
CONCLUSIONS:This is the first case series of negative uE3 interference. It was 
speculated that scavenger ALP molecules bind to endogenous ALP antibodies. 
ALP is the conjugate of manufacturer’s uE3 kit and any molecule interfering 
with ALP affects uE3 kit.
Keywords: Interference, immunoassay, uE3 
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What if all is well except insulin: A macroinsulin case report
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Duzen Laboratories Group, Ankara, Turkey 
OBJECTIVES:Macroinsulin is a larger molecule of insulin comprised of 
insulin and insulin antibody (IA). This phenomenon is rare and generally due to 
exogenous insulin therapy. The aim of this case report is to present a patient with 
macroinsulin who has never had exogenous insulin.
MATERIALS and METHODS:A 75-year old male was admitted to our 
laboratory for routine check-up. All test results including fasting and postprandial 
glucose levels and HbA1c were within age-specific reference intervals, except 
for fasting and postprandial insulin levels (110.80 μIU/mL and 163.80 μIU/mL, 
respectively). He had no history of insulin resistance or diabetes mellitus. His 
fasting and postprandial C-peptide, islet antibody, glutamic acid decarboxylase 
antibody levels were normal However, insulin antibody level was found to be 
eight fold higher than the upper limit. To prove the reason for elevated insulin, 
polyethylen glycol (PEG) solution is used to precipitate the insulin-IA complexes 
and serum insulin was re-analysed from the supernatant. Two different patients’ 
sera with high insulin levels were also treated with PEG as control study.
RESULTS:Result of insulin in PEG-treated patient sample has been found to be 
decreased from 110.80 to 19.20 μIU/mL ( ̴ 80%) of the first insulin measurement. 
Insulin results of the PEG-treated control sera were found to be similar with 
native sera.
CONCLUSIONS:Discrepantly high results of insulin with normal C-peptide has 
to be furtherly investigated with IA measurement and re-analysis of from PEG-
treated serum. Insulin-IA complexes thought to be responsible for the elongated 
half-life of insulin in the circulation.
Keywords: Insulin, macroinsulin, insulin antibody, antigen-antibody complex, 
interference 
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Comparison of biochemical analytes in different blood collection tubes and 
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Inanc Karakoyun1, Fatma Demet Arslan1, Selin Onur1, Yasemin Kilic Ozturk2, 
Hulya Parildar2, Banu Isbilen Basok1 
1University of Health Sciences, Tepecik Training and Research Hospital, 
Department of Medical Biochemistry, Izmir, Turkey 
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OBJECTIVES:In this study, we compared 3 different clot-activator gel tubes to 
a glass reference tube and evaluated the effect of storage time on 31 different 
biochemical analytes.
MATERIALS and METHODS:Blood samples were collected in 4 types of tubes: an 
additive- and gel-free glass tube and three different clot-activator tubes containing 
gel (Samplix, Vacuette, and Vacutainer). In addition to comparison with the glass 
tube, stability analyses were performed in Samplix, Vacuette, and Vacutainer tubes 
after storage for 48 hours at +4°C. Clinically important differences were evaluated 
using the Ricos desirable specifications for bias based on biological variation.
RESULTS:Clinically important differences were found for albumin(bias%, 
-2.39), sodium(-0.29), potassium(2.35) and magnesium(2.78) in Samplix; 
for sodium(-0.27), potassium (2.82), lactate dehydrogenase(4.47) and 
magnesium(2.46) in Vacuette; and for calcium(-1.56), chloride(0.66), 
potassium(3.54), lactate dehydrogenase(9.11) and sodium(0.38) in Vacutainer. At 
the end of the 48 hours, analytes that demonstrated instability were albumin(-3.13), 
chloride(1.01), potassium(2.69), sodium(0.54), and total protein (1.95) in Samplix; 
albumin(-6.45), Cl(1.11), potassium(2.06), and sodium(0.84) in Vacuette; and 
albumin(-4.57), calcium(1.28), chloride(0.64), free T3(-8.87), glucose(2.76), 
potassium(2.19), sodium(0.65), and total protein(2.15) in Vacutainer.
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CONCLUSIONS:Various blood collection tubes (BCTs) in different contents may 
cause clinically important differences in the test results. Therefore, each laboratory 
should verify the reference range transfer or create its own reference range before 
using a new BCT. It should be also considered that in cases where analysis cannot 
be completed immediately after blood sampling, not all clinical chemistry or 
immunological test analytes can maintain their stability in BCTs up to 48 hours.
Keywords: Blood collection tube, Serum, Stability 
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Elevated high sensitivity troponin in the absence of coronary artery 
disease: A case report
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OBJECTIVES:The Joint European Society of Cardiology/American College of 
Cardiology committee for the redefinition of myocardial infarction (MI) states 
that troponins are the preferred cardiac marker for detecting myocardial injury.
There are a few important non-ACS causes of cardiac troponin elevation that 
require immediate attention and treatment.
MATERIALS and METHODS:This is a case of a 56-year-old female came to the 
emergency department complaining of shortness of breath and lightheadedness. 
She denied any chest pain, nausea or vomiting. ECG showed sinus rhythm with 
minimal ST-T deviation,and chest X-ray showed no acute process. Routine 
biochemistry tests were within normal limits, except for hsTnT of 22.05 ng/L( 
(0 – 14 ng/L) and Hgb of 7,1 g/dL (12,5-16 g/dL). Repeat test of hsTnT ( after 1 
hr,and 6 hr ) respectively; 30 ng/L and 25 ng/L
RESULTS:She was diagnosed to have anemia and was given one unit of blood. 
Anemia was considered to be the cause of elevated troponin levels. Severe aortic 
stenosis was detected in the echo performed 6 months later, ECG showed sinus 
rhythm with ventricular HPT findings. NT Pro-BNP was found to be 1952 pg/mL 
(significant > 900 pg/mL)
CONCLUSIONS:Coexistence of aortic stenosis and anemia explains increased 
troponin values. This case report confirms that BNP test can be used as an early 
marker in cardiac function monitoring. It also shows that moderate elevations in 
troponin levels can be an indicator of non cardiac MI The importance of cardiac 
function tests should be discussed for more frequent follow-up of rheumatic 
valve patients.
Keywords: troponin, anemia, aort stenosis, proBNP 
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Serum separation problem on gel tubes: Is it a problem or a clue of some 
clinical conditions?
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OBJECTIVES:Serum separator tubes which contain separator gels are widely 
used by many laboratories. The gel forms a physical barrier between the cellular 
elements of the blood and serum. We report a case with serum separation problem 
in a patient hospitalized for recurrent epistaxis and regulation of hypertension.
MATERIALS and METHODS:The patient was 85 years old female followed 
in internal medicine department. The blood sample was collected into a BD 
Vacutainer SST II Advance (Becton Dickinson, NJ, USA) containing serum 
separator gel tube. After centrifugation, pipetting error alerts were triggered and 
we observed that the gel did not constitute a separating barrier and the serum did 
not occur. We evaluated that the underlying causes of this condition could be 
multiple myeloma, any radio-contrast dye usage or dialysis catheters. A second 
sample was collected into BD Vacutainer CAT (Clot Activator Tube) and the 
serum did not occur, also. A subsequent blood sample was collected into BD 
Vacutainer Barricor LH Plasma tube which has a mechanical separator and after 
centrifugation biochemical analyses were performed with plasma.
RESULTS:The analysis resulted a highly increased IgG (111 g/L (reference 
interval 7.51-15.6 g/L)) and total protein (120.32 g/L (reference interval 66-
83 g/L)) concentration. With these results a bone marrow examination was 
performed and the patient was diagnosed with Multiple Myeloma.
CONCLUSIONS:This case report confirms that laboratories and tube 
manufacturers should be aware of the limitation of the separator gel tubes in 
patients with high plasma density and its effects on test results.
Keywords: separator gel, blood collection tube, hyperproteinemia 
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Evaluation of inflammatory status with procalcitonin and neopterin in 
healthy overweight and obese adults based on waist-hip ratio
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Biochemistry Laboratory, İstanbul, Turkey 
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OBJECTIVES:In this study we aimed to evaluate the role of hs-CRP, 
Procalcitonin (PCT) and neopterin as inflammatory markers in the diagnosis of 
chronic low-grade inflammation associated with obesity.
MATERIALS and METHODS:67 obese, overweight and healthy adults with a 
mean age of 41.1±10 years were included in the study. All participants were divided 
into two groups according to waist hip ratio (<0.9 Group-A, ≥ 0.9 Group-B) and 
three groups according to body mass index (BMI) ( < 25 Group- 1, 25-29 Group- 
2, ≥30 Group-3). Hs-CRP, PCT, neopterin levels of the groups were compared 
between the groups. Lipid profile and blood glucose levels also evaluated.
RESULTS:There was no significant difference in CRP, NP, PCT between the 
groups formed according to waist hip ratio (p> 0.05). In BMI groups, CRP levels 
were found to be elevated with obesity in BMI groups. There was a difference 
between Group-1 and Group-2 and Group-2 and Group-3, but they were not 
significant. The difference between Group 1 and Group 3 was significan t(p 
<0.05). There was no difference in NP levels between the groups (p> 0.05). 
In the PCT levels, there were statistically significant results between Group-1 
and Group-2 and between Group-1 and Group-3, but no difference was found 
between Group 2 and Group 3(p> 0.05).
CONCLUSIONS:It was shown that the increase in total fat mass in the body may 
lead to an increase in inflammation markers. However, it was concluded that this 
difference may be more closely related to the degree of obesity rather than fat 
distribution
Keywords: Obesity, Inflammation, Hs-CRP, Procalcitonin, Neopterin 
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Simultaneous determination, quantitation and validation of the most used 
benzodiazepines in urine
Cigdem Karakukcu, Derya Koçer, Mine Yüce Faydalı 
Department of Biochemistry, Kayseri City Hospital,Kayseri, Turkey 
OBJECTIVES:A single method for confirmation and quantitation of a panel 
of commonly prescribed benzodiazepines and metabolites, flunitrozepam, 
clonazepam, diazepam, lorazepam, oxazepam, bromozepam, clobazam, 
flurazepam, midazolam, and triazolam was developed for urine samples.
MATERIALS and METHODS:Quantitation was by liquid chromatography 
tandem-mass spectrometry (LC-MS-MS) using a AB-Sciex 4500 Q-TRAP 
system. The instrument was operated in multiple reaction monitoring mode 
with an electrospray ionization source in positive ionization mode. Deuterated 
analogues were included as internal standards for all 10 analytes. The method 
was evaluated for recovery, bias, imprecision, linearity, analytical range, 
carryover, and matrix effect.
RESULTS:The measurement of calibration dependence allowed to determine 
the extent of linearity in the concentration range from 12.5 to 500 ng/ml for 
all benzodiazepines except midazolam flunitrozepam, clonazepam, oxazepam, 
clobazam, which were linear through 25 to 500 ng/ml with acceptable coefficients 
of determination (r2>0.99). For all analytes at concentration levels 12.5, 300 and 
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500 ng/ml (n=5, 3 days) BIAS and precision (within-run and between-run) were 
established in the range 2.7 to 4.10 and 0.83 to 9.90, respectively. Detection 
limits (LOD) ranged at 0.95-7.27 ng/ml and quantification limits (LOQ) at 2.89-
22.04 ng/ml for all analytes, which were both highest for Clobazam. No carry-
over was observed after the injection of 500 ppb certificated reference material. 
For matrix effect evaluation, relative recovery was established between 91% to 
97%, except midazolam (absolute recovery 88%, relative recovery 76%).
CONCLUSIONS:The applicability of a simple LC-MS/MS method was proven 
by for analyzing authentic urine samples and third party external quality samples 
in urine matrix.
Keywords: Benzodiazepines, Validation, LC–MS/MS method 
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Association of NUCB2/Nesfatin-1 gene polymorphism with obstructive 
sleep apnea severity
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OBJECTIVES:Obstructive sleep apnea syndrome (OSAS) is characterized by 
repetitive obstruction of upper respiratory tract and associated with decrease 
in blood oxygen saturation. Inflammation is involved in the mechanism of 
obstructive sleep apnea syndrome. The aim of the study was to determine 
distribution of NUCB2 genotypes of nesfatin-1 in OSAS.
MATERIALS and METHODS:38 OSAS and 12 healthy subjects were enrolled 
in this study. Individuals were seperated into four groups (mild, moderate, severe 
and normal) by standard polysomnography, according to the apnea-hypopnea 
index. Chronic inflammatory diseases, psychiatric diseases, malignant diseases 
and neurogenic diseases, were excluded from the study. After sampling, DNA 
isolation and Real-Time PCR were performed.
RESULTS:The mean age of paticipants were 52.02 ± 10.40 years. %18 of 
volunteers were male and %82 of volunteers were female. Control group 
consist of 12 (%24) individuals had an AHI˂5. NUCB2 gene polymorphisms 
were compared with sleep scores (severe, moderate, mild and control). There 
was a significant relationship between rs2634462 polymorphism and sleep 
scores (p=0.002). There was no relationship between rs1330 A/G, rs214101 C/T, 
rs757081 C/G NUCB2 gene polymorphisms and sleep scores.
CONCLUSIONS:It was found that individuals with homozygous C/C genotype 
of the rs2634462 polymorphism had significantly more severe OSAS compared 
to individuals with other genotypes. rs2634462 polymorphism of nesfatin-1 may 
be a new biomarker in predicting the presence of OSAS.
Keywords: NUCB2 gene, Obstructive Sleep Apnea Syndrome, Polymorphism 
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OBJECTIVES:The aim of this study was to investigate the effect of lycopene 
on autophagic pathway against toxicity induced by sodium fluoride in renal cell 
line (NRK-52E).
MATERIALS and METHODS:Cells were grown in vitro by regular passages. 
The IC50 value of NaF and the proliferative concentration of lycopene were 
determined by MTT. In the study, 4 groups were formed as control (K), fluorine 
(F), lycopene (L) and fluorine lycopene (FL). 24 hours after the application of 
fluorine and lycopene to the cells at the specified concentrations, RNA isolation 
and cDNA synthesis were performed and expression of the autophagic genes was 
determined by RT-PCR.
RESULTS:The proliferation enhancing concentration of lycopene (1 µM) and 
the IC 50 concentration of NaF (3200 µM) at 24 h were found. In the FL and 
F groups, Sqstm 1 expression increased 19 and 9 times, Atg5, 9 and 5.5 times, 
Map11c3a 6 and 5 times, respectively. There was no significant change in other 
genes.
CONCLUSIONS:As a result, it was determined that the fluoride given at IC50 
concentration affects the autophagic genes studied and the highest increase 
occurred in Sqstm 1. It can be concluded that lycopene given alone does not 
alter the genes much, and in the FL group, fluorine may increase autophagy by 
inhibiting the proliferative effect of lycopene.
Keywords: fluorine, cell culture, lycopene, autophagy 
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The relationship between WNT signaling activity and organ attitudes in 
scleroderma disease sub-groups
Ayse Kocak1, Duygu Harmancı1, Gul Guner Akdogan3, Merih Birlik2 
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OBJECTIVES:Scleroderma is a chronic inflammatory autoimmune disease 
characterized by fibrosis in the skin and internal organs.The relationship between 
SCC type,stage,pathogenesis,organ involvement and WNT gene family has not 
been identified yet.We aimed to show the relationship of WNT gene family 
and antagonists in development of SSC subtypes of disease and different organ 
involvement.
MATERIALS and METHODS:The study included 85 patients with SSC and 
77 controls.The gene expressions & protein levels of the WNT family and 
antagonists were analyzed from blood samples. The qPCR method was used for 
WNT gene expression levels. WNT antagonists protein levels were determined 
by ELISA method. The relationship between these parameters and disease stage, 
type and organ involvement was evaluated.
RESULTS:There was a significant increase in WNT-1, WNT-10b, WNT-2, 
and WNT-6 genes in the SCC group.Axin-2 is decreased. DKK-1 and Kremen 
protein expressions are decreased in scleroderma. There was a significant 
difference between WNT-3a and WNT-10a gene expression among patients 
with generalized scleroderma and limited SCC.WNT-3a and WNT-10a gene 
expression increased in generalized scleroderma. WNT-1, WNT-2 and AXIN-
2 gene expression increased significantly in PAH positive SCC patients.There 
was a positive correlation between the modified Rodnan skin score (MRS) 
and WNT-2 in patients with SCC.There was a significant positive correlation 
between total GIS involvement score and WNT-1, WNT-2, WNT-4, WNT-8a, 
WNT-9b in scleroderma patients. WNT-1, WNT-2, WNT-4, WNT-8a, WNT-9b 
gene expression expressions increased as the disease severity scale increased.
CONCLUSIONS:WNT-1 and WNT-2 were found to be high in the skin and 
organ involvement of scleroderma. It was found to play a role in the pathogenesis 
of the disease.Therefore, we identified new therapeutic targets in SCC.
Keywords: WNT signaling pathway, WNT antagonists, scleroderma, organ 
involvement
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OBJECTIVES:The use of pharmacogenetic testing in cardiology is rapidly 
expanding and constantly refining. The objective of this study was to evaluate 
the effect of the CYP2C19, ABCB1, PON1 and P2RY12 variants on clopidogrel 
pharmacodynamics and clinical outcomes in Serbian ST-elevation acute 
myocardial infarction (STEMI) patients undergoing primary PCI (pPCI).
MATERIALS and METHODS:One hundred and forty consecutive patients 
referred to pPCI for STEMI in a high-volume cath lab were enrolled in the study. 
Clopidogrel response was assessed with multiple electrode platelet aggregometry. 
The clopidogrel-metabolizing pathway SNPs used were: CYP2C19*2 
(rs4244285), CYP2C19*3 (rs4986893), CYP2C19*17 (rs12248560), ABCB1 
(rs1045642), PON1 (rs854560, rs662), and P2RY12 (rs2046934). The primary 
clinical endpoint was major adverse coronary and cardiovascular event 
(MACCE) defined as death, nonfatal myocardial infarction, ischemia-driven 
revascularization and stroke. The secondary clinical endpoint was bleeding 
occurrence. Bleeding was defined according to the Bleeding Academic Research 
Consortium definition. The follow-up period was one year.
RESULTS:One-year MACCE was 12.9%. All alleles and genotype proportions 
were found to be in Hardy–Weinberg equilibrium (p>0.05). Among the SNPs 
tested, only CYP2C19*17 was significantly associated with MACCE, but not 
with clopidogrel response. Our results did not find CYP2C19*2 or CYP2C19*3 
to be significantly associated with MACCE. Bleeding was not significantly 
different across the CYP2C19, ABCB1, P2RY12 and PON1 genotype groups.
CONCLUSIONS:In clopidogrel-treated patients with STEMI undergoing pPCI, 
CYP2C19*17 was independently associated with an increased risk of MACCE 
independent of clopidogrel responsiveness. The bleeding risk does not appear to 
be explained by CYP2C19 genotype.
Keywords: clopidogrel, pharmacogenetics, STEMI 
 
O-030
Inhibitory effect of glyphosate on butyrylcholinesterase and 
acetylcholinesterase activity
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OBJECTIVES:Herbicide glyphosate (N-phosphonomethyl glycine) began to 
be used in 1974 for weed control in agricultural production areas. In 2015, the 
World Health Organization(WHO) classified glyphosate as a possible carcinogen 
for humans. Increased glyphosate use was correlated with various types of 
cancer, Alzheimer, autism and Parkinson’s diseases. Cholinesterase enzymes are 
found in large amounts in the brain and also inhibit organophosphate poisoning. 
Therefore, we aimed to make a preliminary study on the effect of glyphosate on 
cholinesterase enzyme types.
MATERIALS and METHODS:Inhibition effects of glyphosate at various 
concentrations (282 mg/L, 28.2mg/L, 2.8mg/L, 0.7mg/L) of acetylcholinesterase 
in human erythrocytes and butyrylcholinesterase in human plasma were 
examined for 10 min, 30 min and 1 hour preincubation periods. Colorimetric 
kinetic measurements of cholinesterases were performed using the Ellman’s 
method.
RESULTS:The decrease in measured butyrylcholinesterase enzyme activity was 
measured in the different glyphosate concentrations depend on preincubation 
periods. The most important decrease was observed at butyrylcholinesterase 
with 31% loss of activity at a concentration of 282mg/L glyphosate in 1 hour 
preincubation. Acetylcholinesterase enzyme activity decreased 11% activation 
at a high concentration of glyphosate 282mg /L, while a decrease in time-
dependent on preincubations was not measured. There was no decrease in 
acetylcholinesterase activity at other glyphosate concentrations.
CONCLUSIONS:Some articles have controversial statements about the 
inhibition of glyphosate on cholinesterases. Because of the effect of glyphosate 
in neurological diseases, we investigated the interaction of both enzymes with 
glyphosate in vitro conditions. It was concluded that prolonged exposure to 
glyphosate may cause pathological findings.
Keywords: Glyphosate, Acetylcholinesterase, Butyrylcholinesterase, Ellman’s 
Method 
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Evaluation of Roche Accu-Chek Inform II Glucose test strip system in the 
hospital setting
Settar Kosova 
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OBJECTIVES:Glucometers are widely used in hospital wards as a practical 
tool to get immediate results concerning the patient’s glucose status. Accurate 
bedside glucose measurements are of paramount importance in the evaluation 
and treatment of diabetic patients.
MATERIALS and METHODS:According to our institutional quality assurance 
policy, weekly venous blood samples are analyzed on the sampling by Glucometer 
(Roche Accu-Chek Inform II, performed by nurses) and the Laboratory (Roche 
Cobas c6000, c501). 246 patients’ venous blood glucose results (Glucometer and 
Laboratory) were analyzed. Wilcoxon test was performed on paired venous blood 
sample results. Performance according to ISO 15197 2013 standard including 
consensus error grid analysis was investigated.
RESULTS:Glucometer and Laboratory median glucose (mg/dl) levels were 
136,5 (range: 75 – 461) and 134,5 (range: 71 – 441) respectively (p=0,0061, 
Wilcoxon). Coefficient of variation of paired results was 7,7 % (95 % CI: 5,9 – 
9,2). 91,1 % of glucometer glucose results (224/246) were within allowed limits 
according to ISO 15197 2013. This performance did not meet the ISO 15197 
2013 standard which requires that at least 95 % of results should be within limits. 
Nevertheless, all 22 patients glucose data beyond the standard’s limits were in 
the zones of a (86 %) and b (14 %) of consensus error grid area. Thus fulfilling 
standard’s 2nd necessity at a rate of 100% (at least 99% required).
CONCLUSIONS:According to our routine quality control performance data, 
the Roche Accu-Chek Inform II glucometer system is clinically useful for 
professional use in health care institutions.
Keywords: venous glucose, Accu-chek inform II, Cobas 6000, ISO 15197 
2013, consensus error grid 
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Evaluation of urine drug screening test results between 2016-2018 years in 
Kanuni Education and Research Hospital Laboratory
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OBJECTIVES:Drug abuse one of the most important health problems in the 
world and unfortunately it is rapidly increasing in Turkey as well. In order to 
establish valid policies on this issue, the initial step is to define the extent of 
this problem by determining the prevalence of use. Further information on the 
frequency of substance use is essential for preventive studies. We planned this 
study to determine which drugs are analyzed more widely in Trabzon and to 
evaluate their distribution according to age and sex, and therefore to collect and 
present data to take measures.
MATERIALS and METHODS:Urine drug screening tests (Amphetamine, 
Benzodiazepine, MDMA-Ectacy, Barbiturate, THC-Cannabis, Cocaine, Bonzai-
Spice1 / Spice2, Opiate, Buprenorphine) were evaluated with retrospective LIS 
data and the results were determined as positive by age and sex.
RESULTS:Cannabis (THC) was commonly used banned substance in 16% of 
patients admitted between 2016-2018, followed Benzodiazepine (9.97%) and 
Buprenofrin (8.93%). Bonzai spice1 and spice2, which are thought to be widely 
used, are 0.045% and 0.3% respectively. The important reason for the low usage 
of this substance, which has increased in recent years, is the existence of product 
variety which limits its detection by the current method. Percentages of other 
substances were cocaine 0.3%, MDMA 1.76%, Opiate 1.37%, Amphetamine 
27-31 October 2019Turkish Journal of Biochemistry, 2019
XXVII. Balkan Clinical Laboratory Federation Meeting BCLF 2019 
XXX. National Congress of the Turkish Biochemical Society TBS 2019
Turk J Biochem, 2019; 44 (S3) http://www.TurkJBiochem.com47
2.25%, Barbiturate 0.058%, respectively. 95.61% of the user is male, 4.51% is 
female and the average age is around 31 years and the lowest-highest age is 14-
78.
CONCLUSIONS:The increase in the frequency of substance use among women 
and decreasing user age raises concern. However, the research is regional and 
countrywide studies are needed.
Keywords: drug abuse 
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OBJECTIVES:Pregabalin is an antiepileptic drug that reduces the release of 
excitatory neurotransmitters such as glutamate, substance P. It is approved to 
be used in adult patients who have peripheral neuropathic pain, fibromyalgia, 
epilepsy. Drug bind to the α2-δ subunit of voltage-dependent calcium channels 
in central nervous system. It is well known that pregabalin has some abuses 
potentially. Several databases have warned for overdose fatalities. Overdoses 
of gabapentinoids can become lethal in mixture with other psychoactive drugs, 
especially opioids.In this study, we aimed to reveal the abuse of pregabalin.
MATERIALS and METHODS:In our laboratory, drug analysis is carried out by 
mass spectrometry method with QTrap analyzer. These analysis were performed 
on urine samples. All results which analysed between 01.02.2019-10.07.2019 
were examined retrospectively. Pregabalin positive samples were evaluated 
among the results. Amphetamine and its derivatives, opioids, codeine, morphine, 
heroin, cannabis, cocaine, benzodiazephines, synthetic cannabinoids, pregabalin, 
gabapentin analyzed in all samples.
RESULTS:1522 patients results evaluated. In 22.8% (347/1552) samples, 
pregabalin concentration was higher then 50 ng/ml. It has been found that 140 
positive pregabalin results have a level of over 1000 ng/ml. Moreover, cannabis 
has been found on 68 samples in addition to pregabalin. In some samples it has 
also been found amphetamine or cocaine and multiple substance were positive 
with pregabalin.
CONCLUSIONS:According to our data pregabalin abuse is common. Since 
pregabalin can cause undesirable consequences like other addictive substances, 
health professionals and prescribers must be aware of this misuse potential. 
Laboratory professionals should be able to measure pregabalin in drug 
laboratories.
Keywords: Pregabalin, Lyrica, substance abuse
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OBJECTIVES:The aim of study was to investigate influence of protein 
supplements changes on liver enzymes (ALT, AST, ɣ -GT and LD) in athletes 
with high and low intensity training.
MATERIALS and METHODS:The 180 male athletes were divided in three 
groups of subjects, athletes with high intensity training, athletes with low 
intensity training and the control group. We analyzed the activity of enzymes 
ALT, AST, ɣ -GT and LD, proteins in the urine, as well as urea and creatinine. 
The enzyme activity was determinated with a BS-200 Mindray machine.
RESULTS:The results of enzymes activity in vitro show that using protein 
supplements increase activity of these enzymes: ALT 56.68 %, AST 48.78 %, 
ɣ -GT 14.17 and LD 9.71 % in the serum of athletes during training comparing 
the athletes who do not use supplements. The mean differences between the 
parameters ALT, AST, ɣ -GT and LD between the groups was a statistically 
significant (p <0.05) between subjects who use supplements and those who do 
not use supplements. The Man Whitney U test showed that between subjects 
(high intensity and low intensity training) there is a statistically significant 
difference between the all examined parameters, while the LD did not show a 
statistically significance difference (p > 0.05).
CONCLUSIONS:The protein supplements (Whey protein, Gainer, Isoactive, 
BCAA) increased activity of the enzyme ALT, AST, ɣ -GT, LD in athletes. The 
activity of the enzyme decreases in the serum after a seven-day break of using 
the protein supplements.
Keywords: liver enzymes, Whey protein, Gainer, Isoactive, BCAA 
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OBJECTIVES:During the last years, bariatric surgery has become an established 
procedure for effective and sustainable weight loss. In the majority of patients, 
bariatric surgery improves liver steatosis, inflammation, and fibrosis in 
nonalcoholic fatty liver disease patients with obesity. The aim of our study was 
to investigate the effect of bariatric surgery on ghrelin-hepatosteatosis interaction 
in morbid obese patients.
MATERIALS and METHODS:23 patients who underwent bariatric surgery 
(BMI=49.27±7.46 kg/m2) in Selcuk University Faculty of Medicine Clinic 
of General Surgery were included in the study. Sixteen of these patients were 
operated with laparoscopic sleeve gastrectomy and seven were operated 
laparoscopic Roux-en-Y gastric bypass method. Blood samples were collected 
from the patients before of the operation and at 1st, 3rd, 6th months after the 
operation. Hepatosteatosis were performed by radiologists with ultrasonography. 
Ghrelin levels were studied by elisa method.
RESULTS:There was not found significant difference in ghrelin levels between 
preoperative and postoperative periods (p=0.384). The hepatosteatosis was 
significantly decreased at postop 1st, 3rd, 6th months compared to preop period 
(p<0.05). There was a weak, significant and negative correlations between 
ghrelin levels and hepatosteatosis at postoperative 1st and 3rd months.
CONCLUSIONS:As a result, bariatric surgery has improved some endocrine 
abnormalities, but did not show any significant difference in ghrelin levels. 
Significant reductions in hepatosteatosis were observed after surgery. Further 
studies involving ghrelin and hepatosteatosis should be perform.
Keywords: Bariatric surgery, ghrelin, hepatosteatosis 
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The results in two different provinces in Black Sea Region where 
thalassemia screening was implemented:a rare hemoglobin variant
Durmus Ayan 
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OBJECTIVES:We aimed for assessing the results of a thalassemia test 
implemented for the purpose of screening in the provinces of Amasya and Tokat 
and for revealing the clinical features of a rare variant type of hemoglobin in our 
study.
MATERIALS and METHODS:The results of n=2258 samples ( 55.8% males 
and 44.2%), sent from the provinces of Amasya and Tokat for the purpose of 
thalassemia(hemoglobin variant) screening between 15.10.2018-31.05.2019 
were retrospectively examined in Public Health Laboratory in Central Amasya. 
Hemoglobin variant analysis was carried out through the method of HPLC (High 
Performance Liquid Chromatography) on Primus Ultra2 device. The sample was 
also examined on a different system for the rare hemoglobin variant (Hb Pusan) 
and DNA strand analysis was implemented for substantiation for Hb Pusan 
variant.
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RESULTS:In accordance with the results regarding patients retrospectively 
screened, while the results of n=2170 ( 56.3% males and 43.7% females), 
patients were found to be normal; 37 patients (40.6% male and %59.4 female) 
with suspected of alpha thalassemia was detected), 50 patients (44% males, 56% 
females) with suspected of beta thalassemia was detected, hemoglobin 1 female 
patient with suspected of hemoglobin E variant was detected and hemoglobin 
Pusan variant was detected in n=1 male patient.
CONCLUSIONS:In accordance with our findings, it was discovered that 
frequency of beta thalassemia is higher than other types of variant in both 
provinces.
Keywords: thalassemia, hemoglobin variant analysis, HPLC, hemoglobin 
Pusan 
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OBJECTIVES:Until today, approximately 60 hemoglobin variants have been 
identified in Turkey. One of them, Hb Hamilton, β11(A8)Val→Ile, which is a 
silent mutation, is the substitution of isoleucine for valine in the 11th position 
of the beta chain. This mutation does not change the function of the hemoglobin 
molecule. TheUntil today, approximately 60 hemoglobin variants have been 
identified in Turkey. One of them, Hb Hamilton, α2β211(A8)Val→Ile, which is 
a silent mutation, is the substitution of isoleucine for valine in the 11th position 
of the beta chain. This mutation does not change the function of the hemoglobin 
molecule. The variant can not be determined by cellulose acetate, starch or agar 
gel electrophoresis. It was discovered in an Austrian family living in Canada 
by Triton X-100 acid-urea polyacrylamid gel electrophoresis in 1984. Then, 
cord blood samples of 4581 babies born between 1985 and 1986 in Sardinia 
hospitals screened for Hb Hamilton using the same method. In this case study 
we aimed to report the first observation of Hb Hamilton in Turkey. variant 
cannot be determined by cellulose acetate, starch or agar gel electrophoresis. It 
was discovered in an Austrian family living in Canada by Triton X-100 acid-
urea polyacrylamid gel electrophoresis in 1984. Then, cord blood samples of 
4581 babies born between 1985 and 1986 in Sardinia hospitals screened for Hb 
Hamilton using the same method.
MATERIALS and METHODS:Five milliliters of blood samples from patients 
were collected in ethylenediaminetetraacetic acid (EDTA) vacutainers for 
estimation of blood count. Hemoglobin variants were characterized by high 
performance liquid chromatography (HPLC). Micro column method was used 
for the isolation of DNA samples. Screening of beta globin gene was performed 
by DNA sequence analysis.
RESULTS:During genetic screening of hemoglobinopathies in Diyarbakır, 
hemoglobin Hamilton was detected by DNA sequence analysis. Fourteen 
different β-thalassemia mutations and 3 abnormal hemoglobins (HbS, HbD-
Punjab, Hb Hamilton) were detected in 53 adults. Hb Hamilton was seen in 
combination with beta-thalassemia mutation (IVS1-110 G>A).
CONCLUSIONS:The presence of Hemoglobin Hamilton was reported for the 
first time in Turkey. This variant could not be detected when the sample was 
screened by HPLC.
This project was supported by Dicle University Research Project Unit
(TIP.18.001& TIP.19.008).
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Glanzmann thrombasthenia: A case report
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OBJECTIVES:Glanzmann’s Thrombasthenia (GT) is a rare autosomal recessive 
disorder that affects the platelet glycoprotein IIb/IIIa (GPIIb/IIIa) complex and 
characterized by prolonged bleeding time. The medical history of the patient 
and the family history of consanguinity crucial while evaluating the patient. In 
most cases, bleeding symptoms apparent rapidly early in life, but diagnose of GT 
needs highly specialized centers. In bleeding disorders, routine coagulation tests 
may be normal so as differential diagnosis specific test such as platelet function 
and flow cytometry could be used.
MATERIALS and METHODS:A 40-year-old man, presented to the hematology 
department with spontaneous ecchymosis, was referred to our laboratory for 
investigating the bleeding disorder. In addition to routine hematological tests, 
platelet function tests were performed on an Aggram(Helena) agrometer and 
Innovance-PFA200(Siemens). A Flowcytometeric analysisis (Navios-Ex, 
Beckman Coulter) was used to confirm the results.
RESULTS:Patient’s WBC:3.5*10³/µL, RBC:4.96*105/µL, Hb:13.5g/
dL, Hematocrit:40.1%, Platelet: 160*10³/µL, PT:12.5sec, aPTT:23sec, 
Fibrinogen:235mg/dL. Peripheral blood smear was normal. Closure times in 
PFA analysis; Collagen-epinephrine>300sec and Collagen-ADP:>273sec. In 
aggregometry, collagen, ADP, epinephrine results were normal, while abnormal 
aggregation curve with ristocetin was observed. CD42a expression was normal 
and CD41&CD61 were reduced in flow cytometry. The patient was diagnosed 
with GT.
CONCLUSIONS:GT is a rare bleeding disorder. Clinical findings may vary 
from petechiae, gingival bleeding to severe life-threatening bleeding. Typical 
characteristics are long bleeding time, normal platelet counts and no peripheral 
blood smears. When evaluating a patient with bleeding disorder, GT should be 
kept in mind and further investigations should be performed.
Keywords: Glanzmann Thrombasthenia, Platelet glycoprotein IIb/IIIa, 
Inherited platelet disorder, Platelet function test 
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Abdullah Tuli1 
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OBJECTIVES:Glucose-6-phosphate dehydrogenase (G6PD) has a housekeeping 
role in all cells and is particularly critical to the integrity and functioning of 
red blood cells. In this study, the activity of G6PD on bioactive surface was 
investigated. For this purpose, potentiodynamic polarization curves and cyclic 
voltammetry measurements were used. The surface morphology of the biosensor 
was investigated by scanning electron microscopy (SEM).
MATERIALS and METHODS:BSA/gelatin and gluteraldehyde was used as a 
polymer and cross-linking agent, respectively. Cyclic voltammetry measurements 
were performed using 3-electrode sensing system in 5mM pH 7.0 phosphate 
buffer. Gold electrode as working electrode, Ag/AgCl as reference electrode, 
platinum as counter electrode was used. Furthermore, SEM images of enzyme 
immobilized and enzyme free polymer on electrode surface were compared.
RESULTS:Our study showed that G6PD enzyme carried out the oxidation 
reaction with 2.5µA lower energy. In addition, current flowing reduced by 
enzyme showed that it complied with the OHM law. From the results obtained 
G6PD, electrochemical reaction on bioactive surface was found to be effective 
by reducing energy requirements. Parallel with this information, SEM images 
also showed surface differences of the enzyme immobilized and enzyme free 
polymer.
CONCLUSIONS:These potentiometric measurements showed how much 
enzyme reduced activation energy. Since the main function of enzymes was to 
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lower the activation energy, here we have confirmed that the enzyme worked 
and therefore the immobilization application was successful. Thus, we have 
completed the preliminary study of a sensitive method that we planned. In further 
studies, the responses of G6PD enzyme with natural substrates will be evaluated.
Keywords: Biosensor, G6PD Enzyme, Immobilization, Polarization, SEM. 
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OBJECTIVES:Glucose 6-phosphate dehydrogenase (G6PD) is a key and rate 
limiting enzyme in the pentose phosphate pathway. Many substances, especially 
herbicides, can inhibit G6PD enzyme activity in vitro and in vivo. Glyphosate is the 
most widely used herbicide in worldwide. The aim of this study was to investigate 
the effect of glyphosate on the erythrocyte G6PD enzyme in vitro due to the structural 
similarity of the substrate to the phosphate group of Glucose-6 phosphate.
MATERIALS and METHODS:In this study, the effect of different glyphosate 
concentrations (282 mg/L, 28.2mg/L, 2.8mg/L, 0.7 mg/L) on G6PD enzyme 
activity was investigated. Hemolysate was prepared from erythrocytes obtained 
from healthy, adult male individuals as samples. Enzyme activity was measured 
using the Beutler method.
RESULTS:Inhibition percentages for glyphosate administration at different 
concentrations with 0/10/30. minute incubation; 0.1 M glyphosate 21%, 24.8% 
and 26% respectively, 0.01 M glyphosate 20.8%, 22% and 11.8%, 0.001 M 
glyphosate 1.5%, 9.78% and 10%, 0.0005 M glyphosate 1.3%, 6.25% and 8%, 
0.00025 respectively M glyphosate was observed as 0.07%, 2.8% and 2.14%. 
The increase in activity observed in the 60 minute incubation suggests that the 
enzyme is a semi-competitive inhibitor.
CONCLUSIONS:According to the results of our studies, it is seen that inhibition 
increases due to the increase in the glyphosate concentration and incubation 
time. Due to the high number of individuals with G6PD enzyme deficiency 
and increased exposure to glyphosate in the Çukurova region, our study is very 
important in terms of preventing health problems that may occur.
Keywords: Glyphosate, G6PD, enzyme inhibition 
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OBJECTIVES:Newborns and occasionally patients with malignancy develop 
anemia due to iatrogenic blood loss based on phlebotomy for blood tests, 
including complete blood count (CBC). Reducing the need for blood transfusion 
and thus avoiding the associated risks due to frequent phlebotomy involves 
limiting blood sampling and the use of micro tubes as primary tubes in automated 
analyzers. It is aimed to compare microtubes with the vacuum tubes of the same 
brand in terms of accuracy and ease of use.
MATERIALS and METHODS:Venous blood samples were taken from 40 in-
patients and collected in three different brand microtubes/evacuated tubes 
pairs (Microtainer MAP-0.5 mL/Vacutainer-2.0 mL;Becton, Dickinson and 
Company,USA)(Microvette-0.5 mL/S-Monovette-2.6 mL;Sarstedt Ag & Co. 
KG,Germany)(MiniCollect Complete-0.5 mL/Vacuette-2.0 mL;Greiner Bio-One 
GmbH,Austria). All tubes contained K2EDTA except Microvette. White blood 
cell(WBC), red blood cell(RBC), hemoglobin, platelet(PLT) were analyzed 
using a CBC analyzer (DxH 800, Beckman Coulter Inc., USA).
RESULTS:The bias (%) of WBC, RBC, hemoglobin, and PLT parameters 
between a microtube and a standard tube for each brand was calculated and 
presented as follows: Microtainer MAP vs. Vacutainer -0.41, 0.52, 0.46, and 
-1.34; Microvette vs. S-Monovette -1.09, 0.61, 0.51, and -1.49; MiniCollect 
Complete vs. and Vacuette, -0.24, 0.34, 0.05, and -0.89. All bias calculations 
were within the desirable limits based on the Ricos’ biological variation data.
CONCLUSIONS:According to the results, laboratories using these CBC tubes 
can limit blood sampling in their efforts to reduce iatrogenic blood loss, by 
providing and using micro-volume pairs of the same brand without extra effort, 
especially in patients requiring frequent phlebotomy.
Keywords: blood cell count, blood specimen collection, laboratory automation, 
blood volume 
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OBJECTIVES:Iron is an element that is necessary for life but can damage the 
organism if it is present in excess. Iron performs many important functions in the 
body. Iron deficiency is the most common nutritional deficiency and the leading 
cause of anemia in the world. In this study, we aimed to design a biosensor for 
the quantitative determination of Fe³+ in a short time and at an affordable cost.
MATERIALS and METHODS:The bioactive layer was prepared by immobilizing 
hydrogen peroxidase enzymes on the gold electrode with bovin serum albümin 
(BSA), gelatin, glutaraldehyde with the help of UV light. To ensure separation 
of ferric iron (Fe³+) in the serum from the transferrin, acetate buffer having a pH 
of 5.0 was preferred. Hydroxylamine hydrochloride was then used to reduce the 
ferric iron (Fe³+) to ferrous iron (Fe²+). Ferrous iron (Fe²+) which is produced 
as a result of the reduction was measured by the reaction of hydrogen peroxidase 
enzyme.
RESULTS:The response current in the range of 0.2 and 1.4 V was performed 
on a cyclic voltammogram at a scanning rate of 0.06 V/s. Enzymatic reaction 
rate decreased as substrate concentration increased in an environment where all 
parameters were constant.
CONCLUSIONS:In determining optimum operating conditions, acetate buffer 
was determined at pH 5.0 and 200 mM concentration, scanning speed was 0.06 
V/s and temperature was determined as 40 °C. In this study, the best measurement 
was obtained with gold electrode immobilized with an enzyme concentration of 
0.5 mg/ml was used.
Keywords: biosensor, hydrogen peroxidase, ferric iron
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Correlation between LUC % and thyroid function tests
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OBJECTIVES:In this study, we aimed to determine the correlation between 
thirteen hemogram parameters and thyroid stimulating hormone (TSH), 
thyroxine (T4), and triiodothyronine (T3).
MATERIALS and METHODS:A retrospective study was performed on 18 013 
patients’ data who all presented with thyroid pathologies. Laboratory results 
of TSH, T4 and T3 blood levels, white blood cells (WBCs), large unprotected 
cells (LUC), LUC%, neutrophil count, neutrophil percentage, lymphocyte count, 
lymphocyte percentage, monocyte count, monocyte percentage, eosinophil count, 
eosinophil percentage, basophil count, basophil percentage were analyzed. Blood 
samples were collected by venepuncture and anticoagulated with dipotassium 
ethylenediamine tetra-acetic acid (EDTA) and hematology parameters were 
measured within 1 h of collection on a Siemens ADVIA 2120i hematology 
analyzer (Siemens Healthcare Diagnostics, Germany). Thyroid function tests 
were measured by using the ADVIA Centaur XP analyzer (Siemens Healthcare 
Diagnostics, Germany). Normality tests were performed using single-sample 
Kolmogorov-Smirnov test using SPSS 18.0 for all data. Correlation analysis was 
performed using the Pearson method.
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RESULTS:The relationship between TSH, free T3, free T4 and LUC % were 
r = -0.102, p = 0.001; r = 0.210, p <0.001; r = 0.127, p <0.001; respectively. 
CONCLUSIONS:It can be proposed that LUC% count is weakly but significantly 
associated with thyroid hormon levels observed.
Keywords: inflammatuary marker; LUC%; thyroid function tests 
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OBJECTIVES:The purpose of this study was to investigate the possible 
protective effect of Rhamnetin, as a potent antioxidant on I/R-induced renal 
injury in rats.
MATERIALS and METHODS:We used 28 male wistar albino rat weight 
200-250 g in this research. The animals were randomly divided into 4 groups. 
Each experimental group was consisted of seven animals. Rats were subjected 
to 45 min of renal pedicle occlusion followed by reperfusion. Control Group 
(C): Ischemia/reperfusion was not performed to animals. Rhamnetin Group 
(R): 100 mg/kg Rhamnetin was administered i.p 30 min prior to ischemia and 
immediately before the reperfusion period. Ischaemia/Reperfusion Group (I/R): 
Rats were subjected to 45 min of renal pedicle occlusion followed by 24 hours 
reperfusion. Rhamnetin+Ischemia/Reperfusion Group (R+I/R): Rhamnetin (100 
mg/kg i.p) was administered 30 min prior to ischemia and immediately before 
the reperfusion period. Rats were subjected to 45 min of renal pedicle occlusion 
followed by 24 hours reperfusion.
RESULTS:MDA levels were found to be significantly increased whereas SOD 
and GST enzyme activities were found to be significantly decreased in I/R 
(p<0.05). However, there were no significantly differences in CAT activities and 
between the C and I/R groups. While GST activities were significantly elevated 
in R+I/R group compared to control group, MDA levels were significantly 
decreased.
CONCLUSIONS:These results show that treatment with Rhamnetin may 
prevent the kidney damages due to ischaemia result in increasing oxidant stres 
peroxidation damages further. This study suggests that Rhamnetin may be a 
effective antioxidant agent.
Keywords: Rat, Rhamnetin, ischemia, reperfusion 
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OBJECTIVES:The immunosuppressive agent cyclosporine A (CsA) has 
hepatotoxic potential. Increased reactive oxygen species (ROS) formation is 
among the causes leading to hepatotoxicity. In this study, we aimed to investigate 
the effect of resveratrol (RES) treatment on CsA-induced oxidative stress and 
hepatotoxicity in rats.
MATERIALS and METHODS:Rats were treated with RES (10 mg/kg/
day; i.p.) for 14 days. CsA (25 mg/kg/day; s.c.) was given during the last 7 
days together with RES. Determinations of serum alanine aminotransferase 
(ALT) and aspartate aminotransferase (AST) activities together with hepatic 
histopathological examinations were performed. ROS, thiobarbituric acid 
reactive substances (TBARS), advanced oxidation protein products (AOPP), 
ferric reducing antioxidant power (FRAP), and glutathione (GSH) levels as well 
as superoxide dismutase (SOD), and glutathione peroxidase (GSH-Px) activities 
were measured in the liver tissue.
RESULTS:CsA treatment increased hepatic ROS, TBARS, and AOPP levels 
significantly as compared to the control group. Although hepatic GSH levels and 
SOD activity did not alter, FRAP level decreased and GSH-Px activity increased 
significantly in CsA treated rats. CsA also caused degeneration in hepatocytes 
and sinusoidal spaces. RES treatment ameliorated histopathological changes 
and decreased hepatic ROS, TBARS and AOPP levels significantly. However, 
it did not change serum ALT and AST activities as well as hepatic antioxidant 
parameters in CsA-treated rats.
CONCLUSIONS:RES does seem to have a protective effect on CsA-induced 
hepatotoxicity by reducing oxidative stress. Considering the immunosuppressive 
and hepatoprotective efficiency of RES, the combined use of CsA and RES 
may be useful in hepatic transplantation therapy by reducing hepatotoxicity and 
increasing the immunosuppressive effect of CsA.
Keywords: Cyclosporine, resveratrol, hepatotoxicity, oxidative stress 
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OBJECTIVES:Iron deficiency and harmful effects of iron deficiency anemia; it 
develops due to deficiencies in oxygen transport to tissues and deficiencies in 
iron-containing compounds, in particular enzymes. The oxidative free radicals 
formed during ischemic events increase the level of ischemia-modified albumin 
(IMA) by making chemical changes in the albumin molecule. The state of thiol/
disulfide plays a vital role in antioxidant process. We aimed to determine the 
relationship between native thiol, total thiol, disulfide and IMA in female patients 
with Iron Deficiency Anemia (IDA).
MATERIALS and METHODS:32 female patients diagnosed with IDA and 24 
healthy women were joined in our study. Blood samples were taken for complete 
blood count (CBC),serum iron,total iron binding capacity (TIBC),ferritin and 
thiol / disulfide homeostasis tests after fasting for at least 8 hours. IMA Abs. 
levels were determined by a colorimetric method.Total and native thiols and 
disulfide were analyzed with a novel spectrophotometric method.
RESULTS:We found lower native thiol (-SH)(378.0±135.6 µmol/L), disulfide 
(113.5±7.6 µmol/L), and total thiols (-SH + -S-S-) (613.0±125.8 µmol/L) in IDA 
patients compared to healthy controls (respectively 399.5±158.8, 136.7±63.3, 
and 707.5±119.23 µmol/L). IMA Abs. levels (0.68±0.11 AU) were higher in IDA 
patients compared to controls (0.59±0.15 AU). Total thiols levels were positive 
correlated with both native thiol (r=0.326; p=0.033) and disulfide (r=0.511; 
p=0.001)
CONCLUSIONS:Thiols, disulfide and IMA levels increase with the progression 
of iron deficiency. IDA decreases the antioxidant capacity of erythrocytes and 
triggers oxidative stress. Therefore, the hypoxic state and oxidant balance 
resulting from anemia are important in terms of prognosis of the disease
Keywords: Thiol/disulfide homeostasis, Oxidative stress, Ischemia-modified 
albumin, Iron Deficiency Anemia 
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OBJECTIVES:Animals enter the hibernation by providing the necessary 
conditions to protect themselves from physiologically adverse seasonal 
conditions. After hibernation, hibernating animals raise their body temperature 
to 37 °C within a few minutes and rapidly increase oxygen consumption by 
10-20 times. Oxygen scarcity increases the risk of oxidative stress in sensitive 
tissues in mammalian torpor. The rate of formation of free radicals and their 
rate of removal are in equilibrium in the organism. The serious imbalance 
between antioxidant defense mechanism and free radical formation refers to 
oxidative stress. In our study aimed to determine the level of oxidative stress in 
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hibernation different time (before hibernation, during and after) in liver, lung, 
heart and kidney of Spermophilus xanthomorphius, Spermophilus citellus and 
Spermophilus taurensis living in different ecological zones in Turkey.
MATERIALS and METHODS:Eighteen animals (S. citellus (6), S. taurensis (6) 
and S. xanthomorphius (6)) were included in our study. Three different condition 
(at hibernation, aroused and non-hibernation stage) data were compared. 
They were sacrificed under anesthesia. Glutathione (GSH), reactive nitrogen 
oxide species (NOx) and malondialdehyde (MDA) levels were measured 
spectrophotometrically.
RESULTS:MDA levels during the hybridization were significantly higher in 
all tissues of the three species, while GSH levels were found to be low. After 
the hybridization, MDA and GSH levels were increased before and during the 
hibernation.
CONCLUSIONS:Our data show that an impaired balance exists between 
oxidative stress and antioxidant systems in most organs and tissues during 
hibernation
Keywords: Hibernation, Oxidative stress, Ground Squirrel 
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OBJECTIVES:Neuroglia-derived chronic inflammation and oxidative stress 
play central roles in the pathogenesis of neurodegenerative diseases. Thus, 
increasing evidence indicates that anti-inflammatory activity of plant species and 
their chemical constituents may protect neurons against various brain disorders. 
The genus Phlomis is composed of perennial plants in Lamiaceae family which 
is represented by 46 species from which 30 are endemic in Turkey. The main 
constituents of Phlomis species are reported to exert pharmacological activities. 
In this study, we aimed to evaluate the effects of methanol extracts of Phlomis 
species in H2O2-induced oxidative stress in a cellular model.
MATERIALS and METHODS:At first, antioxidant activities of methanol extract 
were evaluated by DPPH and ABTS assays. The effects of the extracts on cell 
viability were determined by using WST-1 assay. Cells were pre-treated with 
various concentrations (1, 10 and 100 µg/ml) of extracts for 2 h and exposed to 
H2O2 for 1h.
RESULTS:Similar to the results obtained by antioxidant assays, methanol extract 
at 10 µg/ml concentration provided 36.40% neuroprotection against H2O2-
induced toxicity.
CONCLUSIONS:Our preliminary results indicate that more research is needed 
to establish the role of endemic plants as a potential source of neuroprotective 
agents for further therapeutic approaches.
Keywords: oxidative stress, Phlomis species, neuroprotection 
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OBJECTIVES:Morus nigra L. fruits are rich in polyphenols, flavonoids, and 
anthocyanins responsible for their antioxidant and anti-inflammatory activities. 
In this study, we aimed to investigate the potential neuroprotection by optimized 
system extracts of Morus nigra L. fruits in terms of apoptosis related protein 
expressions.
MATERIALS and METHODS:Extraction of Morus nigra L. fruits was performed 
with supercritical carbon dioxide, subcritical water and microwave assisted 
extraction systems as advanced extraction technologies; following conventional 
methods as orbital shaker and sonification. Obtained extracts in two different 
concentrations (10 and 100 µg/ml) were evaluated for neuroprotection against 
L-DOPA-induced cytotoxicity in human neuroblastoma cell lines (SH-SY5Y) by 
using WST-1 assay. The changes in apoptosis-related proteins (Bax, Bcl-2) were 
investigated by using Western Blotting technique.
RESULTS:Most of the extracts at indicated concentrations were found to protect 
cells and regulate Bax and Bcl-2 expression levels in L-DOPA-induced toxicity. 
The maximum protection was observed following subcritical water extraction 
system at 100 µg/ml which significantly increased cell survival from 51.68 ± 
14.19% (L-DOPA-treated cells) to 161.88 ± 20.12% (p<0.05).
CONCLUSIONS:Chosen extracts/fractions were found to be significantly anti-
apoptotic. High yields of polyphenols and other antioxidant compounds by 
advanced extraction techniques may have roles in protecting neuronal cells via 
regulating Bax and Bcl-2 proteins. Selection of extraction method is a crucial 
point for plants to achieve therapeutic potential.
Acknowledgements: This study was supported by the TUBITAK (216S839), 
IKCU BAP and OYP fund supplied by YOK. Novel Fluidic Technologies 
Laboratory and FABAL (Ege University) are highly appreciated.
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OBJECTIVES:We aimed to measure the dynamic thiol-disulfide balance and 
thioredoxin reductase(TrxR) enzyme levels in patients with chronic kidney 
disease (CKD) and to investigate their roles in disease pathogenesis by comparing 
them with systemic oxidative stress and inflammation parameters.
MATERIALS and METHODS:Thirty hemodialyses(HD),30 CKD 
patients(stage3-5) and 30 controls were included in the study. Fasting blood 
samples were collected. After centrifugation at 1500g for 10min, serum and 
plasma samples were portioned and stored at -80°C.IMA levels were determined 
by albumin cobalt binding test(ACB).Dynamic thiol-disulfide balance was 
determined by the colorimetric method developed by Erel et al. Tumor necrosis 
factor(TNF-α) and TrxR levels were determined by ELISA.
RESULTS:We found that native and total thiol levels of CKD and HD 
patients were significantly lower than that of the control group(p=0.001 for 
both). However, disulfide levels were significantly higher in the HD group 
(p=0.001),but there was no significant difference between control and CKD 
groups (p=0.547). A notable negative correlation was found between the native 
and total thiol levels and IMA(r=-0.628;-0.631),BUN (r=-0.747;-0.747),and 
creatinine(r=-0.732;-0.721).There was a significant positive correlation between 
glomerular filtration rate(GFR) and the thiol levels(r=0.835;0.824).TrxR levels 
were significantly higher in the patient groups compared to the controls(p=0.001).
TNF-α and CRP levels of the patient groups were significantly higher compared 
to the controls(p=0.001).
CONCLUSIONS:Colorimetric measurement of dynamic thiol levels can 
be used in disease monitoring as a marker because it is easily applicable in 
routine clinical biochemistry laboratories.The dynamic thiol balance may be 
involved in the pathogenesis of CKD and is associated with disease severity. 
This study was supported by Hatay Mustafa Kemal University, Coordinatorship 
of Scientific Research Projects.
Keywords: Dynamic thiol-disulfide balance, Thioredoxin reductase, Chronic 
kidney disease, Hemodialysis 
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OBJECTIVES:Ischemia refers to the reduction or cessation of blood flow 
which results in tissue damage and causes insufficient oxygen and nutrition 
to the tissues. Oxidative stress due to reperfusion after ischemia causes severe 
functional and structural damage. Free oxygen radicals are responsible for this 
damage. Lycopene is a pigment of the carotene family, wich is naturally found 
in vegatables and fruits. To the best of our knowledge, this is the first study, 
we aimed to investigate the protective role of lycopene in experimental heart 
ischemia reperfusion (I/R) model.
MATERIALS and METHODS:Male Wistar rats were randomly allocated into 
three groups (n = 8, each) as control (I/R group), Sham and Lycopene (therapy 
group) groups. One group received lycopene (50 mg/kg/day as intraperitoneally) 
for both single dose before surgery (I/R+lycopene group), while the other was 
treated intraperitoneally with 0.09 % saline as group (0.3 mL/day) (sham group). 
However, nothing was given to the I/R group. Then; after the venture and surgical 
procedure applied to the all rats groups, 10 minutes ischemia and 10 minutes 
reperfusion of the heart was created. At the end of this experimental, activities of 
catalase (CAT), superoxide dismutase (SOD) and the levels of malondialdehyde 
(MDA) as oxidative stress biomarkers were measured as spectrophotometric 
and, also the levels of nitrotyrosine (3-NTx) and nitric oxide (NO) as nitrosative 
stress biomarkers were measured by ELISA in heart tissues homogenates.
RESULTS:Oxidative/nitrosative stress was confirmed by the significant elevation 
in MDA, NO, and 3-NTx levels concentrations in I/R group (p < 0.05). Also, CAT 
and SOD activities in I/R group were significantly lower than lycopene and sham 
groups (p<0.05). However, increased CAT and SOD activities and decreased the 
levels of MDA, NO and 3-NTx were found in lycopene group compared to I/R 
and sham groups (p<0.05).
CONCLUSIONS:We thought that lycopene may play the protective the role 
against heart I/R damage due to its high antioxidant activity.
Keywords: Lycopene, oxidative/nitrosative stress, heart ischemia-reperfusion 
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OBJECTIVES:Degenerated discs and endplate abnormalities is postulated as a 
possible source of low back pain. Oxidative stress plays an important the role in 
various human diseases. This is the first study, we aimed to investigate the levels 
of oxidative stress biomarkers in disc samples of patients with Modic Changes.
MATERIALS and METHODS:Patients (n:15) were separeted as MCI, II, and III 
types. Of these cases, 3 had complaints for less than 6 months, whereas 3 patients 
had been suffering from low back pain and leg pain for more than 6 months. 
Six patients have been diagnosed with subligamentous type and 3 patients had 
free fragment type of disc degeneration. The activities of catalase (CAT) and 
superoxide dismutase (SOD), and the levels of malondialdehyde (MDA) in disc 
samples were determined on spectrophotometer
RESULTS:Oxidative stress was confirmed by the significant elevation MDA 
levels and decreased of CAT and SOD activities in MCI compared with other 
MCs (p<0.05). The highest CAT and SOD activities were found in patients 
with MCII compared with the other MCs. However, the levels of MDA showed 
moderate increase in this group (p<0.05). In addition, the levels of oxidative 
stress biomarkers in patients with MCIII were slightly higher than the other MCs 
(p< 0.05).
CONCLUSIONS:Our findings indicated that oxidative stress in patients with 
MCI may be aggravated as a result of oxidant/antioxidant imbalance and it may 
cause formation of the lesion in these patients.
Keywords: : Modic Changes, Disc Samples, Oxidative Stress 
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The effect of turmeric on GPER1 and oxidative/nitrosative stress 
biomarkers in cardiac ischemia reperfusion
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OBJECTIVES:Extreme oxidative stress induced by reperfusion after ischemia 
causes functional and structural damages. Free oxygen radicals are mainly 
considered as responsible for the damage. It has been known that there is a 
connection between cardiovascular diseases and estrogen. Estrogen is effective 
on estrogen receptors alpha and beta, and also recently a new estrogen receptor 
depending on G protein has been determined (GPER1). It has been revealed 
in various researches that turmeric has hypoglycemic, anti-inflammatory, 
antioxidant and lipid reducing effects. In this first study, it was aimed to 
investigate the effects of turmeric on GPER1 and oxidative/nitrosative stress 
parameters in heart ischemia reperfusion injury in rats.
MATERIALS and METHODS:The study was carried out with three groups 
(treatment, sham and control) of eight rats each. Heart ischemia reperfusion 
injury was formed experimentally in all rats.Turmeric (50 mg/kg) single dose 
was given intraperitoneally in the treatment group. Physiological saline (0,09% 
NaCl, 0,3 mL) single dose was given intraperitoneally in the sham group. No 
drugs were given in the control group.
RESULTS:Compared to control and treatment groups, antioxidant enzymes 
(SOD, CAT) decreased and MDA levels increased in the ischemia reperfusion 
group (p<0,05). On the other hand, the levels of antioxidant enzymes in the 
treatment group approached the control group and MDA levels decreased 
(p<0,05).
CONCLUSIONS:As a result of this study, it was determined that turmeric has a 
protective role against heart ischemia reperfusion injury.
Keywords: Turmeric, cardiac ischemia reperfusion injury 
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OBJECTIVES:The aim of this study was to investigate the effect of acupuncture 
on dynamic thiol–disulphide homeostasis and ischemia-modified albumin (IMA) 
levels as a novel oxidative stress parameter in migraine patients.
MATERIALS and METHODS:The acupuncture treatment consists of 5 sessions 
with 2 sessions per week. Blood samples have been collected before performing 
acupuncture, after the 1st and 5th session of the acupuncture. And for the control 
group blood samples were collected only once. In this study, the dynamic 
thiol–disulphide homeostasis and IMA levels in the serum samples of migraine 
patients and healthy individuals was determined using an automated method 
newly developed by Erel et al.
RESULTS:There were statistically significant differencies %SS (Disulphide) / 
total thiol levels patient with pre and post acupuncture groups compared with 
control group (P˂0.05). However there was no relationship %SS (Disulphide) 
/ total thiol levels patient with post acupuncture groups compared with pre 
acupuncture groups (P ˃0.05). The average %SS (Disulphide) / total thiol levels 
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was found to be 9,00±3,27 mmol/lt in the patient group and 6,98±2,62 mmol/
lt in the control group. The total %SS (Disulphide) / total thiol levels of patient 
group were found to be higher than the control group but not statistically. Thiol 
disulfide balance and IMA levels, which are oxidative stress markers, were 
increased in migraine patients compared to the control group and this was 
statistically significant (p <0.05). We found that acupuncture treatment caused 
some decrease in thiol disulfide balance but these results were not statistically 
significant. Ischemia-modified albumin (IMA) were not correlated with attack 
frequency, pain intensity, or migraine type. Only 5 sessions could be given 
to these patients. It is possible that if the number of sessions is increased, a 
meaningful result can be achieved.
CONCLUSIONS:This study evaluated dynamic thiol–disulphide homeostasis 
and IMA levels in the serum of patients diagnosed with migraine using a novel 
automated colorimetric method. Because oxidative stress plays an important role 
in the pathogenesis of many diseases, thiol chemistry has been recognized as 
increasingly important. We think the effect of acupuncture on dynamic thiol–
disulphide homeostasis and IMA in migraine patients has revealed that further 
animal and human studies are necessary.
Keywords: Migraine; Acupuncture; Complementary Therapies, Oxidative 
stress; 
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OBJECTIVES:Cisplatin is one of the most potent and widely used 
chemotherapeutic agents for treatment of a wide variety of solid tumors in 
clinic. However, due to various side effects such as nephrotoxicity, its efficiency 
and therapeutic application are limited. Regarding to reduce its side effects, 
combination therapies of cisplatin with other drugs have been highly considered 
to reduce toxicity. N-acetylcysteine (NAC), the N-acetyl derivative of the natural 
amino acid L-cysteine, is a well known antioxidant and anti-inflammatory agent. 
In the current study it was aimed to investigate the effects of NAC on cisplatin 
induced apoptosis in rat kidney.
MATERIALS and METHODS:Twenty four male Wistar rats were separated 
into 4 equal groups: Control, NAC-250, CP (cisplatin), CP+NAC. Rats in the 
experimental groups were treated with a single dose of cisplatin intraperitoneally 
(ip) (10 mg/kg) and NAC (ip, 250 mg/kg) for 3 consecutive days. At the end 
of the experiment, nephrotoxicity was confirmed by blood urea nitrogen and 
creatinine levels and the apoptotic changes were demonstrated by TdT-mediated 
deoxyuridine triphosphate nick-end labeling (TUNEL) and caspase-3 levels in 
rat kidneys.
RESULTS:The number of TUNEL-positive cells and caspase-3 levels were 
significantly increased by cisplatin at day 3 after its injection. Treating the rats 
with NAC significantly decreased TUNEL-positive cells and caspase-3 levels.
CONCLUSIONS:These data suggest that apoptotic cell death are involved, 
at least in part, in the pathogenesis of cisplatin induced nephrotoxicity, and 
inhibition of apoptosis appears to play a central role in the beneficial effects of 
NAC.
Keywords: Cisplatin; Apoptosis; Caspase-3; N-acetylcysteine; Rat 
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OBJECTIVES:Retinopathy, neuropathy and nephropathy are microvascular 
complications of diabetes mellitus. In this study, the role of thiol / disulfide was 
investigated in the development of diabetic microvascular complications.
MATERIALS and METHODS:Individuals (n=266) were divided into five 
groups; Group 1; who have diabetes without any complications for at least 10 
years, group 2; diabetic nephropathy, Group 3; diabetic neuropathy, 4; diabetic 
retinopathy. The 5th group consisted of 50 healthy individuals as the control 
group. Thiol, disulfide, ferroxidase and ischemia modified albümin (IMA) levels 
were measured.in the serum.
RESULTS:Nativ thiol, total thiol and native thiol / total thiol were found lower in 
the retinopathy group than the group with at least 10 years diabetes without any 
complication, the neuropathy group and the control group (p < 0.001). Disulfide 
/ native thiol and disulfide / total thiol levels were found to be higher in the 
retinopathy group than all the other groups, also the level of disulfide was higher 
than the control group and neuropathy group (p < 0.001). Ischemia-modified 
albumin level was found to be higher in the neuropathy and retinopathy groups 
than all the other groups (p < 0.001). Ferroxidase level was found to be lower in 
the neuropathy and retinopathy groups than the nephropathy group.
CONCLUSIONS:The disruption of thiol disulphide homeostasis favor of 
disulfide may play a role in the formation of diabetic retinopathy. Also, increased 
IMA and decreased feroxidase levels may play a role in the development of 
diabetic retinopathy and neuropathy.
Keywords: Diabetes mellitus, microvascular complications, thiol- disulfide, 
ischemia modified albumin, ferroxidase 
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OBJECTIVES:Laboratory-related errors are important part of the medical errors. 
Clinicians usually consider laboratory test results as absolute values. However, 
laboratory tests have pre-analytical, analytical and biological variations (BV). 
The aim of this study was to search how the knowledge and developments 
produced in the laboratory medicine were used by clinicians for the benefit of 
the patients. For this purpose, we selected BV as a model and investigated how 
clinicians use BV data to interpret test results.
MATERIALS and METHODS:A survey comprising 399 clinicians was 
conducted to evaluate knowledge regarding the BV in Turkey. We prepared a 
questionnaire consisting 9 questions. Five questions were open ended and 2 of 
the open ended questions were case based. A scoring system A to D (A indicates 
correct interpretation and D indicates clinician has no knowledge on variations) 
were used to evaluate open ended questions.
RESULTS:Clinicians (46%) used combination of the reference interval, clinical 
evaluation and literature data to interpret test results. In open-ended questions 
83% of clinicians scored C or D. None of the clinicians were using the reference 
change value in monitoring test results. Clinicians did not read an article about 
BV (88.3%) and they were not trained about BV (82%).
CONCLUSIONS:Clinicians are not adequately familiar with the new 
developments in laboratory medicine and do not use BV data to interpret tests 
results. Effective communication/collaboration between laboratorians and 
clinicians will enable clinicians to interpret laboratory tests accurately and use 
BV data more efficiently.
Keywords: Biological Variation, Interpretation of test results, Laboratory-Clinic 
Interaction 
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OBJECTIVES:Continuous monitoring of laboratory performances is a key 
activity in identifying errors and promoting improvement in Laboratory 
Medicine. Since 2008, The Working Group “Laboratory errors and Patient 
safety (WG-LEPS) of the International Federation of Clinical Chemistry 
and Laboratory Medicine (IFCC) has designed a Model of Quality Indicators 
(MQI) and implemented an informative platform to collect QI from laboratories 
worldwide. Data collected are processed, and a report describing the laboratory 
results compared with those of other participating laboratories is periodically 
issued. A working group is established in Turkish Biochemical Society to use of 
these quality indicators and to contribute harmonisation studies. The aim of the 
study was to determine usage of MQI on practical area.
MATERIALS and METHODS:Bağcılar Training and Research Hospital 
Laboratory has been chosen to enter their own data for MQI project. After 
registered to the project web site, data entering has been started since may 2017. 
There were nine selected QIs, four QI were about pre-analytical phase and five 
QIs post-analytical phase.
RESULTS:WG-LEPS publishes performance reports for each indicator as 
annualy. According to these published reports our laboratory data which are 
entered to the system meet high and medium performance criteria.
CONCLUSIONS:There are lot of QIs that are offered. One of the biggest 
challenges is the difficulty in understanding some indicators. Quality indicators 
should be translated to all languages and there should be more detailed 
explanation and calculation methods. Due to difficulties in obtaining data from 
laboratory information system, a common midware is needed.
Keywords: quality indicators, wg-leps, laboratory errors, patient safety 
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OBJECTIVES:The aim was to prepare a national guide for the preparation, 
distribution, and testing of purified laboratory water in clinical laboratories in 
Turkey.
MATERIALS and METHODS:Laboratory Water Guide Working Committee 
was established by Turkish Biochemical Society in 2017. It contained seven 
clinical biochemists. After appointing director, the treasurer, technical experts, 
method scientists and editors were defined. The needs for the country were 
determined. The strategic plan was made. The partners were identified. After 
that, work management was established; literature and resources were reviewed. 
The study was started. Total twelve meetings were performed in different cities. 
The study completed in one and a half year. After evaluation and approval, it was 
reported and the guide book was published in June 2019.
RESULTS:This national guideline defines the Laboratory Water Purification 
System (LWPS). It covers the subjects of laboratory water types and quality 
characteristics, water pollutants, laboratory water purification methods, storage 
and distribution, validation and monitoring of the water system and sampling and 
testing of laboratory water. Laboratory water types and quality characteristics 
were described based on CLSI. The guide defines minimum laboratory water 
quality standards to be considered and the processes to improve water quality 
in clinical laboratories. It also includes the problems that may be encountered 
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during design, and the solutions. LWPS should be operated under control and 
maintained. Thus, it ensures operational stability and meets water quality control 
standards.
CONCLUSIONS:This guide is national, and provides to clinical biochemists 
the information about operation, storage, monitoring and use of laboratory water 
system.
Keywords: Laboratory Water Purification System, Clinical Laboratories, 
Turkish Biochemical Society, Working Committee 
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OBJECTIVES:To evaluate the results of 24-hour urinary creatinine clearance 
(CrCl) with estimated glomerular filtration rate (eGFR) using the Chronic 
Kidney Disease Epidemiology Collaboration (CKD-EPI), CKD-EPI Pakistan 
(CKD-EPI Pak), Cockcroft Gault (CG) and 4-variable Modification of Diet in 
Renal Disease (MDRD) equations.
MATERIALS and METHODS:A descriptive, cross-sectional study was 
conducted at the section of Clinical Chemistry, Department of Pathology and 
Laboratory Medicine, The Aga Khan University, Karachi. Laboratory data of 
subjects’ ≥18 - < 70 years ordering 24-hour urinary CrCl was retrieved. Statistical 
comparison of eGFR using CKD-EPI, CKD-EPI Pak, CG and MDRD with the 
timed urine collection CrCl was done using regression analysis.
RESULTS:The mean age of the group (n=670) was 51.3 ±15.4 years with a 
median of 53 (IQR:22.3) years, 55.7% being males. Median BMI of males and 
females was 26.98 kg/m2 (IQR: 7.09) and 26.16 kg/m2 (IQR: 6.97), respectively. 
Mean GFR using 24-hour creatinine clearance was 57.1 ±35.9 ml/min/1.73m2 
with a median of 51 ml/min/1.73m2. Urinary creatinine clearance showed strong 
correlation with CG, MDRD, CKD-EPI and CKD-EPI Pak, showing r=0.78, 
r=0.79, r=0.82, and r=0.82, respectively. Sensitivity was highest for the CKD-
EPI Pakistan (84.7%). Similarly, CKD-EPI Pakistan equation showed the highest 
agreement (88.7%) with CrCl compared to the other formulae.
CONCLUSIONS:The CKD-EPI Pak equation is more accurate and precise than 
the CG, CKD-EPI and MDRD in estimating GFR in Pakistani population. The 
results of this study support automated reporting of eGFR using CKD-EPI Pak 
equation in laboratories across Pakistan.
Keywords: estimated glomerular filtration rate, equations, Pakistan, adults 
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OBJECTIVES:Unsuitable samples are common problems for laboratories. 
The blood collection tubes need to be validated and verified prior to routine 
laboratory administration in order to reduce this problem. In this study, we aimed 
at comparing the technical qualifications of routinely used BD Serum Separator 
II/SST II™ tubes with BD Barricor™ LH tubes for local technical validation.
MATERIALS and METHODS:150 volunteers were enrolled in the study. 
Samples were collected in two tubes by a single phlebotomist. 12 quality 
indicators were evaluated. The difference (%) was calculated with the formula 
proposed by EFLM. In case of any difference of less than 1% for indicators, the 
evaluated tube was considered adequate.
RESULTS:Indicators, such as tubes with physical defects of manufacturing, 
with no vacuum or that fail to create vacuum, not properly fitting into the blood 
collection device, under filling (10%), cracked tubes or tubes with leaking from 
the cap before/after centrifugation, blood contamination of collection device, 
haemolysed specimens, incorrect positioning of separator after centrifugation, 
tubes including fibrin strand/mass in sample after centrifugation, red blood 
cell adhesion to interior tube walls after centrifugation were found adequate in 
Barricor™ tubes. White particulate matter (WPM) was observed in 24.6% of 
Barricor™. Therefore, the last indicator, tubes including gel/foreign material/
WPM in sample after centrifugation, was found inadequate in Barricor™.
CONCLUSIONS:It was thought that WPM with 24.6% presence would not 
cause any interference in a properly filled tube. Thus, Barricor™ was found to be 
technically adequate. Technical validation studies should be encouraged in terms 
of total quality management.
Keywords: Phlebotomy; blood collection devices; preanalytical errors; 
technical validation; quality management 
 
O-066
The utility of preanalytical quality indicators: A Turkish survey study
Bağnu Orhan1, Derya Sönmez1, Hikmet Can Çubukçu2, Oğuzhan Zengi3, 
Hümeyra Emre4, Ipek Çınaroğlu5, Murat Keleş6, Alper Gümüş7, Cihan Coşkun8 
1İstanbul Training and Research Hospital 
2Erzurum Mareşal Çakmak Devlet Hastanesi 
3İstanbul Bağcılar Training and Research Hospital 
4Kahramanmaraş Necip Fazıl City Hospital 
5Becton Dickinson Life Sciences-Preanalytical Systems 
6Bursa Public Health Laboratory 
7İstanbul Başakşehir State Hospital 
8İstanbul Haydarpaşa Numune Training and Research Hospital 
OBJECTIVES:The utility of quality indicators(QIs) to monitor the total testing 
process of laboratories is able to improve the quality of services and enhance 
patient safety. The present study set out to investigate the harmony between 
the preanalytical QIs within the context of Model of Quality Indicators (MQI) 
determined by IFCC Working Group on Laboratory Errors and Patient Safety 
(WG-LEPS) and the QIs used by Turkish medical biochemistry laboratories. The 
other purpose of this investigation is to assess the usability of IFCC preanalytical 
QIs considering the conditions of Turkey.
MATERIALS and METHODS:A survey consisting of 9 questions prepared by 
Turkish Biochemical Society Working Group of Laboratory Errors and Patient 
Safety was applied to 81 laboratories via Survey Monkey.
RESULTS:According to survey results, 91 percent of participant laboratories 
used QIs proposed by Ministry of Health Quality Standards in Health. While 
some QIs within the context of MQI were utilized by over 80 percent of 
laboratories, some of other QIs were used by under 10 percent of laboratories.
CONCLUSIONS:The majority of the laboratories utilized QIs determined by 
Ministry of Health Quality Standards in Health and Ministry of Health On-site 
Assessment Guide. These standards were found to be partially compatible with IFCC 
WG-LEPS QIs. The inability of the health information system (HIS) limits the usage 
of QIs proposed by WG-LEPS. Education of medicial biochemistry specialists and 
other healthcare personnel and improvement of HIS are crucial for the QIs usage. 
Definitons of QIs should be more plain and understandable.
Keywords: laboratory errors, preanalytic phase, patient safety, quality indicators 
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A web-based application for management of quality control data
Deniz Ilhan Topcu1, Merve Sibel Güngören2 
1Department of Biochemistry, Faculty of Medicine, Başkent University, 
Ankara, Turkey 
2Düzen Laboratories Group, Ankara, Turkey 
OBJECTIVES:In medical laboratories, internal quality control (IQC) is the main 
quality control measure to assess the analytical phase. The main role of IQC is 
to detect errors in the analytical mom to assure patent safety. Regulations also 
obligate laboratories to conduct an IQC scheme. The main gap in IQC is the 
evaluation of results and existing laboratory information systems (LISs) mainly 
lack state of the art evaluation methods for QC data. Although there are some 
advanced software solutions for management of QC data, license costs can be a 
burden for laboratories. The aim of this study is to develop an open source web 
application for evaluation of quality control results.
MATERIALS and METHODS:In this study, a web-based QC data management 
27-31 October 2019Turkish Journal of Biochemistry, 2019
XXVII. Balkan Clinical Laboratory Federation Meeting BCLF 2019 
XXX. National Congress of the Turkish Biochemical Society TBS 2019
Turk J Biochem, 2019; 44 (S3) http://www.TurkJBiochem.com56
software was developed by using R programming language. Shiny tools were 
used for user-friendly interface. For sigma metrics calculation, different 
recommendations for quality requirements were utilized. For this software, QC 
data can be extracted from either LIS or middleware.
RESULTS:General features of this software are evaluation with given target 
values, revision of target values from accumulated data, evaluation with multi 
rules, calculation of bias from EQA results, calculation of total error and sigma 
metrics. This software can be applicable for daily IQC monitoring, periodic 
reporting and analytics.
CONCLUSIONS:This web-based software provides a more accessible way to 
correct QC practices for clinical laboratories.
Keywords: Quality control, internal quality control, data management software, 
open source 
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Quality control application for CBC parameters by ‘Average of Normals’ 
method
Ilknur Alkan Kuşabbi, Neslihan Cihan, Emel Çolak Samsum, Mehmet Şeneş, 
Vildan Fidancı, Doğan Yücel 
Department of Medical Biochemistry, Ankara Health Training and Research 
Center, Health Sciences University, Ankara 
OBJECTIVES:Application of internal quality control (IQC) with ‘average of 
normals (AON) method for complete blood count (CBC) parameters and to 
validate AON method with biased data.
MATERIALS and METHODS:For this study, CBC results in a Sysmex XN-
series instrument in our hospital’s hematology laboratory in July 2019 were 
evaluated. AON method was applied using Sysmex XbarM program. XbarM is 
based on calculation of weighted moving averages derived from Bull’s algorithm. 
Using XbarM ‘target/limit’ function, laboratory-specific target values were 
calculated automatically. When target and % values specified for control limits 
were entered into XbarM, weighted averages were calculated for each batch of 
results. A simulation study was performed with the biases of -80%,-50%,-20%,-
10%,-5%,-2%,2%,5%,10%,20%,50%,100% on the existing patient data. Using 
Excel, based on formula used by XbarM, new moving averages were calculated 
and evaluated for each bias point. Averages were taken every 50 patients. Target 
values for our laboratory were calculated automatically by monitoring patient 
results, control limits were determined according to % values recommended by 
Sysmex.
RESULTS:During follow-up, instrument had 2-8 AON points daily. There was 
no value exceeding control limits and this was consistent with conventional IQC. 
When biases were added, AON method could not detect 2% bias in general, but 
5% and above could be detected in early period.
CONCLUSIONS:AON method is cost-effective and complementary to 
conventional IQC programs especially to detect systematic errors.
Keywords: Average of Normals, Moving Averages, Quality Control, CBC 
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Evaluation of the most common rejection reasons in the preanalytical 
process at our laboratory using six sigma analysis
Mehmet Akif Bozdayı, Seren Orhan, Mustafa Örkmez, Mehmet Tarakçıoğlu 
Deparment of Biochemistry,Gaziantep University,Turkey 
OBJECTIVES:Based on statistical calculations, “Six Sigma Level’’ 
provides information about process performance In our study, we aimed to 
determine the most common reason for rejection of the samples rejected 
in the preanalytical period and to evaluate the effect of corrective and 
preventive actions to reduce this rate by using six sigma level analysis. 
MATERIALS and METHODS:The quality studies which were conducted in 
2019 at our laboratory showed that the most common reason for rejection in 
preanalytical period was inadequate sample collection in sedimentation test. 
Educational programme was organized for the related units to correct this 
ratio. After the educational training, sedimentation test rejection rates were re-
examined and evaluated.
RESULTS:When the distribution of rejection reasons was examined, 
it was found that the highest rate was inadequate sample collection the 
rate was 28.92%.the most frequently rejected test was ESR test with a 
rate of 55%. Educational program was provided to related units. One 
month sigma values were calculated before and after educational training. 
in June 2019(pre-education) sedimentation test total number was: 7455, rejected 
sample number: 418, sigma level was 3.1. in July 2019 (after the educational 
program has been applied ) total number of samples was 9534, rejected sample 
number: 335 sigma level was determined as 3.4.
CONCLUSIONS:The analysis of the main cause of preanalytical problems in 
the laboratory and the initiation of corrective and preventive actions increase the 
quality of the laboratory. We believe that sigma values will improve significantly 
by increasing the frequency of the educational training programs.
Keywords: Preanalytic phase, rejection rates 
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Analytical performance of Cobas 6500 for predicting urinary tract 
infection
Esra Fırat Oğuz1, Arzu Sakallı1, Ipek Mumcuoğlu2, Ortaç Ateş1 
1Clinical Biochemistry Laboratory, Ankara City Hospital, Ankara, Turkey 
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OBJECTIVES:Urinary tract infection (UTI) is the most common disease in 
the community. Urinalysis is the most requested screening test in patients 
with symptoms possible UTI. We aimed to compare the dipstick and sediment 
analysis results of fully automated Cobas 6500 urine analyser with gold standard 
urine culture results.
MATERIALS and METHODS:Data of 571 patients with order for urine dipstick 
test, urine sediment analysis and urine culture between March and November 
2018 were evaluated retrospectively. Sensitivity, specificity, positive and 
negative predictive values and ROC curve analysis was performed for leukocyte 
esterase (LE) and white blood cells (WBC).
RESULTS:349 of 571 patients had positive urine culture results. The sensitivity 
of dipstick leukocyte esterase was found to be 73.35%, whereas the specificity 
was 61.71%. Positive and negative predictive values were 75.07% and 59.56, 
respectively. WBCs showed 70.77% sensitivity with 65.31% specificity with 
positive and negative predictive values of 76.23% and 58.7, respectively. The 
area under the curve (AUC) for LE and WBC were 0.707(0.668-0.744) and 
0.753(0.716-0.788).
CONCLUSIONS:Leukocyte esterase in urine dipstick test and microscopic 
WBC tests had comparable results in predicting UTI. Clinical decisions based 
on dipstick urine and sediment analysis could be both time and cost effective and 
may reduce the need for the conventional urine culture.
Keywords: Cobas 6500, leukocyte esterase, urine culture, WBC 
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A comparison of Sysmex UF-5000 flow cytometer and Fuchs-Rosenthal 
Chamber in urine sediment analysis
Ozlem Unay Demirel 
Bahcesehir University, Faculty of Medicine, Medical Biochemistry, Turkey 
OBJECTIVES:Urine analysis is a basic test in the clinical laboratory. Urine 
sediment analysis is a part of urine analysis that gives laboratory professionals 
valuable information. Since manual examination is the gold standard for analysis 
it is time consuming and work-intensive procedure. In this study we aimed to 
compare the performance of Sysmex UF-5000 flow cytometer with the manual 
Fuchs-Rosenthal chamber in terms of urine sediment analysis.
MATERIALS and METHODS:A total of 127 fresh urine samples from outpatient 
clinics are analyzed. We used Sysmex UF-5000 flourescence flow cytometer for 
urine analysis and Fuchs-Rosenthal chamber for urine sediment analysis.We 
compared two methods by using Passing-Bablok regression analysis, Pearson 
correlation coefficient (r) and Bland-Altman bias plot.Statistical analysis was 
performed using Analyse-it software version 3.80 (Analyse-it Software,Ltd., 
Leeds, UK), Microsoft Excel 2010, and CLSI Statis-Pro software version 3.0.
RESULTS:A good correlation was observed between manual and automated 
white blood cell (WBC) counts in all urine samples. (r = 0.988; y = 1,162x + 
0,489; n = 127). UF-5000 demonstrated a significant proportional overestimation 
with Passing–Bablok regression (95% CI slope: 1,110 to 1,226). For red blood 
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cell (RBC) counts,correlation between UF-5000 and the counting chamber was 
observed in all samples (r = 0,966; y = 1,1x + 0,75).
CONCLUSIONS:This study showed us that urine analysis with flow cytometers 
is a very promising area and with automation getting more commonly used in 
clinical laboratories in the world,it is likely to replace the manual microscopy 
and thus reduce the workload and also time and energy needed in laboratories.
Keywords: Urine analysis, flow cytometer, Fuchs-Rosenthal chamber 
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Determination of serum carbamazepine by tandem mass spectrometry
Duygu Eryavuz Onmaz1, Sedat Abusoglu1, Ali Unlu1, Abdullah Sivrikaya1, 
Gülsüm Abusoglu2 
1Selcuk University Faculty of Medicine, Department of Biochemistry, Konya, 
Turkey 
2Department of Medical Laboratory Techniques, Selcuk University Vocational 
School of Health, Konya, Turkey 
OBJECTIVES:Carbamazepine is a first-line drug for the treatment of different 
forms of epilepsy. Therapeutic range of carbamazepine in plasma is 5 to 
10 µg/ml; more specifically, 7.4 µg/ml for adults and 8.2 µg/ml for children. 
Carbamazepine plasma level is directly correlated with dose, therapeutic effect 
and side effects. Carbamazepine plasma level is affected by several factors. 
It is altered by age and pregnancy status including several other factors. 
Individualization of drug dose with the help of plasma level detection is a must in 
case of carbamazepine therapy. In this study, our aim was to develop a LC-MS/
MS method for the measurement of carbamazepine.
MATERIALS and METHODS:100 μL of the internal standard (gliclazide 
solution) on a standard solution or sample of 250 μL was vortexed for 30 
s by adding 500 μL of acetonitrile included %0.1 formic acid, followed by 
centrifugation at 12 000 rpm for 10 min. The supernatants were taken into glass 
tubes and evaporated with nitrogen gas. The residue was dissolved in 200 μL of 
in the mixture of acetonitrile:water (50:50;%v:v) then enjected into LC-MS/MS 
system.
RESULTS:The calibration curve for carbamazepine was established at a range of 
0.15 to 80 µg/ml. Detection limit and quantitation limit for carbamazepine; 0.15 
µg/ml and 0.3 µg/ml, respectively. The retention time was determined 1.62.Total 
run time was 5 minutes.
CONCLUSIONS:We can conclude that the developed method can be useful 
for clinical studies and routine therapeutic drug monitoring with the desired 
precision and accuracy.
Keywords: Tandem mass spectrometry, drug monitoring, carbamazepine 
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3D placental barrier models: A novel cryogel based method
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OBJECTIVES:Cryogels are formed below the freezing point of the solvent. 
Their advantages are their inherent interconnected three dimentional (3D) macro-
porous structure and utilization as a scaffold in tissue engineering. At the same 
time, cryogels supply biocompatible property, ECM support and will represent in 
vivo better. Poly (2-hydroxyethyl methacrylate-glycidyl metacrylate) [p(HEMA-
GMA)] cryogels are super-macroporous (10-100 µm), hydrophilic cryogels. They 
provide non-specific protein interactions at the minimum level, are mechanically 
and chemically stable and they are resistant to microbial and enzymatic reactions. 
In tissue engineering studies, fibronectin potentially increases the cell adherence 
and folic acid improves the viability of cells.
MATERIALS and METHODS:In this study, galactose containing p(HEMA-
GMA)/gelatin cryogels were synthesized and then fibronectin or folic acid was 
attached on the surface. The proliferative and adhesive effects were investigated 
by seeding BeWo human placental choriocarcinoma cell line on the cryogels. 
Cryogels was characterized by swelling test and scanning electron microscopy 
(SEM). The viability of the BeWo cells on different crogels were investigated by 
Alamar blue assay 48 h after incubation.
RESULTS:BeWo cells and cryogels have been observed to interact well and cells 
were proliferated successfully. Among the cryogel groups, p(HEMA-GMA)/
gelatin-folic acid group had the highest cell viability. Cell viability was lower in 
galactose-bound cryogel groups than in galactose-free groups.
CONCLUSIONS:This novel placenta model reflects the in vivo more precisely 
and can be used as a model in transport of xenobiotics and their metabolites 
such as newly developed and mandatory drugs used in pregnancy and also for 
cosmetics, cleaning products, food additives, nanoparticules.
Keywords: placenta, cryogel, scaffold, cell viability 
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Antioxidant effects of flavonoid neoeriocitrin on streptozotocin-induced 
INS-1E cell diabetic model
Elif Karacaoğlu, Eymen Ece Aldemir, Güldeniz Selmanoğlu 
Department of Biology, Faculty of Science, Hacettepe University, Ankara, 
Turkey 
OBJECTIVES:Diabetes mellitus is a common metabolic disease, and its 
prevalance has been increasing globally. Numerous studies have revealed that 
generation of reactive oxygen species play a crucial role in diabetes. Moreover 
increasing in DNA damage also is a cause of experimental diabetes. Flavonoids 
have been promising therapy especially for preventing diabetes mellitus. 
Neoeriocitrin is a flavonoid which is found in citrus species and it could be a 
promising agent in preventing β-cells against diabetes. Our aim in this study is 
to reveal the antioxidant effects of neoeriocitrin against STZ-induced diabetes 
model in INS-1E cells.
MATERIALS and METHODS:INS-1E cells (rat insulinoma cell line) were pre-
incubated with neoeriocitrin at various concentrations (0, 0.25, 0.5, 1 µM) for 21 
hours then 5 mM streptozotocin (STZ) were added into cells and incubated for 
3 hours. STZ, which is a DNA alkylating agent, was used for inducing diabetes 
in INS-1E cells. Antioxidant ezymes such as superoxide dismutase (SOD) 
and catalase (CAT) were measured in cell lysates by spectrophometrically. 
Additionally, oxidized guanine species as a marker of DNA/RNA oxidative 
damage was measured spectrophotometrically.
RESULTS:STZ-induced INS1-E cells showed elevated SOD activity and 
decreases in CAT activity. Antioxidant status of the cells changed by neoeriocitrin 
treatment. DNA/RNA oxidative damage increased by STZ treatment, and 
neoeriocitrin caused changes in oxidized guanine species.
CONCLUSIONS:Biologically flavonoids have potential to reduce free radicals 
and risk of diabetes. Neoeriocitrin which has an antioxidant activity is a promising 
agent, however further studies are needed to exert mechanism of action against 
reactive oxigen species in INS-1E cells.This research was financially supported 
by Hacettepe University Scientific Projects Coordination Unit (Project No: FBA-
2018-16746).
Keywords: Neoeriocitrin, flavonoid, diabetes, INS-1E cells, oxidative stress 
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In vitro investigation of Argiope bruennichi derived spider silk materials
Seçil Karahisar Turan1, Aysun Kılıç Süloğlu1, Tuncay Türkeş2, Semra Ide3, 
Nurhayat Barlas1 
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2Department of Biology, Niğde Ömer Halisdemir University, Niğde, Turkey 
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OBJECTIVES:Spider silks’ exceptional chemical and mechanical properties lead 
to extensive researches in both industry and medicine. The purpose of this study 
is to investigate the effects of a novel designed biological material, the dragline 
silk of Argiope bruennichi, in surgical applications. As a first step towards this 
purpose, in vitro cytotoxicity assays were performed.
MATERIALS and METHODS:A. bruennichi specimens were collected from 
the Eastern parts of Black Sea region. Special made dragline silking system 
was used to collect the spider silk material for filament preparation. Nanoscopic 
structure analyses of the silk filaments were done by SAXS (Small Angle 
X-ray Scattering) and WAXS (Wide Angle X-ray Scattering) methods. Ab-
initio 3D nanoscale morphologies were also obtained by using SAXS data. 
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Cytotoxic potentials of spider silk based suture materials and their 
nanocomposite/biopolymer coated (film/filament) forms were investigated in 
L929 fibroblast cells by MTT (3-(4,5-Dimethyl-2-thiazolyl)-2,5-diphenyl-2H-
tetrazolium bromide) and LDH (Lactate dehydrogenase) assays.
RESULTS:SAXS analyses indicate that biopolymer coating causes the 
most stable 3D nanoglobular aggregations while the nanocomposite 
coating is convenient to keep the natural nanostructures of the filaments. 
The results of in vitro studies showed that dragline silk of A. bruennichi and 
nanopowdered levan coated films of A. bruennichi silk filaments did not show 
any cytotoxic effect on L929 cells.
CONCLUSIONS:According to the results of in vitro studies, Argiope 
bruennichi silk has a potential usage area in surgical applications. Further in 
vivo studies will be proceeded to investigate the effects of these silk materials on 
wound healing process in a dorsal skin flap model on rats.
Keywords: spider silk, levan, nanopowder, MTT, LDH 
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MicroRNAs in patients with type 2 diabetic nephropathy
Kadriye Akpinar1, Diler Aslan1, Semin Melahat Fenkçi2, Vildan Caner3 
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OBJECTIVES:To evaluate the associations of the diabetic nephropathy (DN) 
with 10 miRNAs that were found to be related to diabetes in human (miR-21a-
3p, miR-29a-3p, miR-29b-3p, miR-29c-3p, miR-126-3p, miR-192-5p and miR-
320c) and animal (miR-129-1-3p, miR-137, miR-212-3p) studies.
MATERIALS and METHODS:Plasma miRNAs were analyzed by RT-PCR 
and correlations with the eGFRs were evaluated in 50 healthy controls (male: 
n=24; age:55±11; female: n=26; age:54±13) and 100 type 2 diabetics (T2DM) 
(male: n=46; age:60±11; female: n=54; age:56±11). Diabetics were divided 
into normoalbuminuric (NAlb, n=51), microalbuminuric (MicAlb, n=25) and 
macroalbuminuric (MacAlb, n=24) groups. Forty-nine diabetics were diagnosed 
as DN.
RESULTS:miR-21 were detected in approximately half of all groups, and found 
significant (p<0.05) decreases in the T2DM, DN and MacAlb than those in the 
controls (T2DM: 5-fold, DN: 7, MacAlb: 7). The decrease in miR-192 that were 
detected in all groups was found significant (p<0.05) (T2DM: 2-fold, DN:2.4). 
The eGFR-based on cystatin C showed positive correlations (p<0.05) with 
miR-21, miR-192 and miR-126 (r=0,262, r=0,203, and r=0,417, respectively). 
miR-21 and miR-29c were correlated (p<0.05) with MDRD eGFR (r=0,243 and 
r=0,188, respectively). The correlation of CKD-EPI-creatinine with miRNA-192 
was significant (r=0,185, p=0,023). miR-21, miR-192, miR-29c and miR-320 
were negatively correlated (p<0.05) with microalbuminuria (r=-0,323, r=-
0,267, r=-0,173 and r=-0,172, respectively). miR-21 and miR-192 were found 
to be significant in distinguishing the DN from healthy subjects (AUC=0,726, 
p=0,0001 and AUC=0,717, p=0,0001, respectively).
CONCLUSIONS:miR-21 and miR-192 could be related to DN. More research is 
needed for the association of miR-29 family, miR-126, miR-212 and miR-320c 
with DN.
Keywords: Diabetic nephropathy, microRNA, miR-21, miR-192 
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Differentiation of osteopetrotic IPSC to osteoclasts: Comparison of 
osteopetrotic&healthy osteoclast
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Hacettepe University, Ankara, Turkey.Faculty of Medicine Pediatric 
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OBJECTIVES:Malign infantile osteopetrosis is a lethal, rare genetic bone-
disease characterized by dysfunctional-osteoclasts. The only available treatment 
for this disease is hematopoietic stem cell transplantation.
MATERIALS and METHODS:The main-purpose of this study was to evaluate 
the osteoclast-dysfunction using osteopetrotic-İPSC-derived-osteoclasts. 
Firstly,iPSC-lines from both TCIRG1-mutation positive osteopetrosis-patients and 
a healthy-donor were differentiated into hematopoietic stem cells-(iHSCs), which 
were characterized with colony-forming-capacity and CD34+CD45+surface-
markers by flow-cytometry. Immunophenotyping was evaluated for myeloid-
immnunuphenotyping. Then iHSCs were differentiated into myeloid-progenitors 
followed by osteoclast differentiation using M-CSF,RANK-L. Immunophenot
yping,immunofluorescence(IF)-staining,Scanning-electron-microscope(SEM) 
analysis, and gene-expression profile related to functionality and maturation of 
iPSCs-derived-osteoclasts were performed.
RESULTS:All iPSC-lines were differentiated succesfully into iHSCs. Patient-
iHSCs were showed to have three-times more CFU-M potential comparing to 
donor, and BFU-E potential was observed only donor-iHSCs. Osteopetrotic-
iPSCs-derived-osteoclasts were stained weakly-positive with Cathepsin-K,and 
Rhodamine-phalloidin comparing to the control. Osteopetrotic-iPSC-derived-
osteoclasts were positive for TRAP, imagined as giant-multinucleated-cells, 
and over 95% of the cells were CD14+CD16+,and CD18+CD51/61+..SEM-
images showed that there was a difference between the size of podosomes of 
patient-and donor-osteoclasts. Osteopetrotic-osteoclasts showed a delayed 
expression of related functional-genes compared to controls. At the end of 
differentiation osteopetrotic-osteoclasts showed significantly reduced expression 
of Cathepsin-K, Calcitonin-R, and NFATC1 genes comparing to controls. All 
results indicate that both donor-and osteopetrotic-İPSCs were differentiated 
into osteoclasts, but osteopetrotic-osteoclasts showed different gene and 
protein expression patterns, and size of podosomes indicating a disease-specific 
functional impairment. Functionality analyses are ongoing.
CONCLUSIONS:The results of our study might help to increase our knowledge 
about normal-and osteopetrotic-osteoclastogenesis, but needs to be supported 
with more detailed functionality-analyses.
Keywords: Osteopetrosis, Osteoclasts, TCIRG1, Induced Pluripotent Stem 
Cells 
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OBJECTIVES:Peroxidase-oxidase mimetic activity materials are important for 
developing new commercial assays.
MATERIALS and METHODS:A new staged-shape templated hydrolysis and 
condensation protocol was developed for the synthesis of monodisperse-porous 
metal oxide microspheres.The magnetic forms were synthesized with the 
accessible magnetic hematite (Fe3O4) nanoparticles tightly immobilized within 
the porous interiors of microspheres.Magnetic SiO2 microspheres and plain 
CeO2 microspheres exhibited peroxidase mimetic activity while oxidase-mimetic 
activity was obtained with the plain MnO2 microspheres.
RESULTS:3,3’,5,5’-tetramethylbenzidine (TMB) and o-phenylenediamine 
(OPDA) were used as the synthetic substrates providing products via oxidase/
peroxidase-like activities of corresponding microspheres, whose formation 
kinetics were followed by UV-Vis spectroscopy or fluorescence spectroscopy.
The interaction of plain and ligand-attached forms of porous metal oxide 
microspheres with the biomolecules resulted in a change in the peroxidase-
oxidase mimetic activity which was proportional to the biomolecule concentration 
in the interaction medium, due to the selective adsorption of biomolecule onto 
the surface of microspheres.
CONCLUSIONS:The concentration of ascorbic acid was determined via oxidase-
like activity of plain, porous MnO2 microspheres, using both colorimetric and 
fluorometric protocols. The ligand attached forms of plain SiO2 microspheres 
were evaluated for developing a colorimetric assay for the determination 
of histidine tagged protein concentration.We believe that the methodology 
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exemplified here will be effectively used for developing new commercial assays 
for the estimation of concentrations of various agents in biological samples.
The research was supported by Hacettepe University Scientific Research 
Projects Coordination Unit contract numbered as FBA-2019-17337, entitled 
‘’ Development of a peroxidase-microzyme-based biosensor for protein 
determination’’. The financial support provided is gratefully acknowledged.
Keywords: Peroxidase activity, Kit fabrication, DNA, Protein, Ascorbic acid. 
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OBJECTIVES:Clinical laboratories are responsible for producing reliable, 
reproducible and accurate test results.Six sigma is a quality managemen 
strategy that enables evaluation of processes, identification and improvement of 
defects. In this context, the aim of our study is to evaluate the analytical process 
performance of routine tests in our laboratory with six sigma method.
MATERIALS and METHODS:Internal quality control(IQC) data of tests were 
obtained retrospectively. Mean, standard deviation and coefficient of variation 
values of IQC were calculated. Process sigma values were calculated using 
the formula “%Allowable Total Error (TEa)- Bias%/CV% “. TEA values were 
determined according to CLIA 88. Sigma ≤3 was considered as low quality, 
sigma between 3 and 6 was considered as good quality and Sigma≥ 6 was 
considered as world class quality.
RESULTS:In the tests we evaluated, all of the process sigma were>3.The 
sigma levels of IQC1 for albumin, creatinine, LDL, urea, chloride,total 
cholesterol,HDL and sodium and IQC2 sigma for albumin, urea, UIBC, chloride, 
creatinine, potassium, sodium, direct bilirubin tests were between 3-6.The 
sigma of IQC1 for ALP, ALT, AST, CK, CKMB, ıron, uıbc, phosphorus, GGT, 
glucose, calcium,LDH, Mg,potassium, total protein, triglyceride, uric acid, 
amylase, lipase, direct bilirubin, total bilirubin, CRP, ferritin and sigma of IQC2 
for ALP, ALT, AST,CK,CK-MB, ıron, phosphorus,GGT, glucose, calcium, total 
cholesterol, HDL,LDL, LDH, magnesium, total protein, triglyceride, uric acid, 
amylase, lipase, total bilirubin,CRP, ferritin tests were≥6.
CONCLUSIONS:Six Sigma Methodology is a very effective method for 
assessing the laboratory’s analytical process performance.In our study, the 
performance of our laboratory was found to be good or worldclass.
Keywords: six sigma, internal qality control, Allowable Total Error 
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Evaluation of analytical quality of cardiac biomarkers in the emergency 
laboratory by sigma metrics
Saadet Kader 
Karapinar State Hospital Biochemistry Laboratory Karapınar, Konya, Turkey 
OBJECTIVES:The Six-Sigma Methodology is a quality measurement method 
in order to evaluate the performance of the laboratory. In the present study, we 
aimed to evaluate the analytical performance of our emergency laboratory by 
using the internal quality control data of cardiac biomarkers and by calculating 
process sigma values
MATERIALS and METHODS:Biological variation database (BVD) are used for 
Total Allowable Error (TEa). Sigma values were determined from coefficient of 
variation (CV) and bias resulting from Internal Quality Control (IQC) results for 
4 subsequent months. If the sigma values are≥6, between 3 and 6, and <3, they 
are classified as »world-class«, »good« or »un -acceptable«, respectively.
RESULTS:When the sigma values were analyzed by calculating the mean of 4 months, 
Troponin I (cTnI), CKMB mass, Myoglobin (Mb) were found <3.
CONCLUSIONS:The “poor quality” levels of cTnT, CKMB mass, Myoglobin 
sigma values, decision is taken for the improvement of cardiac markers in our 
laboratory. It is possible to determine the test with high error probability by 
evaluating the fine sigma levels and the tests that must be quarded by a stringent 
quality control regime. In clinical chemistry laboratories, an appropriate quality 
control scheduling should be done for each test by using Six-Sigma Methodology.
Keywords: Six Sigma, total allowable error, bias, Cardiac Biomarkers 
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Automated Vitamin D immunoassay comparison with LC-MS/MS method
Ercan Saruhan1, Muhittin Serdar2 
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OBJECTIVES:Serum 25-hydroxy (25-OH) vitamin D is the major form of 
vitamin D and the best indicator of vitamin D status in human beings. In this 
study, we compared analytical performance of automated immunoassay method, 
Roche Elecsys Vitamin D total assay, with the liquid chromatography tandem 
mass spectrometry (LC-MS/MS).
MATERIALS and METHODS:A total of 80 samples were used to assess vitamin 
D analytical perfomance. Vitamin D levels were determined in Roche Cobas 
E602. Results were classified into three groups; vitamin D concentration of less 
than 20 ng/mL (LOW, n=20), 20-50 ng/mL (NORMAL, n=41), and >50 ng/
mL (HIGH, n=19). Serums were stored at -80 °C for 2 weeks until LC-MS/MS 
analysis. Regression analysis and Bland–Altman plots were used for comparison 
between methods.
RESULTS:The correlation for all samples was acceptable (n=80, r=0,961). The r 
value was higher in samples with low vitamin D levels (n=20, r=0.948) as compared 
to those with normal vitamin D values (n=41, r=0.902) and high vitamin D values 
(n=19, r=0.715). The mean percent difference of Elecsys was −2.6% compared 
to LC–MS/MS. The results were linear with slope of 1.055, intercept of 0.833 
ng/mL, a correlation coefficient of 0.961, and a mean bias of -2.6% (P<0,0001) 
CONCLUSIONS:Our data show that the Roche Elecsys Vitamin D Total Assay 
has good correlation with LC-MS/MS. Although the LC-MS/MS method is 
considered reference method, it needs a special instrument and personnel and is 
thus expensive. Therefore, Roche’s automated immunoassays for vitamin D total 
assay is more suitable for evaluating vitamin D status.
Keywords: 25-hydroxyvitamin D, correlation, analytical perfomance, 
electrochemiluminescence, liquid chromatography tandem mass spectrometry 
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Calculation of measurement uncertainty of three different biochemistry 
parameters
Seren Orhan, Mehmet Akif Bozdayı, Mustafa Örkmez, Mehmet Tarakçıoğlu 
Department of Biochemistry,Gaziantep University,Gaziantep,Turkey 
OBJECTIVES:Measurement uncertainty is a quality indicator which is 
used to show the distribution level of the test result. In principle, two 
approaches can be used to calculate measurement uncertainty: “bottom-
top” and “top-down”.The “top-down” approach uses laboratory test 
performance information, such as intra-laboratory and inter-laboratory 
quality control data to estimate uncertainty associated with the test results. 
The aim of this study; to calculate the measurement of uncertainty values of three 
biochemistry parameters separately using internal and external quality control 
data. then these values will be compared with the CLIA’s% total permissible 
error (% TEa) values.
MATERIALS and METHODS:In this study, the uncertainty estimation of 
serum ALP GGT CK levels based on the “top-down” approach described in the 
Nordest guideline was used as a practical example. The tests were performed by 
enzymatic method on Beckman Coulter AU5800 analyzer.
RESULTS:Serum ALP GGT and CK analysis measurement uncertainty was found to 
be ALP:18.74%, GGT:13.3%, CK:17.7% in the 95% confidence interval,and these 
values did not exceed the CLIA% TEa (ALP:% 20,GGT:%15,CK:%20) values. 
The %CV values of the tests were ALP control level 1% CV: 7,07 level 2% CV: 
5,36, GGT level 1 % CV: 2,36 level 2 %CV: 3,45, CK level 1 %CV: 5.58 level 
2% CV: 2.9 and bias values were determined as bias(ALP): 0.6, bias(GGT): 2.8, 
bias(CK): 4.79.
CONCLUSIONS:The uncertainty value is a parameter that increases confidence 
in the accuracy of the measurement results.Therefore, laboratories should 
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provide results that do not exceed the target measurement uncertainty values.
Keywords: Measurement uncertainty, Accuracy 
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Development of a LC/MSMS method for quantification of adrenal-derived 
11-oxygenated 19-carbon steroids
Ali Yaman 
Department of Clinical Biochemistry, Marmara University Pendik Education & 
Research Hospital, Istanbul, Turkey 
OBJECTIVES:Recent studies have shown that adrenal-derived 11-oxygenated 
19-carbon (11oxC19) steroids may be associated with congenital adrenal 
hyperplasia (CAH) as well as premature adrenarche, polycystic ovary 
syndrome and castration resistant prostate cancer. In our study, we measured 
11β-hydroxyandrostenedione (11OHA4) and 11β-hydroxytestosterone (11OHT) 
metabolites, which are most likely of adrenal origin, by a LC/MSMS method. 
In addition, we thoroughly validated our method and evaluated whole steroid 
profile in patients who have 21-hydroxylase deficiency (21OHD) which accounts 
for the majority of CAH cases.
MATERIALS and METHODS:11OHA4 and 11OHT standards (Steraloids, 
USA) and 11OHA4-d7 internal standard (Cambridge Isotopes, USA) were used 
in the preparation of the calibrators and internal standard working solution, 
respectively. Plasma samples were prepared by liquid–liquid extraction (LLE). 
Poroshell 120 EC-C18 column (50×2.1mm, 2.7μm; Agilent Technologies, USA) 
was used and the analysis time was set as 15 min. Precursor and product ions for 
11OHA4 (303.2>121.0, 267.0), 11OHT (305.3>121.0, 269.0) and 11OHA4-d7 
(310.43>128.0, 243.0) were determined.
RESULTS:The linear measuring range of method was determined as 0.1–20.0 
ng/mL for 11OHA4 and 50–1000 pg/mL for 11OHT. The %CV values of the 
upper and lower limits of the measuring interval were ˂15%. Two 11oxC19 
steroids were significantly higher in 21OHD patients (n=7) compared to controls 
(n=56) (3–5-fold, P < 0.0001).
CONCLUSIONS:Our findings suggest that 11oxC19 steroids might serve as 
an additional biomarker in patients with 21OHD. LC/MSMS methods which 
have unique advantages like permitting more flexibility in application of new 
biomarkers are considered as reference methods for measuring steroid hormones.
Keywords: 11-Oxygenated 19-Carbon Steroids, congenital adrenal hyperplasia
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Structural bioinformatics approach in bioactive peptide research: Tomato 
vicilin case study
Burcu Kaplan Türköz, Bahar Bakar, Canan Kartal, Semih Ötleş 
Department of Food Engineering, Faculty of Engineering, Ege University, 
İzmir, Türkiye 
OBJECTIVES:Bioactive peptides (BAP) are gaining importance due to their proven 
health benefits. Food proteins are valuable sources for BAPs with antihypertensive 
(ACE inhibitory), antidiabetic (DPP-IV inhibitory), antioxidant and antimicrobial 
activities. There are several bioinformatics tools used in identification of BAPs 
based on amino acid sequence of the protein and the digestion patterns of different 
proteases. However, these tools do not take into account the tertiary structure of the 
protein of interest and therefore can not accurately predict the peptides which will be 
released under experimental conditions.
MATERIALS and METHODS:Tomato seed proteins were extracted using a 
modified protocol and were analyzed using electrophoresis. The structure of 
Solanum lycopersicum (tomato) vicilin was modeled based on the experimental 
structure of Solanum melongena vicilin using I-TASSER and RaptorX. The 
models were visualized and analyzed using PyMol Graphics.
RESULTS:Here, we present a structural biology approach to predict BAP release 
from tomato seed proteins. Among the extracted proteins, vicilin was selected 
for further analysis. The structure of vicilin was modeled and was subjected 
to in silico structure based proteolysis. Our approach takes into account the 
surface accessibility of specific cleavage sites of enzymes; carboxyl terminus 
of lysine or arginine for trypsin and large hydrophobic or aromatic side chains 
for chymotrypsin. The resulting peptides are further evaluated using BIOPEP for 
their ACE and DPP-IV inhibitory activities.
CONCLUSIONS:BAPs are very useful considering their therapeutic 
potential. Structure based approaches will shed light on time 
consuming experimental studies in order to produce targeted peptides. 
Acknowledgements: This work is supported by TÜBİTAK(117O319)
Keywords: Bioactive peptides, Protein Structure, Food proteins
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In silico prediction of antidepressant-binding sites on human glutathione 
reductase
Kerem Teralı, Özlem Dalmızrak, Hamdi Öğüş, Nazmi Özer 
Department of Medical Biochemistry, Faculty of Medicine, Near East 
University, 99138 Nicosia, Cyprus 
OBJECTIVES:Antidepressants, which are available worldwide, represent widely 
used treatments for major depressive disorder. They are grouped into various 
classes of compounds with slightly different mechanisms of action. Glutathione 
reductase (GR; EC 1.6.4.2) is a homodimeric enzyme that plays a crucial role 
in the regeneration of the antioxidant “recharger” glutathione (GSH) from 
glutathione disulfide (GSSG). While reduced antioxidant capacity is associated 
with many pathologies, cancer cells are known to use diverse strategies to 
increase their antioxidant capacity. For this reason, GR inhibition is expected to 
have divergent consequences in human health and disease.
MATERIALS and METHODS:Here, using protein–ligand docking and 
interaction profiling as well as ligand (un)binding simulations, we aim at 
predicting the mode of interaction between human GR and six antidepressants: 
two selective serotonin reuptake inhibitors (fluoxetine and sertraline); two 
tricyclic antidepressants (amitriptyline and clomipramine); and two alternative 
or nontraditional antidepressants (hypericin and pseudohypericin). We evaluate 
our in silico data according to in vitro results from enzyme kinetic studies 
previously conducted and reported by our research group.
RESULTS:All the antidepressants in question appear to be accommodated well 
in an eccentric cavity located in between the two monomers of GR. Hypericin 
and pseudohypericin, with their large rigid hydrophobic ring systems, bind the 
enzyme with the highest predicted affinity.
CONCLUSIONS:Overall, these interactions may subject healthy cells and 
tissues to oxidative stress. On the positive side, however, they may guide 
medicinal chemists in the search for new anticancer drugs.
Keywords: antidepressants, human glutathione reductase, computational 
biology, oxidative stress, anticancer drugs 
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Smart approval service for biochemical tests
Begum Mutlu1, Abdullah Elci2, Ali Ozen Akyurek3, Ersen Uzunal3 
1Gazi University, Department of Computer Engineering, 06570, Ankara, 
TURKEY 
2Istanbul Provincial Health Directorate, Maltepe (Number 3) Public Health 
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3Ventura Software Inc., Ankara, TURKEY 
OBJECTIVES:Biochemical tests’ results have been approved manually by 
clinical laboratory experts for decades. This process causes a remarkable loss 
of time for experts; it is highly likely that some of test results are mistakenly 
approved/unapproved, since massive amounts of test results are produced in 
every passing moment. This study aimed to automatically evaluate the test results 
by handling the problem as binary classification in artificial intelligence (AI).
MATERIALS and METHODS:Utilized AI models were data-driven machine 
learning (ML) approaches (Naïve Bayesian (NB), Support Vector Machine 
(SVM), Multi-layer Perceptron (MLP)) and expert-cooperated Fuzzy Systems 
(FSs). Dataset containing total 28 type of biochemical tests employed in one 
month-period was obtained from Istanbul Provincial Health Directorate, Maltepe 
(Number 3) Public Health Laboratory. There were 379340 manually approved 
and 3568 unapproved tests. Considered properties of tests were test-result, 
gender-of-patient, age-of-sample, has-interference, distance-to reference-range, 
delta-check, average-of-median, test-repeated, has-previous-test, and previous-
test-result.
RESULTS:5-fold cross-validation was applied for each test type and ML 
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method. Performance evaluation was based on area under the Receiver Operating 
Characteristic curve (ROC-AUC). Among the ML approaches, NB dramatically 
outperforms SVM and MLP. Although FSs have lower data-dependency, FS’s 
classification capability was on par with NB (ROC-AUC: 0.9997-0.9996).
CONCLUSIONS:Approval of test results by an automatic decision-making 
mechanism is essential need to make rapid, efficient and standardized evaluation. 
In this study, the feasibility of automatic approval process was empirically 
investigated. The best classification capability was obtained by NB and FSs. 
This research was supported by TUBITAK regarding project “3180740-PROBO 
Smart Approval System”.
Keywords: Biochemical tests, laboratory approval system, artificial intelligence 
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Evaluation of saliva Kallikrein-8 levels related with stress
Rabia Şemsi̇1, Umut Kökbaş2, Aylin Sepici Dinçel1, Erdal Ergünol3, 
Levent Kayrın2 
1Department of Biochemistry, Faculty of Medicine, Gazi University, Ankara, 
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2Department of Biochemistry, Faculty of Medicine, Kyrenia University, 
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TRNC 
OBJECTIVES:Kallikreins are a group of serine proteases that are enzymes 
capable of cleaving peptide bonds in proteins. It is a proteolytic enzyme that 
mediates the conversion of kininogen (α2-globulin) to brandykinin. Kallikrein 
is found in blood, lymph, saliva and various external secretions. The aim of this 
study was to determine whether KLK8 changes in saliva due to stress.
MATERIALS and METHODS:The study included 22 students (15 female 
/ 7 male) from Faculty of Dentstry of Cyprus University of Health and Social 
Sciences, Term-I. General and dental health of the students were evaluated in 
the appropriate anamnesis format. Saliva samples were collected between 
08.00-09.00 am in the morning, before the exam (12.00) and after the exam 
(14.00-15.00). It was collected by SARSTEDT brand saliva collection tubes as 
recommended. Kallikrein levels were measured by KLK 8 Human ELISA kit 
(pg/mL).
RESULTS:Body mass index and mean age (years) of the students were 20.4 
± 0.93 and 21.6 ± 3.46, respectively. In the present study, salivary kallikrein-8 
levels were determined morning, before and after the exam. There were a 
statistically significant differences between salivary samples of kallikrein-8 
values in the morning and before/after exam (p <0.001, p <0.001, respectively). 
However, there was no statistically significant difference between salivary 
kallikrein-8 before and after the exam (p=0.985). Electrobiochemical studies are 
ongoing to confirm the results
CONCLUSIONS:These results show that KLK8 changes in saliva due to stress.
Keywords: Kallikrein-8, Saliva, Stress
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The evaluation of ADAMTS-1 and ADAMTS-13 levels at coronary 
collateral circulation
Abdülhakim Hasan Gül1, Dilek Ülker Çakır1, Sema Uysal1, 
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1Department of Medical Biochemistry, Çanakkale Onsekiz Mart University, 
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OBJECTIVES:Coronary collateral circulation (CCC) plays important roles at 
coronary artery disease. It was revealed that ADAMTS-1, ADAMTS-13 and 
VEGF are included at angiogenesis and arteriogenesis. We aimed to show the 
relationship between ADAMTS-1, ADAMTS-13, VEGF levels and grade of 
CCC.
MATERIALS and METHODS:The patients who were applied to underwent 
coronary angiography according to European Society of Cardiology guide, were 
included in study. Collateral degree was graded according to Rentrope Cohen 
classification. Patients who had grade 0-1 collateral vessels were classified 
poorly-developed collateral group; grade 2-3 collateral vessels were classified 
well-developed collateral group. VEGF, ADAMTS-1 and ADAMTS-13 levels 
were measured by ELISA.
RESULTS:From patients who had >%90 obstruction at Coronary Angiographic 
View,36 patients were at well-developed collateral group and 33 patients were 
at poorly-developed collateral group. There has been no stastically significant 
difference between groups ADAMTS-1, ADAMTS-13 and VEGF levels 
(p=0,428, p=0,577, p=0,450). On the other hand, ADAMTS-1 levels were lower 
in well-developed collateral group (6.6±6.4) than poorly-developed collateral 
group (9.6±11.9).
CONCLUSIONS:According to our results, VEGF levels of patients with 
Coronary Artery Disease (CAD) were higher than the normal population. In 
addition, plasma VEGF level seems not to be associated with development of 
CCC. The alteration of ADAMTS-1 might have role the formation of CCC, but 
ADAMTS-13 level may not be associated with development of CCC. Our data 
highlighted that ADAMTS-1 and ADAMTS-13 molecules cannot be used as 
predictor marker for CCC. Further studies with more participants will elucidate 
the role of ADAMTS-1 and ADAMTS-13 on the development of CCC.
Keywords: ADAMTS-1. ADAMTS-13. Coronary Collateral Circulation 
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Apelin and other adipokines as potential biomarkers in myocardial 
ischemia
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OBJECTIVES:Apelin is an endogenous peptide and ligand of the G protein-
coupled receptor (also known as the APJ receptor). Apelin plays role in 
cardiovascular systems and participates in pathological processes for heart 
failure, obesity, diabetes. Apelin is called new adipokine and can be secreted by 
fat cells. Adipose tissue express and secrete numerous adipokines. CTRP1 and 
CTRP9 novel members of the adipokine family, have intersecting functions in 
the regulation of lipid metabolism and contribute to cardiovascular protection. 
In this study, we investigated the association of serum levels of apelin, CTRP1 
and CTRP9 with patients with and without myocardial ischemia after myocardial 
perfusion scintigraphy.
MATERIALS and METHODS:This study was carried out in 44 patients 
with myocardial ischemia and 44 patients without myocardial ischemia after 
myocardial perfusion scintigraphy. Serum apelin, CTRP1 and CTRP9 levels 
measured with ELISA method, whole blood HbA1c measured with HPLC 
method.
RESULTS:According to t test results for groups; there was a statistically 
significant difference between the groups in serum apelin, CTRP1, CTRP 9 
levels and whole blood HbA1c levels. Serum apelin, CTRP1, CTRP9 levels and 
whole blood HbA1c levels were found statistically significant between groups (p 
= 0.050, p = 0.045, p = 0.043 and p = 0.001, respectively).
CONCLUSIONS:Our data showed serum apelin, CTRP1 and CTRP9 could be 
used as potential biomarkers or supportive parameters for myocardial ischemia, 
and HbA1c, consequently diabetes, may be predisposing factor for myocardial 
ischemia.
Keywords: apelin, ctrp1, ctrp9, hba1c 
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Relationship between platelet activating factor acetylhydrolase and cardiac 
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OBJECTIVES:The cardiovascular mortality risk has increased seriously 
in Chronic Kidney Disease (CKD), especially dialysis patients. PAF-
acetylhydrolase is an enzyme that hydrolyzes platelet activating factor (PAF). 
Atherosclerosis was associated with valvular calcifications and PAF-AH. So we 
investigated the association of PAF-AH activities with valvular calcification in 
dialysis patients.
MATERIALS and METHODS:92 patients treated with hemodialysis (HD) 
and peritoneal dialysis (PD) and 86 CKD patients which were divided into five 
groups according to GFR [grade 1-2(> 60), grade 3a(45-59), grade 3b(30-44), 
grade 4(15-29) and grade 5(<15)] were included in the study. Echocardiography 
was performed to assess valvular calcification. We analysed urea, creatinine, uric 
acid, protein, albumin, ALT, ALP, calcium, phosphate, magnesium, cholesterol, 
triglyceride, HDL, 25-OH D vitamine, iPTH, CRP, NT-proBNP in serum and 
protein, albumin, creatinine in urine. PAF-AH activity was determined by color 
change based on the reaction of DTNB with free thiols which formed due to of 
2-thioPAF by PAF-AH and measured at 412 nm by a rate method.
RESULTS:There was no significant difference between the PAF-AH activities of 
dialysis and control groups (p >0.05). Higher PAF-AH activities in HD patients 
were associated with both valvular calcification and aortic valvular calcification 
(p <0.05). There was no association between PAF-AH and calcification in PD 
and control groups.
CONCLUSIONS:In addition to anti-inflammatory and antioxidative properties 
of PAF-AH, proatherogenic and proinflammatory products formed by enzyme 
complicates the interpretation of activity changes. Findings in our study suggest 
that the elevation of PAF-AH activities in HD patients are associated with 
valvular calcification particularly in aortic valve involvement.
Keywords: Hemodialysis, peritoneal dialysis, PAF-AH, calcification 
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Determination of ADMA and ghrelin levels as a marker of endothelial 
dysfunction in asthma patients
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OBJECTIVES:Asthma is a chronic inflammatory disorder defined as obstruction 
and hyperresponsiveness of airways. Appetite modulating hormone ghrelin plays 
a role in various diseases associated to inflammation. Ghrelin regulates secretion 
of proinflammatory cytokines and induces anti-inflammatory profile, although 
the underlying mechanisms remain elusive. Nitric oxide (NO) plays important 
roles such as airway smooth muscle relaxation, airway mucus secretion, and host 
defense in the lung. Asymmetric dimethylarginine (ADMA) that is defined as a 
marker of endothelial dysfunction is a competitive inhibitor of NO synthesis. To 
date, the role of ADMA in the pathogenesis of asthma has not been elucidated 
completely. The aim of the study was to evaluate ADMA and ghrelin levels in 
asthmatic patients compared to healthy subjects.
MATERIALS and METHODS:Thirty-eight asthma patients and twenty five 
healthy controls were included in the study. The patient group was constituted 
according to the Global Initiative for asthma guidelines. Serum ADMA levels 
were determined by HPLC and ghrelin levels were measured by ELISA.
RESULTS:Serum ADMA levels were significantly higher in the patients 
compared to controls (p=0.014, p<0.05). The median ADMA levels were found 
about 0.56 µmol/L in patient group. In contrast, ghrelin levels (116.24±2.03pg/
ml) were lower in the patients compared to the controls (154.3±21.6pg/ml, 
p<0.05).
CONCLUSIONS:Our findings demonstrated that increased ADMA and 
decreased ghrelin levels may be contributed to asthma pathophysiology. Our 
data support the idea that asthmatic patients have risk of endothelial dysfunction 
for cardiovascular diseases. However, more studies are required to elucidate the 
molecular mechanisms of ADMA as well as ghrelin actions in asthma.
Keywords: Asthma, asymmetric dimethylarginine, endothelial dysfunction, 
ghrelin 
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OBJECTIVES:Fungi, which are of particular importance in the ecosystem 
because of their biodegradable properties, are known to be an important source of 
biologically active components of both food and medical value. Fungal extracts 
are used in the treatment and prevention of many diseases. Lactarius deliciosus 
mushroom is also known as Kanlica mushroom and is an edible mushroom with 
high nutritional value. The aim of this study was to determine the antioxidant 
and antimicrobial activities of water, ethanol and cloform extracts of Lactarius 
deliciosus.
MATERIALS and METHODS:Antioxidant activities of the extracts were 
determined by DPPH (2,2-diphenyl-1-picrylhydrazase) method. Antimicrobial 
activities against Escherichia coli, Candida albicans, Staphylococcus aureus, 
Enterococcus faecalis, Pseudomonas aeruginosa were determined by disc 
diffusion method.
RESULTS:The water and ethanol extracts of Lactarius deliciosus were found 
to have antioxidant activity. And also antimicrobial activity was determined 
according to the solvent used and the type of microorganism. The most 
susceptible strain was P. aeruginosa and the most resistant strain was E.coli.
CONCLUSIONS:Mushrooms are highly important due to their properties such 
as fat, vitamins, carbohydrates and proteins. It is important to evaluate these 
fungi in terms of antioxidant and antimicrobial activity.
Keywords: Lactarius deliciosus, Antimicrobial Activity, Antioxidant Activity 
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OBJECTIVES:Methylglyoxal (MGO) is a glycolysis by-product and was 
found elevated in diabetics. It was described as the most powerful glycating 
agent which results in enhanced AGEs formation. MGO-derived the most 
important physiological AGE is hydroimidazolone 1 (MG-H1). Telmisartan and 
irbesartan were suggested to be protective against MGO. The aim of this study 
was to evaluate the effects of telmisartan and irbesartan on MGO-induced MG-
H1 levels under low and high glucose media in vascular smooth muscle cells 
(VSMCs), those play a prominent role in vascular diseases.
MATERIALS and METHODS:Primary cultured VSMCs were isolated from 
rat aorta. MGO-treated cells (200 µM) were incubated in low and high glucose 
media for 48 hours with or without telmisartan or irbesartan (both 10 µM). MG-
H1 was measured by ELISA technique as triplicates.
RESULTS:MGO raised MG-H1 concentration in low and high glucose media. 
High glucose alone elevated MG-H1 levels similar to MGO treatment in low 
glucose media. While telmisartan and irbesartan did not mitigate MGO-induced 
MG-H1 increase in low glucose media, they both displayed a significant 
reduction in MG-H1 concentration in high glucose media. Though telmisartan 
seemed better to reduce MG-H1 level, there was not any significant difference 
between telmisartan and irbesartan.
CONCLUSIONS:Our findings showed that telmisartan and irbesartan were 
effective against MGO-induced MG-H1 concentration increase in high glucose 
media. The reason could arise from MG-H1 level was highest in MGO-induced 
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cells cultured in high glucose. Further studies supporting our data are needed 
and these may guide clinicians to choose the best antihypertensive medicine in 
diabetic patients.
Keywords: methylglyoxal, MG-H1, telmisartan, irbesartan, high glucose. 
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Reelin enzyme levels in suicide or self harm attempt emergency 
service patients
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OBJECTIVES:Suicide is an important public health problem in our country as in 
the whole world. Although studies have shown that Reelin enzyme plays a role 
in the pathophysiology of neuropsychiatric diseases, information on how these 
enzyme levels change in suicidal behaviour remains unclear. For this reason, we 
aimed to investigate the enzyme levels of Reelin in self-harm or suicidal patients.
MATERIALS and METHODS:This work includes 86 consecutive suicide 
patients who applied to Fırat University, Faculty of Medicine, Emergency 
Medicine Department and 100 healthy age and sex-matched control. Reelin 
levels were analysed in serum samples in accordance with the ELISA kit 
procedure. In addition, the effect of demographic data such as body mass index 
(BMI) and age on Reelin levels were also investigated.
RESULTS:While in the suicide patient group Reelin enzyme level was 3038.31 
ng/L, it was 2271.20 ng/L in the healthy control group. When the demographic 
data were compared with Reelin enzyme levels, it was found that Reelin enzyme 
levels were negatively correlated with both BMI (r=-0.298, p<0.001) and age 
(r=-0.362, p<0.001).
CONCLUSIONS:It was suggested that increases in serum Reelin enzyme 
levels may be helpful in the diagnosis of suspicious suicidal cases. Interestingly, 
people with lower BMI and younger age have higher Reelin levels which calls 
for further research. When elaborating results on suicidal patients, it should be 
remembered that too many environmental and/or social factors are effective in 
suicidal behavior.
Keywords: Suicide, Reelin, Emergency Service, ELISA 
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Relationship between lipoprotein(a) and other lipids in children
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OBJECTIVES:Lipoprotein(a) (Lp(a)) levels are hereditary and essentially 
depend on the Apo(a) gene located on chromosome 6. Lp(a) may cause 
inflammation, oxidative stress, fibrinolysis and plaque instability. The aim of 
this study was to determine the correlation of Lp(a) with total cholesterol (TC), 
HDL-cholesterol (HDL-C), LDL-cholesterol (LDL-C) and trİglycerides (TG) in 
children.
MATERIALS and METHODS:The study included 25 patients with Lp(a) >100 
mg/dL, 25 patients with 50-100 mg/dL, 25 patients with 30-50 mg/dL and 25 
healthy children for the control group. Fasting blood Lp(a) was measured by 
immunoturbidimetric method and TC, TG, HDL-C was measured by photometric 
method in Beckman Coulter AU5800. LDL-C was calculated by the Friedewald 
formula.
RESULTS:In this study, Lp(a), TC, LDL-C, TG were significantly higher 
in all patient groups compared to the control group (p <0.001). There was no 
significant difference in HDL-C (p> 0.05). Only Lp(a) showed statistical 
difference between the groups (p <0.001). No significant difference was found 
in lipid profile (p> 0.05). Lp(a) showed a weak positive correlation with TC, 
LDL-C and TG (r = 0.340, p <0.001; r = 0.326, p <0.001; r = 0.275, p <0.001). 
CONCLUSIONS:Lp(a) is an independent risk factor for premature 
cardiovascular disease. But also it shows a correlation with other cardiovascular 
risk factors such as TC, LDL-C and TG.
Keywords: Lipoprotein(a), LDL-cholesterol, triglycerides 
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Relationship between B-HCG and LUC% levels
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OBJECTIVES:In this study, we aimed to investigate the changes in hematological 
parameters in pregnancy.
MATERIALS and METHODS:Hematology parameters of pregnant (521 
patients) (17180 ± 3652 mIU/mL) and non-pregnant (498 patients) (6.23 ± 0.91 
mIU/mL ) women were compared. BHCG levels were determined with Siemens 
Centaur XP and hematological parameters were analysed with ADVIA 2120i 
Hematology System.
RESULTS:LUC % (pregnant:1.57 ± 0.59, non-pregnant: 1.77 ± 0.80; p = 0.001), delta 
neutrophil index (DNI) (pregnant: 2.07 ± 0.51, non-pregnant: 2.49 ± 0.43; p = 
0.001); WBC (pregnant: 8.25 ± 1.52 x103/uL, non-pregnant: 7.31 ± 1.64 x103/
uL; p = 0.001); neutrophil % (pregnant: 66.54 ± 8.67, non-pregnant: 62.0 ± 9.31; 
p = 0.001); monocyte % (pregnant: 4.87 ±, 1.32, non-pregnant: 5.27 ± 1.5; p 
= 0.001); eosinophil % (pregnant: 1.67 ± 0.39, non-pregnant: 2.05 ± 0.73; p = 
0.001); basophil % (pregnant: 0.31 ± 0.18, non-pregnant: 0.41 ± 0.04; p = 0.001); 
lymphocyte % (26.02 ± 5.66, non-pregnant: 28.49 ± 4.68; p = 0.001) showed 
significant difference.
CONCLUSIONS:Large unstained cells are reported in routine complete blood cell 
(CBC) tests. LUC are large peroxidase-negative cells, which do not fit into other 
subtypes of leukocytes and they usually include virally activated lymphocytes, 
plasma cells, hairy cells, pediatric lymphocytes and peroxidase-negative 
lymphoblasts. In our study, LUC and DNI values were lower in pregnant women 
than non-pregnant women. Immune alterations with pregnancy may impair 
pathogen clearance, resulting in increased severity of disease for several pathogens. 
Therefore, we hypothesized that LUC value would be increased in infection and 
it can be a potential useful marker to differentiate infection. It can be suggested 
that there is resistance to inflammation during pregnancy.
Keywords: inflammatuary marker; LUC%; pregnanant 
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Biological variation of beta-trace protein, a novel marker for eGFR along 
with traditional markers
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OBJECTIVES:Objective evaluation of a test result by the clinician, the 
establishment of an analytical performance goal or deciding the appropriateness 
of population-based reference range require the knowledge on the biological 
variation of the test. In the study, it is aimed to determine the biological variation 
of beta-trace protein (BTP), a relatively filtration marker for glomerular filtration 
rate (GFR) along with the conventional markers such as creatinine and cystatin c.
MATERIALS and METHODS:Twenty-two participants aged between 25 and 
57 were included in the study. “European Federation of Laboratory Medicine 
Biological Variation-WG” recommendations were followed. Whereas creatinine 
levels were analyzed using an autoanalyzer (AU5800,Beckman Coulter 
Inc.,USA), cystatin C and BTP were measured by nephelometric method 
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(Atellica NEPH630 System,Siemens Healthineers,Germany). Intra (CVI) and 
inter-individual (CVG) biological variations for each parameter were calculated, 
reference change values (RCV), and individuality indexes were determined from 
these data.
RESULTS:CVA, CVI, and CVG values were as follows, respectively: 
5.56/3.31/14.50 for creatinine; 3.48/3.15/12.24 for cystatin C, 5.37/9.91/14.36 
for BTP. RCV values for creatinine, cystatin C, and BTP were calculated as 
17.94/13.01/31.24, while individuality indexes were found to be 0.23/0.26/0.69, 
respectively.
CONCLUSIONS:To our knowledge, the study is the first study in literature 
in which the biological variation of BTP is determined. The closeness of CVI 
and CVG results for BTP might be interpreted as the molecule not having a 
substantial natural variation or significant individual characteristics. Because 
of the high individuality of creatinine and cystatin C tests, using RCV values 
instead of population-based reference ranges would be more useful in monitoring 
patients.
Keywords: Biological variation, Beta trace protein, Creatinine, Cystatin C, 
reference change value 
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Calculation of APTTandPT reference intervals from patient data and 
evaluation of preoperative test utilisation in surgical patients
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OBJECTIVES:The purpose of this study was to verify the reference intervals 
of our own laboratory by indirect procedure for activated partial thromboplastin 
time (APTT) and prothrombin time (PT) and investigate whether preoperative 
coagulation test requests are necessary.
MATERIALS and METHODS:Bhattacharya procedure was used for 
determination of reference intervals from data of outpatient clinics between 
January 2017 and June 2019. We eliminated the test requests made by clinics 
of Child and Adult Emergency Department, Anesthesia and Reanimation, 
Obstretrics and Gynecology, Nephrology, Infectious Disase, Child and Adult 
Hemotology outpatients, inpatients and intensive care units. To determine the 
appropriate test utilisation, preoperative APTTandPT requests were used between 
July 2018 - June 2019 (n = 4751). Cardiology, Cardiovascular surgery and 
Oncosurgery patients and repeated test requests were excluded. We evaluated 
preoperative test requests of APTT and PT by using reference intervals that we 
created from our own hospital data.
RESULTS:Reference intervals of APTT (sec) and PT (sec) for 1-3, 4-6, 7-9, 10-
12, 13-18 age groups were 23.98- 34.87; 11.32-14.45, 24.10-33.08; 11.69-14.37, 
24.45-34.67; 11.73-14.38, 24.87-33.90; 11.82-14.45, 24.23-35.18; 11.87-14.42, 
respectively. Adult reference intervals were for 18-39, 40-49, 50-59, 60-69, 70-
79, 80 and above age groups were 24.06-33.63, 11.56-14.87; 23.28-32.40, 11.12-
14.07; 23.88-11.09-14.38; 23.62-32.55,11.17-14.65; 23.10-32.43,11.3-14.59; 
22.73-35.29, 11.35-14.81 respectively. In pediatric patients 77.1% of APTT and 
61.4% PT results; in adult patients 75.8% of APTT and 60.9% of PT results were 
within the reference ranges.
CONCLUSIONS:A large proportion of preoperative coagulation tests are found 
within reference ranges and these test requests are mostly unnecessary, time 
consuming and high costly activities.
Keywords: preoperative tests, hemostasis, reference ranges 
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ICD code specific normal ranges are needed, particularly in total bilirubin 
in this case
Özgür Aydın 
Kepez Public Hospital, Clinical Biochemistry Laboratory, Antalya 
OBJECTIVES:Two healthy young patients admitted to the hospital to obtain a 
formal report of health. Their total and direct bilirubin levels were slightly higher 
than the upper reference level so a call was made to the laboratory to investigate 
the suspicious results.
MATERIALS and METHODS:Internal quality results are validated daily for 
each instrument in our laboratory and they are nearly perfect; while external 
quality results for the previous month were also satisfactory. The total and 
direct bilirubin analysis were repeated in another auto-analyzer but there was no 
change in the results..
RESULTS:These two individuals were recorded in the laboratory information 
system (LIS) with a specific ICD code Z02 namely “Encounter for administrative 
examination”. Prior to medical health check, all nominees had to pass a written 
exam followed by a physical exam including a long distance running. A pubmed 
search with key words “sports” and “hemolysis” defined a rise in bilirubin levels 
of athletes.
CONCLUSIONS:The elevation in bilirubin is thought to be caused by 
mechanical factors, and named as “marching hemolysis”. The literature suggests 
to use a dedicated reference range for total bilirubin concentration in relation to 
the group of athletes. This case is an evidence based application to use reference 
intervals dedicated to individuals defined by the mentioned specific ICD code. 
Unfortunately, we can only define reference intervals for age and gender with 
the LIS we currently use just like the ones we used before which is a limitation.
Keywords: ICD codes, reference ranges 
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Pending laboratory tests at discharge in emergency department
Murat Alisik 
Polatli State Hospital 
OBJECTIVES:Emergency department (ED) is a department that requires 
rapid, accurate and effective intervention to patients. However, it is frequently 
encountered that patients are discharged before all tests are resulted. Laboratory 
test results pending at discharge (TPAD) from emergency department is a major 
patient safety concern and can have major adverse health outcomes. The goal of 
this study is to evaluate the TPAD ratios and factors that affect this situation in 
our hospital.
MATERIALS and METHODS:Two groups are established as TPAD and tests 
reported before discharge(TRBD) from the patients admitting to ED and having 
laboratory test requisition.
RESULTS:Total number of patients with test requisition were 13347, and total 
number of tests were 34104.
TPAD ratio is detected as 16,4%.TPAD is more frequent in biochemical 
tests(19,5%), hormones(42,4%), urine tests(18,7%), cardiac markers(21,4%) and 
coagulation tests(27,1%), while it is less frequently encountered in hematology 
tests(10%), blood gas analysis(4,6%), and blood ethanol levels(10,9%).
Consideration of delaying tests, regarding the determined test completion time for 
requested from ED, showed 5,5% delay in TPAD while it was 1,7% in TRBD(p<0,001). 
Regarding the referral status and reporting the tests before discharge of 370 
results with elevated Troponin tests, TPAD ratio was 12,1%(n=38) in non-
referred patients and 3,5%(n=2) in referred ones.
CONCLUSIONS:Current study indicates that patient discharge ratios before 
evaluating the test results is high. This situation endangers the safety of both the 
physician and the patient. Discharging the patients before the laboratory test are 
reported, especially the troponin levels in myocardial infarction suspicion, may 
give rise to irreversible results.
Keywords: Pending tests, laboratory 
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The effect of blood lactate levels on mortality in patients with sepsis
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OBJECTIVES:Severe sepsis and septic shock are one of the major causes 
of mortality in intensive care units, and elevated blood lactate levels are an 
important indicator of mortality. In this study, we aimed to investigate the effect 
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of blood lactate values on mortality rate of patients in intensive care unit.
MATERIALS and METHODS:The files of 74 patients diagnosed with sepsis 
since 01/01/2018 in the Reanimation Intensive Care Unit of Konya Training and 
Research Hospital were investigated retrospectively.
RESULTS:The mean age was 67.1±15.2 years in the group with mortality within 30 
days (n: 45) and 64.9±20.1 years in the group without mortality (n: 29). There was 
no difference between the groups in terms of age and gender (respectively, p=0.76, 
p=0.88). The mean duration of hospitalization in patients with sepsis was 12.3 ± 11.1 
days and 60.8% of them died. In the group with mortality, the input lactate value was 
4.2±3.9 mmol/L and the output lactate value was 7.3±5.4 mmol/L. In patients who 
were discharged, the input lactate value was 2.5±1.7 mmol/L and the output lactate 
value was 2.3±3 mmol/L. In our study, we found that the last measured lactate levels 
of the patients in the intensive care unit were higher than the first measured lactate 
levels in the group with mortality and this difference was statistically significant 
(p=0,000).
CONCLUSIONS:Lactate was an independent predictor of sepsis prognosis. Serial 
lactate monitoring helps to identify patients at high risk of developing mortality and 
is important for assessing the adequacy of treatment given to these patients.
Keywords: Sepsis, mortality, lactate 
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OBJECTIVES:Inflammatory diseases, including sepsis, are often accompanied 
by loss of appetite. As an orexigenic peptite, orexin increases appetite; however 
little is known about its role in sepsis related inflammatory conditions. Thus, 
the aim of the study is to investigate the role of orexin in Escherichia coli 
lipopolysaccharide (LPS) induced endotoxemia by using its dual receptor 
antagonist almorexant.
MATERIALS and METHODS:Sprague Dawley rats (male=female; 250-300g) 
were used: (1) Control and (2) Endotoxemia (E) groups were treated with saline; 
(3) E + orexin antagonist group was treated with almorexant (30 mg/kg ip) for 
3 days. On the 4th day, saline (control group) or LPS (others) was injected. Six 
hours after LPS injection, rats were sacrificed; their trunk blood, duodenum, 
stomach, liver, colon and kidney samples were collected. Tissue samples were 
analyzed for myeloperoxidase (MPO) activity, malondialdehyde (MDA) and 
glutathione (GSH) levels and microscopic damage was scored. Cortisol, tumor 
necrosis factor (TNF)-α, Interleukin (IL)-1β and IL-6 levels were measured in 
serum samples.
RESULTS:Endotoxemia increased MPO activity, MDA levels in all tissues 
and caused GSH depletion. MPO activity and MDA levels in all tissues and, 
cortisol, TNF-α, IL-1β and IL-6 levels in serum were decreased with almorexant 
injection compared with the endotoxemia group. Microscopic damage scores 
also reduced. However, almorexant treatment could not prevent GSH depletion 
induced by endotoxemia.
CONCLUSIONS:The results of our research showed that almorexant has anti-
inflammatory effects on LPS induced sepsis. Probably, dual orexin receptor 
antagonist, almorexant showed its anti-inflammatory effects by inhibiting tissue 
neutrophil infiltration and preventing lipid peroxidation.
Keywords: Orexin, Almorexant, Sepsis, Endotoxemia, inflammation 
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Correlation of CRP with blood-based inflammatory markers; large cohort 
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OBJECTIVES:The aim of the study is to examine the relationship between CRP 
and several blood-based markers (neutrophil/lymphocyte, platelet/lymphocyte, 
lymphocyte/monocyte, monocyte/HDL ratio), which have recently become 
popular in a large population of patients.
MATERIALS and METHODS:Samples were taken at Amasya Central Public 
Health Laboratory between 01.01.2018-31.12.2018 and the results of n=26,691 
(18,243 females, 8,448 males) patients were screened retrospectively. The 
correlation between CRP and neutrophil/lymphocyte ratio (NLR), platelet/
lymphocyte ratio (PLR), lymphocyte/monocyte ratio (LMR), monocyte/HDL 
ratio (MHR) were determined using the SPSS 15 for Windows program.
RESULTS:According to the results of the study, there was a positive correlation 
(r: 0.301, p <0.01, r: 0.180, p<0.01, r: 0.305, p<0.01, respectively) between CRP 
and NLR, PLR, and MHR, while there was a negative correlation (respectively: 
r: -0.224, p<0.01, r: -0.102 p<0.01) between CRP and LMR and HDL.
CONCLUSIONS:Based on the positive correlation (excluding LMR) of the 
rates of hematologic parameters and CRP, a marker of classical inflammation, 
we think that these rates can be used as a supportive marker for inflammation in 
patients under CRP follow-up. However, we believe that these rates should be 
supported by further studies to be conducted in various patient groups.
Keywords: inflammatory markers 
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Serum cytokine and complement levels in amyotrophic lateral sclerosis and 
their association with LRP antibody positivity
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OBJECTIVES:It has been known that neuroinflammation plays an important 
role in the pathophysiology of amyotrophic lateral sclerosis (ALS), and few anti-
neuronal antibodies have been detected in some studies. The aim of this study 
was to investigate the role of primary T helper subset Th1 (IFN-gama), Th2 (IL-
4) and Th17 (IL-17) cytokines and their association with complement factors.
MATERIALS and METHODS:25 patients with ALS (mean age 56.5±6.9 
years;16 males/9 females) and 25 healthy controls (58.7±8.5 years;14 males/11 
females) were included in the study. Serum C1q, C3, IL-4, IL-17 and IFN-
gama levels were measured by ELISA and LRP4-antibody was demonstrated 
by immunofluorescence method performed with HEK cells transfected with the 
plasmid encoding LRP4.
RESULTS:Serum C1q and C3 levels were lower and IL-17 levels were higher in 
ALS patients compared to healthy controls. There was no significant difference 
between IL-4 and IFN-gama levels. In spinal-onset ALS patients serum C1q and 
C3 levels were higher than those with bulbar onset. LRP4 antibody was found in 
4 cases. All patients with LRP4 antibody positive sera had spinal onset. C1q and 
C3 levels were significantly higher in the LRP4 antibody positive sera. In primer 
neuron culture studies, only LRP4 antibody-positive ALS serum IgG molecules 
binded neurons.
CONCLUSIONS:Our results support that the predominant role of Th17-type 
immunity in ALS. The increase of complement factors in spinal-onset cases 
suggests that the complement system is involved in pathogenesis of these 
patients. Conceivably, LRP4 antibodies might bind LRP4-expressing motor 
neurons thereby activating the complement system and thus contributing to 
motor neuron destruction.
Keywords: Amyotrophic Lateral Sclerosis, complement factors, Cytokine, 
LRP4 antibody 
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The relationship between standard sedo-analgesia implementation and 
serum procalcitonin levels in intensive care unit
Yeşim Güvenç Demirağcı1, Idil Teki̇n2, Orhan Kılıç2, Demet Aydın2 
1Department of Medical Biochemistry, Manisa Celal Bayar University Faculty 
of Medicine, Manisa, Turkey 
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OBJECTIVES:Inflammatory pain is a common symptom in intensive care unit 
(ICU) patients. Procalcitonin levels increase in systemic inflammation. The aim 
of this study was to determine the relationship between serum procalcitonin 
levels and standard sedo-analgesia in the control of inflammation-related pain 
levels in the ICU patients.
MATERIALS and METHODS:The study included 69 patients hospitalized to 
the Anaesthesiology and Reanimation ICU of Manisa Celal Bayar University. 
Patients are divided into two groups; Group 1(n = 36): within two months before, 
and Group 2(n = 33): within two months after standard sedo-analgesia protocol 
was implemented. Before the implementation of the sedo-analgesia protocol, 
patients were treated based on the subjective evaluation of physicians and nurses 
at irregular intervals. After the implementation of sedo-analgesia protocol, 
pain and sedation requirements, were evaluated regularly with reliable scales, 
and treated with appropriate prescribed drugs and doses. Serum procalcitonin 
levels were daily measured for five days. Serum procalcitonin levels were daily 
measured for five days with Cobas e411 autoanalyser.
RESULTS:Procalcitonin difference between day 1 and day 5 was analyzed in 
both groups and no statistically significant difference was found between Group 
1 and Group 2 (p=0.41). When the 5-day procalcitonin values of both groups 
were compared, no strong correlation was observed (r=0.412, -0.150, 0.053, 
0.365, 0.291, respectively).
CONCLUSIONS:Procalcitonin did not show a different course in the five-day 
follow-up with the start of our sedo-analgesia protocol. Thus, we conclude that 
procalcitonin may not be used as a biomarker to monitor the standart sedo-
analgesia protocol.
Keywords: Pain, Procalcitonin, Sedation, Analgesia, Inflammation 
 
O-108
Midkine can not be accepted as a new biomarker for the diagnosis and the 
treatment of unexplained female infertility
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OBJECTIVES:This study aimed to investigate whether a growth factor and a 
cytokine midkine (MK) can be a new biomarker for the diagnosis and the treatment 
of unexplained female infertility (UFI) cases.
MATERIALS and METHODS:Serum (S), follicle fluid (FF) and cumulus cells 
(CCs) of the patients aged 20-45 years, diagnosed with male factor (MF), UFI 
and polycystic ovary syndrome (PCOS) and undergoing Intracytoplasmic Sperm 
Injection (ICSI) procedure were used. The Anti-Müllerian hormone (AMH) and MK 
levels with other hormone levels, the oocyte and embryo qualities, the fertilization 
and pregnancy rates, and cumulus cells (Number, ultrastructure, and apoptosis) were 
evaluated. Student-T-test was performed and p<0.05 was considered statistically 
significant.
RESULTS:The lowest and highest numbers of CCs were found at UFI and PCOS, 
respectively (p<0.05). The lowest viability rate with the highest apoptosis rate was 
determined at PCOS (p<0.05). The lowest apoptosis rate with the highest viability 
rate was evaluated at MF (p<0.05). The ultrastructural evaluation revealed that there 
were widespread autophagic vacuoles at PCOS and lipid droplets at UFI with MF. 
CCs with apoptotic appearance was frequently detected at PCOS. Highest AMH and 
MK levels (S, FF) were found at PCOS; however, the lowest levels of them were 
detected at UFI (p<0.05). These values found at UFI were similar to MF (p>0.05).
CONCLUSIONS:MK can not be accepted as a new biomarker for the diagnosis and 
treatment of UFI.
Keywords: Unexplained female infertility, midkine, anti-müllerian hormone, 
polycystic ovary syndrome, cumulus. 
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OBJECTIVES:C-peptide indicates endogenous insulin production. It is a 
good marker for β-cell capacity. In recent years, the use of β-cell capacity 
for insulin use in the treatment of Type 2 DM has been recommended. 
According to the C-peptide level, the use of oral antidiabetics has been 
prescribed. C-peptide is used for monitoring pancreatic capacity. In this 
study, we aimed to emphasize the importance of C-peptide in the of DM. 
MATERIALS and METHODS:The number of C-peptide tests studied by the 
biochemistry laboratory of our hospital in the last 5 years were classified according 
to years. Subsequently, the annual changes were grouped as below 1.1, 1.1-4.4 and > 
4.4 and % ratios were found.
RESULTS:6794 C-peptide analyzes have been performed in our laboratory in the 
last 5 years. Percentage distribution of patients by years was found respectively 
as 11.2, 11.4, 18.0, 23.2, 36.3. The annual percentage distribution of patients with 
C-peptide <1.1 was respectively 23.2, 42.1, 19.7, 35.0, 10.9. The ratio of patients 
with C-peptide between 1.1-4.4 were 56.0, 31.4, 62.7, 52.1, 73.6 per years. The ratio 
of patients with C-peptide> 4.4 to overall patients in the same year was 20.8, 26.5, 
17.6, 12.9, 15.4.
CONCLUSIONS:There was a continuous increase in the number of test requests. 
The C-peptide is used not only for DM classification but also for the follow-up of 
DM patients. We think that this will reduce the need for parenteral insulin treatment. 
We think that the clinical laboratory planning should be made accordingly.
Keywords: C-peptide, DM, β-cell 
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Development and validation of a biosensor for measurement of serum 
hypoxia-inducible factor-1
Zihni Onur Uygun1, Hilmiye Deniz Ertuğrul Uygun2, 
Sinem Nur Şengöz Coşkun3, Yasemin Akçay1, Şevki Çetinkalp3, Ferhan Sağın1 
1Medical Biochemistry Dept., Faculty of Medicine, Ege University, İzmir, Turkey 
2Center for Production and Application of Electronic Materials, Dokuz Eylül 
University, İzmir, Turkey 
3Endocrinology Dept., Faculty of Medicine, Ege University, İzmir, Turkey 
OBJECTIVES:Normal oxygen delivery is essential for survival. Hypoxia, 
which is a common feature of various pathological conditions, ranging from 
cancer to inflammatory diseases, occurs when normal oxygen delivery is altered 
by an imbalance between cellular oxygen demand and tissue oxygen supply. 
Among the intricate mechanisms organisms have developed to maintain oxygen 
homeostasis, a family of hypoxia-inducible transcription factors (HIFs), are 
found to be the main regulator adaptive cellular response to hypoxia. Although 
ELISA can be used for its measurement, the lability of the protein and length 
of the analysis (>5 hours) pose limitations. Thus, our aim is to develop an 
electrochemical impedance spectroscopy (EIS) based biosensor system for quick 
and reliable measurement of HIF-1α in tissue.
MATERIALS and METHODS:HIF-1alpha antibodies have been used as a biota 
receptor. For immobilization, the electrode was first modified with albumin, 
followed by PAMAM. The new biosensor was compared with the conventional 
ELISA method.
RESULTS:Based on the chronoimpedance data, total analysis time for EIS was 
chosen as 15 minutes. Calibration curve was constructed by locating electron 
transfer resistance on y-axis and HIF1 concentration on x-axis, between 50-1000 
pg/mL. LOD and LOQ of the biosensor were calculated as 14.45 pg/mL and 
43.8 pg/mL, respectively. The new biosensor showed very good correlation when 
compared with the conventional ELISA method (R2= 0.99649).
CONCLUSIONS:We developed and analytically validated a biosensor system 
to measure HIF-1α in serum. This new biosensor promises more timely and 
accurate measurements in determining the tissue oxygenation in patients who 
have hypoxia related conditions such as diabetic foot.
Keywords: hypoxia inducible factor 1 alpha, biosensor, impedance, PAMAM 
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A fast and convenient UPLC - MSMS method for routine analysis of 
GALT activity from dried blood spot
Muhammet Topbaş1, Erhan Canbay1, Ebru Demirel Sezer1, Sema Kalkan Uçar2, 
Mahmut Çoker2, Eser Yıldırım Sözmen1 
1Department of Medical Biochemistry, Faculty of Medicine, Ege University, 
Izmir, Turkey 
2Department of Pediatric Metabolic Diseases, Faculty of Medicine, Ege 
University, Izmir, Turkey 
OBJECTIVES:Galactosemia is a disorder of carbohydrate metabolism most 
commonly caused by galactose-1-phosphate uridylyltransferase(GALT) 
deficiency.Currently,GALT deficiency screening is performed by fluorometric 
method from dry blood spots(DBS) and comfirmed by LC/ MSMS from whole 
blood samples.The aim of our study is to develop a fast,low cost,reliable LC/
MSMS based method for detection of GALT activity from DBS which does 
not need whole blood samples for verification and to compare the method 
performance with a commercial fluorometric neonatal GALT kit.
MATERIALS and METHODS:In the developed method,ACQUITY UPLC 
HSS-T3,2.7 μm,2,1x50mm column was used as the stationary phase and 5mM 
ammonium formate in acetonitrile/water 50/50% was used as the mobile phase.
Injection volume was 5μL while flow rate was 0.4mL/minute.Mass spectrums 
were determined with Waters Xevo TQD MS/MS system.
RESULTS:The method has been fully validated to ensure good selectivity,a 
satisfactory detection limit at 6.2nM for UDP-Galactose, acceptable intra- and 
inter-day accuracy and high precision.A linear response function was established 
for the range of concentrations between 0.05 –100μM(R²= 0.9992) for ¹³C6-
UDPGalactose.Controls’ enzyme activity levels were clearly distinguishable 
from patients’ levels (p<10-7) with a mean value of 42.29±19.73μmol/gHb/h 
(n=50) for controls and 0.03±0.025 μmol/gHb/h for patients (n=7).Recovery was 
found as 88% for low QC and 89% for high QC whereas matrix effect was found 
as 88% for low QC and 102% for high QC.
CONCLUSIONS:This fast, accurate, reliable and sensitive method to analyze 
GALT levels with LC-MS/MS system in DBS could contribute to facilitate a 
national newborn screening program in Turkey.
Keywords: GALT, DBS, LCMSMS, newborn screening, validation 
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Magnetic bead based electrochemical food and enzyme activity analysis by 
using SPE dependent immunosensors
Ebru Saatçi, Tuğba Özkaya Ferak, Mahmood Taha Noori Al Sadoon 
Department of Biology, Erciyes University, Kayseri, Turkey 
OBJECTIVES:Gathering magnetic beads (MBs) and screen printed electrode 
technology allows a highly sensitive and innovative methodology for the 
development of amperometric immunosensors. These researchs purpose are the 
detection of β-casomorphine-7 peptide in cheese rennet and analyze the substrate 
effect on HRP-based amperometric immunosensors by using this combined 
technology.
MATERIALS and METHODS:Both study were based on direct and competitive 
immunosensor protocols in which antigen-antibody and labeled enzyme 
immunoassay procedure was followed. HRP substrates ABTS and TMB 
were used to measure the HRP activity as the last step of the amperometric 
immunosensor analysis. Signal of the biosensors was in nano amper (nA) range.
RESULTS:For BCM-7 detection, competitive type immunosensor sensitivity 
was found in ng/ml range and the detection limits were found as 0.5-200 ng/ml. 
BCM-7 detection in different commercially available cheese rennets was also 
done. For HRP-based enzymatic sensor development, it is found that TMB is 
more sensitive than ABTS as the substrate of the HRP.
CONCLUSIONS:BCM-7 detection in cheese rennet with MB-SPE based 
immunosensor is the first study in the literature. For the other study, HRP activity 
detection with immunosensor type biosensor by using different substrates gives 
us the best substrate for HRP activity determinations in amperometric detection. 
These studies were supported by Erciyes University Scientific Research 
Projects Unit under the code of FYL-2018-8413 and Tübitak 1509, 9130058, 
PrintECELISA project.
Keywords: Amperometric immunosensor, BCM-7, HRP, ABTS, TMB 
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Transcriptomic meta-analysis in pancreatic ductal adenocarcinoma reveals 
therapeutic targets and diagnostic biomarkers
Sevcan Atay 
Department of Medical Biochemistry, Ege University Faculty of Medicine, 
Izmir, Turkey 
OBJECTIVES:Pancreatic ductal adenocarcinoma (PDAC) is the most common 
form of pancreatic cancer, which has the highest mortality rate of all solid tumors. 
The absence of an effective screening process and distinctive symptoms, causes 
a delay in diagnosis. Traditional chemotherapy and curative surgery have limited 
benefits on patient survival. Enzymes are one of the most important groups of 
drug targets and are preferred markers for the detection of various diseases. 
This study aims to identify up-regulated genes encoding enzymes in PDAC to 
suggest novel therapeutic targets for more effective treatments to be developed 
and diagnostic biomarkers for PDAC.
MATERIALS and METHODS:NCBI Gene Expression Omnibus (GEO) was 
searched for datasets using keywords ‘pancreatic ductal adenocarcinoma’. The 
inclusion criteria were i) Gene expression microarray data, ii) human-derived 
pancreatic ductal adenocarcinoma tissues and normal pancreatic tissue samples. 
All data processing and integration procedures were performed using ExAtlas. 
The false discovery rate is less than 0.05, and the change of gene expression is 
≥ 10-fold were considered significant. The up-regulated enzyme-coding genes 
were detected in the differentially expressed gene list.
RESULTS:The random effect integrative meta-analysis of five submissions 
(GSE46234, GSE19280, GSE43795, GSE41368, and GSE71989) 
containing 24 tumor-normal tissue pairs revealed 22 up-regulated genes, two of 
which encoding enzymes. The enzyme-coding genes with 10-fold differential 
expression compared to the controls were SULF1 (sulfatase, fold change=22.135) 
and KYNU (kynureninase, fold change=10.716).
CONCLUSIONS:The results of this study suggest that sulfatase and kynureninase 
may have the potential to become diagnostic biomarkers and therapeutic targets 
for PDAC, which merits further investigation.
Keywords: Pancreatic Ductal Adenocarcinoma, microarray, meta-analysis, 
enzyme, gene expression.
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Assessment of Vitamin D levels in Şanlıurfa region
Nihayet Bayraktar, Oruç Aslan, Müjgan Ercan, Ekrem Yaman, 
Mesut Yardimcıel, Melek Alan, Ataman Gönel 
Harran University Medical School, Department of Medical Biochmistry, 
Şanlıurfa 
OBJECTIVES:The aim of this study was to determine serum vitamin D levels in 
Şanlıurfa region and to investigate the existence of difference between its level 
saccordingtoage, sex and season.
MATERIALS and METHODS:Scanning the findings of serum 25-hydroxy 
vitamin D at software system of Biochemistry Laboratory, Education and 
Research Hospital, Harran University was applied during the period 01.01.2018 
and 01.06.2019. Serum 25-hydroxy vitamin D level had determined by LCMS-
8045 liquid chromatography mass spectrometer auto-analyzer. SPSS version 
21 program was used to evaluate normality test with Kolmogorov-Smimov 
test. Descriptive statistics were expressed as median (min-max) since the data 
were nonparemetic. Mann-Whitney U test andKrusskal-Wallis test were used fo 
rstatistical difference among the studied groups. Significance level was accepted 
as P <0.05. Intra-laboratory variation coefficients (CV%) of all methods used 
were<3%..
RESULTS:In our retrospective study, vitamin D deficiency was found in 68.21% 
of 6182 patients. In comparison the results according to gender, age, and season, 
a significant difference (p <0.001) was found in serum vitamin D levels and this 
was in accordance with the literature.
CONCLUSIONS:As a result, In Sanliurfa, the reference range of vitamin D level 
was determined according to age, sex and seasonal parameters. Considering the 
influencing factors, we strongly recommend checking serum vitamin 25 (OH) 
-D during annual controls and to raise public awareness about importance of 
sunbathing to prevent vitamin D deficiency.
Keywords: Vitamin 25-OH, Age, Sex 
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The role of HDL-associated MPO and PON-1 for coronary artery disease in 
Hashimoto Thyroiditis
Emre Avci1, Gizem Uncu1, Gulcin Alp Avci1, Alpaslan Karabulut2, 
Cumhur Bi̇lgi̇3 
1Hitit University, Faculty of Arts and Sciences, Department of Molecular 
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Medicine,Corum,Turkey 
3Yüksek İhtisas University, Faculty of Medicine, Department of Medical 
Biochemistry,Ankara,Turkey 
OBJECTIVES:Hashimoto’s thyroiditis is an autoimmune disease of the thyroid 
gland.Free radicals have been reported to be responsible for the complications 
observed in the pathogenesis of thyroid diseases and in the later stages of the 
disease.MPO,which is released during inflammation, is an oxidative enzyme 
present in phagocytes.MPO could be a key element responsible for oxidative 
damage in the artery wall.PON-1,which is one of the molecules that play a role in 
oxidant balance, is an enzyme that has the role of inhibiting lipoprotein oxidation 
by hydrolyzing lipid peroxides in oxidized LDL structure.We investigated 
the role of HDL-associated MPO and PON-1 in patients with HT in terms of 
coronary artery disease
MATERIALS and METHODS:Our study group consisted of 54 patients with 
Hashimato diagnosis and 28 healty individuals as control group.MPO and PON1 
levels were determined spectrophotometrically
RESULTS:When the study groups were evaluated,PON1 levels were 
significantly lower in patients with hashimato thyroiditis than healthy subjects 
(p<0.05,p=0.032).When the study groups were evaluated, MPO levels were 
significantly higher in patients with hashimato thyroiditis than the control group 
(p<0.05,p =0.001).A negative correlation was obtained between MPO and 
PON1(r=-0.685)
CONCLUSIONS:The decrease in PON1 activity and increase in MPO activity 
due to hypothyroid effect increases lipid peroxide formation and accelerates 
oxiLDL formation,which leads to decrease in antioxidant capacity and 
development of atherosclerosis.Since oxidative stress in thyroid diseases is also 
responsible for the complications observed in the later stages of the disease,we 
think that important data were obtained with this study in terms of both diagnosis 
and treatment
Keywords: Hashimoto Troiditis, MPO,PON-1,HDL
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Drug-induced (quinine) acute hepatitis with high level of serum vitamin 
B12
Özlem Özün1, Ferhat Demirci2
1Özlem Özün, University of Health Sciences Suat Seren Chest Diseases and 
Surgery Training and Research Hospital, Medical Biochemistry Laboratory, 
Izmir, Turkey
2Ferhat Demirci, University of Health Sciences Suat Seren Chest Diseases 
and Surgery Training and Research Hospital, Medical Biochemistry 
Laboratory,Izmir,Turkey
OBJECTIVES:Acute hepatitis; viruses, drugs, alcohol, metabolic diseases, 
toxins caused by liver cell necrosis and inflammation of the liver. Since liver 
plays an important role in the metabolism of drugs, drugs are one of the most 
common causes of toxic liver damage.The diagnosis of drug-induced hepatitis 
is usually made by ruling out other causes and it should be remembered in the 
patient’s history.
In this case, a patient who presented to the infectious diseases clinic with fatigue 
was presented.
MATERIALS and METHODS:Drug-induced liver damage (IBCT) is one of the 
most common causes of hepatotoxicity
RESULTS:In liver pathologies, ALT, AST, ALP, GGT and bilirubin tests, 
which are described as liver function tests, are expected to increase or decrease 
according to the severity of the clinic. What is striking in this patient is the 
change in vitamin B12 measurements. Although it was initially thought to be the 
interference of quinine in immunassay methods, a B12-quinine interference was 
not found in the literature review.
CONCLUSIONS:The elevation of vitamin B12 in liver cell damage suggests that 
it can be used as a marker in the diagnosis and / or treatment of acute hepatitis. 
Furthermore, as observed in cirrhosis cases, rapid decrease after elevation in 
AST and ALT enzymes indicates a poor prognosis and a prolonged tendency to 
increase in B12 levels may indicate a poor prognosis.
Keywords: Acute hepatitis, vitamin B12, quinine
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Determination of serum tryptophan and its’ metabolites by tandem 
mass spectrometry
Ali Unlu1, Sedat Abusoglu1, Duygu Eryavuz Onmaz1, Abdullah Sivrikaya1, 
Gülsüm Abusoglu2 
1Department of Biochemistry, Selcuk University Faculty of Medicine, Konya, 
Turkey 
2Department of Medical Laboratory Techniques, Selcuk University Vocational 
School of Health, Konya, Turkey 
OBJECTIVES:Tryptophan (Trp) is an essential amino-acid and the precursor 
of several biologically active compounds such as kynurenine (KYN) and 
serotonin (5HT). Its metabolism is associated with various physiopathological 
conditions, such as cardiovascular diseases, cancer, immunomodulation or 
depression. Our aim of this study is to determine and validate serum tryptophan 
and its’ metabolites by high performance liquid chromatography tandem mass 
spectrometry (LC-MS/MS).
MATERIALS and METHODS:100 µL of internal standard (L-Kynurenine-d4) 
was added to 300 µL serum sample and 1000 µL acetonitrile (containing 1% 
formic acid) was added as a precipitating agent. Then the mixture was vortexed 
at 12 000 rpm for 10 min. 1000 µL of the supernatant was transfered into clean 
glass tubes and evaporated under nitrogen. The residues in the tubes were 
dissolved in 200 µL acetonitrile: water (25:75, v/v) mixture containing 0.1% 
formic acid and 40 µL was injected to ABSCIEX API 3200 mass spectrometry. 
Total run time was 5 minutes
RESULTS:Limit of detection-quantation levels were 1.62-3.25, 1.22-2.44, 0.48-
1.95, 0.97-1.94, 1.56-3.12 µg/mL for tryptophan, kynurenine, kinurenic acid, 
3-hydroxy kynurenine and 3-hydroxy- anthranilic acid, respectively.
CONCLUSIONS:Evaluation of tryptophan pathway with all metabolites may 
help to elucidate the role of this pathway in disease pathogenesis. For this 
purpose, the mass spectrometer technique can be considered as a suitable method.
Keywords: Tryptophan, Tandem mass spectrometry, Pathway 
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Determination of tryptophan and kynurenine by LC-MS/MS by using 
amlodipine as ınternal standard
Burcu Eser1, Yeşim Özkan2, Aylin Sepici Dinçel3 
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2Department of Biochemistry, Faculty of Pharmacy, Gazi University, Ankara, 
Turkey 
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OBJECTIVES:Tryptophan (Trp) is an essential amino acid that plays an 
important role in cell metabolism and Kinurenine (Kyn) is its main metabolic 
pathway. By using ultra-high-performance liquid chromatography coupled to 
electrospray ionization triple quadrupole mass spectrometry (UHPLC-ESI-MS/
MS), tryptophan (Trp) and kynurenine (Kyn) were determined using Amlodipine 
(Aml) as internal standard (IS).
MATERIALS and METHODS:The analysis was carried out on a ACE-C18 
(4.6mm × 50 mm, 5 μm) reversed-phase analytical column using gradient 
elution mode. For quantitative determination, Amlodipine was used as an 
internal standard. Detection was performed using multiple reaction monitoring 
in electrospray ionization mode at m/z 205.1→117.7 for tryptophan, m/z 
209.1→146 and 93.9 for Kyn, m/z 409.2 → 294.1 for IS (Aml). Good linearity 
of an analyte to internal standard peak area ratios was seen in the concentration 
range 1.25–4000 ng/mL for tryptophan, 0.5–1600 ng/mL for kynurenine.
RESULTS:The method showed excellent linearity with regression coefficients 
0.99 for Kyn and 0.996 for Trp. The limits of quantification (LOQ) were 0.55 ng/
ml for Trp and 0.47 ng/ml for Kyn. %RSD for all analytes ranged from 0.3–3.4% 
for intra-day and 0.4–8.9% for inter-day experiments.
CONCLUSIONS:A simple LC-MS/MS method has been developed and 
validated for measuring Kyn and Trp by using an affordable and more easily 
available IS (Aml).
Keywords: Tryptophan, Kynurenine, Amlodipine, LC-MS/MS 
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Relation between the oligoclonal band presence and IgG index in multiple 
sclerosis
Dilek Iren Emekli1, Cemile Çakmak1, Sibel Yıldırım1, Zübeyde Erbayraktar2 
1Erbayraktar Private Medical Laboratories, Izmir, Turkey 
2Department of Biochemistry, Dokuz Eylul University Medical Faculty, Izmir, 
Turkey 
OBJECTIVES:IgG index and Oligoclonal Band research are the prevalent tests 
in the diagnosis of Multiple Sclerosis disease (MS). The goal of this study is to 
evaluate the relation between the IgG index levels and Oligoclonal band (OCB) 
presense in cerebrospinal fluid (CSF).
MATERIALS and METHODS:Serum and CSF samples of 58 persons who 
applied to our laboratory for the test due to suspicion of MS, were included in 
the study. In the evaluation IgG index and simultaneously OCB in serum and 
CSF, were studied. Presence of OCB in CSF were evaluated by using isoelectric 
focus method. Albumin and IgG levels in serum and CSF were measured by 
immunoturbidimetri method.
RESULTS:In 24 (%41) samples OCB presense was seen. In 16 (%67) OCB 
(+) samples IgG index referance range limit was calculated as 0,7 and over. In 
8(%33) OCB (+) samples IgG index was calculated as < 0,7. In 34 OCB (-) 
samples IgG Index was found 0,55 on average; in samples with IgG index under 
0,55. In 21 (%36 ) samples of 58 IgG index was found at 0,55-0,70 range. In 8 
(%38) of them OCB (+) was seen and this is also %33 of all OCB(+) samples.
CONCLUSIONS:In this study relation between IgG index and CSF OCB, that 
are common tests which are used in MS researches, was studied independently 
of cllinic value. When the index exceed 0,70 there was always connection, that 
OCB presence would be available between OCB analysis result and IgG index 
size.
Keywords: IgG index, Multiple Sclerosis, Oligoclonal Band 
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Comparison of the novel Access procalcitonin assay with Radiometer AQT 
90 Flex
Özlem Doğan, Erdinç Devrim, Aslıhan Avcı 
Department of Biochemistry, Ankara University, Ankara, Türkiye 
OBJECTIVES:Procalcitonin (PCT) is considered the most useful biomarker for 
severe systemic inflammation, infection and sepsis although not totally specific 
for sepsis. Elevated PCT concentrations have a high positive predictive value 
for the diagnosis of sepsis, severe sepsis or septic shock (PCT >0.5 to >2 μg/L). 
Currently, there are several different assays available for PCT measurement. This 
study compared the performance of the AQT90Flex immunassay time resolved 
fluorometric technology with a new immunassay Access sysytem technology
MATERIALS and METHODS:148 EDTA-anticoagulated blood samples of 
hospitalised patients and outpatients for routine laboratory testing were included. 
The samples were analysed in duplicate for procalcitonin with RadiometerAQT90 
Flex () and Access (Beckmann Coulter)
RESULTS:The Radiometer and the Access showed good correlation for the 
measurement of procalcitonin. The correlation coefficient (r) was 0,99 with 
(95% CI: of 99,1 to 99,5%). There are very small differences at very low 
concentrations which are of no clinical significance. A good correlation between 
the two methods was observed also in terms of clinical classification as indicated 
0.5 ng/Ml. In particular, the percentage of concordance between the two assays 
using a cut off of 0.5 ng/mL is 98.4% (95% CI: 96.5– 98.5%).
CONCLUSIONS:In our study, the fully automated Access PCT agrees well with 
the Radiometer PCT and is suitable for early diagnosis of sepsis, severe bacterial 
infection and guiding antibiotic therapy
Keywords: procalcitonin 
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Evaluation of precision and bias of 10 analytes on Alinity c and i systems: 
A user perspective
Deniz Ilhan Topcu, Nilüfer Bayraktar 
Department of Biochemistry, Faculty of Medicine, Başkent University, Ankara, 
Turkey 
Verification of analytical performance of measurands becomes an essential 
requirement for the laboratories before proceeding to patients’ samples testing.
In our study we have verified the performance of ten analytes on Alinity ci 
systems against manufacturers’ claims using CLSI EP15-A3 Guidelines. 
Manufacturer precision claims were obtained from analyte specific assay 
files(ASAF), and analyte specific product requirements documents(ASPR). 
After familiarization period, selected analytes were measured for 5 days in 3 
replicates by using third party internal quality control(IQC) materials. Two 
and three levels of IQC material were used for Alinity c and i respectively. 
“Repeatability” and “Within laboratory imprecision” estimates were calculated 
and compared with manufacturer claims for precision evaluation. Varying 
levels of proficiency testing (PT) samples were used as reference material for 
bias estimation.Peer group means were used as target values(TV). Standard 
deviations from PT and precision results from our study were used to calculate 
standard errors(sec).Finally verifications intervals(VI) were calculated as 
VI=TV±(mxsec).All calculations performed by using R statistical software.
An additional R script file is also created for reproducible calculations. 
For Alinity c, repeatability was between 0.3-2.4% coefficient of variation(CV) 
and Within laboratory imprecision was between 2.4-5.0% CV. For Alinity i, 
repeatability was between 1.7-5.3% CV and Within laboratory imprecision was 
between 5.3-7.7% CV. All analytes except creatinine and HbA1c had lower 
precision estimates than stated in ASAF. Creatinine and HbA1c had lower precision 
estimates than stated in ASPR.All analytes bias estimates were between VI. 
Our preliminary results show that our calculated precision and bias estimates are 
consistent with manufacturer claims.
Keywords: Abbott Alinity, user verification, CLSI EP15A-3, R 
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25-Hydroxy Vitamin D2 and 25-Hydroxy Vitamin D3 in lyophilized serum, 
UME CRM 1308
Gökhan Bilsel, Kevser Topal, Ahmet Ceyhan Gören, Bilgin Vatansever, 
Seda Damla Çakmar 
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Gebze-Kocaeli / Turkey 
OBJECTIVES:Vitamin D is a fat soluble vitamin in the form of vitamin D2 and 
vitamin D3. Measurement of vitamin D in serum is used in the investigation of 
bone health and emerging non skeletal conditions. 25-hydroxy vitamin D2 and 
25-hydroxy vitamin D3 are the most common metabolites measured in human 
serum. Number of available Certified Reference Material (CRM) to be used in 
these measurements is very limited. In this study, the production, certification, 
homogeneity, stability and characterization of UME CRM 1308 “25-hydroxy 
vitamin D2 and 25-hydroxy vitamin D3 concentrations in lyophilized serum” 
is described.
MATERIALS and METHODS:UME CRM 1308 was prepared by adding 
25-hydroxy vitamin D2 and 25-hydroxy vitamin D3 standards into the horse 
serum containing 25-hydroxy vitamin D3 endogenously. Horse serum was 
purchased from Biochrom AG (Germany) and pure standards were purchased 
from Sigma-Aldrich (USA). NIST SRM 2972 “25-Hydroxyvitamin D2 and D3 
Calibration Solutions” and NIST SRM 972a Level 3 “Vitamin D Metabolites 
in Frozen Human Serum” were used for traceability. Isotope Dilution Liquid 
chromatography Mass Spectrometry (ID-LC-MS) was used for quantification.
RESULTS:The certified value is the mean of the ID-LCMS results, which is a 
primary method traceable to the SI. The certified value of 25-hydroxy vitamin 
D2 in human serum was 50 ng/g with an expanded uncertainty of 2.9 ng/g. The 
certified value for 25-hydroxy vitamin D3 was 48.8 ng/g with an expanded 
uncertainty of 2.6 ng/g.
CONCLUSIONS:CRM is used as a useful tool for proving traceability of 
measurement result and enhances measurement quality.
Keywords: ID-LC-MS, vitamin D 
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The importance of to determine their own SD values in medical 
laboratories
Gulce Koca, Ozlem Gulbahar, Burak Arslan, Niyazi Samet Yılmaz, 
Canan Yılmaz 
Gazi University Medical Faculty Medical Biochemistry Department 
OBJECTIVES:During internal quality control applications,in order to 
statistically evaluate the performance characteristics of a test measurement,the 
actual values for mean and SD should be determined in the laboratory.In this 
study,we calculated our own mean, SD, TAE values for 25 biochemistry tests in 
our laboratory.
MATERIALS and METHODS:2 levels of internal QC was performed once 
a day for 20 days in AU5800 (Beckman Coulter) instrument for 25 clinical 
chemistry tests.Using the QC data,mean and SD were calculated to compare 
with commercial QC material’s values.For calculating TAE, %Bias values from 
external quality control data (Biorad) was used. TAE calculated by the formula 
proposed by the Ministry of Health.(%TAE=%Bias+1,65x%CV)
RESULTS:%CV values for 25 tests are between 0.4% and 3.7%.When our 
own SD and mean values are used to calculate TAE,all tests were within the 
appropriate range.The SDs recommended by the manufacturers were 2 to 12 
times higher than our calculated SD values.When calculated SDs are used,the 
control and calibration should be performed more frequently as the false rejection 
rate increases.
CONCLUSIONS:Although it was recommended to use the calculated own SD 
values in textbooks and guides,no studies were found in the literature on this 
subject.In the study,we obtained results quite different from the commercially 
recommended SDs. If the manufacturer’s suggested target and SD values 
are used,it will be difficult to notice errors. Although not cost-effective, each 
laboratory should use its own mean and SD values, as it is different from the 
manufacturer’s.
Keywords: Mean, SD, %CV, TAe 
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Evaluation of performance characteristics of ELISA method for NGAL
Jasna Jezdimir Bogdanska1, Diellor Rizaj2, Vasko Aleksovski1, 
Katerina Tosheska Trajovska1, Beti Zafirova Ivanovska1, Sonja Topuzovska1 
1Institute of Medical and Experimental Biochemistry, Medical Faculty, Skopje, 
University “Ss Cyril and Methodius”,Republic of North Macedonia 
2University of Gjakova “Fehmi Agany” Faculty of Medicine, Kosovo 
OBJECTIVES:Seeking for new useful biochemical markers in diagnosis of 
various diseases is a goal for many years. So far, NGAL is generally used as 
an early marker in kidney diseases, but recently, it was suggested to be one of 
the new early markers for diagnosis and prognosis of multiple sclerosis (MS). 
The aim of our study was to calculate the performance characteristics of NGAL 
measuring by ELISA method in patients with multiple sclerosis (MS).
MATERIALS and METHODS:MATERIAL-METHODS: Material for our 
study was plasma obtained from 30 healthy subjects (control group) and 55 
subjects with diagnosed MS. NGAL was measured using ELISA method 
with commercial kits manufactured by Bioporto Diagnostics. Performance 
characteristics of interest were: sensitivity, specificity, positive predicative value, 
negative predicative value, accuracy, diagnostic odd ratios and were calculated 
using statistical program WinStat for Windows.
RESULTS:Our results have shown that the sensitivity and specificity of the test 
were 100% and 93% respectively, with 93% of positive predictive value and 
41% of negative predictive value. The accuracy of the test was 74, 7%and the 
diagnostic odd ratio was 10,3.
CONCLUSIONS:We may conclude that ELISA method for measuring the 
concentrations of NGAL in patients with MS has satisfactory performance 
characteristics in discriminating healthy subjects from the patients correctly. 
Further studies are needed with a larger number of subjects.
Keywords: NGAL, performance characteristics, multiple sclerosis 
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Biological variation of newly developed red blood cell and reticulocyte 
parameters
Mehmet Senes1, Mesude Falay2, Selçuk Korkmaz3, Gökmen Zararsız4, 
Turan Turhan5, Gülsüm Özet2, Doğan Yücel1 
1University of Health Sciences, Anklara Training and Reserch Hospital, 
Department of Medical Biochemistry 
2University of Health Sciences, Ankara Numune Training and Research 
Hospital, Department of Hematology 
3Trakya University, Faculty of Medicine, Department of Biostatistics 
4Erciyes University, Faculty of Medicine, Department of Biostatistics 
5University of Health Sciences, Ankara Numune Training and Research 
Hospital, Department of Medical Biochemistry 
OBJECTIVES:Reliable biological variation data is needed for safe clinical 
application of laboratory tests. The aim of this study was to calculate biological 
variation of newly developed red blood cell parameters and reticulocyte indices 
used for diagnosis of anemia and monitoring of anemia treatment.
MATERIALS and METHODS:Blood samples were drawn from 30 healthy 
volunteers (20 female, 10 male) and analyzed using a Sysmex XN 3000 
instrument during the 10 weeks period. Data were assessed in terms of 
normality, tendencies, outliers and variance homogeneity prior to applying 
coefficient of variance (CV)- analysis of variance (ANOVA) test. Sex-stratified 
within-individual (CVI ) and between-individual (CVG) BV estimates of Hb, 
RBC, MCV, RBC-He (Hypo-He, Hyper-He, Micro R, Macro R), reticulocyte, 
reticulocyte-He (IFR, LFR, MFR and HFR) and Delta-He were determined.
RESULTS:For RBC parameters, with the exception of MCV, RBC-He, Hypo-He 
and Micro-R, and Delta-He there were significant differences between female 
and male CVI. However no differences were found for reticulocyte indices 
between both sexes.
CONCLUSIONS:New techniques and hematological parameters may reveal 
important information about functional integrity of bone marrow, diagnosis of 
anemia and monitoring anemia therapy. However, biological variation of these 
newly developed parameters should be considered in reporting and interpretation.
Keywords: Biological variation, anemia, red blood cell, reticulocyte. 
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Experimental study for determinate Risk-Based SQC procedure in our 
clinical laboratory by using six sigma
Murat Keleş, Ipek Sabuncu, Hatice Demirtürk 
Bursa Public Health Laboratory, Bursa, Turkey 
OBJECTIVES:Six Sigma Methodology; is a quality management tool that focuses 
on process variables and provides information about process performance, and 
widely used in clinical laboratories. For risk-based SQC procedures, “The goal 
is to use a QC strategy that can detect change in performance reliably before the 
clinical quality requirement is exceeded while also minimizing the frequency of 
false rejections.” We aimed to design Risk-Based SQC plan for our laboratory 
and determine QC frequency by using six sigma.
MATERIALS and METHODS:Sigma metrics were calculated based on internal 
and external quality data by using (%TEa-%bias)/CV formula. Total allowable 
error (%TEa) was determinated analyte-based to the quality expectations of 
our laboratory in line with Milan hierarchy. The analyte-based workload of our 
laboratory was calculated and SQC run size nomogram was used for estimating 
the QC frequency.
RESULTS:In our study, Amylase, AST, ALT, D.Bilirubin, Triglycerid, Uric acid 
had >6 sigma value. In this context, they had longest QC frequency run size 
with >1000 patient sample by using 1:3s N:2 rules. Albumin, Chloride, Calcium, 
Creatinin, Sodium and Total Protein had <4 sigma value and the shortest QC 
frequency run with <45 patient sample by using 1:3s/2:2s/R:4s/4:1s N:4 rules.
CONCLUSIONS:It is important that clinical laboratories should have SQC plan 
for each analyte in which determine the levels, run size of control materials, and 
procedures for evaluating obtained control results. Risk-Based SQC procedure 
was found to be costly and difficult for analytes with low sigma values. In 
addition, tolerance limits should be harmonized for ensure an objective SQC 
plan.
Keywords: Six Sigma, Risk-Based SQC Schedule, Quality Management, 
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Effects of transportation time and seasonal temperature changes on
routine coagulation tests
Güzin Aykal1, Hatice Esen2, Ayşenur Yeğin1, Muhammed Ali Aydın1 
1Clinical Biochemistry Laboratory, Antalya Education and Research Hospital, 
Antalya, Turkey 
2Department of Research and Development, Antalya Education and Research 
Hospital, Antalya, Turkey 
OBJECTIVES:Pre-analytical issues in hemostasis testing are an important cause 
of diagnostic error and can lead to significant adverse clinical events. The aim of 
the present study was to investigate the impact of transport times and seasonal 
temperature changes on routine coagulation test results, that is, PT and aPTT.
MATERIALS and METHODS:Coagulation tests results were examined in 
the biochemistry laboratory of Antalya Training and Research Hospital from 
central and peripheral districts out-patients clinics. Results were divided 
into two groups to evaluate the seasonal changes effect (January, July) 
Transport times were less than 30 minutes for the central samples and 2-4 hours 
from the peripheral samples. Patients who applied for pre-operative investigation 
were included. Cardiovascular surgery patients were excluded. Coagulation tests 
were performed using the ACL TOP 500 analyzer.
RESULTS:According to the chi square test results with SPSS v21; there 
was not any significant difference between central and district outpatient 
activated partial thromboplastin time(aPTT) results. and also different 
season (January and July 2019) results. (p>0,05) On the contrary there 
was statistically significant difference between the prothrombin time(PT) 
results of two groups (central and district out-patient ) due to chi square 
test, and also different season results (January and July 2019) p <0.05 
According to the One Way ANOWA test results,there was no difference in the 
aPTT test for age groups. (p>0,05) There was a statistically significant difference 
in PT test. (p <0.05).
CONCLUSIONS:Preanalytical phase standardization in coagulation testing is 
critical to prevent unreliable results which might finally jeopardize the patient’s 
health.
Keywords: Preanalytical effects, Coagulation tests, temperatue, transportation 
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Agreement of hemoglobin and hematocrit values determined by co-
oximetry and SLS hemoglobin: a retrospective study
Osman Oguz, Huriye Serin 
Department of Medical Biochemistry, Istanbul Training and Research 
Hospital,Istanbul, Turkey 
OBJECTIVES:Hemoglobin can be measured on a variety of devices using 
different methods. Blood gas devices have recently been widely used as point 
of care testing devices (POCT) in intensive care and emergency services. The 
reliability of the results obtained from these devices should be statistically tested. 
In this study, we aimed to see concordance of Co-oximetry and SLS Hemoglobin 
methods in the term of measuring Hemoglobin and calculated Hematocrit.
MATERIALS and METHODS:Between January 2019 and June 2019, 12049 
patients who applied to the emergency department of Istanbul Training and 
Research Hospital were requested for complete blood count and venous blood 
gas analysis simultaneously. Samples were analyzed with Sysmex XN-1000 (SLS 
Hemoglobin) and Siemens Rapidlab-1265 (Co-oximetry). Passing Bablok and 
Bland Altman analysis were performed to show analytical methods concordance.
RESULTS:The correlation coefficient of both method for Hemoglobin and 
Hematocrit was 0.89 and 0.87, respectively (P<0.0001). Passing and Bablok 
regression analysis indicated that there was significant deviation from 
linearity (p<0.01). The Bland-Altman plot indicated that the two methods 
did not have good agreement for each tests. Bias % was calculated as 4% 
for Hgb and 1.1% for Hct. The Total Error was calculated as 5.8 % for Hgb. 
The calculated bias for Hct and calculated total error for Hgb was lower than 
that reported in online database by Westgard (6% for Hct, 7 % for Hgb). 
CONCLUSIONS:Although each tests show significant deviation from linearity 
when comparing the two methods, blood gas devices could be used for Hgb 
measurements since the calculated bias remains acceptable.
Keywords: Blood Gas Devices, Co-oxymetry, SLS Hemoglobin 
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Effects of sampling time on routine coagulation tests in emergency service
Muhammed Ali Aydın1, Güzin Aykal1, Hatice Esen2, Ayşenur Yeğin1 
1Clinical Biochemistry, Antalya Education and Research Hospital, Antalya, 
Turkey. 
2Department of Research and Development, Antalya Education and Research 
Hospital, Antalya, Turkey 
OBJECTIVES:Pre-analytical issues in hemostasis testing are an important cause 
of diagnostic error and can lead to significant adverse clinical events. The aim 
of the present study was to investigate the impact of sampling time on routine 
coagulation tests in emergency service, that is, PT and aPTT.
MATERIALS and METHODS:Coagulation tests results were analyzed in 
the biochemistry laboratory of Antalya Training and Research Hospital from 
emergency clinic. In January 2019, routine coagulation test results of patients 
admitted to the emergency department of Antalya Training and Research 
Hospital were examined retrospectively. The test results were divided into 6 
groups at four hour intervals. Coagulation tests were performed using the ACL 
TOP 500 analyzer.
RESULTS:In this period, routine coagulation tests were 
performed in 1168 patients admitted to the emergency department. 
According to the one way ANOVA test results with SPSS v21; there was not 
any significant difference between the prothrombin time(PT) results of six 
sampling time groups(p>0,05). On the contrary there was statistically significant 
difference between the activated partial thromboplastin time(aPTT) results of six 
groups (p <0.05).
CONCLUSIONS:Studies on circadian rhytms show that such variability can 
be observed with regard to many blood parameters, including parameters of 
hemostasis systems. Due to the nature of the emergency department must accept 
the patient for 24 hours. The reference value ranges for coagulation tests should 
be revised considering the circadian rhythm.
Keywords: Preanalytical effects, Coagulation tests, circadian rhythm, 
emergency department 
 
 
P-017
Unnecessary test requests of HbA2 in a university hospital
Rukiye Nar, Esin Avci, Saadet Han Aslan, Kadriye Akpınar, Eltaf Doğan 
Department of Medical Biochemistry, Faculty of Medicine, Pamukkale 
University, Denizli, Turkey 
OBJECTIVES:Laboratory physicians should be aware of unnecessary test 
requests because of cost effects. One of the most important contributors of this 
is unnecessary test requests. In this study, we aimed to reveal unnecessary test 
requests of haemoglobin A2 in a university hospital.
MATERIALS and METHODS:We retrieved Hemoglobin Variant analysis test 
request from laboratory information system between 01.01.2018- 04.07.2019. 
Hemoglobin Variant analyses were done with Tosoh G8 HPLC systems (Tokyo, 
Japan). Recurrent test requests were determined. All data were analyzed with 
Microsoft Excel 2010 Excel program.
RESULTS:There were 931 test request; 6 samples were rejected (3 inadequate 
volume and 3 inappropriate sample). 889 samples were analyzed with Tosoh G8 
HPLC systems for variant hemoglobin. In 66 patient recurrent test requests were 
detected; in 59 patients there were two recurrent requests and in 7 patients there 
were three recurrent requests.
CONCLUSIONS:In the present study, we revealed only three test needed to 
repeat. In one sample patients’ HbA2 test result 3.2% previously and his clinic 
is in accordance with iron deficiency anemia (IDA). We recommended IDA 
treatment and repeating HbA2 test recurrent request. After therapy of regular iron 
patient HbA2 result raised to 3.7 with microcytosis (MCV=68 fl) with normal iron 
condition. In the other two samples there were a decreasing in HbA2 because of 
hemolytic anemia so test request recurrence may be meaningful. Consequently, in 
56 samples recurrent test request is unnecessary. Unnecessary test requests in HbA2 
might be a problem in clinic laboratory and needed to solve.
Keywords: Unnecessary test, unnecessary test request, Hemoglobin A2 
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Comparative analysis of the number of leukocytes in two different 
haematological modules
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Center“, Doboj, Bosnia and Herzegovina 
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OBJECTIVES:Counting of leukocytes (WBC) is an important part of routine 
laboratory tests. The aim of this study is to compare WBC values obtained by 
measurements performed on two hematology analyzers with assessment of their 
parallel use in laboratory work.
MATERIALS and METHODS:50 whole blood samples were included in the 
study. For the counting of WBC (103/μL), we used Sysmex XT-1800i reference 
module (fluorescent flow cytometry) and module Siemens Advia 2120 (flow 
cytometry). The accuracy and precision of the analyzers were checked. The 
results were statistically analysed in MedCalc software.
RESULTS:A shortened analytical evaluation has determined the satisfactory 
accuracy and precision of the analyzers. The lowest number of WBC measured 
on the Sysmex XT-1800i was 2.24, and the highest 12.25. The lowest number 
of WBC measured on the Siemens Advia 2120 was 2.3, and the highest 13.00. 
The Scatter diagram points to the diversity of data distribution. Bland Altman 
graph shows that almost all values were distributed within ± 1.96 SD. In 
Passing-Bablok regression analysis, when comparing the Sysmex XT-1800i 
with the Siemens Advia 2120, the following results were obtained for WBC 
y = 0.0997170 + 0.966038 x. Intercept a = 0.09972 (95% CI -0.04517 to 
0.2750). Slopes b = 0.9660 (95% CI 0.9375 to 0.9897). Results for the slope 
indicate that there is a discrete proportional error, with no clinical significance. 
Cusum’s linearity test estimates that there is no deviation in linearity (P = 0.89). 
CONCLUSIONS:Both haematological modules can be used simultaneously in a 
routine laboratory practice.
Keywords: Leukocytes WBC, Flow cytometry, Hematology 
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Detection of deletional alpha thalassemia by multiplex PCR
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2Department of Biochemistry, Cukurova University, Adana, Turkey 
OBJECTIVES:Alpha thalassemia is a common genetic disorder that is 
characterized by deficient or absent synthesis of α-globin chains of the Hb 
molecule (HbA:2α2β). Alpha thalassemia usually result from deletions involving 
the α-globin genes, less commonly they are due to point mutations. Most 
α-thalassemia determinants are deletions involving one (α-thal-2: -α/αα) or both 
(α-thal-1: --/αα) α-globin genes on the same chromosome. A person with three 
α-genes (-α/αα) is not anemic but a heterozygote who inherits two functional 
α-genes (--/αα) has mild hypochromic microcytic anemia. Combinations of 
α-thal-1 and α-thal-2 determinants (--/-α) cause HbH disease. A patient who 
inherited a single α-globin gene (--/-α) has HbH disease with a chronic hemolytic 
anemia. Five different gene deletions [α-thal-1 (-17.4kb, -26.5kb, -20.5kb) and 
α-thal-2 (-3.7kb, -4.2kb)] were reported in Turkey.
MATERIALS and METHODS:Blood samples with EDTA as anticoagulant 
were taken for hematologic and hemoglobin analysis. A complete blood count 
was taken using a cell counter. HPLC have been used for both determination 
of hemoglobin variants and quantification of the Hb levels. Alpha globin gene 
deletions were detected by using one tube multiplex PCR.
RESULTS:In this study, alpha gene deletions of 81 carriers were detected 
by Multiplex PCR. Genotypes and hematological parameters of different 
α-thalassemia carriers were analyzed and 54 of them had one gene deletion 
(α-thal-2) and 27 of them had two alpha globin gene deletions (α-thal-1).
CONCLUSIONS:Distribution of alpha globin gene deletions were detected in 
Çukurova region.
This project was supported by Çukurova University Research Projects Unit 
(FDK-2019-11888).
Keywords: Alpha thalassemia, Gene deletion, HbH disease 
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Frequency of Silent Beta Globin Gene Mutations in Çukurova Region
Yasemin Özküçük, Başak Günaştı, Duygu Düzgünce Boğa, 
Ebru Dündar Yenilmez, Abdullah Tuli 
Department of Biochemistry, Medical Faculty, Çukurova University, Adana, 
Turkey 
OBJECTIVES:The β-thalassemias are characterized by a quantitative deficiency 
of β-globin chains underlaid by a striking heterogeneity of molecular defects. 
There are two main varieties of β-thalassemia; β0-, and β+-thalassemia. The 
diagnostic feature of β-thalassemia is an elevated level of HbA2 in heterozygotes. 
There are, however, less common forms of β-thalassemia, which the HbA2 level 
is normal in heterozygotes. Broadly, they are classified into two varieties; type 
1 called ‘silent β-thalassemia’ is no associated hematological changes, and 
the hematological findings of type 2 are typical of β-thalassemia trait with a 
raised HbA2. In this study, we aimed to investigate the incidence of silent beta 
thalassemia between 2008-2019 in Çukurova population.
MATERIALS and METHODS:Samples were obtained from Çukurova 
University Medical Biochemistry Department. DNA was extracted from whole 
blood. β-globin gene mutations were detected by Amplification Refractory 
Mutation System (ARMS) method, Restriction Fragment Length Polymorphism 
(RFLP) method and Deoxyribose Nucleic Acid (DNA) sequence analysis.
RESULTS:In our study, 3324 patients were retrospectively evaluated for 
hematologic data. 119 of 3224 patients were found to have normal hematological 
data. Silent β-thalassemia mutations were investigated in these patients. 93, 
22, and 4 of totally 119 patients were detected as to be -30, -101, and CAP +1 
mutations, respectively.
CONCLUSIONS:Our study showed that more common silent beta thalassemia 
mutations were -30 (T→A) in Çukurova Region. Despite normal hematological 
data, the possibility of silent β-thalassemia should not be excluded. As a result, 
it should be careful when evaluating individuals with normal hematological data 
for β-thalassemia.
Keywords: β-Thalassemia, Silent Beta Gene Mutation 
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Practice of an autoverification application
Özgür Durlanık, Aylin Haklıgör 
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Adana, Turkey 
OBJECTIVES:Autoverificaton systems are getting more prevalent day by day 
and becoming essential for clinical laboratories. The laboratories intending 
to install these systems should answer several questions and make several 
calculations. Unfortunately, there are limited scientific documents for evidence-
based studying.
MATERIALS and METHODS:Our laboratory has the know-how that can be 
used as a starting point to calculate autoverification ranges and delta check limits; 
and to create algorithms for automatic release of results.. We have calculated 
autoverification limits with four different approachs: 1- Shih MC and friends’s 
suggestion: Distribution intervals of patient data between %2 and %98 2- Feitosa 
MS and friends suggestion: A formula using the midpoint of reference range 
and linearity range 3- Limits from Li, Jiancheng and friends’s article for thyroid 
hormones. 4- Analytical range at Troponin I and CK-MB Mass tests.
RESULTS:The acquired experience suggests the necessisity to generate a 
procedure to evaluate the specimens that have failed delta check evaluation. In 
our laboratory, over 20 thousand biochemistry tests are studied in a day and more 
than 600 of this tests fail at delta check evaluation. Unfortunately there is no 
enough manpower in clinical laboratories to examine those samples. In order 
to make this procedure realistic and feasible, it is necessary to reduce the rate 
of false positivity and thereby decrease the number of samples to be controlled. 
CONCLUSIONS:Thanks to the experience gained and the new technical 
capabilities at hand to implement the medical information, autoverification is 
assumed to have potential for continuous developing without an end.
Keywords: Autoverification, Delta check, Limit check 
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In Silico analysis of missense mutations in the gene for human glutathione 
reductase
Özlem Dalmızrak, Kerem Teralı, Hamdi Öğüş, Nazmi Özer 
Department of Medical Biochemistry, Faculty of Medicine, Near East 
University, 99138, Nicosia, Cyprus 
OBJECTIVES:At the molecular level, mutations are alterations in the nucleotide 
sequence of genes, resulting in variants that can be transmitted to the next 
generation. Mutations for which the clinical significance is currently unresolved 
are known as variants of uncertain significance (VUS). VUS generally involve 
missense mutations or in-frame deletions. As a part of the enzymatic antioxidant 
defense system, the homodimeric flavoprotein glutathione reductase (GR; EC 
1.6.4.2) serves to regenerate glutathione (GSH) from glutathione disulfide 
(GSSG). Given the crucial role of GR in maintaining the body’s GSH pools, 
hereditary GR deficiency is likely to have a dramatic impact on human health. 
MATERIALS and METHODS:Here, we aim at predicting the structural 
consequences of clinically relevant missense mutations in the gene for human GR. 
The identities of missense mutations were retrieved from the Human Gene Mutation 
Database (HGMD) and ClinVar, and their effects on GR stability, flexibility 
and function were estimated using a diverse array of in silico prediction tools. 
RESULTS:The sequence- and structure-based predictors reveal that nearly all 
of the missense mutations in question have the potential to affect local protein 
dynamics or enzyme catalysis. This allows for more accurate classification of 
the VUS into several different categories ranging from benign to pathogenic. 
CONCLUSIONS:Overall, our work provides new insights into the ‘molecular 
phenotypes’ of hereditary GR deficiency and allow for the rational design of 
further in vitro and ex vivo studies.
Keywords: Missense mutations, variants of uncertain significance, glutathione 
reductase 
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Correlation between blood gas glucose parameter and biochemistry 
autoanalyzer glucose
Tuğba Öncel, Hayat Özkanay Yörük, Leyla Demir, Mert Üğe, 
Saliha Aksun, Figen Narin 
Izmir Katip Celebi University Atatürk Research and Training Hospital,Medical 
Biochemistry, İzmir, Turkey 
OBJECTIVES:Blood gas analysis is a vital diagnostic method on both clinical 
and emergency&intensive care patients.This study aimed to investigate the 
usability of glucose parameters measured on blood gas analyzer instead of 
biochemistry analyzers.
MATERIALS and METHODS:Blood gas and glucose parameters in 
biochemistry devices which was requested simultaneously from 23297 patients 
who applied to Izmir Katip Çelebi University Atatürk Training and Research 
Hospital were examined retrospectively between 01.07.2018-01.07.2019.Blood 
gas parameter was studied on Radiometer ABL800 Flex device and Abbott 
C16000 device was used for biochemistry parameter.Statistical analysis of the 
outcomes was performed in SPSS 21.0 program.The distribution of the groups 
was analyzed on Kolmogorov-Smirnov test.Paired t test was performed to get the 
significance of difference between biochemistry and blood gas glucose.Pearson 
test was used for correlation.
RESULTS:The groups were suitable for Gaussian distribution.The mean value of 
glucose on the automatic analyzer was found as 153.19 ± 90.11.Blood gas device 
glucose mean value was found as 150.26 ± 76.59.It was found that there was a 
statistically significant difference between biochemical glucose and blood gas 
glucose arithmetic mean(p<0.001).Correlation coefficient was(R =0.936 p<0.001)
and the significant positive correlation was determined between outcomes. 
CONCLUSIONS:According to the results of our study; although the difference 
was statistically significant, the values obtained were similar so as not to affect 
the clinical decision.Therefore,it is thought that glucose can be examined by 
means of blood gas analysis method until biochemical glucose parameters are 
resulted.This process will gain time to clinician especially on critical patients.
Thus the possibility of early intervention will be increased accordingly.
Keywords: blood gas, correlation, glucose 
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Chemical analysis of the cyst fluid is an option to be kept in mind
Özgür Aydın1, Uğur Kesimal2, Dilek Çiçek3 
1Kepez Public Hospital, Clinical Biochemistry Laboratory, Antalya 
2Kepez Public Hospital, Radiology, Antalya 
3Kepez Public Hospital, Surgical Pathology, Antalya 
OBJECTIVES:Anamnesis, physical examination and radiological examination 
are generally sufficient to diagnose a cystic lesion in the neck. When needed, 
Fine Needle Aspiration Biopsy(FNAB) is a diagnostic tool in the management 
of neck masses.
MATERIALS and METHODS:61 years old male patient admitted to our 
hospital because of a lesion in the neck region. Physical examination followed 
by ultrasonography revealed a 25x17 mm subcutaneous cystic lesion located in 
superior anterior midline, strongly suggesting a thyroglossal duct cyst(TDC). The 
patient was unwilling for the excision of the lesion that a FNAB was performed. 
4 cc opaque white material was sent to pathology and a portion of 1 cc was 
separated for chemical analysis for thyroglobulin and thyroid hormones.
RESULTS:Results showed that the cyst material contained 0,72 ng/mL 
thyroglobulin (1,6-50 ng/mL serum normal values), a free T4 level (0,55 ng/dL 
) lower than the patients serum FT4 value (1,11 ng/dL) and a free T3 level (3,13 
pg/mL) higher than the patients serum FT3 value (2,74 pg/mL). Pathology report 
confirmed a benign lesion.
CONCLUSIONS:If a FNAB is performed with any reason, it should be kept 
in mind that the aspiration material is probably suitable for chemical analyses 
of various parameters. Thyroglobulin measurement is already recommended by 
the American and European Thyroid Association guidelines to diagnose cystic 
thyroid cancer metastases. The levels of tiroglobulin and thyroid hormones were 
supportive for a diagnosis of a TDC in this case although a final diagnosis is still 
absent because the lesion was not excised.
Keywords: Aspiration biopsy, Cystic lesion, Thyroglobulin, Hormones, 
Biochemistry 
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Myeloproliferative syndromes and their association with lymphoid 
neoplasms
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OBJECTIVES:The association of myeloproliferative syndromes with lymphoid 
neoplasia is very rare. There are about 52 cases, worldwide, where these two 
syndromes coexist within the same patient.
MATERIALS and METHODS:This abstract will present 2 clinical cases 
presented at the Haemetology Department which were initially presented as 
myeloproliferative syndrome, specifically: polycythemia vera, and subsequently 
lymphoid neoplasia, specifically: CLL, and Non-Hodgkin malignant lymphoma.
RESULTS:First CASE: Male, 51 years old, showing the following hematological 
parameters: WBC: 15000/m3, HGB: 14.5g/dL, RBC: 4.74x106/mm3, PLT: 
175000/mm3.A myelogram and Immunophenotyping were performed 
on the patient, which were compatible with Polycythemia Vera, and no 
immunophenotipically pathogenic clone cells were identified. 2 months after the 
examination the patient showed up an adenopathy. A bone marrow biopsy was 
performed. The latter showed infiltration to the bone marrow of lymphomas with 
small CD 20 positive cells.
Second CASE: Male, 49 years old. Presented with a hematological framework 
compatible with the myeloproliferative syndrome: WBC: 20000/mm3, HGB: 
17.2g/dl, RBC: 7.01x106/mm3, PLT: 966000/mm3.
A myelogram, Immunophenotyping and bone marrow biopsy were performed 
on the patient. The myelogram and the immunophenotyping resulted compatible 
with Polycethymia Vera, and no immunophenotipically pathogenic clone cells 
were identified.
Based on the results of the biopsy and immunohistochemistry the patient resulted 
in lymphoid infiltration by non-Hodgkin’s malignant lymphoma.
CONCLUSIONS:The association of myeloproliferative syndromes with 
lymphoid neoplasia happens, more frequently in males. age of the affected is 
about 50 years. (in both cases presented), although in literature cases with this 
occurrence prevail in young ages.
Keywords: myeloproliferative syndromes, lymphoid neoplasia 
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OBJECTIVES:Colorectal cancer (CRC) is a common cancer type and treated 
with applications such as surgery, radiotherapy and chemotherapy. However, 
it is known that these methods have serious side effects. Therefore, alternative 
treatment strategies and new therapeutic molecules with less side-effect are 
needed. Photodynamic therapy (PDT) has emerged as a new method in the 
treatment of many cancer types. In recent years, boron-containing BODIPYs 
which are the photosensitizers, have been used in photodynamic therapy due 
to high absorption coefficient,high singlet oxygen yield, good solubility, low 
toxicity in dark. In this study, anticancer effects of water soluble pyridine group 
containing BODIPY compound (1a) were investigated against CRC.
MATERIALS and METHODS:Singlet oxygen quantum yield and CT-DNA 
binding effects of 1a were examined using UV-Vis spectroscopy. The pBR322 
plasmid DNA photocleavage activities of 1a were investigated using agarose gel 
electrophoresis. The cytotoxic and phototoxic effects of 1a were tested against 
human colorectal (HCT-116) cell line using MTT assay for 24, 48 and 72 h.
RESULTS:Singlet oxygen quantum yield of 1a was found to be 0.30. The DNA 
binding studies showed that 1a bound to DNA with non-covalent interaction. 1a 
cleaved pBR322 plasmid DNA via singlet oxygen pathway upon irradiation. 1a 
showed remarkable phototoxic effect against HCT-116 in a concentration and 
time-dependent manner.
CONCLUSIONS:The results claimed that 1a had a potential anticancer agent for 
CRC. Further in vivo studies are required to clarify the therapeutic effect of 1a. 
This study was supported by The Research Fund of Karadeniz Technical 
University (Grant no: 8134), Trabzon, Turkey.
Keywords: BODIPY; colorectal cancer; photocleavage. 
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Effects of somatostatin, curcumin and quercetin on the fatty acid 
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OBJECTIVES:Breast cancer is one of the most common cancer diagnosed in 
women in the world. Among the polyphenols; quercetin (Que), curcumin (Cur) 
have been reported to have strong potential to prevent breast cancer. However, so 
far, no comprehensive study has been performed to demonstrate anticarcinogenic 
effects of Cur, Que and their combinations with somatostatin on the fatty acid 
profile of breast cancer cell membranes.
MATERIALS and METHODS:The doses of somatostatin, curcumin and 
quercetin to be used in the incubations were determined by MTT test. For fatty acid 
analysis, membrane lipids were isolated, extracted, derivatized to methyl esters 
and characterized using Gas Chromatography in two breast cancer cells incubated 
with somatostatin, curcumin, quercetin, SST+Cur or SST+Que for 24 hours. 
RESULTS:In MDA-MB231 cells, incubations with Cur, Que and SST+Que 
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induced the most significant membrane remodeling with elevation of stearic 
acid, and diminution of omega-6 linoleic, arachidonicacids, omega-3 acids. 
In MCF7 cells, omega-6 linoleic acid in cells incubated with SST+Que, Que 
increased and omega-3 fatty acids in cells incubated with SST+Cur compared 
to SST decreased, and significant increases in docosapentaenoic acid levels were 
found in cells incubated with SST+Que compared to the control cells.
CONCLUSIONS:Based on our findings, lipid isomerization in breast cancer 
cells has been shown to change in response to Somatostatin, Cur, Que and their 
combinations. The results of lipidome analysis highlighted the role of SST+Cur 
and SST+Que induced fatty acid membrane remodeling, and suggest potential of 
lipid-based strategies for influencing cell response in breast cancer cells.
This study was supported and funded by TUBITAK (Project number: 217S253) 
and Akdeniz University Research Funds (TDK-2017-2096).
Keywords: Somatostatin; curcumin; quercetin; breast cancer; membrane fatty 
acid profile 
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OBJECTIVES:MDA-MB 231, which has a more aggressive structure compared 
to other breast cancer cell lines, is metastatic and angiogenic cells. Metastasis and 
angiogenesis are regulated by transcription factors such as the Twist1 gene. Twist1 is 
a transcription factor (TF) that can bind specific DNA regions and control the activity 
of genes. Twist1 is effective in various differentiation processes of healthy embryos 
as a positive or negative regulator in the cell cycle. In studies, Twist1 gene has been 
shown to result in a poor prognosis in patients with protein re-expression after 
embryonic period. Twist1 also regulates the expression of micro-RNA (miRNA) 
genes associated with cancer. Many studies have shown that these small molecules 
are critical in cellular mechanisms such as metastasis, angiogenesis and apoptozis. 
In this study, the effect of silencing Twist1 TF gene which active in MDA-MB 231 
breast cancer cell was affected by expression levels of miRNAs.
MATERIALS and METHODS:In the MDA-MB 231 cells, the regulatory Twist1 
gene was suppressed by the anti-sense Twist1 vector transfection. Differences in 
miRNA expression levels were analyzed by Real Time PCR analysis.
RESULTS:As a 43 miRNA results examined in the study, it was found that miR-1-1 
and miR-210-3p expressions were upregulated and miR-193b-3p, miR-181b-5p and 
miR-148a-3p expressions were downregulated.
CONCLUSIONS:The expression levels of some miRNAs associated with invasion, 
metastasis and apoptozis were changed by silencing Twist1 gene expression. It 
was concluded that silencing the Twist1 gene may effect invasion, metastasis and 
apoptozis in breast cancer.
Keywords: MDA-MB 231; miRNA; twist1 
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OBJECTIVES: Bladder carcinoma (BC) is the most frequently seen urinary 
system malignancy among men all over the world. In this study, we aimed to 
identify specific gene-pathway relationships that could play fundamental role in 
the progression of bladder carcinogenesis.
MATERIALS and METHODS:Samples (n=12) of high-grade invasive bladder 
cancer patients and their non-tumoural paired controls (n=12) were collected at 
the Department of Urology of Istanbul Faculty of Medicine after getting ethical 
permission from Istanbul University. The genome wide expression levels of high 
grade BC patients and paired controls were profiled following to RNA isolation 
and hybridization steps. Ingenuity Pathway Systems (IPA), iPathway Guide 
and Cytoscape softwares were used to determine statistically significant genes, 
networks, biological pathways between tumor and control groups.
RESULTS:The most statistically significant biofunctions were post-translational 
modification, protein degradation, cell death and cell survival, cellular movement 
and intercellular signalling. These findings were supplied us understanding 
which molecular reactions were involved in bladder carcinogenesis. In regards 
to these results, we also identified the top canonical pathways that were included 
in the development of BC. The data showed that collagen degradation, activation 
of matrix metalloproteinases (MMPs), degradation of the extracellular matrix 
(ECM), inflammatuar response and BC signalling were the most important 
pathways in bladder carcinogenesis, as expected.
CONCLUSIONS:We showed that biological reactions including degradation 
of collagen and ECM as well as MMP activation reactions were found the 
most statistically significant pathways in BC. It was also determined that 
inflammation and cytokine signalling could be related with the progression of 
bladder carcinogenesis.
Keywords: Invasive Bladder Carcinoma, Biological Pathways, Matrix 
Metalloproteinases, Degradation of the Extracellular Matrix 
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OBJECTIVES:Amphoricarpos Praedictus (Testiotu) is a member of the 
Asteraceae family. Many Asteraceae species are rich in secondary metabolites 
such as phenolics, sesquiterpenes and lactones. Asteraceae species are known 
as medicinal plants with antioxidant effect, and antimicrobial activities. 
Literature is limited about the biological activity of Amphoricarpos species.The 
aim of this study was to determine the antioxidant and cytotoxic properties of 
Amphoricarpos Praedictus.
MATERIALS and METHODS:The present study assessed total phenolic and 
flavonoid content, reducing antioxidant power, radical scavenging activity of 
Amphoricarpos Praedictus by using spectrophotometric methods. The cytotoxic 
effect of Amphoricarpos Praedictus on a normal human lung fibroblast (WI-38) 
cell line was assessed using the XTT assay.
RESULTS:Accordingly, the results of the Amphoricarpos Praedictus exhibited 
higher radical scavenging activity, and selective cytotoxic effect on WI-38 cells. 
These results showed that the Amphoricarpos Praedictus has power antioxidant 
properties and selective cytotoxic effect.
CONCLUSIONS:Thus, Amphoricarpos Praedictus appear to be a promosing 
source of new anticancer agent.
Keywords: Amphoricarpos Praedictus, Antioxidant activity, Cytotoxic Activity 
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OBJECTIVES:T cell regulated signals play an important role in maintaining 
peripheral tolerance immune homeostasis. Studies have also reported that 
the coinhibitory and costimulatory signals interact with each other like as 
PD-1 / PDL-1 interaction triggered cd28 inactivation in the suppression of T 
cell activation. In this study, we aim to investigate PD-1 (rs2227981), PDL-1 
(rs2890658), CD28 (rs2267966) and CD27 (rs3116496) genotypes in laryngeal 
cancer (LC) patients.
MATERIALS and METHODS:We examined PD-1 (rs2227981), PDL-1 
(rs2890658), CD28 (rs2267966) and CD27 (rs3116496) polymorphisms in 132 
subjects (57 subjects with LC and 75 controls) by using PCR-RFLP.
RESULTS:We found an increased frequency of PDL-1 AA/CC genotypes in 
laryngeal cancer patients (p=0.04) than controls but not for PD-1 genotypes. 
There was a tendency toward a higher frequency of CD 28 T allele and CT 
genotype,respectively( p=0.034, Odds ratio (OR): 1,180; 95 %CI1,019-1,366; 
p=0.001, odds ratio (OR), 2,538; 95% CI 1,470-4,380). CD27 genotype results 
showed a higher incidence of A allele in patients versus controls, p=0.001, 
OR: 1.228; 95 %CI 1,091-1,382).The frequency of AT genotype was found 
to be increased in laryngeal cancer patients and this value was statistically 
significant p=0.002, OR, 1,888; 95% CI 1,258-2,833. We also found significant 
relationships between these genotypes and patient’s clinical and histopathological 
findings, perineural invasion, the presence of reflux.
CONCLUSIONS: Our results suggest that CD27, PD1 and PDL1, especially 
CD28 are thought to be important candidates implicating some changes affecting 
this mechanism. These molecular markers may use to be target molecules for 
identifying subjects, better prognosis and response to treatments.
Keywords: Laryngeal Cancer, İmmune Checkpoints, Molecular Biomarkers, 
Carcinogenesis, Polymorphism 
 
 
P-035
Investigation of in vitro and in vivo therapotic effect of curcumin and 
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OBJECTIVES:This study aimed to investigate the cytotoxic, genotoxic, 
apoptotic, and anti-cancer effects of curcumin – the active ingredient of turmeric 
– and 5-Fluorouracil in combination against in vitro and in vivo colon cancer 
while illuminating possible action mechanisms.
MATERIALS and METHODS:Initially, Luciferase transfection was performed 
in LoVo colon cancer cells to which curcumin, 5-FU, and combinations 
of different concentrations were given, and they were incubated for 24 
hours. Cytotoxicity, genotoxicity, apoptosis, intracellular glutathione level, 
mitochondrial membrane potential are determined. Transfected LoVo cells have 
been injected subcutaneously to nude mice for the following: control, curcumin, 
5-FU, and combined. 3 weeks of treatment with curcumin, 5-FU, and combined 
therapy have been initiated 3 weeks after the injection. At the end of this period, 
tumor size was measured with the IVIS device and caliper.
RESULTS:Compared to the monotherapy with curcumin and 5-FU on colon 
cancer, combined treatment has been found in low doses to increase cytotoxicity, 
DNA damage, apoptosis and intracellular reactive oxygen species in the cell 
culture studies, while decreasing mitochondrial membrane potential and 
glutathione levels. Also, the expression of apoptotic proteins increased while the 
anti-apoptotic protein expression decreased. Combination therapy was found to 
be more effective than mono therapies in vivo colon cancer, which was formed 
by the xenographic method. While tumor size decreased.
CONCLUSIONS:According to the data obtained through this study, in colon 
cancer curcumin has been found to increase the anti-tumor effects of the normal 
therapy of 5-FU in vitro and in vivo.
Keywords: curcumin, colon cancer, 5-FU, IVIS 
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after radiotherapy
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OBJECTIVES:Breast cancer is one of the most important cancer type in the 
world. Radiotherapy plays an important role in the treatment of non-metastatic 
breast cancer. The DcR3 family, known as tumor necrosis factor receptor 
superfamily member (TNFRSF6B). It has emerged important regulators 
of various biochemical events as it has roles in various cancer and several 
inflammatory tissues. The aim of this study was to determine the effect of 
radiotherapy on soluble DcR3 protein, which has not been yet clarified as a 
tumor suppressor or promoter molecule.
MATERIALS and METHODS:22 women with non-metastatic breast cancer 
enrolled to the study. Blood samples were taken just before and after radiotherapy, 
soluble DcR3 proteins levels were determined with ELISA kit. Wilcoxon test 
was used for statistical analysis.
RESULTS:Soluble DcR3 protein level was significantly found to be decreased 
after radiotherapy treatment (p<0.011).
CONCLUSIONS:Our study demonstrated that soluble DcR3 could be 
considered as a novel follow up parameter for the treatment of breast cancer 
malignancy. In other words, modulation seen at the soluble DcR3 protein level 
suggests that it may also provide a new strategy for breast cancer treatment. 
This work is the part of project entitled ‘Evaluation of the effect of radiotherapy 
on some biochemical parameters in breast cancer patients’ supported by the 
grand from Erciyes University (Grand no:TYL-2019-8672).
Keywords: DcR3, Breast Cancer, Radiotherapy 
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OBJECTIVES:Fulvestrant (ICI 182 780), a selective estrogen receptor inhibitor, 
has been used in treating patients with hormone-sensitive breast cancer. 
Bisphenol A (BPA) has been considered as an endocrine disrupting chemical. 
In this study, we examined whether the effect of low dose BPA on fulvestrant 
treatment can lead to the proliferation and migration of HepG2 human hepatoma 
cells which may induce metastasis.
MATERIALS and METHODS:Human hepatocellular carcinoma cells (ATCC) 
were treated with certain concentrations BPA, ICI and the combination of 
ICI with BPA. MTT assay was conducted to examine the effect of BPA, ICI 
and BPA+ICI on cell proliferation of HepG2 cells. Effects on cell migration 
were examined by wound healing assay and results were analysed by Image 
J software. Additionally, the expression of N-cadherin were detected by N 
27-31 October 2019Turkish Journal of Biochemistry, 2019
XXVII. Balkan Clinical Laboratory Federation Meeting BCLF 2019 
XXX. National Congress of the Turkish Biochemical Society TBS 2019
Turk J Biochem, 2019; 44 (S3) http://www.TurkJBiochem.com77
Cadherin-Enzyme-Linked ImmunoSorbent Assay.
RESULTS:Low dose BPA and BPA+ICI significantly increased cell viability of 
HepG2 cells compared to vehicle control. Their effects on motility of HepG2 
cells were measured by the use of wound healing test and as a result significantly 
increased wound closure was determined as compared to the control group. BPA 
also stimulated the migration of HepG2 cells. BPA+ICI increased N-cadherin 
expression which might be the indicator of epithelial to mesenchymal transitions.
CONCLUSIONS:According to these results, it was suggested that BPA and 
Fulvestrant may induce the proliferation and migration in HepG2 cells
Keywords: Bisphenol A, fulvestrant, HepG2 
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OBJECTIVES:One of the main features of cancer cells is a persistent pro-
oxidative state that leads to intrinsic oxidative stress. Additionally, the 
inflammatory condition of malignant tumors continually exposes cancer cells 
to reactive oxygen species (ROS) and the activation of the antioxidant defense 
system. Quercetin is an antioxidant flavonoid known to induce cell cycle arrest 
and apoptosis of hepatocellular carcinoma cells. Activation of several signaling 
pathways has been implicated in the pathogenesis, i.e. ROS which can trigger 
oxidative damage of biomolecules. The objective of the present study was to 
determine the effect of treatment with hydrogen peroxide and quercetin on 
HepG2 cells.
MATERIALS and METHODS:Effects of different stress conditions were 
evaluated. For this purpose, cells were cultured under two different stress 
conditions. Cell viability/apoptosis/cell cycle, proteasome and antioxidant 
enzyme activities were detected.
RESULTS:Hydrogen peroxide and quercetin resulted in decrease cell viability 
of HepG2 cells in 30 minutes. The percentage of total apoptosis were 9.66 and 
10.93 for H2O2 and quercetin, respectively at 50 µM concentrations and 16.45 
and 18.78 for H2O2 and quercetin, respectively at 200 µM concentrations. 
Quercetin decreased proteasome activity significantly. Quercetin also influenced 
cell cycle distribution and significantly decreased G0/G1 ratio.
CONCLUSIONS:Our findings demonstrate the pleiotropic effects of quercetin 
on liver cancer cells and open the possibility of utilizing it as a chemo-preventive 
agent in hepatocellular carcinoma.
This work was supported by The Scientific and Technological Research Council 
of Turkey TUBITAK (Project no: 21S963).
Keywords: HepG2 cells, hydrogen peroxide, quercetin 
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OBJECTIVES:Oxidative stress is thought to take part in the etiopathogenesis of 
many systemic diseases, including cancer. SMF plays a critical role in activating 
and/ or alternating the molecular mechanisms in cancer cells. The aim of this 
study was to find out the antioxidant effect of static magnetic field on breast 
cancer MCF-7 cell line.
MATERIALS and METHODS:Oxidative stress determinations were performed 
by total antioxidant status (TAS) (Relassay), total oxidant status (TOS) 
(Relassay) in MCF-7 cell line. Oxidative stress index (OSI) was calculated by 
TOS/TAS ratio. Statistical analyzes were evaluated by SPSS programme.
RESULTS:TAS levels were found to be significantly increased in SMF exposed 
group compared to controls [(0.201 ± 0.003 vs 0.183 ± 0.002 mmol Trolox 
Equiv./L, p<0.001)]. OSI levels were significantly lower compared to controls 
[(0.311 ± 0.005 vs 1.00 ± 0.117, p<0.001)].
CONCLUSIONS:Taken together, our results suggest that exposure of SMF on 
MCF-7 cell lines diminished oxidative stress parameters. According to these 
results, SMF administration can increase the antioxidant effect; this may offer a 
protective strategy for cancer therapy.
Keywords: TAS; TOS; MCF-7; Static Magnetic Field. 
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OBJECTIVES:Cancer drugs are one of the most studied topics, especially since 
their half-life is very short, the disintegration products are toxic and they cannot 
distinguish between healthy or diseased cells. This increases the number of studies 
on immobilization by binding to many organic or inorganic support materials 
through intermolecular interactions or covalent bonds. The aim of this study 
was to immobilize idarubicin via imine band to 3-Aminopropyltriethoxysilane 
(3APTES) coated magnetite, to prepare a cancer drug with stability and low 
toxicity levels.
MATERIALS and METHODS:IDA was immobilized to 3-APTES coated 
magnetite and its activity in HL-60 cell line was studied. Synthesized materials 
were characterized by spectroscopic devices. IDA immobilized magnetite was 
administered to HL60 cell line with various doses, ATP and MTT cell viability 
analyzes were studied and compared to free IDA. In this study, idarubicin was 
immobilized to an amine group for the first time.
RESULTS:IC50 value of immobilized IDA was 4-folds lower than that of free 
IDA in HL60 cell line according to in-vitro cytotoxicity tests. Furthermore, 
idarubicin binding amount was calculated as 0.2 g/100 g magnetite/3APTES.
CONCLUSIONS:The results of this study showed that magnetite-induced 
idarubicin is effective in eliminating cancer cells even at doses 4 times lower. By 
applying this method in the clinic, patients will experience less toxic exposure. 
Using this structure for the first time and giving better results than free idarubicin 
will provide a new approach to cancer.
This study was supported by TUBITAK BIDEB 2218.
Keywords: Magnetite, HL60 cell line, 3-Aminopropyltriethoxysilane, 
idarubicin 
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Comparison of immunoassay methods (CMIA and ECLIA) for 
determination of tumor markers HE4 and CA 125
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OBJECTIVES:In our study, we investigate the performance of the Cobas e 601 
HE4 and CA 125 compared with Architect and SR 2000.
MATERIALS and METHODS:The investigation included 200 serum samples 
that were investigated using Cobas e 601 (ECLIA) and Architect and SR 2000 
(CMIA).
RESULTS:Using CMIA, the coefficients of variation (CVs) varied from 2.13 % 
to 4.16 % for CA 125 and from 1.10 % to 4.60% for HE4, and reproducibility 
from 2.60% to 5.20% for CA 125 and from 1.70% to 4.90 % for HE4. Using 
Cobas ECLIA, the CVs varied from 0.55 % to 2.09 % for CA 125 and from 
0.36 % to 2.30 % for HE4, and reproducibility from 1.0 % to 3.50 % for CA 125 
and from 070 % to 4.05 % for HE4. The CMIA and ECLIA regression equation 
for CA 125 was y (ARCHITECT) = 1.675 + 1.027 x(Cobas) and have intercept 
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(95% CI 0.418 to2.932) and slope (95% CI: 0.979 to 1.076). The regression 
equation between CMIA and ECLIA for HE4 was y (ARCHITECT) = 4.330 + 
1.502 x(Cobas) and have intercept (95% CI -8.461 to 17.12) and slope (95% CI: 
0.924 to 1.373). A high agreement was found between the two immunoassays for 
determination HE4 and CA 125.
CONCLUSIONS:The various immunoassay techniques using different 
monoclonal antibodies and methods of detection which leads to different results. 
The tumor markers CA 125 ad HE4 should be determined if it is possible in only 
one method.
Keywords: CMIA, ECLIA, HE4 and CA 125 
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OBJECTIVES:OBJECTIVES: Pancreatic cancer is known to be one of the 
most lethal human cancers with 2-3% 5-year survival rate due to strong invasive 
and metastatic properties and high recurrence capacity. Pancreatic ductal 
adenocarcinoma (PDAC) is the most common type of pancreatic cancer with 95% 
of all pancreatic cancers. Therefore, the novel therapeutic agents urgently need 
to be developed for these patients. However, it is only possible when molecular 
mechanisms related to PDAC are investigated in detail. To be able to develop the 
new therapeutic approaches for PDAC, we aimed to investigate the role of miR-
196a in cell proliferation and clonogenicity in Panc-1 and MiaPaCa-2 PDAC 
cell lines. The therapeutic potential of targeting miR196a was investigated using 
specific inhibitor because of high oncogenic properties of miR-196a in cancers.
MATERIALS and METHODS:MATERIALS-METHODS: For this purpose, 
MTS and cell colony formation assays were performed for the evaluation of cell 
proliferation and clonogenicity, respectively, followed by transfection of Panc-1 
and MiaPaCa-2 cells with 50 nM negative miRNA or miR-196a inhibitor for 72 
h under regular culture condition.
RESULTS:RESULTS: Our data clearly shown that miR-196a inhibitor decreased 
cell proliferation in both Panc-1 and MiaPaCa-2 cells as 38.6% and 42.1%, 
respectively, compared to negative miRNA. Additionally, cell clonogenicity 
were decreased when the both cells transfected with miR-196a inhibitor.
CONCLUSIONS:CONCLUSIONS: According our results, the downregulation 
of miR-196a might be the new therapeutic approach for PDAC. We believe that 
these data will help to guide both our further investigations and other researcher 
in this field.
Keywords: pancreatic cancer, PDAC, miRNA, miR-196a, cell proliferation 
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OBJECTIVES:Curcumin has been used as a medicinal plant and a food additive 
and has many different biological activities such as anti-inflammatory, anti 
tumor, anti-oxidant effects and induces apoptosis and inhibits cell proliferation 
in different cells. We aimed to investigate the effect of curcumin on HCT-116 
colorectal cancer cell line.
MATERIALS and METHODS:Cells were treated with different concentration 
of curcumin for 24 h. Cell survival rate and cell migration was measured by 
MTT assay and scratch assay, respectively. Apoptosis was monitored by Acridine 
Orange and Propidium Iodide double staining. The expression level of MMP-9, 
P53 and Caspase 3 was analyzed by RT-PCR.
RESULTS:Curcumin decreased cell survival and migration rate after 24 h 
compared to control (p<0.0001). Curcumin down-regulated the expression level 
of MMP-9 and Caspase 3 and up-regulated the expression level of P53 (p< 
0.0001). The highest percentage of apoptosis observed at concentration of 5 µM 
curcumin.
CONCLUSIONS:These results demonstrated that curcumin inhibits HCT-116 
cells survival, migration and invasion and also curcumin could induce apoptosis 
through modulating the expression of apoptotic genes.
Keywords: cells survival, proliferation, apoptosis, invasion, migration 
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OBJECTIVES:The aim of the current study was to assess whether serum 
undercarboxylated matrix Gla-protein (ucMGP) levels are associated with 
coronary artery calcium score (CACS) in a moderate-to-high risk patients 
without and with cardiovascular diseases (CVD).
MATERIALS and METHODS:A total of 67 patients (48 females and 19 males), 
mean age 69.4±11.9 years) who visited the Cardiology Clinics at the University 
Hospital of Varna between October 2018 - July 2019 were enrolled in the study. 
Moderate- and high-risk patients without CVD (n=33) served as controls. 
Patients with paroxismal and persistant atrial fibrillation and those with heart 
failure and sinus rhythm with ejection fraction >40% repesented the CVD group. 
All participants underwent a multislice computed tomography examination. 
Fasting venous blood was drawn for laboratory tests. The measurements of 
ucMGP were performed using a competitive mono-antibody ELISA kit (Cusabio 
Technology LLC, USA). The routine biochemical parameters (lipid profile and 
uric acid) were assessed on automated biochemical analyzer. Standard statistical 
methods (descriptive statistics, one way ANOVA, Spearman correlation analysis) 
were applied.
RESULTS:Increased ucMGP levels by 24.3% were found in the CVD group 
when compared to the controls (4.489±1.081µg/ml vs 3.612±0.508µg/ml). 
Significant positive correlation was established between ucMGP levels, CACS 
(r=0.29), total cholesterol (r=0.32), and uric acid levels (r=0.72).
CONCLUSIONS:This preliminary study shows that high ucMGP concentrations 
are associated with higher CACS in CVD patients. In this regard, our results are 
consistent with the findings of other studies and contribute to the hypothesis that 
ucMGP plays a pathophysiologic role in vascular calcification.
Keywords: undercarboxylated matrix Gla-protein, coronary artery calcium 
score, cardiovascular diseases 
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metabolic syndrome
Sibel Kiliç1, Emre Avci1, Burcu Baba2, Gülçin Alp Avci1, 
Alpaslan Karabulut3, Cumhur Bi̇lgi̇2 
1Department of Molecular Biology and Genetics, Faculty of Arts and Sciences, 
Hitit University, Çorum, Turkey 
2Department of Medical Biochemistry, Faculty of Medicine, Yüksek İhtisas 
University, Ankara, Turkey 
3Department of Internal Medicine, Faculty of Medicine, Hitit University, 
Çorum, Turkey 
OBJECTIVES:Metabolic syndrome (MetS) is characterized by the coexistence 
of systemic diseases such as abdominal obesity, insulin resistance, hypertension, 
hyperlipidemia, that increases the risk of diabetes and cardiovascular diseases. 
Arginine vasopressin (AVP) may be implicated in MetS by altering pituitary 
ACTH release, liver glycogenolysis, and secretion of glucagon and insulin. 
Copeptin is considered as an useful surrogate marker for AVP. It has been 
suggested that ghrelin with multiple functions including modulating appetite, 
control of energy metabolism and vascular function, is involved in the 
development of MetS. The pro-B-type natriuretic peptide (proBNP) has also 
been proposed as a promising cardiac biomarker for heart function. The aim of 
this study was to evaluate the relationship between MetS and three different bio 
markers that related to metabolism and cardiovascular system.
MATERIALS and METHODS:The present study enrolled a total of 44 patients 
with MetS and 30 healthy subjects. Serum copeptin and ghrelin levels were 
determined using the ELISA technique. The serum levels of proBNP were 
measured by using chemiluminescence method. The biochemical parameters 
including blood glucose and insulin levels, lipid profiles were also measured.
RESULTS:Copeptin and ghrelin levels were significantly lower in patients with 
MetS than controls. ProBNP levels were significantly higher in patients than in 
controls.
CONCLUSIONS:Depending on our outcomes it can be postulated that ghrelin, 
copeptin and proBNP may be associated with components of MetS and involved 
in pathogenesis of MetS. Therefore, these parameters are thought to be a guide in 
the follow-up of risky patients.
Keywords: Copeptin, ghrelin, metabolic syndrome, proBNP 
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OBJECTIVES:Apolipoproteins play an important role in lipid metabolism. 
Dyslipidemia is well known risk factor for CAD, thus apolipoproteins are 
considered as risk factors for coronary artery disease, too. The aim of this study 
was to evaluate the association of higher apolipoproteins levels, ApoB/A1 ratio 
and coronary artery disease (CAD).
MATERIALS and METHODS:ApoA1 and Apo B were determined by 
immunonephelometric methods in plasma of 119 CAD patients and 182 healthy 
subjects; Apo B/A1 ratio was calculated mathematically.
RESULTS:Patients with CAD compared to healthy subjects had statistically 
significant higher levels serum levels of triglycerides (2.54 ± 0.79 vs. 1.32 ± 
0.41, p<0.001), total cholesterol ( 5.49 ± 1.33vs. 4.65 ± 0.99; p<0.0001), LDL 
cholesterol (3.55 ± 1.02 vs. 2.79 ± 0.96;p<0.001), Apo B (1.27 ± 0.41 vs.0.78 
± 0.25, p<0.0001), and Apo B/A1 ratio (1.20 ± 0.37 vs. 0.65 ± 0.21 p<0.0001); 
decreased levels of ApoA1 (1.073 ± 0.21 vs. 1.19 ± 0.19, p< 0.002 ) and HDL 
cholesterol (0.89 ± 0.24 vs. 1.22 ± 0.27, p<0.0003) were found in CAD patients 
compared to control group
CONCLUSIONS:The results indicate that dyslipidemia and Apo B levels, apoB/
A1 ratio and decreased apoA1 are associated with CAD.
Keywords: CAD, apolipoproteins, dyslipidemia 
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OBJECTIVES:This study’s objective is to explore the value of hematological 
indices as biomarkers of major adverse cardiovascular events during the 
hospitalization after acute myocardial infarction (AMI).
MATERIALS and METHODS:230 patients with AMI were enrolled in this 
study. Venous blood was collected at admission. Total white blood cell (WBC), 
neutrophil, lymphocyte, monocyte, platelet (PLT) counts, MPV, PDW and 
RDW were calculated using an automated blood cell-counter. Neutrophil-to-
lymphocyte ratio (NLR) was computed from the absolute values of neutrophils 
and lymphocytes. Patients were categorized in groups according to the 
occurrence or not of heart failure, rhythm disorders and survival. Statistical 
analysis was performed using SPSS/IBM. P-value<0.05 was considered 
statistically significant.
RESULTS:AMI patients (mean age 68+/-12, 73.5% males) had an average 
WBC count of 9611/mm3 despite their in-hospital outcomes. Major adverse 
cardiovascular events happened in 99 patients (43%). WBC, Absolute Neutrophil 
Count (ANC), NLR and Monocyte Count (P<0.001), PLT (p=0.046), MPV 
(p=0.003), PDW (p=0.042) were significantly higher in patients who developed 
heart failure compared to those who didn’t. Cut-off values ANC 7120/mm3 and 
NLR 4.215 show high sensitivity and sensibility for heart failure. Nonsurvivors 
had higher WBC, ANC, MPV, PDW, RDW (p<0.001), NLR (p=0.005) at 
admission. Old age, female gender and ST-segment elevation (STEMI) had 
significantly higher mortality. Heart rhythm disorders were better predicted by 
higher WBC (p=0.019) and ANC (p=0.036).
CONCLUSIONS:Hematological indices are useful and cost-effective 
cardiovascular biomarkers for the occurrence of heart failure, rhythm disorders 
and death during the hospitalization after AMI, potentially impacting the clinical 
prognosis and management.
Keywords: hematological indices, cardiovascular biomarkers 
 
P-055
Correlation between Troponin I and complexity of coronary lesions in 
patients with acute coronary syndrome
Nevila Heta Alliu1, Iva Shehaj2, Etleva Refatllari1, Irena Korita1, Anyla Bulo1 
1Laboratory Department, University Hospital Center “Mother Teresa”, Tirana, 
Albania 
2Salus Hospital,Tirana, Albania 
OBJECTIVES:The aim of our study is to explore the correlation of Troponin I 
(TPI) with the complexity of coronary lesions in patients with Acute Coronary 
Syndrome (ACS) with evaluation according SYNTAX score, and to evaluate 
the correlation of Troponin I (TPI) with TIMI and GRACE clinical scores, as 
predictors of future cardiovascular events.
MATERIALS and METHODS:We studied a group of 107 patients: 31 females 
and 76 males with ACS who underwent coronary angiography. TPI is measured 
by chemiluminescent immunometric assay. Statistical analysis of clinical, 
laboratory and coronary angiographic data was performed by the SPSS 22 
program.
RESULTS:The average age of the studied population is 62.71±10.4. Most of 
patients were in Killip1 (87.9%) also 26 % of patients had STEMI, 52.1% Non 
STEMI, and 21.9% unstable angina. TPI levels are significantly higher in group 
with stenosis ≥ 50% vs. group without stenosis < 50% ( 77.33 ng/ml vs. 2.5 ng/
ml, p = 0.000). Positive correlation was found between levels of TPI and Syntax 
score (r = 0.416, p = 0.00), TIMI score (r = 0.514, p = 0.00) and GRACE scores 
(r = 0.509, p = 0.00). TPI levels between IAM STEMI and IAM Non STEMI 
was not statistically significant (122.3±42 ng/ml vs 100.5±32 ng/ml, p = 0.0678).
CONCLUSIONS:TPI is a reliable biomarker in evaluation of the complexity of 
coronary lesions, we found a positive correlation between TPI levels and Syntax 
score, also TPI has a positive correlation with TIMI an GRACE clinical score, 
suggesting a higher risk of future cardiovascular events.
Keywords: Troponin I, Acute coronary syndrome 
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OBJECTIVES:Latter studies demonstrate that inflamation has a key role in the 
whole atherosclerotic process; onset and progression. One of the atherosclerosis 
spesific inflamattory indicator is pentraxin 3 which is synthesised from cells, 
found in atherosclerotic origin, such as endotel, macrophages, smooth muscle 
cells.PTX-3 is one of the member of pentraxin family such as hs-CRP and a 
component of the natural immunity. In our study, we evaluated the serum PTX-
3 of patients who have diagnosis of the “stabile angina pectoris” and whom 
coronary obstruction degree was determined with the gensini score
MATERIALS and METHODS:Our patients were consisted of 88 individuals 
who approached Cardiology Institute of İstanbul University and diagnosed 
as “stabile angina pectoris”(SAP) by coronary angiography. Biochemical 
parameters were observed in the biochemistry laboratory of Haseki Education 
and Research Hospital. Serum PTX-3 was analysed by ELISA kit related with 
sandwich method.
RESULTS:Group 1 ( patients with mild coronary artery diseases and/or gensini 
score <50)was compared with 2.group 2 (1,2 and 3 vessels affected patients 
and /or gensini score over 50). The patients who have severe coronary artery 
disease (Group 2) have distintctly higher ptx-3 levels, found statistically quite 
significant.
CONCLUSIONS:In our study, it is thought that the statistically high PTX 
3 levels are related with atherosclerosis in the evaluation of coronoary artery 
obstruction degree of SAP patients. Detection of the plasma PTX3 levels of 
patients diagnosed as SAP before angiography may indicate the severity of the 
disease thus it may help the detection of atherosclerosis degree and lead to give 
an angiography decision.
Keywords: Stable Angina Pectoris, Coronary Artery Disease, Pentraxin 3 
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OBJECTIVES:Cushing’s disease is a clinical condition of glucocorticoid 
secretion due to pituitary adenoma secreting ACTH(adrenocorticotropic 
hormone).The patient, who had been diagnosed with breast cancer before, was 
diagnosed as Cushing’s disease according to the laboratory result during routine 
biochemistry controls. In this study, we aimed to emphasize the importance of 
multidisciplinary (laboratory-clinical) approach in the diagnosis of diseases that 
are directed by biochemical parameters.
MATERIALS and METHODS:A 61-year-old patient with operated breast 
cancer and diabetes mellitus for 30 years had a fasting blood glucose of 430mg/
dl. HbA1c:15.1% Cortisol:28µg/dl(n:5-22µg/dl). 1mg and 2mg dexamethasone 
suppression test was performed,there was no suppression in the test results. It 
was not accept by the patient the next step,8mg dexamethasone suppression 
test. Hospitalization was recommended for further examination and pituitary 
MR(magnetic resonance) was planned.
RESULTS:MRI findings were interpreted as empty sella or partial empty sella. 
Inferior petrosal sinus sampling (IPSS) was planned and ACTH levels from the 
interventional radiology samples were studied.In the sample taken from the left 
petrosal sinus, ACTH levels were 0.min18.4pg/ml,5.min558pg/ml,10.min778pg/
ml; in the sample from the right petrosal sinus 0.min19.8pg/ml,2.min25.8pg/
ml,5.min124pg/ml,10.min350pg/ml; in the samples from the peripheral vein 
0.min16.4pg/ml,2.min25.3pg/ml,5.min726pg/ml,10.min145pg/ml has been 
concluded. Based on these laboratory findings, the patient was diagnosed with 
left lateralized pituitary cushing syndrome.
CONCLUSIONS:In this case, according to the MR findings and the results 
obtained from IPSS for the diagnosis of Cushing’s disease; it was observed that 
timely and accurate samples are helpful in the diagnosis process and also they 
save the time for the treatment and follow-up of the patient.
Keywords: Cushing’s disease, Inferior petrosal sinus sampling (IPSS)
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Falsely low HbA1c level on the Roche Cobas 6000 platform in a diabetic 
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OBJECTIVES:Recent episodes of hypoglycemia, Hemolytic anemia or a high 
percentage of HbF may result in lower than expected HbA1c in diabetic patients.
MATERIALS and METHODS:A diabetic patient (Male, 35) on medication with 
an average fasting blood glucose of about 157 mg/dl (range 122-195, within two 
years) recently without any hypoglycemic symptoms had a low normal level of 
HbA1c (4,6 %, NGSP or 27 mmol/mol, IFCC). Biochemistry and hormone tests 
were performed on the Roche Cobas 6000 system. To elucidate the discrepancy 
various hematological and biochemical tests were performed: Complete Blood 
Count (Sysmex XN 1000) and manual differential count, anemic test panel 
(Ferritin, Vitamin B12, Folate, Iron/UIBC/Transferrin Saturation), Haemolytic 
test panel (Coombs tests, LDH, Bilirubins, Reticulocytes) and Hb Electrophoresis 
(Sebia Capillary Electrophoresis).
RESULTS:The Patient had normal Hemoglobin and red blood cell indices. 
Due to normal hemolytic test panel results, we ruled out hemolytic anemia. Hb 
Electrophoresis showed high levels of Hb F 42,1 % (with 57 % HbA and 0,9 % 
HbA2). According to Roche HbA1c method insert if Hb F is present in more than 
10 % than falsely low Hb A1c result may be seen.
CONCLUSIONS:In the absence of recent episodes of hypoglycemia 
and hemolytic anemia, lower than expected HbA1c values obtained with 
Roche Hemoglobin A1c may be due to high HbF levels. In these cases, the 
determination of Hb F percentage by hemoglobin electrophoresis is required. If 
Hb F is elevated by more than 10% than another method for HbA1c or Glycated 
Albumin is required for proper glycemia status evaluation.
Keywords: Roche HbA1c, HbF, Haemolytic anemia, Haemoglobin 
electrophoresis, 
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OBJECTIVES:Homocysteine is formed by demethylation of methionine, which 
is abundant in animal protein and is the core determinant of the methylation 
cycle. A number of studies also showed that enhanced plasma Hcy level is 
associated with increasing urinary albumin excretion in diabetic patients. There 
is also evidence supporting that Hcy abundance is closely related to renal status 
in the elderly. These results all suggest that Hcy is a marker of impaired renal 
function in diabetic patients. Our aim of this study is to investigate the levels of 
homocysteine in patients with diabetic nephropathy and control group.
MATERIALS and METHODS:61 controls and 38 patients with diabetic 
nephropathy were enrolled to this study. Homocysteine levels were measured 
by LC-MS/MS. 50 μL plasma, calibrator and control samples were mixed with 
50μL in-ternal standard (10μM d8-homocysteine iso-tope DLM-3619-1) and 
50 μL reducing reagent (300 mmol/L 1,4-Dithiothreitol) and incubated at room 
temperature for 15 minutes. 300 μL of precipitating reagent (15% trichloroacetic 
acid Cat No: Merck 100810) was added to precipitate proteins, mixed for 10 
seconds and centrifuged at 13.000 rpm for 3 minutes. 10 μL of superna-tant was 
injected.
RESULTS:Serum homocysteine levels were significantly higher in patients 
with diabetic nephropathy (18.7±7.2 µmol/l ) than controls ((16.1± 4.8 µmol/l); 
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p<0.05).
CONCLUSIONS:In our study, we found that serum homocysteine levels were 
significantly higher in patients with diabetic nephropathy than control group. 
Therefore, we concluded that homocysteine may be a very useful marker in the 
diagnosis of diabetic nephropathy.
Keywords: Diabetic nephropathy, homocysteine, LC-MS/MS
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OBJECTIVES:Diabetes is a metabolic disorder, which is usually caused by a 
combination of hereditary and environmental factors and an excessively high 
level of blood glucose (hyperglycemia). Hemoglobin A1c (HbA1c), also known 
as glycosylated hemoglobin, is a blood test used to measure the effectiveness 
of the treatment in diabetes and to diagnose diabetes. Hemoglobin A1c levels 
are given as percentage (%) in blood by NGSP method. Normally accepted 
Hemoglobin A1c is between 3 % and 6 %. Hemoglobin A1c levels are measured 
by various analytical methods. The most commonly used Hemoglobin A1c 
measurement methods in the literature are 2D-HPLC-CE-UV, HPLC-UV and 
HPLC-ESI-MS.
MATERIALS and METHODS:Highly precise and accurate liquid 
chromatography–mass spectrometry (LC–MS/MS) procedure will be developed 
to measure HbA1c in blood. Also, commutability of HbA1c reference material 
will be provided by HPLC-UV method as a secondary method for HbA1c 
measurements.
RESULTS:Firstly, HPLC-UV method was developed for HbA1c measurement 
in blood. The correlation coefficient (r) of the Calibration Curves obtained was 
above 0,999 and the accuracy of the Quality Control check was in the acceptance 
range. We observed no problem at repeatability. Recovery was calculated 
between 86%-104%.
CONCLUSIONS:HPLC-UV method for measuring HbA1c was developed. 
Validations of this method has done. After that, to measure HbA1c LC–MS/MS 
method will be developed. Produced reference material will be certificated with 
these methods. This certificated HbA1c reference material will be a nationally 
sourced alternative reference material for clinical area. Also this CRM will 
reduce outward dependence.
Keywords: Reference material, HbA1c, LC-MS/MS 
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OBJECTIVES:In our study, we aimed to analyze the diagnostic distribution 
of oral glucose tolerance test (OGTT) results according to American Diabetes 
Association (ADA) criteria.
MATERIALS and METHODS:Standard oral glucose tolerance test (OGTT) 
was applied to 298 men and 408 women aged between 18 and 75, who were 
requested from the outpatient clinics of Kırşehir Training and Research Hospital. 
Fasting plasma glucose and second hour plasma glucose were measured.
RESULTS:According to the American Diabetes Association (ADA) criteria, 
39% of the cases were evaluated as normal (108 males, 172 females), 16% 
were diabetes (45 males, 70 females), 8% were isolated IFG (impaired fasting 
glucose) (20 males, 34 female), 33% isolated IGT (114 male, 116 female), 4% 
IFG + IGT (11 female, 16 male).
CONCLUSIONS:Currently, the incidence of diabetes mellitus and the associated 
microvascular and macrovascular complications are gradually increasing. 75 g 
oral glucose tolerance test (OGTT), which is evaluated as proper in accordance 
with American Diabetes Association (ADA) criteria, has an important role in 
early diagnosis of diabetes and prevention of complications.
Keywords: Diabetes mellitus, OGTT 
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OBJECTIVES:In the case of carbamylation, isocyanic acid reacts in an 
irreversible manner with α-and ε-amino groups of proteins, generating 
α-carbamylated proteins and homocitrulline (HCit,ε-carbamoyllysine) residues, 
respectively. Our aim of this study is to determine serum homocitrulline levels in 
patients with diabetic nephropathy.
MATERIALS and METHODS:103 diabetic nephropathy and 35 controls 
were included. 250 µL of serum and 100µL of D4-L Citruline were vortexed 
by pipetting with 1000µL of Methanol. The samples were allowed to incubate 
at room temperature for 10 minutes. It was then centrifuged at 13000rpm for 
5 minutes. The supernatant was transferred to a glass tube and the sample was 
evaporated under 65 degrees nitrogen. 200 µL of 3N HCl + N-Butanol was added 
to the tube. The cap of the tube was closed and allowed to incubate at 65 degrees 
for 30 minutes. The sample was evaporated again under nitrogen. 250µL of 
20% acetonitrile was dissolved with 0.1% formic acid. Phenomenex Luna C18 
column and ABSCIEX API 3200 LC-MS/MS were used for the measurements.
RESULTS:Serum homocitrulline levels were higher in patient group [255 (124-
415) ng/mL] compared to controls [248 (103-884) ng/mL] (p=0.009).
CONCLUSIONS:Like glycation process, carbamylation might be responsible 
for the prognosis of kidney disease in diabetes mellitus. Thus, a carbamylation 
biomarker, homocitrulline, may be considered as a alternative candidate test.
Keywords: Homocitrulline, Tandem mass spectrometry, Nephropathy 
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OBJECTIVES:T helper (Th) cells and their cytokine secretions are thought to 
have roles in pathogenesis of type-1 DM. Their frequencies are claimed to change 
in relation with disease progression while they are thought to be contributors of 
immune attack to pancreatic beta cells.
MATERIALS and METHODS:Heparinised venous blood samples (20 ml) were 
drawn from patients with type-1 DM (n=20) and healthy controls (n=10). The 
mean age+Standart Deviation (SD) of the patients with type-1 DM and healthy 
controls were 29.3±5.6 years (10 males-10 females), 28.4±4.6 years (5 males-5 
females), respectively. Duration of disease is 7.5±3.7 years. Peripheral blood 
mononuclear cells (PBMCs) were isolated using Ficoll-gradient centrifugation 
from whole blood. PBMCs were incubated with the PMA (50 ng/ml) and 
Ionomycin (1 mg/ml) for 4 hours at 37 °C with 5% CO2. Before incubating, 
Brefeldin A (3 µg/ml) was added as well. After 4 hours, cells were harvested 
and stained for surface molecule expressions of CD3, CD4. In addition, the 
intracellular staining was performed for the expression of IL-22 and IL-
9. Expression of cell surface and intracellular markers was assessed using 
flow cytometry whose name is BD FACSCantoII, and data were analyzed by 
FACSDiva software.
RESULTS:Frequencies of IL-22 and IL-9 of CD3+CD4+ Th cells in patients 
with type 1 DM were significantly increased compared to healthy controls (p= 
0.003 and p=0,022 ).
CONCLUSIONS:These results show that frequencies of IL-22 and IL-9 
cytokines of Th may have roles in pathogenesis of type-1 DM.
Keywords: Diabetes, T helper, IL-22, IL-9 
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OBJECTIVES:Diabetes mellitus, regardless of the type, is a prothrombotic state 
characterized by platelet hyperreactivity and hyperaggregability.Mean Platelet 
Volume (MPV) is considered a hallmark of impaired thrombopoiesis in diabetes 
mellitus. Since the data related to diagnostic significance of MPV are lacking and 
contradictory, in this work, we aimed to compare platelet morphology among 
children in Bosnia and Herzegovina with Type 1 Diabetes Mellitus (T1DM) 
and their healthy peers and to analyze possible correlation between platelet 
morphology and glycated haemoglobin (HbA1C).
MATERIALS and METHODS:The study included 100 children with T1DM and 
100 non-diabetic, healthy children as control group. The control group was age- 
and sex-matched to the study group. In both groups, platelets (x109/L), MPV 
(fL), HbA1C (%) and glucose (mmol/L) were analysed.
RESULTS:There was no significant difference in BMI and platelet count values 
between the groups, while HbA1c, glucose and MPV values showed significant 
differences (p=0.0001 for all three). HbA1c, glucose and MPV were significantly 
higher in children with T1DM in comparison to healthy children. Positive 
correlation was observed between MPV and HbA1c (R=0.146, p=0.039), and 
MPV and glucose (R=0.199, p=0.005).
CONCLUSIONS:MPV is significantly higher in Bosnian children with 
T1DM when compared to controls. Positive correlation between MPV and 
HbA1c suggests that MPV levels may serve as a early, inexpensive marker for 
determining the risk of diabetic microvascular and macrovascular complications.
Keywords: Type 1 diabetes mellitus, Hemoglobin A1c, Mean Platelet Volume, 
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OBJECTIVES:Neutrophil gelatinase-associated lipocalin (NGAL) is a member 
of the lipocalin protein family. NGAL might be an important factor in the 
pathophysiology of micro- and macro-vascular complications in patients with 
poorly controlled diabetes. The aim of the study is to evaluate the levels of plasma 
and urinary NGAL (pNGAL and uNGAL) as a marker for risk of complications 
in patients with type 1 diabetes mellitus (T1DM) compared to HbA1c values.
MATERIALS and METHODS:The study included 38 patients with T1DM 
lasting for more than 5 years, classified into two groups according to the HbA1c: 
good (< 7.5%) and poor glycemic control (>7.5%). pNGAL and uNGAL were 
quantitatively measured in plasma and a spot urine sample using particle-
enhanced turbidimetric immunoassay (BioPorto).
RESULTS:The group consists of 38 children (22 female and 16 male), the 
middle age is 14.2±2.5 years. 34.2% of the patients were with good and 65.8% 
with poor glycemic control. The difference in pNGAL levels between the two 
groups did not reach a statistical significance. The mean uNGAL/Creatinine ratio 
(NCR) levels were significantly higher in the group with poor glycemic control 
(6.06±8.32g/mmol vs 1.65±0.98g/mmol, p=0.001). Pearson correlation analysis 
showed significant positive correlation between NCR and: HbA1c (r=0.549, 
p=0.001), Albumine/Creatinine ratio (ACR) (r=0.551, p=0.001), Triglycerides 
(r=0.395, p=0.025); and negative correlation with HDL-cholesterol (r=-0.355, 
p=0.046).
CONCLUSIONS:NCR levels are higher in patients with poorly controlled 
diabetes probably in response to tubulointerstitial renal injury. More studies are 
needed to clear out the role of NGAL as an early marker for diabetic nephropathy.
Keywords: NGAL, Type I diabetes mellitus 
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OBJECTIVES:The medical biochemistry lectures are processed within 
the first 3 years of the whole period of our University’s faculty of medicine. 
The survey which includes questions about preanalytic phase, diseases and 
biochemistry is aimed to be carried out in the group of the pregraduate students.
MATERIALS and METHODS:The study designed as a cross-sectional. Data 
collection instrument prepared by the researchers themselves. The instrument 
included 22 items have multiple choice options. The data collected from 
the students were entered into a standard data base by the researchers. The 
questionnaire has been directed in to 120 pregraduate student in Izmir Katip 
Celebi University Medical Faculty. For the analysis of the study data, descriptives 
statistics were used. Data analysis performed using PASW statistics for Windows 
(SPSS,Inc.IBM) version 21.0.
RESULTS:%37.5 of the participants don’t have the knowledge about correct 
tube for coagulation and hemogram. The urine collection method of 24 hours 
and urine sample type for special analysis couldn’t be known by the students. 
%40 of students didin’t know the correct sample for prenatal screening. 
CONCLUSIONS:In order to correct examination process, to minimize the 
preanalytic failure range, to evaluate the analysis outcomes more accurate after 
the graduation period, it will be very effective if the medical biochemistry 
education is added into the rotation programme before the graduation.
Keywords: medical biochemistry education 
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OBJECTIVES:Cardiotrophin-1, a member of the interleukin-6 family of 
cytokines, protects several organs from damage by promoting survival and 
anti-inflammatory effects. Polycystic ovary syndrome (PCOS) is a reproductive 
and metabolic disease associated with increased risk of cardiovascular events. 
The aim of this study was to estimate serum cardiotrophin-1 levels in women 
with PCOS and to find possible relationships between cardiotrophin-1, insulin 
resistance and biochemical parameters in these patients.
MATERIALS and METHODS:Forty-six women with PCOS and 36 age 
matched healthy women were participated in this case-control study. Serum 
insulin level, homeostasis model assessment of insulin resistance (HOMA-IR), 
and biochemical parameters were measured. Serum cardiotrophin 1 levels were 
measured using sandwich-enzyme-linked immunosorbent assay.
RESULTS:Cardiotrophin-1 levels were significantly higher in the PCOS group 
than in the control group (269 ± 188 pg/ml vs. 177 ± 136 pg/ml, p = 0.01). In 
addition, HOMA-IR, serum insulin, triglyceride and testosterone levels were 
significantly higher in the patient group than in the control group. Cardiotrophin- 
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1 levels in the serum of women with PCOS patients were positively correlated 
with serum insulin and HOMA-IR.
CONCLUSIONS:The circulating levels of cardiotrophin-1 was significantly 
increased in women with PCOS. Our results suggest that cardiotrophin-1 has a 
relationship with insulin resistance in PCOS. Elevated cardiotrophin-1 levels can 
be a predictor of increased cardiovascular risk in PCOS subjects.
Keywords: polycystic ovary syndrome, cardiotrophin-1, insulin resistance 
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OBJECTIVES:The objective of this case report is to highlight the unusual high 
level of Procalcitonin (PCT) to help to make the right diagnosis in future cases.
MATERIALS and METHODS:The level of PCT in serum samples was 
measured using enzyme-linked fluorescence assay (ELFA) B.R.A.H.M.S. 
PCT Vidas PC Biomerieux. The levels of thyroid hormones,TSH,fT4,fT3,and 
thyroid antibodies,anti- thyrglobulin and anti-thyroid peroxidase levels in the 
serum samples were measured using two-site Immunoenzymatic assay Access 
2,Beckman Coulter. CRP was measured in the serum samples using turbidimetrc 
method AU 480 B Coulter. WBC was measured in the whole blood EDTA 
samples -automated hematology analyzer Sysmex XN 550. Thyroid ultrasound 
and fine needle aspiration cytology was performed.
RESULTS:After total abdominal hysterectomy 52 years-old women, first day 
after surgery had a fever (38°C). Levels of PCT in serum sample was 14,1 ng/
ml, levels of CRP and WBC were in reference ranges. After antibiotics therapy, 
measurement of PCT, CRP and WBC were repeated. PCT levels was the 13,9 
ng/ml and after 48 hours, 13,1 ng/ml. WBC and CRP were the same. General 
condition of the patient was good. Levels of TSH, anti-thyroglobulin and anty-
thyroid peroxidase in the serum sample were increased (TSH 6,1 µIU/ml,TPO 
Ab 54,1 µIU/ml,Tg-Ab 17,4 µIU/ml). Levels of fT4 and fT3 were in reference 
ranges. Thyroid ultrasound detected a thyroid heterogeneous nodule. Fine needle 
aspiration cytology revealed thyroid follicular benign nodule. Diagnosis was 
thyroiditis chronica.
CONCLUSIONS:The increased level of PCT may indicate thyroid disease in 
certain circumstances.
Keywords: Procalcitonin,Thyroid disease,biomarker 
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OBJECTIVES:Obesity is a serious metabolic disorder that results from 
imbalance between energy intake and expenditure. In the central nervous 
system (CNS), the hypothalamus is a significant brain area in regulating feeding 
behavior and energy balance. Homeostasis of the CNS microenvironment is 
maintained by the blood-brain barrier (BBB). BBB is a highly specialized and 
dynamic barrier. The structural integrity of BBB is sustained mainly by tight 
junction (TJ) proteins and adherens junctions. Disruption of BBB TJ can lead 
to impaired BBB function and might initiate vasculopathy. Phenylbutyric acid 
(PBA) is a chemical chaperone that enhances the capacity of the endoplasmic 
reticulum and decreases the endoplasmic reticulum stress response signal. It was 
aimed to evaluate the effect of chemical chaperone PBA on the expression of TJ 
protein occludin in the hypothalamus.
MATERIALS and METHODS:In the study, lean and ob/ob male mice were 
divided in two groups (n=8) and administered with either vehicle or PBA for 
thirty days. After thirty days, all mice were sacrificed and brain tissues were 
removed. The expression of the TJ protein occludin in the hypothalamus were 
assessed by western-blotting.
RESULTS:Our initial results demonstrated that the expression of the tight 
junction protein occludin increased in the hypothalamus of PBA-treated ob/ob 
mice compared to ob/ob controls.
CONCLUSIONS:The results indicated that obesity induced dysregulation of 
occludin expression might be compensated via administration of chemical 
chaperon PBA.
Keywords: Obesity, occludin, phenylbutyric acid, tight junctions, vasculopathy 
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OBJECTIVES:PCOS is an endocrinopathy which is caused to chronic 
anovulation and anovulatory infertility. Menstruation irregularities, symptoms of 
androgen excess, obesity and sometimes hirsutism are clinical signs of PCOS. 
The relationship of between obesity and PCOS isn’t explained completely. 
TRB3 (Tribbles homolog 3) is a mammalian homolog of the drosophila tribble 
gene. The synthesis of TRB3 increases under various stressful conditions such 
as endoplasmic reticulum stress and starvation. Increasing of TRB3 causes 
to hypoglysemia and IR also inhibits adipocyte differentiation. Sestrin-2 is 
a member of the stress-stimulated protein family which regulates metabolic 
homeostasis. Sestrin-2 is as a protective antioxidant protein against oxidative 
stress, ROS and cardiovascular diseases. We predicted that sestrin-2 and TRB 
levels can be related with metabolic disturbances in PCOS.
MATERIALS and METHODS:57 patients were included who have PCOS 
to the study. 22 healthy women were enrolled as control group. Patient group 
was separated to obese and non-obese groups. Metabolic parameters, TRB3 
and sestrin-2 tests were performed on patients and control groups. TRB3 and 
sestrin-2 were measured by microelisa method.
RESULTS:Sestrin-2 mean values were lower in obese PCOS group than non-
obese PCOS group (p<0.005). In Obese PCOS group, sestrin-2 has negative 
correlation with HOMA-IR, insülin and BMI. TRB3 mean values were higher in 
both PCOS groups than control group (p<0.005).
CONCLUSIONS:Our study showed that the changes of serum levels of TRB3 
and Sestrin-2 is related to metabolic disturbances. These parameters can be used 
to evaluating of metabolic status in obese and non-obese women with PCOS.
Keywords: Sestrin-2, TRB3, Obesity, PCOS 
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OBJECTIVES:Obesity is a low-grade systemic inflammatory disease. Galectin-3 
is a member of the lectin family and plays a role in inflammatory processes. The 
aim of our study was to investigate the possible relationship between galectin-3 
level and obesity and to evaluate the metabolic inflammatory process before and 
after obesity surgery through this marker.
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MATERIALS and METHODS:Total of 100 patients (normal weight, overweight, 
1st, 2nd, and 3rd degree obese) were included in the study. The 3rd degree obese 
patients were evaluated at 3rd and 6th months after bariatric surgery. In samples 
taken from all patients, glucose, insulin, HbA1c, lipid profile, high sensitivity 
C-reactive protein (hsCRP), galectin-3, interleukin (IL) -6, IL-10, adiponectin, 
and leptin levels were measured.
RESULTS:The average age of the individuals included in the study was 41±9 
years. The mean body mass index (BMI) of the 3rd degree obese patients 
decreased significantly after the 3rd and 6th months of surgery. Galectin-3 levels 
were higher in the 3rd degree obese individuals compared to the normal weight 
group. After surgery glucose, insulin, HbA1c and HOMA-IR, IL-6, galectin-3, 
and hsCRP levels were decreased. IL-6, galectin-3, leptin, and hsCRP levels 
were found significantly higher in the insulin resistant group (HOMA-IR≥2.5). 
There was a significant correlation between levels of galectin-3 and IL-6, leptin, 
and hsCRP.
CONCLUSIONS:In our study, serum galectin-3 levels decreased together with 
the parameters related to postoperative inflammation and insulin resistance. 
These findings support that galectin-3 is one of the molecules involved in the 
linkage between meta-inflammation and insulin resistance.
Keywords: Bariatric surgery, galectin-3, inflammation, insulin resistance, 
obesity 
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OBJECTIVES:High-fat-high-carbohydrate (HFHC) diet is one of the leading 
etiological factors in obesity, cardiovascular diseases and metabolic syndrome. 
Animal models are an affordable way to study the negative effects of HFHC diet. 
They provide a basis for comparison of gender variations. The aim of our study 
is to compare the effect of the HFHC diet on the lipid profile in female and male 
rats.
MATERIALS and METHODS:Wistar rats (n = 32) were divided into 4 groups - 
female and male control (FC and MC) and female and male dietary-manipulated 
(FD and MD). Groups FD and MD were subjected to a HFHC diet, and FC and 
MC received standard rat chew, for 16 weeks. At the end of the experiment, 
after decapitation, mixed blood was collected. Serum concentrations of total 
cholesterol, HDL- and LDL-cholesterol, and triglycerides were determined.
RESULTS:Compared to the controls, dietary-manipulated groups had higher 
total cholesterol (1.67 ± 0.1mmol.l-1 vs 2.00 ± 0.1mmol.l-1, P < 0.05), LDL-
cholestorol (0.24 ± 0.05mmol.l-1 vs 0.59 ± 0.05mmol.l-1, P < 0.05) and 
triglycerides (0.99 ± 0.4mmol.l-1 vs 2.48 ± 0.4mmol.l-1, P < 0.05). Compared 
to females, the male rats had higher total cholesterol (1.68 ± 0.1mmol.l-1 
vs 1.98 ± 0.1mmol.l-1, P < 0.05), triglycerides (1.04 ± 0.4mmol.l-1 vs 2.43 ± 
0.4mmol.l-1, P < 0.05) and lower HDL-cholesterol (1.36 ± 0.05mmol.l-1 vs 1.06 
± 0.05mmol.l-1, P < 0.05).
CONCLUSIONS:The used HFHC diet increases the serum concentrations 
of studied lipid parameters in both genders. These disturbances were more 
pronounced in male rats.
Keywords: lipid profile, hfhc diet, wistar rats, obesity 
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OBJECTIVES:Obesity is a complex metabolic disorder which is one of the 
most common contemporary health problems. Numerous researches show the 
connection between chronic,low intensity inflammation and obesity, as well as 
the connection between lipid metabolism disorder and obesity. The aim of this 
research was to determine connection between waist circumference, lipid status 
and hsCRP concentration in adult, metabolically healthy subjects.
MATERIALS and METHODS:The research included 82 subjects.in accordance 
with International association for diabetes mellitus, subjects were divided into 
2 groups. The group of subjects with abdominal obesity and control group. 
Concentration of cholesterol, triglycerides, lipoproteins, hsCRP was measured 
on the Architect c4000
RESULTS:The average measurements of waist circumference were 
(100.83±8.12 to 74.68±9.35 cm). Using the Student’s test, significantly higher 
concentrations were observed in group of obese people (cholesterol P<0.001; 
LDL cholesterol P<0.001; VLDL cholesterol P<0.001; triglycerides P<0.001). 
By analyzing and comparing the values of HDL cholesterol, significantly lower 
concentrations of HDL were observed in obese people group. (P<0.001). HsCRP 
serum concentration was significantly higher in obese subjects (p<0.0001).
We established positive correlation between hsCRP concentration and waist 
circumference, total cholesterol, triglyceride, LDL concentration and waist 
circumference has been proven, as well as negative correlation between waist 
circumference and HDL concentration.
CONCLUSIONS:Our results indicate that, given the fact that these changes 
in lipid profile represent a risk factor in development of atherosclerosis, a 
proatherogenic lipid profile is favorized in the organism of obese people.
Keywords: Obesity, lipids, atherogenesis, inflamation, hsCRP 
 
P-080
Determination of 8 OHDG levels in metabolic syndrome
Emre Avci1, Semra Ozcelik1, Alpaslan Karabulut2, Cumhur Bilgi3 
1Deparment of Molecular Biology and Genetics, Hitit University, Corum, 
Turkey 
2Department of Internal Medicine, Hitit University, Corum, Turkey 
3Department of Medical Biochemistry, Yuksek Ihtisas University, Ankara, Turkey 
OBJECTIVES:Metabolic syndrome is an important cause of morbidity affecting 
more and more people both in Turkey and all over the world. Metabolic 
syndrome is an endocrinopathy in which individuals have multiple factors such 
as diabetes, impaired fasting glucose, impaired glucose tolerance or insulin 
resistance.As a result of increasing reactive oxygen species and insufficient 
antioxidant mechanisms in the body, a number of pathological events called 
oxidative stress occur. It is known that oxidative stress causes various events and 
causes damage by showing various effects on DNA by different mechanisms. 
Therefore, in this study, we aimed to determine the levels of 8 OHDG which are 
indicative of oxidative DNA damage in individuals with metabolic syndrome and 
healthy volunteers as control group.
MATERIALS and METHODS:World Health Organization (WHO) diagnostic 
criteria were used for the diagnosis of metabolic syndrome. In determining 
8-OHdG levels, Enzyme-Linked Immuno-Sorbent Assay method was used.
RESULTS:Serum 8-OH-dG (pg/mL) level was found statistically to have 
increased when compared with those of the control group (0.18 ± 0.14) in METS 
patients (0.99 ± 0.21).
CONCLUSIONS:In this study, we have tried to show the changes in oxidative 
stress markers in MetS patients and healthy participants.Many factors that cause 
metabolic syndrome also trigger oxidative damage. The role of oxidative stress 
in the pathogenesis of methanolic syndrome needs to be studied and the status of 
cardiovascular diseases should be demonstrated.
Keywords: Metabolic sendrom, 8-OHdG,oxidatif stress 
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OBJECTIVES:Asymmetric Dimethyl Arginine(ADMA) is an endogenous 
inhibitor of endothelial nitric oxide synthase and reduces nitric oxide release 
from the endothelium, and causes endothelial dysfunction and local vasospasm.
Hashimoto’s Thyroiditis is the most common cause of hypothyroidism and is an 
autoimmune disease caused by antibodies directly attacking the thyroid gland.
Graves’ disease is an autoimmune disease that causes hyperthyroidism due to 
hyperactivity of the entire thyroid gland. Non-toxic multinodular goiter(MNG) 
is an endemic condition in Turkey with multiple nodules in the thyroid gland 
without increased hormone release.Increased ADMA levels are recently 
recognized as a novel risk factor for endothelial dysfunction and cardiovascular 
events.Our aim was to investigate the association between circulating ADMA 
levels and autoimmune thyroid disorders thought to increase cardiovascular 
disorders.
MATERIALS and METHODS:A total of 200 euthyroid individuals were enrolled 
in this prospective study, including 50 patients with Hashimoto’s Thyroiditis,50 
patients with Graves diseases, 50 individuals with MNG and 50 healthy controls 
who admitted Selçuk University Medical Faculty between 01.01.2018 and 
01.12.2018.Statistical analyses were performed using the IMB SPSS,v21.
RESULTS:ADMA levels were statistically higher in patients with Graves’ 
disease (mean:0.64±0.27 µmol/l) compared to Hashimoto thyroiditis (mean: 
0.53±0.18 µmol/l), MNG (mean: 0,51±0,24µmol/L) and control group (mean: 
0.49±0.21µmol/l) (p=0.023,p=0.012 and p=0.005,respectively).There were no 
relationships among ADMA levels, thyroid hormones, TSH or BMI.
CONCLUSIONS:Our study demonstrated that serum ADMA concentrations 
were significantly increased in patients with Graves’ disease, not influenced by 
gender, age, thyroid hormone levels, BMI and smoking. These findings may 
explain the biochemical pathway of increased cardiovascular disease in Graves’ 
disease.
Keywords: Hashimoto, Multinodular Goiter, ADMA,Graves’ Disease 
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OBJECTIVES:Hashimoto’s thyroiditis (HT) is the most common 
inflammatory disease of the thyroid. The hypothyroid in which Hashimato 
cases are seen is characterized by a decrease in oxidative metabolism 
and a significant increase in lipid and lipoprotein plasma levels. 
This situation causes the balance of metabolism in the organism to be disrupted 
and oxidant-antioxidant balance changes.Ischemia-modified albumin (IMA) is a 
biomarker that is an indicator of ischemia and oxidative stress and is measured 
by albumin cobalt binding test. Several changes that occur at the amino terminal 
end of human serum albumin during ischemia are caused by oxidative free 
radicals and in particular reduce the binding capacity of transition metals such as 
cobalt. Therefore, in this study, we aimed to investigate whether ischemia marker 
IMA has changed in hashimoto, an autoimmune thyroid dysfunction, and how it 
affects thyroid damage.
MATERIALS and METHODS:24 patients diagnosed with HT and 25 healthy 
women were joined in our study. IMA levels were determined by albumin cobalt 
binding test, a colorimetric method
RESULTS:Plasma IMA level was higher in HT patients compared to controls 
(0.64±0.11 AU and 0.53±0.14 AU respectively). There was no statistically 
significant difference between the groups in terms of IMA levels. (p˃0.05,p= 
0.392)
CONCLUSIONS:When the functions of the thyroid are impaired (both in 
hypothyroidism and hyperthyroidism), the organism’s use of oxygen and thus 
metabolic events that are primarily responsible for heart ischemia change. 
Therefore, we think that further research is needed for IMA which is evaluated as 
an important indicator and evaluated with heart ischemia
Keywords: Hashimoto Thyroiditis, IMA, Oxidative stress 
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OBJECTIVES:Obesity in pre-pubertal and pubertal children is a serious 
problem,being connected with systemic low-grade inflammation and endothelial 
dysfunction and different disorders like metabolic syndrom, insulin resistance, 
hypothyroidism. The data related to inflammatory markers in these characteristic 
populations are lacking in Bosnian children, therefore, major aim of this work 
was to determine differences in concentration of selected inflammatory markers 
in Bosnian obese pre-pubertal and pubertal children and to define their possible 
relationship with inflammation.
MATERIALS and METHODS:Body Mass Index (BMI - kg/m2), number of 
leukocytes (n x109//)L), neutrophils granulocytes, lymphocytes, platelets, 
as well as neutrophils/lymphocyte ratio, platelet/ lymphocyte ratio, systemic 
immune-inflammatory index (SII) and C-reactive protein (CRP- mg/L) were 
analyzed in 115 obese and 100 non-obese children as a control group who were 
further subdivided into prepubertal and pubertal children.
RESULTS:Significantly elevated BMI, leukocytes, neutrophils/lymphocyte 
ratio, platelet/ lymphocyte ratio, SII and C-reactive protein (p<0.001 for all 
parameters) were observed in the group of obese children in comparison 
to controls. Neutrophil granulocytes, Lymphocytes Neutrophil/lymphocyte 
(p<0.001), Platelets/Lymphocytes (p=0.016), and SII (p<0.001) were 
significantly affected by age while leukocytes and CRP were not altered 
significantly. In the obese group, positive correlation was observed between 
BMI and: neutrophil granulocytes (r=0.416; p<0.001); SII (r=0.316; p<0.001); 
neutrophils/lymphocyte ratio (r=0.333; p<0.001) and Platelets/Lymphocytes 
ratio (r=0.269; p<0.001).
CONCLUSIONS:There is a positive association between BMI and several 
inflammatory parameters such as neutrophil granulocytes, SII, neutrophil/
lymphocytes and platelets/lymphocytes ratios. Early identification of those 
biomarkers in defined populations may help in the prevention of obesity 
associated complications.
Keywords: Childhood obesity, inflammation, inflammatory markers, age 
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OBJECTIVES: The basic interactions between obesity and bone is complex and 
not well known. Research findings suggest that obesity is detrimental to bone 
health despite potential positive effects of mechanical loading conferred by 
increased body mass on bones. Recently, the wnt/ beta-catenin signaling pathway 
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and its one of the inhibitor sclerostin were found to be involved in the control of 
bone mass. The aim of this study was to investigate the serum sclerostin levels 
in obese and non-obese children and adolescents and compare with other bone 
turnover markers and bone mineral density (BMD).
MATERIALS and METHODS: The study included 38 obese children and 
adolescents (19 males and 19 females) aged from 7 to 17 years and 38 healthy 
normal-weight controls (18 males and 20 females) aged from 6 to 17 years. 
Serum sclerostin levels were measured by ELISA method using commercially 
available kit.
RESULTS: Body mass index (p=0.000) and sclerostin (p<0.05) levels of the 
obese children was significantly higher than that of non-obese children.
CONCLUSIONS: Our result of higher serum sclerostin levels of the obese 
children and adolescent showed a tendency toward bone loss in obese children 
and adolescents.
Keywords: Obesity, Osteoporosis, Sclerostin 
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OBJECTIVES:In this study, we aimed to investigate the relationship between 
vitamin D levels and lipid profiles of obese patients.
MATERIALS and METHODS:The study included 142 people who applied 
to endocrine polyclinic for weight loss. Patients were divided into two groups 
according to body mass index. Demographic and laboratory data were obtained 
from patient files.
RESULTS:The mean age of the 142 participants was 34 ± 6 years. The number 
of women was 120 (85%), while the number of men was 22 (15%). When obese 
subjects were compared to non-obese subjects, waist circumference, fat mass, lean 
body mass, total body water and basal metabolic rate were increased, while high 
density lipoprotein levels were significantly lower. When fasting blood glucose, 
HbA1C and insulin resistance were compared between obese and non-obese, there 
was a significant difference between the two groups. There was no relationship 
between obesity and gender (Pearson Chi square test 0.435, p = 0.500). There was 
no significant difference between obese and non-obese groups in terms of vitamin 
D levels (Mann-Whitney U test 2881, p = 0.663). However, when the groups were 
divided into three groups as 30 ng / mL according to 25-OH vitamin D levels, there 
was a statistically significant relationship between vitamin D and obesity (Pearson 
Chi square test 5.575, p = 0.0179). Serum total cholesterol, TG and LDL levels were 
lower and HDL levels were higher than patients.
CONCLUSIONS:This may be explained by vitamin D deficiency itself or by 
differences in vitamin D metabolism during the development of obesity.
Keywords: Vitamin D, Lipid profile, Obesity. 
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OBJECTIVES:Polycystic ovary syndrome (PCOS) is the most frequent endocrin 
disorder in reproductive-age woman (5-10%). As a multisystemic, reproductive-
endocrinologic disorder that carries long term health risks such as type 2 
diabetes, dislipidemia, cardiovascular diseases and endometrial carcinoma, 
PCOS is a public health issue. Insulin resistance may play important roles in the 
pathophysiology of PCOS.
MATERIALS and METHODS:Our study group included 53 patients diagnosed 
with PCOS and 42 healty volunteers. Patient group and control group has been 
divided into two groups; “normal weight” as BMI < 25 and “over weight” as BMI 
> 25. Demographic properties of Patient group and control group determined. 
Hirsutism scoring, pelvic or vaginal US examination performed. Serum glucose, 
insulin, total testosteron, SHBG, LH, FSH, total cholesterol, triglicerides, HDL 
cholesterol and LDL cholesterol levels are determined in all individuals. HOMA-
IR calculated to determine insulin resistance. SAI calculated for biochemical 
hyperandrogenism. Adiponectin, ghrelin, resistin and visfatin level determined. 
Main groups and sub-groups compared.
RESULTS:There was significant difference between control group and patient 
group in adiponectin, ghrelin, resistin and visfatin levels. Adiponectin and 
visfatin levels were lower, ghrelin, resistin, LH levels and LH/FSH ratio 
were higher in PCOS group. Insulin and HOMA-IR was also high. There was 
significant difference between groups in total testosteron levels and SAI. There 
was a negative weak correlation between adiponectin and ghrelin.
CONCLUSIONS:Adiponectin, ghrelin, resistin and visfatin may play roles 
in insulin resistance. In this study, alteration of parameters showing insulin 
resistance demonsrated that insulin resistance plays an important role in the 
pathogenesis of PCOS.
Keywords: Polycystic ovary syndrome,adiponectin, ghrelin, resistin, visfatin 
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OBJECTIVES:Butyrylcholinesterase (BChE) plays a secondary or supportive 
role in cholinergic neurotransmission and is recognized as a therapeutic target 
in the fight against Alzheimer’s disease. Today, there is a growing interest in 
identifying natural or synthetic small-molecule BChE inhibitors, whose drug-
likeness is investigated both by binding and enzyme kinetic studies. In BChE 
activity assays, these potential drug candidates are normally dissolved in one 
of several water-miscible organic solvents. However, the inhibitory effects of 
common solvents on BChE remain largely unknown. Here, we aim at exploring 
the inhibitory activities of acetone, acetonitrile, dimethyl sulfoxide, ethanol and 
methanol against mammalian BChE.
MATERIALS and METHODS:BChE activity was assayed colorimetrically 
using butyrylthiocholine (BTCh) as substrate and dithiobisnitrobenzoate as 
chromogen. The kinetic parameters and mode of inhibition were determined 
statistically by nonlinear regression (curve-fitting), and the data were then 
graphed in Lineweaver–Burk and Dixon plots for illustration purposes.
RESULTS:Our results show that all of the solvents tested inhibit BChE in a 
dose-dependent manner, albeit to varying extents. Methanol is the least potent 
inhibitor of the enzyme (IC50 = 12,199 mM, or ~49% (v/v)) at 1 mM BTCh, 
while acetone is the most potent inhibitor of the enzyme (IC50 = 707 mM, or 
~5% (v/v)) at 1 mM BTCh. The mode of BChE inhibition by acetone is best 
described as competitive with respect to BTCh.
CONCLUSIONS:Our findings suggest that great care must be taken in BChE 
activity assays using acetone in particular to ensure that solvent-related inhibitory 
effects do not conceal the true kinetics of BChE–inhibitor interactions.
Keywords: butyrylcholinesterase, Alzheimer’s disease, enzyme inhibition, 
solvent-related effects, acetone 
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OBJECTIVES: In this study, the relationship between auto antibodies 
against erythrocyte antigens and these macromolecules will be investigated. 
MATERIALS and METHODS: The study included 35 patients with auto 
antibody positive using gel Centrifugation and colon agglutination methods and 
35 healthy donors who came for blood donation. ALP, AMY, AST, CK, GGT and 
LDH tests were measured before and after precipitation with 25% polyethylene 
glycol using serum from all participants. Recovery calculations were made after 
precipitation with PEG.
RESULTS: It was found that the recovery of AMY and LDH was lower in 
patients with auto antibody positive compared to the control group (respectively, 
AMY: 0.64±0.09, 0.49±0.18 and LDH: 0.64±0.09, 0.49±0.18; p<0.001
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CONCLUSIONS: The presence of auto antibodies against erythrocyte antigens 
is associated with the formation of macromolecules, which are believed not to 
show complete biological activity, particularly in AMY and LDH.
Keywords: Macro lactate dehydrogenase, Macro amylase and Auto antibody 
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OBJECTIVES: Thiopurine methyltransferase gene is located on chromosome 6 
and is approximately 34 kb in length. More than twenty eight genetic variants 
have so far been identified, the majority of which are associated with low levels 
of TPMT activity. The aim of this study was set up a PCR based method for 
screening of TPMT mutations.
MATERIALS and METHODS:Whole-blood samples collected into 4 mL EDTA 
tubes. Genomic DNA was isolated from each blood samples using AccuPrep 
Genomic DNA Extraction Kit (Bioneer). Two reactions containing a mixture 
of wild-type primers, mutation-specific primers and a pair of positive control 
primers were performed on genomic DNA. Multiplex PCR PreMix tubes 
(Bioneer) consisted of a total volume of 20 µL containing 200 µmol/l dNTP, 
0.5 µM of each primer, 4.0 mmol/l MgCl2, 1 U of Taq DNA polymerase, and 
100 ng of genomic DNA. Temperature cycles (30 in total) were 94°C for 30 
s, 65 °C for 30 s, and 72 °C for 40 s. PCR products were run by 1.5% agarose 
jel electrophoresis. Amplified DNA fragments were visualised using ethidium 
bromide, under UV light.
RESULTS:We set up multiplex, allele-specific polymerase chain reaction (PCR) 
method that detects the 238G>C, 460G>A, and 719A>G mutations, allowing for 
identification of TPMT*2 and TPMT*3 alleles.
CONCLUSIONS:Molecular diagnosis of TPMT polymorphism is a strong 
alternative for enzyme activity assays. This multiplex PCR assay for common 
TPMT mutations is simple, rapid, accurate, and cost-effective option for 
screening of patients in clinical research studies.
This project was supported by Çukurova University Research Projects 
Unit(FDK-2019-11950).
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OBJECTIVES:Alkaline phosphatase is a zinc metalloenzyme which hydrolyze 
organic phosphate esters from phosphate group in alkali medium. Although 
glyphosate as a herbicide, which is thought to cause cancer, kidney damage and 
many neurological damages, is allowed to be used in the European Union for 
another 5 years, it is first completely banned in Austria. Since glyphosate has 
a phosphate structure, we aimed to carry out activity studies considering that it 
would have inhibitory effect on alkaline phosphatase.
MATERIALS and METHODS:Alkaline phosphatase activity was modified by 
Bower and McComb’s method and endpoint measurement was performed. Two 
different buffers with glycine and 2A2M1P were used for determination of alkaline 
phosphatase in human serum. The inhibitory effect of glyphosate(282mg/L) 
on alkaline phosphatase, as well as the effect of dexamethasone(160mg/L), 
alendronate(12.8mg/L) and deoxycholic acid(654mg/L) on inhibition with 
glyphosate were investigated.
RESULTS:Glyphosate activity in glycine buffer(83%) was decreased more than 
2A2M1P(%94). It has been observed that deoxycholic acid decrease alkaline 
phosphatase activity in both buffers and potentiates the inhibition effect of 
glyphosate. Dexamethasone was measured to reduce the inhibitory effect of 
glyphosate in glycine buffer. Alendronate did not alter the inhibitory effect of 
glyphosate in the glycine buffer but caused an increase in the slight inhibitory 
effect of glyphosate in the buffer with 2A2M1P(90%).
CONCLUSIONS:Alkaline phosphatase activity differed between the two 
buffers. The presence of glycine in the glyphosate structure may have reduced 
the inhibitory effect on activity in the glycine buffer. In addition, dexamethasone 
decreased glyphosate inhibition and alendronate wasn’t effective in inhibition, 
suggesting further studies.
Keywords: Glyphosate, Alkaline Phosphatase, Enzyme Inhibition 
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OBJECTIVES:Behçet’s disease (BD) is a multisystemic and inflammatory 
disease characterized by recurrent oral aphthous ulcers, genital ulcers, uveitis, 
epididymitis, mucocutaneous, joint, gastrointestinal, neurological, and vascular 
involvement. In this study; we aimed to investigate the levels of serum 
homocitrulline, a characteristic carbamylation-derived product, in BD and 
healthy people.
MATERIALS and METHODS:This study was performed with 30 control 
subjects and 30 patients with Behçet’s disease, who admitted to the Selcuk 
University Faculty of Medicine, Department of Rheumatology. Serum 
homocitrulline and lysine levels were determined by liquid-chromatography 
tandem mass spectrometry. Statistical analysis was performed with SPSS v16.
RESULTS:The homocitrulline levels of the patient group (1.11±0.74 mmol/
mL) were significantly higher (p=0.001) than control group (0.38±0.12 mmol/
mL). Homocitrulline/lysine ratios were higher in the patient group (1.15 ± 0.89 
mmol/mol) compared to the control group (0.31 ± 0.10 mmol/mol) (p<0.001). 
However, lysine analysis showed no significant difference between groups.
CONCLUSIONS:In this study that was performed for the first time, there 
was a positive relationship between behçet disease and homocitrulline levels. 
Therefore, it is thought that homocitrulline levels may be used as biomarkers in 
behcet disease.
Keywords: Behçet’s disease; Homocitrulline; Inflammation 
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OBJECTIVES: Ankylosing spondylitis (AS) is a chronic inflammatory 
disease of the spine and sacroiliac joint with unknown etiology. Inflammation 
is associated with increased oxidative stress; recent studies have implicated 
increased oxidative stress in the pathogenesis of AS. Ischemic-modified albumin 
(IMA) is an altered form of albumin and increases in oxidative stress. The aim of 
this study was to investigate the IMA levels and the relationship between in AS.
MATERIALS and METHODS:The study included 63 patients (28 female, 35 
male) diagnosed with AS according to Modified New York Criteria and 48 
participants (22 female, 26 male) as healthy controls. The patients and controls 
had no known cardiovascular risk factors. Both groups were examined for serum 
protein, albumin, lipid profile, C-reactive protein (CRP), and hemogram. Serum 
IMA levels of the groups were compared.
RESULTS:The patient and control groups were similar in terms of age and 
gender. Serum IMA levels were significantly higher in the patient group than in 
the controls. Among the patients with AS, serum IMA levels were significantly 
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higher in those with active disease (BASDAI ≥4). The IMA and CRP levels were 
positively correlated in the patients with active disease.
CONCLUSIONS:Higher levels of IMA in patients with AS or in those with 
active disease suggest that it may be associated with pathogenesis and activity of 
the disease. However, more comprehensive studies with larger number of patients 
would be necessary in order to evaluate the IMA level as an inflammatory marker 
in AS.
Keywords: ischemic-modified albumin, ankylosing spondylitis, c-reactive 
protein 
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OBJECTIVES:The objective of this study was to determine the short-term 
effects of sleeve gastrectomy on some metabolic health variables in the blood 
of obese patients.
MATERIALS and METHODS:A total of 9 patients (men, 3; women, 6) with 
obesity (BMI ≥30 kg/m2) visiting Pamukkale University Hospital from March 
to July 2019 were included in this study. Blood samples were collected before 
and after 2 months of sleeve gastrectomy. Levels of serum hepatic enzymes, 
and serum sodium, potassium, and chloride levels were determined by 
spectrophotometric procedures. The whole blood and sera were analyzed for 
Glycated hemoglobin (HbA1c), total cholesterol (TC), triglyceride (TGs), high 
density lipoprotein cholesterol (HDL-C) and low density lipoprotein cholesterol 
(LDL-C). Urea, creatinine and blood urea nitrogen levels were also detected.
RESULTS:Serum urea and creatinine contents were significantly (p <0.05) 
decreased in postoperative obese patients compared to preoperation. Remarkable 
improvements in perturbed metabolic variables approaching normality were 
perceivable. Serum albumin and total bilirubin concentrations were significantly 
increased (p < 0.05).
CONCLUSIONS:Obesity, defined as a multi-factor disease which is very 
common in all over the world. Obesity resulted in perturbations of whole body 
metabolism. Sleeve Gastrectomy is a widely applied surgical procedure which 
aimed the weight loss in obese people by reducing the stomach volume. Metabolic 
parameters were normalized and improvements in the general health status of the 
patients were observed in a short-term period after sleeve gastrectomy.
Keywords: Obesity, Sleeve gastrectomy, Metabolic variables 
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OBJECTIVES:Rheumatoid arthritis affects 0.3% to 1% of the population. It is an 
autoimmune disease characterised by chronic synovial inflammation. Currently, 
the most well-known and established test is Anti CCP. It is extremely specific 
for rheumatoid arthritis, and is present early in disease, and predicts the erosive 
states of disease.
MATERIALS and METHODS:This prospective interventional study was 
performed between January 2019 and May 2019 in the PHO Clinical Hospital 
in Bitola. The study included 30 subjects - 21 females are with join pain and 9 
males. The blood samples were taken after overnight fast (12 hours). Anti CCP 
and RF were determined by Abbot Architect CI 4100 analyzer.
RESULTS:We found increased level of Anti CCP in 6 patients (4 females, 2 
males), 11 patients have increased level of RF (7 females, 4 males), 3 patients 
have increased level of Anti CCP and RF (2 males, 1 women) and 16 patients 
have normal values of Anti CCP and RF. We found a great correlation in 19 
patients between Anti CCP and RF
CONCLUSIONS:We found a significant correlation between RF and Anti CCP.
Keywords: anti-cyclic citrullinated peptides (anti-CCPs), rheumatoid factor, 
rheumatoid arthritis 
 
 
P-100
The role of netrin-1 in rheumatoid arthritis
Duygu Eryavuz Onmaz1, Sedat Abusoglu1, Ali Unlu1, 
Abdullah Sivrikaya1, Gülsüm Abusoglu2 
1Selcuk University Faculty of Medicine, Department of Biochemistry, Konya, 
Turkey 
2Department of Medical Laboratory Techniques, Selcuk University Vocational 
School of Health, Konya, Turkey 
OBJECTIVES:Rheumatoid arthritis (RA) is a chronic systemic autoimmune 
disease that primarily affects the lining of the synovial joints and is associated 
with progressive disability, premature death, and socioeconomic burdens. Netrin 
1 was initially identified as an axon guidance factor, and recent studies indicate 
that it inhibits chemokine-directed monocyte migration. Despite its importance 
as a neuroimmune guidance cue, the role of netrin 1 in osteoclasts is largely 
unknown. Recent studies have shown high levels of netrin 1 in rheumatoid 
arthritis patients. The aim of this study is to clarify the role of Netrin-1 in the 
diagnosis, progression of RA.
MATERIALS and METHODS:34 control and 45 patients with RA were enrolled 
to this study. Collected serum samples were stored at −80°C, then analyzed for 
netrin-1 by ELISA (kit from USCN Life Sciences Inc.).
RESULTS:Serum Netrine-1 levels were significantly higher in patients with RA 
(2775.14(437.25-6226.16)) than controls (589.14(235.13-869); p<0.001).
CONCLUSIONS:We concluded that netrin-1 can be a useful marker in the 
diagnosis of rheumatoid arthritis. However, further studies with larger clinical 
groups are necessary to identify the possible relation between netrin-1 and 
pathogenesis of RA.
Keywords: Netrin-1, rheumatoid arthritis, inflammation 
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OBJECTIVES: Behçet’s Disease (BD) is a rare systemic vasculitis disorder of 
unknown etiology characterized by recurrent attacks of oral aphthous ulcers, 
genital sores, and ocular lesions (triple-symptom complex). Recurrent attacks 
of acute inflammation characterize Behçet’s disease. Netrin-1, a secreted 
laminin-like protein identified as an axon guidance molecule. Netrin-1 regulates 
inflammation but the mechanism by which this occurs is unknown. Our aim 
of this study is to investigate the role of Netrin-1 in the diagnosis of Behcet’s 
disease.
MATERIALS and METHODS: The study was conducted with 35 controls and 
35 patients with Behçet’s disease. Serum samples were stored at -80 ° C until 
analysis, serum netrin-1 levels were analyzed by ELISA (kit from USCN Life 
Sciences Inc.).
RESULTS: Serum Netrin-1 levels were significantly higher in patients with 
Behcet’s disease (3732 ± 934.99) than control group (524.88 ± 160.83); p<0.001).
CONCLUSIONS: In our study, serum Netrin 1 levels were significantly higher 
in patients with Behçet’s disease than control group. Therefore, we concluded 
that netrin 1 may be a useful marker in the diagnosis of Behcet’s disease.
Keywords: Netrin-1, Behcet’s disease, inflammation 
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OBJECTIVES: To evaluate the serum adiponectin level and determine the 
association between adiponectin and various clinical and laboratory findings in 
patients with primary Sjögren’s syndrome (pSS).
MATERIALS and METHODS: A total of 50 patients and 30 healthy 
volunteers were enrolled in the present study. Serum adiponectin levels were 
detected by colorimetric enzyme-linked immunosorbent assay. The medical 
history of patients including complete blood count analysis; high sensitive 
C-reactive protein; erythrocyte sedimentation rate (ESR); complement 
component 3; complement component 4; low density lipoprotein cholesterol; 
triglyceride; immunoglobulin G (IgG), IgA, and IgM levels; and the status of Ro 60, 
Ro 52, Sjögren’s syndrome A, Sjögren’s syndrome B, and rheumatoid factor were 
obtained from laboratory information system.
RESULTS: Serum adiponectin levels were 2.34 (0.77–4.95) ng/mL and 1.73 
(0.01–7.76) ng/mL in patients and controls, respectively (p=0.316). Positive 
correlation was observed between the values of serum adiponectin, ESR (p=0.013, 
rho=0.362), and body mass index (p=0.018, rho=0.362) in patients.
CONCLUSIONS: These findings indicate that adiponectin does not play a 
crucial role in the immunological and clinical patterns of pSS.
Keywords: Sjögren’s syndrome, adiponectin
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OBJECTIVES:Resolvins originate from ω-3 PUFA (polyunsaturated fatty acid) 
precursors and play a role in the resolution of inflammation. The aim of this 
study was to determine the serum ResolvinE1 levels in patients with ulcerative 
colitis (UC) and to evaluate the relationship between the serum ResolvinE1 
levels and ulcerative colitis disease activity.
MATERIALS and METHODS:Serum samples were collected from 51 patients 
with UC and 30 healthy controls for the determination of Resolvin E1 levels. 
Firstly, we compared the serum Resolvin E1 levels between the UC patients and 
the control group. Subsequently, Resolvin E1 levels were analyzed in patients 
with active UC and UC in remission. Finally, the correlation between Resolvin 
E1 and C-reactive protein (CRP) and partial Mayo score (p-MS) was analyzed to 
determine the efficacy of Resolvin E1 in predicting disease activity
RESULTS:Serum Resolvin E1 level was determined in the UC group (3126 ± 
1413 ng/ml) and in the control group (2758 ± 1065 ng/ml) (p = 0 187). Serum 
Resolvin E1 levels were determined in patients with active UC (3114 ± 1166 
ng/ml) and patients in remission (3132 ± 1520 ng/ml) (p = 0 749). In the UC 
group, a low-grade positive significant association was found between Resolvin 
E1 and CRP (r = 0 303, p = 0 031). There was no significant association between 
Resolvin E1 and partial Mayo score (r = −0 207, p = 0 146).
CONCLUSIONS:There was no sufficient evidence that Resolvin E1 was an 
appropriate inflammatory marker to determine disease activity in UC.
Keywords: resolvin e1, inflammotory bowel disease, ulcerative colitis, 
inflammation, biomarke 
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The role of inflammation on vascular endothelial growth factor in patients 
on peritoneal dialysis
Radmila Zivojin Obrenovic, Sanja Djordje Stankovic, Ivana Borivoje Vujosevic, 
Biljana Branislav Stojimirovic 
Center for Medical Biochemistry, Clinical Center of Serbia, Belgrade, Serbia 
OBJECTIVES:: Synthesis of vascular endothelial growth factor (VEGF) is under 
the influence of a chronic peritoneal dialysis process due to which VEGF is found 
in the drained dialysate (dd). The objective of this prospective study was to evaluate 
the concentration of vascular endothelial growth factor (VEGF) in serum and 
ddVEGF during the first six months of the PD, as well as the relationship between 
these concentrations and demographic and biochemical parameters, the presence of 
diabetes, peritonitis and the use of drugs.
MATERIALS and METHODS:The study included 20 patients, with an average age 
of 62.9 ± 12.69, of whom 11 were ill with diabetes. Blood samples were taken at the 
beginning and after six months of PD, in a vacutainer without additives.
RESULTS:After six months of PD, concentrations of sVEGF increased significantly 
without significant change in ddVEGF. Concentrations of sEGEGF at the onset of 
chronic PD treatment directly correlated significantly with serum fibrinogen, and 
after six months with fibrinogen and glycemia. Patients who received angiotensin-
converting enzyme (ACEi) inhibitors had sVEGF and ddVEGF levels slightly 
below those who did not use ACEi, however sVEGF increased significantly over six 
months PD. After six months of PD, ddVEGF was significantly higher compared to 
those who did not use ACEi. Treatment with statins did not significantly affect the 
levels of sVEGF and ddVEGF during monitoring.
CONCLUSIONS:VEGF serum concentrations and drained dialysis in PD patients 
are associated with a weaker metabolic profile, while the role of inflammation and 
treatment agents needs to be further studied.
Keywords: VEGF, Peritoneal dialysis
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Red blood cell distribution width as a biomarker of inflammation
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Department of Medical Biochemistry, Pamukkale University School of 
Medicine, Denizli, Turkey 
OBJECTIVES:Recent studies have demonstrated that red cell distribution width 
(RDW) is associated with inflammation and it can serve as a potential parameter 
for inflammation. The aim of the study was to investigate the relationship 
between RDW levels and some traditional inflammation biomarkers.
MATERIALS and METHODS:We retrospectively retrieved 8354 patients’ 
RDW, erythrocyte sedimentation rate (ESR), serum C-reactive protein (CRP) 
and serum ferritin results for six-month period from the laboratory information 
system. Patients were divided into two groups in terms of their RDW values. 
Patients with RDW results <14.5% were determined as the first group (n =3559) 
and those with ≥14.5% as the second group (n=4795).
RESULTS:CRP and ESR levels in the second group were found to be statistically 
significant higher than the first group (p<0.001). Ferritin levels were higher in 
the first group but there was no significant difference between the two groups 
(p=0.059). There were a positive, but weak correlations between RDW and CRP 
(p<0.001, r=0,215); RDW and ESR (p<0.001, r=0,158).
CONCLUSIONS:Our study showed a possible relation of RDW with CRP and 
ESR. RDW may be a useful diagnostic marker of inflammation and should be 
confirmed with follow-up studies in future.
Keywords: Inflammation, red blood cell distribution width (RDW), CRP, ESR. 
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OBJECTIVES: Asthma is a heterogeneous disease characterized by chronic 
airway inflammation associated with airway hypersensitivity to direct 
or indirect stimuli. There is strong evidence that apoptosis dysfunction 
may play an important role in the pathogenesis of asthma-induced airway 
inflammation. Therefore, it is important to understand the pathways 
of apoptosis and the role of apoptosis in the pathogenesis of asthma. 
This study aimed to determine how apoptosis biomarkers in asthma patients are 
affected, and also in the diagnosis of the disease whether apoptosis biomarkers 
may be used as blood-based biomarkers.
MATERIALS and METHODS: The patient group (n = 40) consisted of people 
who were diagnosed with asthma and had not started taking medication. The 
control group consisted of volunteers who were similar in terms of age and sex to 
the patient group (n = 40). Serum levels of Caspase-3, caspase-8, caspase-9 and 
Granzyme B were measured by ELISA method on blood samples collected from 
patient and control groups.
RESULTS: It was observed that Caspase-3, caspase-8, caspase-9, and Granzyme 
B levels were higher in the patients’ group compared with the control group 
(p<0,001).
CONCLUSIONS: This study demonstrates that increased levels of apoptosis 
may play a role in the pathophysiology of asthma and that the increase in serum 
caspase-3, caspase-8, caspase-9, and granzyme B levels may be blood-based 
biomarkers for apoptosis. However, further studies are needed to understand the 
role of apoptosis in asthma.
Keywords: Asthma, Apoptosis, Caspase, Granzyme B 
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Evaluation of sample quality for coagulation analysis on the Sysmex CS-
5100: HIL index
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OBJECTIVES:Hemolysis, icterus and lipemia (HIL) in specimen may affect the 
reliability of coagulation test results. This possible interference can be influenced 
by several factors including the level of interfering substance in plasma, the assay 
principle and the end-point detection system, that is optical versus mechanical 
detection. The aim of this study was to determine frequency of HIL in patients’ 
sample for coagulation assays.
MATERIALS and METHODS:We assessed 7712 patients’ sample over a two 
month period and determined the incidence of HIL, reling on the manufacturer 
to document HIL estimates on instrument. Plasma samples were run on CS5100 
autoanalyser (Sysmex, Japan), photo-optical clot detection. The instrument 
identifies HIL specimens with a specific flag. The quality of the sample is 
automatically detected with a combination of the multi-wavelength detection 
method and HIL detector.
RESULTS:Percent of hemolyzed specimens was determined as 1.18%. We also 
identified the frequency of lipemia as 0.3%. Total of 533 samples (6.9%) were 
icteric. Due to severe lipemia and hemolysis, 7 and 8 of samples were rejected, 
respectively.
CONCLUSIONS:The laboratories must monitor and evaluate the quality of the 
samples and identified problems. Quality results are dependent on quality of 
specimen. Visual evaluation of the sample is not appropriate because there is 
significant inaccuracy and inter-individual variation in this type of assessment. 
HIL may interfere the optical instuments. These interferences can be determined 
by coagulation analyzer, possessed HIL detection system using multiwavelength 
light and incorrect results prevented. A test-based interference approach may be 
useful to avoid unnecessary sample repetition.
Keywords: Coagulation, hemolysis, icterus, lipemia 
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OBJECTIVES:We aimed to evaluate the laboratory income and expense analysis 
in Ankara province of the Public Hospitals Association based on employee 
resource, population density and foreign currency.
MATERIALS and METHODS:Laboratuvary service procurement, 
procurement of goods and total expenses and income were obtained from 
TDMS between2013-2017. The number of laboratory tests, number of working 
physicians and technicians, total number of outpatients and inpatients, population 
density and growth rates were also evaluated. The ratio of laboratory costs within 
total health expenditures and the change in years was also calculated.
RESULTS:The number of tests between the years were 67.897.658-72.922.524-
74.610.415- 82.749.391 and 112.261.365, respectively. Expense per test 
increased from1.35T.L. to 1.50T.L. Service procurement and material purchase 
rates in laboratory expenses were 60%-40% in 2013, this ratio completely 
reversed in 2017.Between these years, the ratio of laboratory expenses in total 
health expenditures was 5,46%-5,12%-4,84%-5,41% and 5,89%,respectively. 
While the population density increased 8%, the number of tests increased 65% 
and the number of polyclinics increased 55%. The number of tests per person and 
the number of policlinics per person were 13,45-14,15-14,15-15,47-20,61 and 
3,35-3,56-4,10-4,41-4,81, respectively. The number of physicians increased from 
374 to 512 while the number of technicians increased from 950 to 976.
CONCLUSIONS:The fact that the increase in the number of policlinics and 
the number of tests is not parallel to the population growth rate,which reflects 
the increase in health service application and the tendency to seek further 
investigations. All these findings will shed light on the determination of future 
health policies.
Keywords: Cost analysis, Procuerment, Laboratory, Health Service, Population 
Density 
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emergency clinical hospital
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OBJECTIVES:The study aim was to identify the relevants quality indicators-QIs 
to inhance patient safety by continous improvement of our clinical laboratory 
activity.
MATERIALS and METHODS:Prospective study, carried out for 18 months for 
in-patients, by analyzing collected data on e-requests and types of biological 
samples received for clinical chemistry and hematology compartments.The 
calculated values for the 12 selected Qis were expressed as %, defects per million 
-DPM and on six sigma scale.
RESULTS:During the follow-up time we had received 29454 request forms 
and 36746 biological samples. The data analysis of selected Qis values showed 
the highest % rate for the Pre InpMT and the PreMisR (0.89% and 0.94%), 
respectively the lower one for the PreUnIns (0.065%).The 3.9 Sigma score 
value associated to the the critical errors corresponding to the Pre InpMT 
and to PreMisR showed an immediate need to staff training as mandatory 
corrective action.We have obtained a 4.4 sigma score for the hemolysed primary 
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samples. Reporting errors Sigma score 4.4 associated to the biological samples 
for hematology compartment was over the 4.2 value obtained for the clinical 
biochemistry specimens. We proved a good performance by the Sigma score 
between 4.1 to 4.4 for 8 monitored Qis, but the accuracy improvement of 
entering data process in e-request form it’s a must.
CONCLUSIONS:Study results were used as entry data for management analysis 
to ensure risk mitigation especially in the extraanalytical phase by improving 
communication and training of clinical staff in order to increase lab performance
Keywords: Quality indicators, DPM, Sigma scale, risk mitigation 
 
 
P-113
Analysis of complete blood count critical values reporting in a university 
hospital
Esin Avci, Hülya Aybek 
Department of Medical Biochemistry, Faculty of Medicine, Pamukkale 
University, Denizli, Turkey 
OBJECTIVES:The critical value is a result suggesting that the patient was in 
imminent danger unless appropriate therapy was initiated promptly. We aimed to 
analyze four hemogram parameters critic value reporting in a university hospital.
MATERIALS and METHODS:We retrieved critic value reporting results of 
hemoglobin, hematocrit, platelet, white blood cell (WBC) and neutrophil count 
from laboratory information system (LBS) between 01.01.2018- 30.06.2019. 
Critic value reporting types were classified under three headings as “there was 
no information because of accordance with prior result”, “there was a call but 
nobody was reached” and “at least one staff was informed about critic value”. 
Microsoft 2010 excel program was used.
RESULTS:There were 3305 critic value reporting in four tests; 811 WBC, 
244 hemoglobin, 422 hematocrit, 1395 platelet and 433 neutrophil. 305 results 
reported to emergency department, 250 to outpatient, 1800 intensive care unit 
and 1005 to services. Distribution of three critic value reporting types were 
65.2%, 10,2% and 24,6% respectively.
CONCLUSIONS:In the present study, we provide a comprehensive view 
of the critical value reporting process in a university hospital. All critic value 
reports were recorded in LBS and tried to interpret related services. The main 
problem is that many times laboratory staff could not reach any health staff for 
reporting critic value. Improving communication nets between laboratory and 
other hospital services and continuous education about this topic has taken an 
important place.
Keywords: Critic value, critic value reporting, university hospital 
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OBJECTIVES:Assays for the Cancer Antigen 15-3 (CA15-3) are sensitive for 
breast cancer, especially used to monitor patients who were undergone surgery. 
Because breast cancer occurs %1 of men, care must be taken to request this test. 
CA15-3 assays were investigated to determine the erronous test request in male 
patients.
MATERIALS and METHODS:CA15-3 tests which were analyzed by 
chemiluminescence method on Advia Centaur XPT (Siemens) analyzer were 
investigated over a 6-month period (from January to July 2019) from laboratory 
information system (ALIS, Ventura). Patients were selected according to 
reference range (0 - 32 U/mL) and gender.
RESULTS:A total of 6,487 CA15-3 test requests were in 6 months. 895 test 
requests were carried on for male patients (13.8%). According to reference range, 
although it was found that 832 (93%) test request were within the range, the only 
63 (7%) test results were observed to be higher than reference range (median: 42, 
min: 33, max: 179). It was observed that the most unintelligible CA15-3 requests 
were from Internal Medicine (38.8%) and General Surgery (12.4%) clinics.
CONCLUSIONS:Unnecessary tests cause the laboratory workload and high 
costs. The use of tumor markers for screening purposes in patients with no 
complaints is one of the most common reasons for unnecessary test ordering. The 
fact that CA15-3 test can be ordered from various departments in hostitals causes 
the unnecessary initial test requests. Department-based test ordering restrictions 
and displaying a warning message during the CA15-3 test request through the 
hospital information system may decrease the unnecessary test ordering.
Keywords: CA15-3, breast cancer, unnecessary test request 
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OBJECTIVES:In recent years, the number of patients admitted to hospitals and 
tests performed in laboratories has increased,so the workload.This may increase 
the likelihood of errors.There is a need for an approach to support the clinical 
biochemistry specialist,as well as to improve turnaround time(TAT).In large-scale 
laboratories, a method is required to ensure standardization of verification and 
to prevent errors that may occur during the verification of thousands of results. 
In our study,a significant proportion of results planned to verify via middleware 
according to rules and algorithms established by a clinical biochemist.It is aimed 
to improve quality and speed(TAT) and devote more time focus on results require 
interpretation.
MATERIALS and METHODS:The study was carried out in Gazi University 
Faculty of Medicine Central Biochemistry Laboratory. 22 biochemistry tests 
on AU5800 autoanalyzer(Beckman Coulter) autoverified by middleware 
program(Remisol,Beckman Coulter) in cooperation with LIS(Nucleus,Monad). 
Autoverification algorithms prepared by clinical biochemists consisted of 
QC,critical values, serum indices, autoanalyzer flags, measurement intervals, 
related tests, relationship of delta check value with RCV and validation range 
steps. Validation of the autoverification system was performed with simulated 
and real patients’ samples. Performance of the system evaluated daily and 
weekly.
RESULTS:Performance of the autoverification evaluated.Test and tube-
based autoverification rates were 81% and 27%,respectively.Thanks to 
autoverification,TAT of 22 tests improved approximately 12 minutes.As a lean 
approach,the status of the system can be monitored online with a dashboard in 
laboratory.
CONCLUSIONS:Consequently, standardization of verification,early detection 
of analytical errors,shortening of TAT and concentration of laboratory specialist 
on more important results were achieved by means of autoverification system.
Keywords: Autoverification, postanalytical phase, middleware 
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1University of Health Sciences Suat Seren Chest Diseases and Surgery Training 
and Research Hospital, Medical Biochemistry Laboratory, Izmir, Turkey
2University of Health Sciences Suat Seren Chest Diseases and Surgery Training 
and Research Hospital, Medical Biochemistry Laboratory,Izmir,Turkey
OBJECTIVES: The laboratories help the clinician to make the right 
decision with the results of the analysis. Responsibility is very important 
as the results to be reported will affect the patient and the clinician 
positively or negatively. Therefore, the main task of medical laboratories 
is to produce quality, accurate, reproducible results and to report on time. 
However, the analytical results that we assume are not always accurate. 
The definition of uncertainty according to the VIM (International Vocabulary of 
Basic and General Terms in Metrology); It is the parameter that characterizes 
the distribution of the values  that are included with the measurement result and 
which can reasonably correspond to the measured size. Measurement uncertainty 
is a parameter that occurs during the measurement procedure and includes 
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factors that affect the measurement result, and the measurement uncertainty must 
be included with any measurement result actually obtained.
MATERIALS and METHODS: We used Cobas 8000 autoanalyzer system for 
this report. We worked on emergency markers which are more needed at ER and 
used some formulas about uncertainty of measurement, based on GUM.
RESULTS:We compared the results that we obtained and determined 
measurement uncertainty of each test. And with this report, we can help the 
clinician to make the right decision with the results of the analysis.
CONCLUSIONS: Accordingly, the reported measurement result should be the 
sum of the measurement value and the measurement uncertainty (1).
Keywords: Laboratory, uncertainty, measurement, accuracy 
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quality of clinical chemistry
Süleyman Demir, Esin Avci, Kadriye Akpinar, Saadet Han Aslan 
Department of Biochemistry, Faculty of Medicine, Pamukkale University, 
Denizli, Turkey 
OBJECTIVES:Different quality specifications have been defined by different 
organizations in various countries for clinical chemistry tests. The aim of this 
study was to evaluate the total error in our laboratory according to the defined 
allowable total error (TEa) targets.
MATERIALS and METHODS:Monthly deviations for creatinine and glucose 
were obtained from external quality assessment data of our laboratory for twelve 
months (July 2018- June 2019). In this period, the total error and six-sigma 
values of the laboratory were calculated for each test according to the different 
target TEa values offered by the quality specification programs.
RESULTS:Our total error of creatinine calculated by desirable biological 
variation (dBV) (Tea:8.87%) and CLIA2019 (Tea:10%) targets were higher than 
TEa for ten and eleven months, respectively. Calculated by CLIA (Tea:15%), 
RiliBak (Tea:20%) and Turkey (20%) targets, total errors for creatinine were 
mostly smaller than TEa. Total error of glucose calculated by dBV (6.96%) 
and CLIA2019 (8%) targets were smaller than TEa for six and ten months, 
respectively. According to CLIA (10%), Turkey (11%) and RiliBak (15%) 
programs, our laboratory total errors of glucose were smaller than their target 
TEas for all months. Sigmametric evaluation for two tests were in accordance 
with these results.
CONCLUSIONS:Inconsistent TEa targets from different sources causes 
difficulty and confusion in evaluating the laboratory quality control. The 
international biochemistry community need to agree on a single TEa target 
values for each analyte.
Keywords: total allowable error, quality specifications, glucose, creatinine, 
quality requirements 
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OBJECTIVES:Although today several studies have investigated and 
confirmed the existence of an association between ABO blood phenotype 
with atherosclerosis. However the present study, according to the best of our 
knowledge, is the first study that focuses on apparently healthy men blood 
donors and investigating a relationship between AB blood group and the serum 
paraoxonase (PON1).
MATERIALS and METHODS:This study was conducted with one hundred and 
eighty-eight apparently healthy male blood donors. Laboratory test included 
assessment of ABO blood typing, total cholesterol (TC), high-density lipoprotein 
cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), triglycerides 
(TGs) and serum PON1 concentrations.
RESULTS:The most essential finding was the identification subjects of 
significantly lower values of PON1 (p<0, 01) and higher values atherogenic 
plasma index (AIP); log10 (TG/HDL-C) ratio (p<0, 05) in blood group AB 
phenotype compared with those with non-AB blood phenotypes.
CONCLUSIONS:Especially statistically significant association between AB 
blood phenotype PON1 and AIP levels supports its potential role of novel 
atherogenic risk parameters in the pathogenesis of atherosclerosis and the 
clinical observations of tendency to cardiovascular disease of individuals with 
non-O blood groups.
Keywords: ABO phenotyping, atherosclerosis, atherogenic indices, 
paraoxonase, atherogenic index 
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OBJECTIVES:Values of certain biochemical parameters must be interpreted in 
relation with values for given population. Many factors influence biochemical 
parameters of newborn, especially on lipid status. One of them is mother lipid 
status.
MATERIALS and METHODS:Lipid status were measured by Roche (Cobas 
c501) and Abbott (Architect c8000) in 372 newborns, aged 1-5 days in Center of 
Clinical Laboratory Diagnostic, Clinical Center of Montenegro. Serum samples 
were obtained between 7 and 13 h. IBM SPPS ver. 21 program was used for 
statistical analysis.
RESULTS:Samples were devided into five groups (from first to fifth day). 
First group: Cholesterol: (median: 1.75; Iq: 1.41-2.27), Triglycerides: (median: 1.11; 
Iq: 0.96-1.40), HDLc: (median: 0.80; Iq: 0.60-1.06), LDLc: (mean value: 0.45±0.41). 
Second group: Cholesterol: (mean value: 1.95±0.64), Triglycerides: (median: 1.61; 
Iq: 1.34-1.93), HDLc: (mean value: 0.78±0.25), LDLc: (median: 0.42; Iq: 0.27-0.70). 
Third group: Cholesterol: (mean value: 2.22±0.54), Triglycerides: (median: 1.86; Iq: 
1.47-2.26), HDLc: (median:0.77; Iq: 0.58-0.93), LDLc: (mean value: 0.64±0.34). 
Fourth group: Cholesterol: (mean value: 2.70±0.65), Triglycerides: (median: 1.85; 
Iq: 1.49-2.61), HDLc: (median:0.80; Iq: 0.65-1.09), LDLc: (mean value: 0.90±0.44). 
Fifth group:: Cholesterol: (mean value: 2.90±0.70), Triglycerides: (median: 1.80; 
Iq: 1.48-2.43), HDLc: (mean value: 1.14±0.43), LDLc: (mean value: 1.03±0.60). 
Statistically significante was evidenced for tested parameters between each of 
groups by ANOVA test, level p<0.001.
CONCLUSIONS:All parameters of lipid status in fifth group were statisticaly 
higer than in other groups. The reason for this was either samples which were 
delivered in laboratory in diferent time, or physiological changes which hapened 
by newborn growth.
Keywords: lipid status, newborn, population 
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OBJECTIVES:The ABO blood group has been associated with risk of 
cardiovascular disease and risk of cancer in observational studies. Also elevated 
serum Oxidized cholesterol -rich low -density lipoprotein (OxLDL) has 
been positively associated with increased risk of various types of cancer and 
atherosclerotic diseases. Relevantly, a prominent feature related to dysregulated 
lipid metabolism and inflammation is the increased production of OxLDL, 
which results from elevated oxidative stress. However, the effect of ABO blood 
group has never been studied in subjects affected by dysregulated oxidative lipid 
modifications.
MATERIALS and METHODS:In the present study, total cholesterol, triglyceride, 
HDL-cholesterol and LDL-cholesterol, OxLDL concentrations were evaluated in 
one hundred eighty eight 188 apparently healthy men medical staff blood donors 
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aged from 18 to 58 years and the association between these variables and ABO 
blood groups was examined.
RESULTS:In the population studied we did not find any association between 
cholesterol, triglyceride, HDL-cholesterol and LDL-cholesterol and ABO blood 
groups while OxLDL levels were higher in individuals with A antigen than in 
subjects without this antigen(p<0,001).
CONCLUSIONS:Our data has findings that support previous studies showing 
that individuals with Group A may be more prone to atherosclerotic diseases.
Keywords: ABO phenotyping, oxLDL, cancer, atherosclerosis 
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OBJECTIVES:Today, bariatric surgery is very common. High-density 
lipoprotein cholesterol (HDL-C) amount and HDL function are very important 
for atheroprotection. Obese patients with metabolic syndrome have significantly 
reduced HDL-C levels and are often at increased risk for atherosclerotic diseases. 
Although weight loss benefits these patients, its effects on the change in HDL 
quantity and its functionality are currently poorly studied. We investigated how 
rapid weight loss affects HDL values and its antioxidant potential in patients 
undergoing a malabsorptive bariatric procedure.
MATERIALS and METHODS: Fasting plasma samples were collected from 30 
morbidly obese patients with body mass index >40 one day before and 6 months 
after bariatric procedure, then HDL, ApoA1 and oxidized LDL (OxLDL) were 
analyzed using biochemical techniques.
RESULTS: The amount of OxLDL decreased dramatically after the surgery 
(p=0,01) and we observed a statistically significant increase in HDL 
concentration (+16%, P=0.0025). ApoA1 levels entered a post-operative 
upward trend, but a significant increase was seen in six months (p<0,05). 
CONCLUSIONS: Rapid weight loss shows significant improvement in HDL 
concentrations and functionality, which may contribute to the anti-atherosclerotic 
effect of malabsorptive bariatric procedures. In addition to these findings, the 
decrease in oxLDL might suggest that bariatric surgery has made a positive 
contribution to the antioxidantive effect of HDL.
Keywords: Bariatric surgery, Paraoxonase, High-density lipoprotein 
cholesterol, OxLDL 
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OBJECTIVES:Oxidative/nitrosative stress has a critical role in the pathogenesis 
of vitiligo. However, the specific molecular mechanism involved in oxidative/
nitrosative stress-induced melanocyte death is not well characterized. 
Furthermore, little is known about the impact of oxidative/nitrosative stress on 
the expression of miRNAs and their targeted mRNAs in patients with vitiligo.
MATERIALS and METHODS:Vitiligo patients and age- and sex-matched 
controls subjects were enrolled in this study. 34 different miRNAs in plasma 
samples were studied. These miRNAs were evaluated using high throughput 
quantitative real-time PCR. Furthermore, the activities of erythrocyte 
catalase (CAT) and superoxide dismutase (SOD), and the levels of plasma 
malondialdehyde (MDA) were determined on spectrophotometer. Also, 
3-nitrotyrosine (3-NTx) and nitric oxide (NO) levels in plasma as nitrosative 
stress biomarkers were measured measured by ELISA.
RESULTS:The results of study demonstrated that the expression level of 
miR-373-3p, miR-25-3p, miR-34a-5p, miR-193a-5p and miR-196a-5p was 
significantly upregulated in patients when compared with the control (p<0.05). 
The expression level of miR-2b-5p, miR-223-3p, miR-23a-3p, miR-423-5p, miR-
92a-3p and miR-156-5p was significantly downregulated in patients (p<0.05). 
In addition, expression of 23 miRNA had upregulated or downregulated, but 
not statistically significantly different when compared with the control group. 
Besides, MDA,NO and 3-NTx levels in plasma were significantly higher, and 
SOD and CAT activities were significantly lower, in patients compared with 
controls.
CONCLUSIONS:Our results suggest that plasma miRNA levels may alter in 
Vitiligo and, some miRNAs and oxidative/nitrosative stress may an important 
the role in pathogenesis this disease.
Keywords: Vitiligo, miRNAs, oxidative/nitrosative stress 
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OBJECTIVES:Epoxyeicosatrienoic acids (EETs), a cytochrome P450 
epoxygenase metabolite of arachidonic acid, have a role in ion transport and have 
vasodilator, anti-inflammatory as well as pro-fibrinolytic properties. The soluble 
epoxide hydrolase (sEH) enzyme encoded by the EPHX2 gene that converts EETs 
into less bioactive diols. It was demonstrated that inhibition of sEH, exhibit a 
protective effect on animal models of many cardiovascular diseases, include also 
abdominal aortic aneurysm (AAA). rs41507953 polymorphism in the EPHX2 
gene that cause an increase in sEH activity have been associated with developing 
coronary artery disease, ischemic stroke. However, it remains unknown whether 
rs41507953 polymorphism are associated with AAA. Therefore, the objective of 
this study is to evaluate the association between AAA and EPHX2 rs41507953 
polymorphism.
MATERIALS and METHODS:In this study, rs41507953 polymorphism 
was determined in 50 healthy and 50 AAA patients. Genotyping of EPHX2 
rs41507953 polymorphism was performed by the real-time PCR using double-
dye hydrolysis probes.
RESULTS:Although we found that development of AAA risk in individuals 
carrying heterozygous genotype for rs41507953 polymorphism was found to be 
1.78 times higher than individuals carrying wild-type allele, this result failed to 
reach statistical significance
CONCLUSIONS:In conclusion, although heterozygous individuals have 1.78 
times higher risk ratio for AAA development, statistical results showed that there 
was no association between the EPHX2 rs41507953 polymorphism and AAA 
in the Turkish population. However, further studies are needed to evaluate the 
association of this polymorphism and AAA in various populations which include 
more individuals and / or of different origins.
Keywords: Epoxyeicosatrienoic acids, abdominal aortic aneurysm, soluble 
epoxide hydrolase 
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OBJECTIVES:There is evidence that increasing consumption of vegetables 
reduces the risk of certain chronic diseases such as hypertension, stroke, 
and cardiovascular diseases partly as a result of consumption of antioxidant 
substances. In this study, it was aimed to investigate the effects of zucchini 
and potato consumption methods on their antioxidant activity (AA) and total 
phenolic content.
MATERIALS and METHODS:Zucchini and potato were homogenized in 
distilled water at concentration of 10 g/dL. Raw group (n=10) was stored in the 
refrigerator at +4°C, frozen group (n=10) was stored in freezer at -20°C and 
cooked group (n=10) was heated in oven at 150°C for 20 minutes. Phenolic 
substance amount was determined by using Folin-Ciocalteu reagent and AA was 
determined by detecting 2,2-diphenyl-1-picrylhydryl (DPPH) radical scavenging 
activity. Results were given as mean±SD.
RESULTS:The phenolic content and AA values (DPPH%) of potato were 
compared among the groups; AA values of the raw group (3.01±0.52%) 
were significantly higher than frozen (0.44±0.28%; p˂0.001) and cooked 
group (2.06±0.84%; p˂0.05). Moreover, the phenolic content of raw group 
(3.78±0.15mg/dl) was significantly higher than frozen (2.84±0.18 mg/dl) and 
cooked group (1.88±0.17 mg/dl) (p˂0.001 for both). For zucchini, it was found 
that the AA values were significantly higher in cooked group (2.92±0.46%) 
than raw (0.14±0.55%) and frozen group (1.07±0.49%) (p˂0.001 for both). 
Additionally, the cooked group (2.70±0.08 mg/dl) had significantly higher 
phenolic content than raw (1.64±0.06 mg/dl) and frozen group (2.10±0.14 mg/
dl) (p˂0.001 for both).
CONCLUSIONS:Findings of this study might be used to increase the beneficial 
effects of vegetables according to the consumption methods.
Keywords: antioxidant, cooking methods, phenolic compounds, potato, 
zucchini 
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OBJECTIVES:Vitamin B12 (cobalamin) is a water-soluble vitamin that plays 
essential roles in red blood cell formation, cell metabolism, nerve function and 
the production of DNA. Vitamin B-12 deficiency can lead to anemia, fatigue, 
muscle weakness, intestinal problems, nerve damage and mood disturbances. 
The aim of this study was to investigate serum vitamin B12 levels in Sanliurfa 
city.
MATERIALS and METHODS:Serum vitamin B12 levels of 4022 patients 
were evaluated. The patients who had admitted to Harran University Hospital 
between June 31-July 31 2019 were retrospectively screened. Serum B12 levels 
<100 ng/ml is accepted as deficiency, 100-400 ng/ml is moderate and >400 ng/
ml sufficient.
RESULTS:The mean B12 levels were 74.73±19.15 ng/ml in 15 patients (0.38%) 
that referred to deficiency (<100 ng/ml), 271±64.24 ng/ml 3028 in patients 
(75,28%) referred to moderate (100-400 ng/ml) and 484.8±64,94 ng/ml in 979 in 
patients (24,34%) referred to sufficiency (>400 ng/ml).
CONCLUSIONS:In this study, in patients who admitted to our hospital Sanliurfa 
city, no serious vitamin B12 deficiency was detected and in most patients th 
elevels were found moderate. Vitamin B12 levels vary according to region and 
nutritional conditions in different age groups and gender.
Keywords: Sanlıurfa, Vitamin B12, Prevalence, Reference Range 
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OBJECTIVES:It is known that long-term fasting (IF) model in humans can 
reduce inflammation and severity of chronic diseases, delay aging and increase 
health. The most important finding known is that the body is exposed to abundant 
ketone bodies as a result of fat destruction during prolonged fasting. In this study, 
we aimed to investigate the changes in energy metabolism in neuron cell cultures 
and the contribution of ketone bodies in these changes.
MATERIALS and METHODS:SH-SY5Y (human neuroblastoma-ATCC / CRL 
2266) cells were used in the project.Cells were incubated for 16 hours with 
normal diet, calorie restriction media, fasting model (glucose reduced blood) 
and also non-glucose medium.Ketone was added to the other flasks containing 
the same media simultaneously and mitochondrial functions were evaluated in 
the cells while lactate, lactate dehydrogenase, ketone and glucose levels were 
measured in the media to show changes in the energy metabolism of all cells.
Mitochondrial functions were determined by performing citrate synthase activity 
and flow cytometry measurements.
RESULTS:The results obtained from repeating experiments have shown us 
that the cells use ketones,regardless of the amount of glucose, especially in the 
ketone-added models.There were positive changes in mitochondrial functions 
of ketone added cells.When ketones were added, especially in the models with 
fasting model,the increase in membrane potential and flow cytometry activity 
were observed.
CONCLUSIONS:With these findings, we think that the presence of ketone in 
cell mediums has a great contribution to neuron cell energy metabolism and 
it may be beneficial to use exogenous ketone treatment in the treatment of 
neurological diseases.
Keywords: Neuron Cells, Fasting, Keton Bodies, Mitochondrial Function 
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OBJECTIVES:Wheat is a highly important cultivation plant used to meet a 
large part of our nutritional needs. Demand for wheat as food is increasing all 
over the world, including countries whose climates are not suitable for growing 
wheat.Wheat, which is one of these cultivated plants, is black wheat. ‘Siyez’ 
or ‘spa’ are the local names of einkorn in Turkey. It is known that black wheat 
(Triticum monococcum spp. Monococcum), which is one of the ancestors of 
wheat (Triticum ssp.), Contributes to human nutrition and health.High protein, 
carotenoid and tocol content of black wheat (einkorn) and lower toxicity than 
other Triticum species. Therefore, we aimed to determine the antioxidant and 
antimicrobial activity of einkorn (Triticum monococcum L) extracts.
MATERIALS and METHODS:The einkorn wheat was obtained from, 
Kastamonu (Turkey). The determination of antimicrobial activity of einkorn 
extracts against Pseudomonas aeroginosa (ATCC 27853), Escherichia coli 
(ATCC 25922), Enterococcus faecalis (ATCC 29212), Staphylococcus aureus 
(ATCC 25923) and Candida albicans (ATCC 10231) were investigated by 
disc and agar-well diffusion method. Radical scavenging activities of einkorn 
extracted in solvent was measured via spectrophotometric methods.
RESULTS:As a result, it was determined that water extracts of siyez wheat had 
high free radical scavenging effects. In this study, it was found that wheat extracts 
used showed various degrees of antimicrobial activity against microorganisms 
tested.
CONCLUSIONS:Due to its rich content and high biological activity, it is thought 
that it should be developed in modern healthy wheat varieties and included more 
effectively in the nutrition process.
Keywords: Triticum monococcum L,Antimicrobial activity,Antioxidant activity 
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OBJECTIVES:Obstructive sleep apnea syndrome (OSAS) is associated with 
repeated episodes of upper airway obstruction during sleep. Obstruction of 
the upper airway can lead to a decrease in blood oxygenation which is mainly 
associated with metabolic diseases. Orexin is a neuropeptide, which is important 
in the regulation of eating behavior and sleep. Adropin is a small peptide encoded 
by energy homeostasis associated gene. In this study we hypothesized that orexin 
and adropin levels are changed during sleep in OSAS patients. The aim of this 
study was to determine circulating orexin and adropin levels in newly diagnosed 
OSAS patients.
MATERIALS and METHODS:OSAS patients (n=7) and age/gender matched 
healthy subjects (n=30) are added in the study. After polysomnographic recording 
whole blood were collected. Adropin and orexin levels were determined 
using commercial available ELISA kits in serum samples. Blood biochemical 
parameters and PSG results are correlated. Results are given as mean±SD and 
p<0.05 were identified as significant.
RESULTS:Our results show that apnea/hypopnea index(AHI) was significantly 
higher in OSAS patients (28,5±21,8 vs. 1,9±0,9;p<0.001). Orexin levels were 
significantly reduced in patients with OSAS(643,8±239,8 vs. 1217,7±701,9 pg/
ml;p<0.001) but adropin levels (1205,4±232,2 vs.1269,6±181,3 pg/ml;p=0,2199) 
were not changed, with respect to the control group. CRP,triglyceride, total 
cholesterol and LDL-cholesterol levels are significantly higher in OSAS 
patients, because HDL-cholesterol, total lipid and fasting glucose levels were 
not changed.
CONCLUSIONS:In conclusion, our results show that orexin levels are 
significantly associated with AHI in OSAS patients, as expected. Orexin is the 
major neuropeptide that regulates the metabolism and sleep pattern is OSAS 
patients.
Keywords: Obstructive sleep apnea syndrome, adropin, orexin, 
polysomnography. 
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OBJECTIVES:Liver fibrosis (LF) affects between 4.5 and 9.5% of the 
world population. Тhe liver biopsy still is the golden standard for the 
diagnosis of the LF, but it is invasive, requires trained personnel, and 
carries the risk of adverse reactions. Thus, the utility of serum fibrosis 
markers is under investigation for predicting changes of the LF status. 
Our study aimed to evaluate the pertinence of the eLIFT (easy Liver Fibrosis 
Test) algorithm for non-invasive assessment of liver fibrosis and cirrhosis in 
patients with confirmed Chronic Hepatitis B infection or (ALD) alcoholic liver 
disease; also to compare the diagnostic significance of the eLIFT with other 
commonly used serum biomarkers, such as AAR, APRI, GPRI, Fib-4, ELF.
MATERIALS and METHODS:The investigation was conducted with 
100 healthy controls, 150 patients with HBV, and 50 patients with ALD. 
All participants were tested for the above stated parameters. The combined 
mathematical equations with direct and indirect markers are considered more 
reliable.
RESULTS:The results for sensitivity and specificity: a) AAR - 81.3% and 
55.3%; b) APRI and GPRI show similar results - approximately 70% and 65% 
respectively; c) Fib-4 - 97% and 65%; d) ELF algorithm for moderate LF 69% 
and 98%, for cirrhosis – 83% and 97% respectively.
CONCLUSIONS:eLIFT is appropriate for advances and for mild LF diagnosis, 
thus it is appropriate for the first line of testing for LF. It is convenient test 
because it is easily accessible and reasonably costly and shows acceptable 
sensitivity and specificity for ADL and HBV.
Keywords: eLIFT, Liver Fibrosis 
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OBJECTIVES:Two forms of membranous nephropathy (MN) have been 
described - the primary form (PMN) and the secondary form (SMN). It is 
believed that phospholipase A2 receptor (PLA2R1) is a target autoantigen in 
about 80% of patients with MN. The aim of our study was to compare the levels 
of anti-phospholipase A2 receptor antibodies (anti-PLA2R1) in patients with 
PMN, SMN, others glomerulonephritis (OGN) and healthy controls (HC).
MATERIALS and METHODS:The study included patients with PMN (n = 
52), SMN (n = 12), OGN (n = 49) and HC (n = 50). The serum concentration 
of anti-PLA2R1 was determined with ELISA kit (Anti-PLA2R ELISA, 
IgG, EUROIMMUN, Lübeck, Germany) using MR-96A microplate reader 
(MINDRAY). All data are presented as mean ± SD. Significance was defined 
as P < 0.05.
RESULTS:The groups did not differ significantly in mean age (P = 0,055) 
and gender (P = 0,872). There was significant difference in mean anti-
PLA2R1 concentrations between groups (P < 0.0001). The mean anti-PLA2R1 
concentration of patients with PMN was significantly higher than the HC (213.97 
± 588.69 RU/ml vs 5.32 ± 3.91 RU/ml, P = 0.00l). There was no difference in 
anti-PLA2R1 between SMN patients and HC (6.34 ± 11.68 RU/ml vs 5.32 ± 3.91 
RU/ml, P =0.193). OGN patients showed lower anti-PLA2R1 than the HC (3.52 
± 3.91 RU/ml vs 5.32±3.91 RU/ml, P = 0.002).
CONCLUSIONS:Our data suggest that anti-PLA2R1 shows a significant 
elevation in PMN patients and may be used as a diagnostic biomarker.
Keywords: membranous nephropathy, anti-phospholipase receptor antibodies 
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OBJECTIVES:Enzyme-based chemical biosensors are based on biological 
recognition. Temperature and UV light are important factors affecting the 
balance of enzymes and the rate of enzymatic reactions. In this study, optimum 
temperature and UV light duration were investigated in biosensors developed for 
the determination of iron in serum.
MATERIALS and METHODS:The bioactive layer was prepared by immobilizing 
the hydrogen peroxidase enzymes on the gold electrode with UV light using 
bovine serum albumin (BSA), gelatin and glutaraldehyde. Measurements were 
obtained using acetate buffer (10mM, pH 6.0) with electrodes immobilized 
by applying UV light for 30, 40, 50, 60 and 70 minutes. Measurements were 
performed at 30 °C, 35 °C, 40 °C and 45 °C with the electrode prepared using 40 
min uv light time to measure the optimum temperature.
RESULTS:In this study, the best measurement was obtained with electrode 
applied to the bioactive layer with a UV light time of 40 minutes and under 
operating conditions where the temperature was 40 °C.
CONCLUSIONS:For biosensors prepared with bioactive layer hydrogen 
peroxidase enzyme, we can recommend 40 minutes UV light time and 40 
minutes temperature for optimum working conditions.
Keywords: biosensor, hydrogen perxidase, optimization 
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OBJECTIVES:Metabolic syndrome (MS) appears to be much more common 
in patients with bipolar disorder (BPD) than in the general population. In 
the treatment of BPD, valproic acid (VPA) is one of the commonly used 
pharmacological agents. In many studies, it has been reported that the levels of 
appetite-enhancing ghrelin are related to MS. The aim of this study is to assess 
the effect of VPA on ghrelin levels in patients with MS and BPD.
MATERIALS and METHODS:40 BPD patients with VPA treatment and 20 
healthy controls were included in the study. BPD patients were divided into 
2 groups: 1. BPD patients with MS, 2. BPD patients without MS. The BPD 
patients diagnosed according to the Diagnostic and Statistical Manual for 
Mental Disorders (DSM IV). The MS diagnosis was based on the National 
Cholesterol Education Program (NCEP) Adult Treatment Panel (ATP III) 
criteria. Serum ghrelin levels of control and patient groups were determined 
spectrophotometrically according to ELISA method.
RESULTS:Serum ghrelin levels were significantly lower in BPD patients with 
MS compared to BPD patients without MS and control group (p <0.001).
CONCLUSIONS:These results indicate that serum levels of ghrelin and 
adiponectin are related to MS, but VPA therapy does not affect the results of the 
ghrelin.
Keywords: Metabolic syndrom, bipolar disorder, valproic acid, ghrelin. 
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OBJECTIVES:Tumor markers (TMs) result from the re-expression of substances 
by embryologically related tissues. Many are found in different tumors of the 
same tissue. Therefore, they have low specificity and are not sufficiently sensitive 
as a screening test. The aim of this study is to evaluate the TM requesting habits 
of clinicians in Usak Training and Research Hospital, and the appropriateness of 
the test requests with the diagnosis.
MATERIALS and METHODS:Data of 6998 serum TMs requested from 3316 
patients between May 1 and July 31, 2019 were obtained from Laboratory 
Information System and grouped as sex, age, disease diagnoses and multiple 
requests (more than 3 tests simultaneously). Compliance with diagnosis was 
evaluated as appropriate or inappropriate based on published guidelines for 
indications for TM requests.
RESULTS:796 of the 6998 TMs requested from inpatients (2.75 markers/patient) 
and 6202 from outpatients (2.04 markers/patient). Most TMs were made in 
the 50-70 age range (48.3%). Multiple TMs were mostly demanded from the 
Obstetrics and Gynecology Clinic with the diagnosis of menstrual irregularity. 
Also, 1078 of 1408 total PSA and 28 of 191 free PSA tests were requested with 
appropriate pre-diagnosis.
CONCLUSIONS:This study is an example of the use of data mining for 
conformity assessment purposes of the TM requests. Accordingly, it was 
found that the TMs were often incompatible with the diagnosis and were used 
for general screening purposes. In order to minimize misuse, evidence based 
indicators should be developed and clinician awareness should be increased by 
creating test request algorithms that support the diagnosis.
Keywords: Tumor marker, request, diagnosis 
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OBJECTIVES:Chronic kidney disease (CKD) is an increasingly important health 
problem in the World. Inflammation and anemia is a common feature in dialysis 
patients and is associated with cardiovascular complications and poor outcome. 
Bioelectrical impedance analysis (BIA) provides a non-invasive assessment 
of body composition. In this study, we aimed to compare the inflammation 
and bioimpedance data by using Hepcidin, IL-6, TNF-α, hsCRP, sTFR, LRG 
parameters.
MATERIALS and METHODS: For this purpose, 74 hemodialyzed patients 
who applied to the nephrology outpatient clinic of Selcuk University Faculty 
of Medicine were included in the study. Hepcidin, IL-6, TNF-α, sTFR, LRG 
analysis of the remaining blood samples after the routine tests and controls 
of the patients were performed by ELISA and hsCRP analysis was performed 
nephelometric method
RESULTS:We found a close relationship between functional anemia parameters, 
inflammation and arterial stiffness markers, central hemodynamics and 
nondiping status.
CONCLUSIONS:This relationship should be evaluated for routine availability in 
the larger patient group.
Keywords: Hepcidin, IL-6, sTFR, LRG, hsCRP and bioimpedance 
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OBJECTIVES:Serum is the most widely used sample in biochemical analysis, 
but plasma has some advantages when compared to serum such as reduction 
in turnaround time, no fibrin and gel-based interference and more accurate 
reflection of the in vivo situation. The aim of this study was to evaluate whether 
there is a difference between serum and plasma for 20 analytes.
MATERIALS and METHODS:Total of 50 healthy subjects were included in 
the study. Blood samples were collected in tubes with gel (BD) and containing 
lithium heparin (BD, 4.0 mL). Samples in tubes with gel were allowed to clot at 
room temperature. Serum and plasma were obtained by centrifugation at 2000 
g for 10 minutes. Hemolysis index was lower than 30 in serum and plasma 
samples. Biochemical measurements for 20 analytes were performed within two 
hours on Cobas c702 (Roche Diagnostics GmbH, Mannheim, Germany).
RESULTS:Lactate dehydrogenase (LDH) activity, potassium and phosphate 
levels were higher (p<0.001) although total protein was lower (p<0.001) in 
serum when compared to plasma.
CONCLUSIONS:The use of serum reference ranges is not suitable for plasma 
LDH, potassium, phosphate and total protein measurements. Plasma is a better 
quality sample because it is independent of fibrin and gel interference. Each 
laboratory may prefer serum or plasma according to their test panel.
Keywords: Serum, plasma, biochemical analysis 
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OBJECTIVES:Urea is a harmful substance that is formed as a result of the 
use and breakdown of protein foods. This substance is excreted in the form of 
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urine by draining by the kidneys. If the kidneys cannot remove this substance 
sufficiently, they begin to accumulate in the blood. Its elevation has a toxic effect 
on the body, and when it is too high it is impossible to live. Because of these 
reasons, urea determination is of great medical importance.Enzymes are not very 
resistant to strong acids and bases.Therefore, the determination of the pH in the 
enzyme studies is very important.
MATERIALS and METHODS:. In this study, we aimed to design a new 
amperometric biosensor for urea determination.In this study for the determination 
of Urea, urease enzyme was immobilized on the graphite electrode by using 
BSA/gelatin and crosslinking by glutaraldehyde. Measurements were carry out 
at 0.2 V. Optimization studies of the designed biosensor were carried out first for 
the bioactive layer components and ph optimization.
RESULTS:From the bioactive layer optimization studies; gelatin, bovine serum 
albumin amount and optimal percentage glutaraldehyde were determined as 0.45 
gr, 0.030 gr and %2.5 for the Graphite/BSA- Gelatin/ Urease /glutaraldehyde 
modified biosensör. Ph 5 was found in 100 mM acetate buffer
CONCLUSIONS:As a result, it is recommended as the optimum ph 5 for the 
designed biosensor.
Keywords: Urea biosensor, urease, optimization 
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OBJECTIVES:In addition to the product quality and its validation, cost-
effectiveness is also important in the blood collection tube (BCT) selection. 
Thus, a manufacturer may prefer to add a more cost-effective BCT option to 
its portfolio without compromising quality and may offer different options to 
a customer at once. However, when a laboratory administrator needs to select 
a BCT or to replace, local validation of BCT should be met first. We aimed to 
ensure local clinical validation of different brands of BCTs, including a new tube 
in the market for complete blood count (CBC).
MATERIALS and METHODS:Venous blood samples were taken from 
40 inpatients and were collected in four different brand evacuated tubes 
with K2EDTA (Vacutainer;Becton, Dickinson and Company,USA) 
(S-Monovette;Sarstedt Ag & Co. KG,Germany) (Vacuette;Greiner Bio-One 
GmbH,Austria) (Samplix;Greiner Bio-One GmbH,Austria). White blood 
cell(WBC), red blood cell(RBC), hemoglobin, platelet(PLT) were analyzed 
using a CBC analyzer (DxH 800;Beckman Coulter Inc.,USA).
RESULTS:The Vacutainer, current BCT for CBC in routine were compared 
with S-Monovette, Vacuette, and Samplix and bias (%) results were calculated 
as follows: 1.85,-0.05, and -0.43 for WBC; 0.27,-0.11, and -0.39 for RBC; 
0.07, -0.07, and -0.33 for hemoglobin; 0.06, 0.25, and 0.53 for PLT. All bias 
calculations were within the desirable limits based on the Ricos’ biological 
variation data.
CONCLUSIONS:Similar CBC results were obtained among BCTs, including 
Samplix, when compared to the Vacutainer, the tube in laboratory use. Before 
selecting or replacing a BCT tube, it must be validated locally by comparing with 
the tube in use, thus ensuring the sustainability of CBC results.
Keywords: Blood cell count, blood specimen collection, validation studies 
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OBJECTIVES:We aimed to investigate the nutritional state of children who 
suffer from cerebral palsy and autism.
MATERIALS and METHODS:A questionnaire was applied to 70 children with 
cerebral palsy and 32 children with autism who continue their education at the 
İller Bankası Special Education and Rehabilitation School. In total 102 students 
participated in the study with 21 healthy siblings as the control group.
RESULTS:The ratio of boys to girls with cerebral palsy was 1% while it was 
4,3% in the autism group. 66,7 % of children with cerebral palsy were slim while 
33,3% of children were with normal weight. 50 % of children with autism were 
overweight and obese. The ratio of epilepsy was 30% in children with cerebral 
palsy, while it was 21,9% in children with autism. There are studies showing 
that various special diet and sustenance provides positive behavioral change on 
children with autism. It was identified that only 4 children (3,92 %) with cerebral 
palsy (3) and autism (1) from the total of 102 children was following a special 
diet and this is a low rate. Given the detrimental effects of undernutrition on 
physical and cognitive development, monitoring of nutritional status is important 
in children with neurological disorders.
CONCLUSIONS:According to the results, the rate of people who has normal 
BMI amount has been found %37,5, considering children with both cerebral 
palsy and autism and healthy siblings. According to the clinical diagnosis; 
sex, additional health problems, supplemen tay food consumption, digestive 
system problems, the difference between the past important operation has been 
found significant statisticaly (p<0,05). While considering the harmful effect 
of undernourishment on both physical and mental development, following 
nutritional aspect of a children who has neurological disorders has quile 
importance. In the light of our survey we know that further researches are 
essential on the topic of nutrition disorders and behavioral problems of children 
with autism, digestive system diseases the relation between the past attacks and 
crisis, the prevention of undernourishment of children with celebral palsy, and 
the contribution of diet on the treatment of epilepsy.
Keywords: cerebral palsy, autism, nutrition 
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Comparison of serum hemolytic index and manual spectrophotometric 
measurement of free hemoglobin
Elmas Öğüş, Hatice Sürer, Pınar Koyuncu, Tuba Özgün, Aytül Kılınç, Doğan 
Yücel 
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OBJECTIVES:The effect of hemolysis as a preanalytical error on laboratory 
test results is significant. In this study, it was aimed to evaluate hemolytic index 
(HI) values obtained from emergency and routine biochemistry laboratory and to 
compare them with those the results of a manual free hemoglobin method.
MATERIALS and METHODS:In April 2018 and 2019, serum HI values of 
emergency and routine biochemistry laboratory obtained from laboratory 
information management system were examined. One hundred of serum samples 
with different hemolytic index values within a wide range (25–619) were studied 
by Cobas 6000/8000 analysers and hemoglobin concentrations were determined 
by a manual spectrophotometric method. Hemoglobin levels in mg/dL were 
calculated by two different methods by absorbance measurements at 380, 415 
and 450 nm and 415, 450 and 700 nm, Method 1 and Method 2, respectively. 
Regression analysis and % bias values were calculated between serum hemolytic 
index and manual method results.
RESULTS:HI values >50 mg/dl were 16.82%, 12.21% in emergency laboratory 
and 1.69%, 1.22% in routine laboratory, respectively. Serum HI showed a high 
correlation with Method 1 ( r=0.969) and Method 2 (r=0.973). Percent bias 
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values were 9.43% and 8.88% for Method 1 and 2, respectively.
CONCLUSIONS:Because of the effect of hemolysis on test results, many 
samples may be rejected although redundant and lead to delayed patient results. 
This can be reduced by appropriate blood collection and training of laboratory 
technician and use of serum HI. Evaluation of HI by laboratory specialist may 
contribute to accurate clinical interpretation and reduction of sample rejection.
Keywords: Serum hemolytic index, hemolysis, preanalytical error 
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OBJECTIVES:The newly introduced BD barricore plasma collection tubes 
provides ease of use for laboratory workers. In this study, we aimed to compare 
vitamin D levels in BD Vacutainer K2 EDTA tube with Vacusera gel tube and BD 
Vacutainer barricore plasma collection tubes.
MATERIALS and METHODS:Twenty healthy volunteers participated in the 
study. Venous blood samples were collected in each type of tubes in the morning. 
The tubes without anticoagulant was allowed to coagulate for 20 minutes. The 
samples were then centrifuged at 1500 g for 10 minutes. Vitamin D levels of 
all three samples were analyzed by HPLC. The distribution of the data were 
evaluated. Since the distributions were non-Gaussian, the differences between 
the groups were investigated by Wilcoxon test. Then, the relationships between 
the groups were examined by Spearman correlation test.
RESULTS:There were no statistically significant differences between BD 
Vacutainer K2 EDTA tube, Vacusera gel tube and BD Vacutainer barricore 
plasma collection tubes (p=0.911, p=0.823, respectively). BD Vacutainer K2 
EDTA tube and Vacusera gel tube and BD Vacutainer barricore plasma collection 
tube results were well correlated with each other (r=0.892, p<0,01; r=0.920, 
p<0,01, respectively).
CONCLUSIONS:Although HPLC is a reliable method for vitamin D analysis, 
it is known that serum seperator gels may cause interference. The use of EDTA 
tubes is therefore recommended by the manufacturer. In our study, Vacusera gel 
tube and BD Vacutainer barricore plasma collection tube were compared with 
BD Vacutainer K2 EDTA tube and the results were found to be consistent.
Keywords: vitamin D, barricore plasma collection tube, compare 
 
 
P-143
Retrospective evaluation of vitamin D, calcium and vitamin B12 levels
Kamile Yücel1, Said Sami Erdem2 
1Medical Biochemistry, KTO Karatay University School of Health Sciences, 
Konya, Turkey 
2Department of Biochemistry, Konya Training and Research Hospital, Konya, 
Turkey 
OBJECTIVES:Vitamin D, calcium and vitamin B12 are known to have important 
effects on human health through various mechanisms. In this study, we aimed to 
determine whether vitamin D, vitamin B12, and calcium levels differ in terms of 
age and sex in hospital admissions in the last 6 months.
MATERIALS and METHODS:6087 patients who applied to Konya Training 
and Research Hospital between 01.01.2019-01.07.2019 were screened on the 
hospital information system.
RESULTS:Of the 6087 patients, 73.1% (n=4448) were female and 26.9% (n=1639) 
were male. The mean age of the patients was 41.19 ± 20.14 (0-96), the mean calcium 
level was 9.55 ± 0.44 (5,05-12,90), the mean vitamin D value was 16.33 ± 11.8 
(2,10-138,95), and the mean vitamin B12 value was 382.42 ± 167.13 (103-1973). 
Vitamin D and calcium were significantly higher in males than females 
(respectively, p=0.011, p=0.000). In women, there was a positive correlation 
between calcium and vitamin B12, between vitamin B12 and vitamin D, and 
between calcium and vitamin D (respectively, p=0.082, p=0.232, p=0.091). 
There was a low positive correlation between vitamin B12 and vitamin D in male 
(p=0.141). İn addition, vitamin D was found to be lower in age 65 and over.
CONCLUSIONS:In our retrospective study, we found that vitamin D was highly 
insufficient in elderly people and that it was lower in women compared to men. 
We think that vitamin D supplementation may be beneficial in elderly and 
women.
Keywords: Vitamin D, calcium, vitamin B12 
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OBJECTIVES:We aimed to evaluate the ability of maternal serum plasma 
protein A (PAPP-A) and free beta-human chorionic gonadotropin (free ß-hCG) 
values measured in the first trimester screening test to predict complications that 
may develop in later gestational weeks.
MATERIALS and METHODS:The study included 3166 women between 16-46 
years old of age. Their gestational ages were between 10 weeks and 6 days to 
13 weeks and 6 days. They had a single live pregnancy, and no any complicated 
obstetric history and chronic systemic disease. The results of 3166 pregnant, 
applied to the Biochemistry Laboratory of Gaziosmanpasa University Faculty of 
Medicine between 2017 and 2019, were evaluated retrospectively. p values less 
than 0.05 were considered statistically significant.
RESULTS:The mean age of the patients was 27.43 ± 5.46 and their weight was 
65.66 ± 13.13 kilograms. Crown rump lengthes (CRL) were determined as 60.71 
± 8.56 mm. Free ß-hCG levels were 55.1 ± 132.07 ng / mL and PAPP-A values 
were 3683.53 ± 2486 mIU / l. Nuchal translucency measurement (NT) was 
determined as 1.38 ± 0.37mm. None of patients had age risk. Only 2 patient (% 
0,1) had Trisomy 18 risk while 59 patient (% 1,9) had Trisomy 21risk.
CONCLUSIONS:The accuracy and performance of 1st trimester screening 
tests, which are used in the diagnosis of neural tube defects and chromosomal 
anomalies and guide for further interventional procedures, should be improved. 
Measurements should be performed with strict internal and external quality 
programs.
Keywords: free ß-hCG, PAPP-A, Binary screening test, 1st Trimester 
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OBJECTIVES:The study of chemical neurotransmitters has acquired in 
recent years a very large scale, driven mainly by the discovery and use of 
methodologies and techniques for investigating more complex and more accurate. 
Given the pathophysiological importance of noradrenaline, dopamine, serotonin 
and γ-aminobutyric acid, we plan to study the effect of active drugs on the central 
nervous system on brain levels of these neurotransmitters.
MATERIALS and METHODS:We used white Albino Swiss mice which was 
randomized into seven groups treated with the following drugs: valproic acid (V), 
risperidone (R), fluoxetine (F), lithium (Li), and associations: V+F,V+Li,V+R. 
Brain tissue was collected, and were determined the concentrations of neuronal 
noradrenaline (NA), dopamine (DA) by HPLC, serotonin (5-HT) by LC-MS, 
and gamma-aminobutyric acid (GABA) was determined by a spectrofluorimetric 
method.
RESULTS:The administered drugs increased the noradrenaline 
brain concentration. Lithium was the most potent catecholaminergic 
stimulator of the brain concentration (406.66% effect increase) 
(p˂0.001) between all the studied drugs. Co-administration of Li + Q 
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triggers, molecular mechanisms that cause a sudden decrease of the NA. 
The risperidone acts as an atypical antipsychotic: increasing concentrations of 
NA, DA, 5-HT and decrease the concentration of GABA.
CONCLUSIONS:The experimental results presented in this paper led, in addition 
to unique conclusions for the current scientific research, as well as potential 
theories and responses to multidrug resistance in various neuropsychiatric 
disorders.
Keywords: multidrug resistance, neurotranmitters, CNS active drugs 
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OBJECTIVES:Serum creatinine is measured as a kidney function test in almost 
all clinical laboratories.Creatinine methods used in clinical laboratories are 
generally based on automated chemical or enzymatic methods.Jaffe assays 
remain the predominant method type in most developed countries.It is stated that 
enzymatic method is the most compatible method with reference method.The 
aim of this study is to compare the analytical performance characteristics of Jaffe 
and enzymatic methods.
MATERIALS and METHODS:Serum specimens were collected from 107 
hemodialysis patients (pre- and post-dialysis samples),50 patients with high 
creatinine levels from nephrology service,160 patients with normal creatinine 
values from other sections.Samples were measured with two original creatinine 
reagent kit(BECKMAN COULTER) based on different methodology (Jaffe and 
Enzymatic),by using AU 5800 autoanalyzer at Gazi University Medical Faculty 
Hospital Biochemistry Laboratory.Statistical analysis was performed with 
MEDCALC and SPSS for method comparison.
RESULTS:We found significant and strong correlation between the two methods.
(r=0,995,p<0,0001).However,in the analysis of Deeming regression equations 
gave a slope of 1,0853 and an intercept of -0,06130.When we analyze the data 
by dividing it into normal and high values,Deeming regression equations gave a 
slope of 1,0638,1,0959 and an intercept of - 0,01073,-0,1455,respectively.Mean 
values for Jaffe first and second,enzymatic first and second measurements were 
3.78mg/dL,3.86mg/dL and 4.05mg/dL, 4.11mg/dL,respectively.There was a 
significant difference according to T test(p <0.05).
CONCLUSIONS:Although it was seen that jaffe method gave higher results 
than enzymatic method in literature,we found that enzymatic method measured 
higher.We explain this with differences between methods. Therefore, more 
comprehensive studies with different patient groups and different methods are 
needed.
Keywords: creatinine,enzymatic,Jaffe,method comparison 
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diagnosis
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OBJECTIVES:Influence of diabetes on development of ACS is well known, as 
well the active smoking that can pose a particular risk in increasing heart muscle 
ischemia. Several proposed models by international associations, indicate an 
increased risk and confirmation of the definition of myocardial infarction (MI) 
with presence of diabetes and cigarettes smoking habit in patients.
MATERIALS and METHODS:Our study included 200 patients admitted to the 
emergency department with symptoms of AMI. Patients samples were submitted 
for CK, CKMB, TnT, TnI, Myoglobin determination and estimation for presence 
of diabetes and smoking habit. The obtained data were compared and statistically 
processed versus group of patients without any of risk factors.
RESULTS:We found that 34% of patients has stable/unstable angina, and 
49% was diagnosed as MI. Higher percentage of diabetic patients 28.8% has 
MI compared to 13.4% in patients with angina pectoris. In terms of smoking 
as a risk factor, 54.6% of patients with MI were active smokers compared to 
34.3% in patients with angina pectoris. At diabetic patients MI was confirm with 
significant upper CK activity (65%), CKMB (56.8%) and TnT concentration 
(142%). Regarding the smokers, the most significant change was found in higher 
CK activity (60%) and myoglobin concentration (127.3%) in patients with AMI.
CONCLUSIONS:Result shows that those two risk factors can afford valuable 
data in primary diagnosis along with some sensitive but not most specific 
parameters such CK and Myoglobin. This attitude is based concerning their 
effects on metabolic oxygen supply of heart muscle.
Keywords: risk factors,myocardial infarction, cardiac markes. 
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OBJECTIVES: Emphysema; pathologically, alveoli is a lung disease with 
expansions, alveolar wall destruction and irreversible alveolar losses if filled with 
excess air. Pathological factors such as inflammatory cell response, protease/
antiprotease imbalance, oxidative stress, apoptosis, and regeneration dysfunction 
in alveolar epithelium due to environmental or genetic factors play a role in the 
development of the disease. Dyspnea, cough, activity restriction as the disease 
progresses, loss of appetite and intense weight loss are the most obvious symptoms. 
The aim of this study was to measure the serum levels of Adropin, Desnutrin 
(ATGL) and Glucagon-like peptide-1 (GLP-1), which have important effects 
on carbohydrate and lipid metabolism of the patient and control groups, and 
to determine the effects of these parameters on the diagnosis and treatment of 
emphysema
MATERIALS and METHODS: The study group consisted of 35 patients 
diagnosed with Emphysema and 35 healthy subjects.
RESULTS: The study group consisted of 35 patients diagnosed with Emphysema 
and 35 healthy subjects. As a result of experimental analysis Adropin (p=0,002), 
Desnutrin (p=0,001) and GLP-1 (p=0,006) levels were compared statistically; 
the difference between the patient and control groups was significant (p<0,05).
CONCLUSIONS: In conclusion, in our study, it was determined that serum 
Adropin, Desnutrin and GLP-1 levels decreased significantly in patients 
with emphysema. Therefore, we believe that these parameters will contribute 
significantly to the diagnosis and treatment of emphysema. We think that the data 
obtained will shed light on the more comprehensive research for the treatment of 
emphysema.
Keywords: Emphysema, Adropin, Desnutrin, Glucagon like peptide-1 
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OBJECTIVES:Nonsyndromic cleft lip with/without cleft palate (NSCL/P) is 
one of the most common human congenital  defects. Reactive oxygen species 
and oxidative stress act as teratogenic agents, leading, during embryogenesis, 
to several structural changes in the developing fetus. Numerous reports have 
described free radical-mediated congenital defects. The aim of this paper is to 
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determine the oxidative status in patients with cleft lip and/or palate.
MATERIALS and METHODS:Patients with NSCL/P (n = 12) and age- and 
sex-matched healthy control subjects (n = 13) were enrolled in this study. 
Malondialdehyde (MDA) concentrations as oxidative stress biomarker in 
plasma, and the activities of superoxide dismutase (SOD) and catalase (CAT) 
as antioxidant enzymes in erythrocyte were determined as spectrophotometric.
RESULTS: Oxidative stress was confirmed by the significant elevation in MDA 
concentrations (p<0.05). Besides, increased CAT and SOD activities were found 
in patients with NSCL/P compared with the control group (p<0.05).
CONCLUSIONS: Our findings indicated that increased the antioxidant enzyme 
activities and MDA concentrations in  patients with NSCL/P may be an 
adaptative response to against oxidative stress.
Keywords: Oxidative stress, Nonsyndromic cleft lip with/without cleft palate, 
MDA 
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OBJECTIVES:Biological structures are susceptible to oxidative stress 
and lipid peroxidation having a limited number of bio molecules active as 
antioxidants at physiological concentrations. The objective of the study was to 
determine the antioxidant capacity of melatonin, the main pineal hormone with 
multiple biological roles as antioxidant, anti-aging, DNA defense agent and 
neuroprotector, and arginine, a semi-essential amino acid studied for its effects in 
cell division, immune system modulation and carcinogenesis, and as a precursor 
of NO synthesis.
MATERIALS and METHODS:White male Albino Swiss mice were randomized 
in 4 groups administered for a period of three weeks with arginine and 
melatonin, single or in combination. The hepatic and brain tissue homogenates 
were subjected to the assessement of lipid peroxides, in temporal dynamics, 
by the reaction with thiobarbituric acid, the results being expressed in nmol 
malondialdehyde/mg protein.
RESULTS:At the cerebral level, the dynamics of the lipid peroxidation process 
recorded interesting values demonstrating protective effects for the studied 
substances against oxidative processes, the best results being obtained for 
arginine + melatonin treated groups. In the hepatic tissue, melatonin registered 
the lowest antioxidant effect, but it was achieved a substantial improvement by 
its association with arginine.
CONCLUSIONS:The lipid peroxidation process is a characteristic of each tissue, 
depending on the intensity of cellular oxidative processes and the mechanisms 
underlying the balance between pro-oxidant factors and antioxidants. The 
obtained results demonstrate the synergistic effect of melatonin and arginine 
as effective modulators of redox processes, significantly diminishing the tissue 
potential of lipid peroxidation.
Keywords: arginine, melatonin, lipid peroxidation, malondialdehyde, oxidative 
stress 
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OBJECTIVES:Oxidative stress is a condition which occurs as a result of 
physiological imbalance between the levels of antioxidants and oxidants (ROS 
- reactive oxygen species) in favour of oxidants. It causes oxidative damage and 
processes that happen in the body contribute to the development of a number 
of interrelated risk factors as hyperglycemia, dyslipidemia, hyperinsulinemia, 
insulin resistance. The effects of an increased oxidative load are reduced by 
antioxidant enzymes that convert ROS to less harmful molecules. Superoxide 
dismutase (SOD) is the first detoxification enzyme and most powerful antioxidant 
in the cell. The aim of our study is to evaluate changes in serum SOD in women 
with polycystic ovary syndrome (PCOS).
MATERIALS and METHODS:The study includes 55 women, divided into two 
groups: 29 women with PCOS and 26 clinically healthy women. Serum SOD 
was determined with an ELISA kit (MyBioSource, USA). SOD concentrations 
were measured by a multiparameter photometer “Sirio S microplate reader”, 
SEAC, Italy. All data was presented as mean ± SD. Significance was defined as 
P < 0.05.
RESULTS:The mean age of women with PCOS was 25.03 ± 4.94 yrs. and 
of healthy women was 30.34 ± 5.76 yrs. Serum concentrations of SOD were 
significantly lower in women with PCOS compared with healthy controls (14,06 
± 3,17 vs 38.95 ± 45.32, P < 0.001).
CONCLUSIONS:Our results indicate decreased SOD serum concentrations in 
studied women. It is believed that serum SOD could be a helpful biomarker in 
assessment of oxidative stress in women with PCOS.
Keywords: SOD, PCOS, oxidative stress 
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OBJECTIVES:Pneumatic tourniquets are commonly used in the orthopedic field 
to reduce blood loss and maintain a clear surgical field in limb surgery. Despite 
their beneficial effects, tourniquet-related adverse effects such as vascular injury 
and limb ischemia–reperfusion injury have been identified in many studies. The 
aim of our study was to investigate the effect of tourniquet usage on preoperative 
and postoperative (1th and 24th hours) ADMA, SDMA, L-NMMA, arginine, 
citrulline levels undergoing unilateral total knee arthroplasty (UTKA) patients.
MATERIALS and METHODS:31 patients who underwent UTKA with or without 
tourniquet in Selcuk University Faculty of Medicine Clinic of Orthopedics and 
Traumatology were included in the study. All parameters were analyzed by LC 
unit coupled to an ABSCIEX API 3200 mass spectrometer. Paired sample t test 
was used for statistical analysis. p <0.05 was taken to be statistically significant.
RESULTS:It was determined a reduction between ADMA0-ADMA24, Cit0-
Cit1, Cit0-Cit24 (with tourniquet), Cit0-Cit24 (without tourniquet) periods 
(p=0.002; p=0.025; p=0.001; p=0.003 respectively). There were no significant 
differences in other periods and parameters, both two operation methods. 
CONCLUSIONS:In many studies, ıt was reported that usage of tourniquet 
during surgery increases oxidative stress status depending on ischemia in knee 
arthroplasty. Oxidative stress has been shown to increase the activity of arginine 
methylating and ADMA degrading enzymes leading to increased ADMA 
concentrations. When the results obtained in our study were evaluated, it was 
observed that in the long term ADMA levels decreased, in the short and long term 
citrulline levels decreased in the patients who were operated with tourniquet.
Keywords: Knee arthroplasty, tourniquet usage, oxidative stress, ADMA 
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Oxidative status in patients with inflammatory bowel disease
Mariana Yordanova1, Daniela Gerova1, Antonya Atanasova2, Bistra Galunska3 
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– Varna, Varna, Bulgaria 
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OBJECTIVES: To evaluate the role of free radical oxidation and antioxidant 
defense for the progression and activation of inflammatory bowel disease (IBD).
MATERIALS and METHODS: 54 IBD patients (mean age 44,5±14,3y) 
and 80 healthy age-matched controls (43±10.8y) were enrolled in the study. 
According to CDAI and Mayo indexes, the patients were divided into two 
subgroups: moderate/severe activity (36 patients) and remission/mild activity (18 
patients). CRP and fecal calprotectin were measured as inflammatory markers. 
Hydroperoxide levels and serum antioxidant capacity were evaluated using 
commercial kits dROMs and BAP-test (Diacron Labs, Italy). Standard statistical 
methods (descriptive statistics, Student’s t-test, and Spearmann correlation) were 
used for data analysis.
RESULTS: Significantly increased levels of dROMs were measured in IBD 
patients vs controls (418.1±124.4UCarr vs 341.2±37.48UCarr, р<0.0001). 
Patients with active form of IBD revealed significantly higher dROMs compared 
to mild/remission subgroup (437.8±131.4UCarr vs 357.0±81.74UCarr, 
р<0.05). Serum antioxidant capacity was significantly decreased in the IBD 
group vs controls (2122±468.6umol/l vs 2683±279.9umol/l, p<0.0001). A 
tendency for weaken antioxidant defense was found with the severity of the 
disease (2047±608.9umol/l for the subgroup with moderate/severe activity and 
2206±432.8umol/l for the mild/remission subgroup). The increase of dROMs 
was significantly associated with CRP (Spearman r=0.5545, p<0.0001) and 
calprotectin levels (Spearman r=0.3295, p<0.05). BAP-test correlated negatively 
with CRP levels (Spearman r=-0.5419, p<0.0001) and with calprotectin 
(Spearman r=-0.2078, ns).
CONCLUSIONS: Increased free radical oxidation and diminished antioxidant 
defense with the severity of the disease and their associations with routine 
inflammatory markers suggest a possible role of oxidative stress in the 
pathogenesis of IBD.
Keywords: IBD, oxidative stress, antioxidant defense, CRP, calprotectin 
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Nitric oxide increased in preeclampsy independently from malondialdehyde
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Ebru Kale, Mehmet Zahit Çıracı 
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OBJECTIVES: Preeclampsia, which is a complication that usually develops in 
the later stages of pregnancy, is still being debated in relation to nitric oxide (NO) 
and oxidant / antioxidant system. The aim of this study was to determine the 
maternal serum concentrations of nitric oxide and malondialdehyde (MDA) in 
preeclamptic pregnancies and to compare them with healthy patients.
MATERIALS and METHODS: The study included 38 pregnant women with a 
gestational age of 30-38 weeks with preeclampsia and 42 normotensive pregnant 
women with the same gestational week. Serum NO levels were measured by the 
Griess method as described by the colorimetric assay kit manufacturer (NB98, 
Oxford Biomedical Research). The absorbance of a pink complex formed after 
MDA reacted with thiobarbituric acid was measured spectrophotometrically at 
535 nm.
RESULTS: In our study, serum NO levels of preeclampsia pregnant women 
were higher than healthy pregnant women (P <0.05). However, there was no 
difference between the groups in terms of MDA levels (P> 0.05). In addition, 
there was no statistically significant correlation between NO and MDA levels of 
all participants (Spearman r = -0.01169 P = 0.9180).
CONCLUSIONS: Especially in preeclampsia patients who developed after 
30th week, NO levels were found to increased. However, this increase was not 
associated with MDA, an indicator of oxidative stress.
Keywords: Preeclampsia, nitric oxide, malondialdehyde 
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Haptoglobin polymorphism may cause atherosclerotic changes
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OBJECTIVES:Human gene of haptoglobin is presented by two alleles. 
Haptoglobin types are 1-1, 1-2 and 2-2. Different studies shows role of type 
2-2 in cardio-vascular disease occurrence during diabetes. Haptoglobin type 1 
is known to suppress hemoglobin based oxygenation of HDL and LDL, acting 
like antioxidant.
MATERIALS and METHODS:We aimed that Bulgarian population is 
haptoglobin 2-2 type, which causes frequent morbidity by systematic diseases, 
such as atherosclerosis, diabetes, diabetic nephropathies, gestational diabetes, 
anemia, etc. 39 volunteers were included, age 36.7 ± 5.3. IMT, ABI, CBC, iron 
homeostasis, hsCRP and haptoglobin type were evaluated.
RESULTS:Increased serum hepcidin concentrations were established in patients 
with atherosclerotic a. carotis changes (109.7 ± 10.1 µg/L) compared to healthy 
controls (21.1 ± 1.9 µg/L), P<0.001. In haptoglobin type 2-2, was found strong 
positive correlation between hepcidin levels and changed IMT and ABI (r=0.901, 
r=0.919, resp.; P<0.01). Three volunteers were with haptoglobin type 2-1; 
no changes of serum hepcidin concentration and IMT, ABI was found in this 
phenotype.
CONCLUSIONS:The main reason for acute coronary thrombosis is 
atherosclerotic plaque rupture. Extra-vascular hemoglobin plays role as 
start mechanism for inflammation in the plaques. Important contra-active 
mechanism is played by haptoglobin. Thus, it prevents kidney injury 
from free hemoglobin. Released iron from destructed erythrocytes forms 
reactive oxygen radicals through Fenton’s reaction. Hepcidin regulates iron 
homeostasis by its interaction with intracellular iron exporter ferroportin. 
Acknowledgements: This project is sponsored by MU-Sofia, as part of Grant 
Д-213/2018.
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Determination of glucose levels in sports active children
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OBJECTIVES:Physical activity is a very important part of healthy lifestyle 
in children and adolescents. Physical activity is known to increase glucose 
consumption, which is used as an energy source, thereby reducing blood glucose 
levels.
MATERIALS and METHODS:Sports active children included children who 
were actively involved in sports in addition to physical activity at school. It 
included 158 healthy children (82 boys and 76 girls) aged 4-6 years and 12-14 
years. There were 76 children active in sports and 82 inactive. Glucose levels 
have been determined by routine laboratory methods.
RESULTS:Comparisons are made by age and gender in relation to whether or 
not they are involved in sports. In the group of younger children and older boys 
there is no statistically significant difference in glucose level.Comparing glucose 
level in girls group, glucose levels were significantly lower (p <0.01) in girls 
engaged in sports activity versus girls inactive in sport (4.95 ± 0.2 mmol/L versus 
5.20 ± 0.32 mmol/L ).
CONCLUSIONS:Based on the results, we can conclude that although 
there was no difference in glucose concentration in young children, the 
puberty period is critical and special attention should be paid to prevention. 
Playing sports has the effect of improving health and quality of life. Diet and 
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exercise should be adapted to each child. Systematic examinations of children 
involved in sports should be regular and should include control of the risk 
parameter for the development of diabetes mellitus as well as the parameters for 
the development of cardiovascular disease.
Keywords: Children. Sports. Glucose 
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OBJECTIVES:Hypothyroidism is a clinical condition that arises out of the 
development defects of the thyroid gland.The most frequently endocrinologic 
problem encountered reason of permanent hypothyroidism is the congenital 
reasons.Incidences in our country, hypothyroidism was found as one per every 
2183 alive births.Tests are conducted using the National Newborn Screening 
Program developed Ministry of Health since 2006.
MATERIALS and METHODS:The TSH eliza method is employed for 
hypothyroidism at a threshold value of up to 15 mg/dl. Since the symptoms and 
findings of early diagnosis sometimes is difficult. In non-treated cases, serious 
mental retardation but treatment is easy, inexpensive, and efficient. In Avcılar 
Hospital, number of alive births for the year 2017 is 721. Heel blood is taken 
from all newborns after at least 24 hours of feeding, and a Guthrie card is filled 
in.If the blood samples taken here are insufficient, repetition is requested.
RESULTS:Appropriate samples are worked on in the screening laboratory, and 
any results above the normal values are taken into further examination. Screening 
test results examined in the hospital for the congenital hyperthyroidism are as 
follows: TSH was above normal level in 11. According to these results, 4% 
samples in total among the babies born in this hospital were required to be taken 
again. Among these, 0.3% were required to be redirected to the concerning clinic 
for further follow up.
CONCLUSIONS:Sampling from all alive births in the hospitals and efficient 
participation of big centers such as the maternity wards into screening purpose 
surveys makes contribution to obtaining the country-wise data.
Keywords: Hypothyroidism 
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OBJECTIVES: In this project,we aimed to evaluate the performance of pediatric 
tubes by comparing the results of 2.7 ml coagulation tubes containing %3.2 
sodium citrate and 0.5 ml pediatric tubes containing %3.2 sodium citrate. 
MATERIALS and METHODS: In addition to the standard coagulation sample,0.5 
mı of blood was collected from our adult volunteers over 18 years old who applied 
to our hospital for coagulation tests. Prothrombin Time(PT), Activated Partial 
Thromboplastin time(aPTT) and Fibrinogen tests were analyzed from these 
two samples on Sta Compact Max. We then compared the results statistically. 
RESULTS: No statistically significant results were found between PT, aPTT, 
fibrinogen test results of pediatric coagulation tubes and normal coagulation tubes.. 
CONCLUSIONS: Pediatric coagulation tubes may be used in pediatric patients 
or in adult patients with difficult blood collection.
Keywords: Pediatric coagulation tubes,PT,aPTT, Fibrinojen,coagulation tubes 
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A method comparison study of a novel point of care test for hemolysis 
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OBJECTIVES:Hemolysis is a frequent pre-analytical error accounting for 
up to 70% of all rejected specimen in clinical laboratorys. Considering that 
biochemical analysis impact clinical outcomes, errors may subject patients 
to adverse effects and place an unnecessary economic burden on a hospital 
budget. A line of evidence indicates that hemolysis usually is traced to the blood 
collection. To mitigate this an effective approach could be to identify hemolysis 
at the point of care. Here a novel method for point-of-care hemolysis detection 
is evaluated.
MATERIALS and METHODS:Lithium heparin tubes part of routine care was 
collected and roughly 100 µL whole blood was analyzed for hemolysis in plasma 
with Helge (Helge, Hemcheck, Karlstad, Sweden) at an emergency department 
(ED) in Sweden. Results were recorded at the ED, and samples were sent with 
pneumatic dispatch to central laboratory for routine handling. Hemolysis index 
was collected from the reference method Vitros 5.1 FS (Ortho Diagnostics Inc. 
New Jersey, United States). Clinically relevant hemolysis was 0.5 g/L free 
hemoglobin.
RESULTS:794 samples were collected during four weeks for calculation of 
performance. The proportion of hemolytic samples was 9.9% (n=79) according 
to the reference method. The sensitivity and specificity of Helge were 81.0% and 
97.8% respectively. The positive and negative predictive values were 80.0% and 
97.9% respectively.
CONCLUSIONS:Hemolysis is a frequent pre-analytical error, in this study 9.9% 
of included blood samples were rejected. If a non hemolyzed sample could be 
taken following a positive test, in this study, the proportion of rejected samples 
would be reduced from 9.9% to 1.9%.
Keywords: Hemolysis Point-of-Care Systems Pre-Analytical Phase 
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OBJECTIVES:Prenatal screening tends to be performed in central hospitals as it 
requires expertise for interpretation of results and quality management and cost 
effectiveness as well. For this reason, samples taken from peripheral hospitals 
are transferred to the central laboratory on a certain day of the week. During this 
period, samples can be frozen and stored. The aim of this study is to investigate 
the effect of storage on prenatal screening tests and risk analysis.
MATERIALS and METHODS:TotalβhCG,PAPP-A(n17) for double screening; 
total βhCG,AFP,uE3,inhibin-A(n:21) for quadruple screening were studied on 
freshly drawn blood samples on Beckman-Coulter-Access2 analyzer on the same 
day. Risk assessment was performed in BenetechPRA software. The cutoff value 
was 1/250 for the risk of Down syndrome. The same serum samples were frozen 
immediately and thawed after one week of freezing at -30°C and the tests were 
re-studied to calculate the risk analysis.
RESULTS:The median and IQR(Q1-Q3) values of fresh and frozen samples 
were as following: PAPP-A:617(417-1195)µg/L and 671(472-1252)µg/
L;totalβhCG:117030(75836-174448)IU/L and 100007(77363-196865)IU/L 
in double screening; and AFP:31.6(21.6-42.4) ng/mL and 37.0(25.0-44.5)
ng/mL;total βhCG:57415(40687-83812)IU/L and 62800(47078-93462)IU/
L;inhibin-A:284(204-458)pg/mL and 315(224-471)pg/mL in quadruple screening, 
respectively. The difference was statistically significant between fresh and frozen 
samples(p<0.05). There wasnt a statistical difference between uE3 results. Risk 
analysis also did not showed a difference after storage(p>0.05).
CONCLUSIONS:Freezing and thawing of the samples did not change the risk 
analysis, although the test results could change. In addition to biochemical tests, 
maternal characteristics such as maternal age, weight, race, diabetes mellitus, 
smoking and USG findings are effective in calculating the risk of Down syndrome.
Keywords: Prenatal screening tests, risk analysis, fresh sample, frozen sample 
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OBJECTIVES:This study was aimed to investigate the effect of hormones on the 
duration of separation of plasma skin to skin contact.
MATERIALS and METHODS:The study was conducted with 20 cases, 20 
controls. Blood samples were taken during routine check-up before and after 
the birth of 1 cc of blood for our study. Blood samples were stored in the 
deep freezer at -80 degrees until all of the bloods were collected. Then, beta-
endorphins, catecholamines and oxytocin were analyzed. Data were taken using 
the socio-demographic data form. In addition, the effect of skin to skin contact on 
placenta seperation time was measured with an observational chronometer. The 
Mann-Whitney U test was used to evaluate the data.
RESULTS:The mean age of mothers in the case group was 28,55±5,97, the mean 
age of mothers in the control group was 26,75±6,58. Statistically, the levels 
of oxytocin in control prepartum and case prepartum groups decreased, while 
beta-endorphin levels increased and catecholamine levels did not change. There 
is no significant difference between control postpartum and case postpartum 
groups in terms of oxytocin, beta-endorphin and catecholamine levels (p>0,05). 
In addition, the seperation time of the placenta was shorter in the case group 
compared to the control group. There is a statistically significant difference 
between them (p<0,05).
CONCLUSIONS:Skin to skin contact at birth is a factor affecting the separation 
time of the placenta. Health professionals should be informed and awareness 
about skin to skin contact should be increased in the early postpartum period.
Keywords: Skin to skin contact, oxytocin, beta-endorphin, catecholamine, 
placenta
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quadruple prenatal screening tests
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OBJECTIVES: In this study, we aimed to determine the median values of the 
biochemical parameters of the prenatal screening tests of double (DS) (PAPP-A 
and total ß-hCG) and quadruple (QS) (AFP, uE3, total ß-hCG, Inhibin A) and to 
compare with the median values given by the company.
MATERIALS and METHODS: Data of 2111 pregnant women between 11-13 weeks 
for DS and 1683 pregnant women between 15-19 weeks for QS were included in the 
study.Pregnants with diabetes, IVF and twin pregnancy, smoking and were excluded.
Pregnant women with a risk of Smith-Lemli-Opitz syndrome and above the threshold 
of 1/250 for Down syndrome, 1/300 for trisomy 18, 1/104 for neural tube defect were 
also excluded.All analyses were performed on a Beckman-Coulter Access2 analyzer 
and risk analysis was performed with Benetech PRA.The “sign test for medians” was 
used for the comparison of medians.
RESULTS: For DS, the new median values were significantly different(p <0.05) 
for all three weeks(11-13.) than the medians recommended by the company.For 
QS, the median of inhibin A at weeks 15th-19th, AFP at weeks 15-17th, uE3 at 
weeks 15-17th and 19th, total ß-hCG was significantly different at the only 17th 
week(p <0.05) compared to the default medians.
CONCLUSIONS: Median values of biochemical parameters in prenatal 
screening tests may vary according to geographical regions.Newly found medians 
are different from than the default ones.This may be due to the large number of 
refugees coming to our country in recent years.Thus, in terms of maternal and 
fetal safety, each laboratory should calculate and use its own median values.
Keywords: double prenatal screening test, quadruple prenatal screening test, 
median value 
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OBJECTIVES:Between 11-14th weeks (1st trimester) ß-hCG and PAPP-A are 
examined from maternal serum to determine the risk of trisomy 21.Higher hCG 
values increase the risk of trisomy 21.HCG and TSH hormones consist of alpha 
and beta subunits and alpha subunits are structurally similar.High levels of HCG 
during pregnancy show thyrotropic effect by binding to TSH receptors.The aim 
of this study is to investigate the relationship between TSH and ß-hCG levels 
during the first trimester.
MATERIALS and METHODS:The study included 331 pregnant women 
investigated for first trimester scrreening and had TSH request simultaneously.
Of these 52 pregnants had also simultaneous free T4 requests.Total β-hCG and 
PAPP-A were studied on a Beckman-Coulter Access2 and TSH on a Roche Cobas 
6000 e601 analyzer.Risk analysis was performed in Benetech PRA software.The 
study group was divided in three subgroups according to TSH values:<0.1mIU/
L,0.1-2.5mIU/L and >2.5mIU/L as hyperthyroid,euthyroid and hypothyroid, 
respectively.The relationship between the analytes in these three subgroups was 
analysed and risk analysis was re-evaluated.
RESULTS:There was a negatively significant weak correlation between TSH 
and total β-hCG(r =-0.125; p<0.05) and TSH and Down syndrome risk(r=-0.147; 
p <0.01).There was no significant relationship between TSH and PAPP-A.There 
was a statistically significant difference between TSH subgroups for total β-hCG 
MoM(p=0.003).There was no significant relationship between TSH subgroups 
and total β-HCG.There was a nonsignificant weak correlation between T4 and 
TSH(r =-0.217; p>0.1), and free T4 with total β-HCG(r=0.203, p>0.1).
CONCLUSIONS:In the first trimester,increased hCG may affect the thyroid 
function.Therefore,thyroid disease and drug use should also be taken into 
consideration during pregnancy.
Keywords: TSH, maternal screening, down syndrome, correlation
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OBJECTIVES: Increased ß-hCG and inhibin-A values, decreased AFP and 
uE3 values increase risk of Down syndrome (DS). Higher AFP concentrations 
increase risk of NTD. The aim of this study is to calculate measurement 
uncertainty (MU) of analytes used in quadruple screening and to perform risk 
analysis again considering worst probability.
MATERIALS and METHODS: MU of each parameter was calculated according 
to Nordtest NTTR537 and ISO/TS21748 guidances. Analytes were studied 
on Beckman-Coulter Access2 analyzer and risk analysis was performed on 
Benetech PRA software. 200 consecutive patients were included; patients were 
divided into two groups as 35 years and older; and younger (n=20 and n=180, 
respectively). Cut-off values for DS and NTD were taken as 1/250 and 1/104, 
respectively. First risk analysis was compared with the worst probability risk 
analysis considering MU.
RESULTS: Extended MUs% of total ß-hCG, AFP, uE3 and inhibin-A analytes 
were ± 25.46, ± 21.82, ± 11.17 and ± 25.25, respectively. When all patients 
(n=200) were considered, 8 patients had a positive risk for DS and this number 
increased to 40. Risk for NTD increased from 2 to 5. In patients <35 years, risk 
for DS increased from 8 to 34, while the number for NTD did not change.
CONCLUSIONS: It was found that pregnant women with low risk were not 
affected but clinically significant risk increase was found in pregnant women 
with close to cut-off. MU can be given with test result in results close to cut-off 
value in prenatal screening tests. It would be useful to inform clinicians on this 
issue.
Keywords: Prenatal screening test, Measurement uncertainty, Risk estimation 
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OBJECTIVES:The management of preanalytical errors is important for efficient 
and reliable analyze of patient results. The objective of this study is to determine, 
classify and evaluate the frequency of sample rejections in the preanalytical 
phase.
MATERIALS and METHODS:The samples sent to our Laboratory between 
of January 1st 2019 and June 30th 2019 were analyzed.The data obtained were 
proportioned and all the rejection reasons were evaluated according to the 
frequency rates.
RESULTS:Between the dates mentioned above, our Laboratory received 950.554 
patient sample. 17.518 samples were rejected. Thus, 1,84% of all samples were 
rejected.The rejected samples were received from adult emergency(18.87%), 
intensive care units(11.59%), pediatric emergency(6.85%) and other services 
and clinics(62.69%).When all the results were analyzed, it has been found that 
the most frequent rejection rates were in neonatal intensive care unit(10,59%), 
pediatric cardiology(8.84%), infectious diseases service(8,69%) and child 
health and diseases department(7,31%).Comparing the rejection rates among 
the intensive care units, the highest rates were found in neonatal intensive care 
unit(10,59%), pediatric intensive care unit(4,92%) and thoracic surgery intensive 
care unit(4,86%).The most frequent causes of sample rejections within the test 
groups are found as insufficient sample(33,69%), hemolyzed sample(19,11%) 
and clotted sample(17,77%).Other rejection causes were found as taking samples 
at the wrong level, inappropriate test requests and samples which are not 
delivered to the laboratory.
CONCLUSIONS:Detecting and documenting the problems are important. 
Evaluating the results, a training program named “Bloodletting and Sample 
Transfer” was held in June. We aim to decrease the number of defined error rates 
through increasing the frequency of training programs.
Keywords: Preanalytical errors, sample rejection 
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Evaluation of analytical process performance of ethanol with Six Sigma 
values
Hediye Çiğdem Şimşek1, Sibel Çiğdem Tuncer1, Esra Dökümcü2, Murat Keleş3 
1Aksaray Education and Research Hospital, Turkey 
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OBJECTIVES:Today, within the scope of the performance evaluation of 
analytical quality, internal quality control (IQC) and external quality control 
(EQC) applications are made in clinical laboratories. On the other hand Sigma 
metrics have become a useful tool for all parts of the quality control (QC) design 
process. We aimed to evaluate the Six Sigma Methodology for Analytical Process 
Performance Assessment using ethanol test results in our study
MATERIALS and METHODS:The Analytical Process Performance was 
evaluated according to the Six Sigma methodology by taking advantage of the 
IQC and EQC results for April, May, June of 2019 for ethanol. Coefficient of 
variance (CV) was calculated from IQC for two level quality control material. 
Percentage bias for these parameters was calculated from the RIQAS. Total 
allowable errors were followed as per Clinical Laboratory Improvement 
Amendments (CLIA) guidelines.
RESULTS:QC-2 sigma values were found to be more than 6, but QC-1 sigma 
values were found be between 4 to 5.
CONCLUSIONS:Ethanol results for QC -1 level signifying more QC rules to 
be implemented. No significant difference was found in context to sigma value 
in April, May, June of 2019 ethanol results. Six Sigma Methodology allows 
laboratories to easily visualize performance, optimize the QC rules and numbers 
of control measurements.
Keywords: Six Sigma Methodology, Ethanol, Total allowable error, Bias, 
Coefficient of variance 
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Usability of exponentially weighted moving average on patient based 
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Deniz Ilhan Topçu1, Hikmet Can Çubukçu2, Merve Sibel Güngören3, 
Çiğdem Sönmez4 
1Department of Medical Biochemistry, Başkent University Faculty of Medicine, 
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4Medical Biochemistry Laboratory, Ankara Abdurrahman Yurtarslan Oncology 
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OBJECTIVES:Conventional quality control (QC) approach requires periodic 
analysis of QC samples within predetermined frequency which can be as few as 
once per day. As many systematic errors may be overlooked with this approach, 
patient-based QC monitoring real-time patient results has attracted attention. We 
aimed to investigate the usability of exponentially weighted moving average 
(EWMA) on patient-based QC via a simulation study.
MATERIALS and METHODS:Patient results within reference intervals 
representing normal distribution were generated for 10 analytes including 
sodium, potassium, calcium, urea, creatinine, AST, CRP, free thyroxine (fT4), 
thyroid stimulating hormone (TSH) and prolactin. 1,000,000 results (n=500 
per day, d=2,000) were produced. For each day, four gradually increasing 
systematic errors (SE) were added seperately starting from every 100th result. 
The maximum value of %SE added to the results was adjusted to correspond 
total allowable error(TEa). The average number of patient samples affected until 
error detection(ANPed) and optimum weighting factors for stated analytes were 
determined. ANPed-%SE graph was plotted to calculate the area under the curve 
(AUC) and reveal optimum weighting factors.
RESULTS:Optimum weighing factors and corresponding minimum AUC values 
are 0.1;16.1, 0.1;38.7, 0.1;12.7, 0.4;3.7, 0.1;9.17, 0.1;10.5, 0.1;28.8, 0.2;1.21, 
0.1;36.3 and 0.1;23.9 for AST, CRP, fT4, calcium, creatinine, potassium, 
prolactin, sodium, TSH and urea, respectively. Weighting factors greater than or 
equal to 0.5, 0.7, 0.8 and 0.5 were found to be unable to detect any %SE up to 
TEa for calcium, TSH, urea and potassium, respectively.
CONCLUSIONS:Outcomes of present study elucidated both optimum and 
useless weighting factors of EWMA for 10 common analytes.
Keywords: Exponentially Weighted Moving Average, Patient Based Quality 
Control, Quality Control, Systematic Error, Quality Management 
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Assessment of critical values notification in a Turkish clinical biochemistry 
laboratory
Medine Alpdemir, Mehmet Fatih Alpdemir 
Clinical Biochemistry Laboratory, Balıkesir State Hospital,, Balıkesir, Turkey 
OBJECTIVES:The critical values are the laboratory testing results which 
required attention or action by the physicians. The aim of this study was to 
investigate critical value results from our laboratory and compare our critical 
value prevalence with others in the literature
MATERIALS and METHODS:The study was conducted by retrospectively in 
the Balıkesir State Hospital. In this retrospective study, We performed analysis 
of critical values from data obtained by the laboratory information system during 
2 years. The critical results were identified by clinical chemistry laboratory 
according to guidelines.
RESULTS:The critical values was found by 0.5% of total laboratory tests. 
We determined 4736 critical values notification, of which 20.4% came from 
emergency units, 44.9% from intensive care units, 15.3% from routine inpatients 
and 19.4% from routine outpatients. The highest rate of critical values was shown 
for oxygen partial pressure(pO2) (21.1%), followed by white blood cell(WBC) 
and platelet (PLT)(11.7% and 10.9%) concentrations. According to department, 
the highest rate of the critical value notification were pO2, glucose, WBC and 
potassium ion concentrations for emergency patients, were PLT, WBC, and 
hemoglobin phosphate concentrations for inpatients and, were WBC, pO2 and 
prothrombin time concentrations for outpatients. Mean time for notification for 
all departments was 12 min.
CONCLUSIONS:The analysis of critical values notification in our hospital is 
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in suitable with that declared in the literature. This study will contribute in the 
establishment of international harmonized postanalytical phase-related criteria 
and indicators of the critical values notification
Keywords: Critical values, critical values notification, post-analytical phase, 
patient safety  
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Monitoring of quality indicators in preanalytical phase of laboratory 
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Ozlem Ozbas Demirel, Dogan Yucel 
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Center, Health Sciences University, Ankara, Turkey 
OBJECTIVES:Quality indicators (QIs) are fundamental tools enabling users 
to quantify the quality of laboratory services. Preanalytical variables account 
for 32-75% of laboratory errors and encompass the time from when the test 
is ordered by the physician until the sample is ready for analysis. Aim of this 
study is to quantify performance in the pre-analytical phase of testing in Medical 
Biochemistry Laboratory of SBÜ Ankara SUAM using quality indicators and to 
assess the quality of our laboratory services.
MATERIALS and METHODS:Pre-analytical process error data between 1 
st July 2017 – 31 st June 2019 were obtained from the laboratory information 
management system. Every type of error percentages have been calculated and 
evaluated according to the Quality Indicators developed by the IFCC Working 
Group on “Laboratory Errors and Patient Safety” (WG-LEPS).
RESULTS:A total of 2 496 748 samples received to our laboratory. 33 939 of 
them were rejected, giving a rejection rate of 1.4 %. The main causes of sample 
rejection were clot formation (38.3%) and hemolysis (32.3%). The other sample 
rejection reasons were inadequate sample volume (24.4 %), incorrect samples 
(7.8%) and missing tests (4.5%). When these results were compared with 
specifications of IFCC (WG-LEPS): QI-7, QI-9, QI-10 and QI-12 were found to 
be within optimal level whereas QI-11 was within desirable range. Sigma values 
also were within acceptable range.
CONCLUSIONS:The preanalytical performance of our laboratory is favorable 
and complies with international quality specifications.
Keywords: Preanalytical error, quality indicator, sigma metric
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2Department of Medical Biochemistry, Dogubayazit Dr. Yasar Eryilmaz State 
Hospital, Agri, Turkey 
3Department of Medical Biochemistry, Faculty of Medicine, Hacettepe 
University, Ankara, Turkey 
OBJECTIVES:The primary purpose of medical laboratories is to provide the 
most accurate and reliable results appropriate to the patient’s medical condition. 
Therefore, the reliability of each laboratory must be scientifically proven. 
Approximately 15% of laboratory errors occur in the analytical phase. To evaluate 
the analytical process of laboratory, we aimed to perform performance evaluation 
according to six sigma methodology. The tests evaluated for this purpose; 
albumin(Alb), alanine aminotransferase(ALT), aspartate aminotransferase(AST), 
chlorid(Cl), total cholesterol(TChol), creatinine(Crea), glucose(Glu), HDL 
cholesterol(HDL-C), lactate dehydrogenase(LD), potassium(K), total 
protein(TP), sodium(Na), triglyceride(Tg) and blood-urea-nitrogen(BUN).
MATERIALS and METHODS:Mean, standard deviation(SD) and coefficients 
of variation(%CV) were calculated from the 1-month internal quality control 
data of the 14 most frequently used biochemistry parameters in the laboratory 
(Roche-Cobas-c501). Bias was determined using the control target value of the 
firm. Acceptable total error(%Tea), was determined according to the CLIA and 
Turkey(TR) criteria. Sigma values were calculated via (%TEa -% Bias)/%CV 
formula. According to sigma levels; <3 unacceptable; 3–6 are acceptable; ≥6 
world-class performance, divided into three groups.
RESULTS:According to the CLIA sigma assessment, both levels of Cl and Na 
and the second level of Alb’s performance were unacceptable, other tests were 
found to be acceptable or world-class performance while according to TR sigma 
assessment, all tests were acceptable or world-class performance.
CONCLUSIONS:Sigma measurements should be routinely performed in 
laboratories to assess the analytical period performance of the laboratory and 
improve its quality through regulatory preventive actions. Our study allowed 
us to see and improve our measurement quality by determining the 1-month-
periodic performance of laboratory tests.
Keywords: Internal quality control, Analytical performance assessment, Six 
sigma methodology, Total allowable error (Tea) 
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OBJECTIVES:Vitamin D deficiency is a public health concern worldwide and 
defined as a 25(OH) vitamin D3 (25(OH)D) level less than 12 ng/mL. This study 
aimed to evaluate the 25(OH)D levels in the clinical laboratory of Bursa Uludag 
University and estimate vitamin D deficiency in adults.
MATERIALS and METHODS:The results of 25(OH)D levels from 44873 
outpatients (13417 males, 31417 females) aged 18-65 years were collected from 
the laboratory information system for a period of 3 years. Chemiluminescent 
Microparticle Immunoassay on Architect i2000SR analyzer of Abbott was 
used for the measurement of 25(OH)D levels. The Architect 25(OH)D assay 
demonstrated linearity from 3.4 to 155.9 ng/mL.
RESULTS:Vitamin D levels lower than 12 ng/mL were observed in 17532 of 
44873 patients in total (39.0%), 3641 of 13417 males (27.1%) and 13891 of 
31417 females (44.1%). The median values of all subjects, males and females 
were 14.4, 17.1 and 13.2 ng/mL, respectively. The mean (+/- SD) vitamin D 
levels of all subjects was 17.48 +/- 14.1 ng/mL with the value for females being 
lower at 16.77 +/- 14.7 ng/mL com¬pared to males at 19.10 +/- 12.2 ng/mL and 
the difference was statistically significant (p<0.001).
CONCLUSIONS:The prevalence of low vitamin D levels may be increasing 
globally. Data from the NHANES in the US showed a decrease in mean 25(OH)
D concentrations from 24 to 19.9 ng/mL. However, our data shows that in Turks 
25(OH)D concentrations are lower than these values and vitamin D deficiency 
may be more prominent in Turkey.
Keywords: 25(OH) vitamin D3, Vitamin D deficiency, Turkish adults, 
Laboratory data 
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Determination of whole blood reference ıntervals from hospital data – 
A Bhattacharya analysis
Ayşenur Macun Ayan, Emel Çolak Samsum, Neslihan Cihan, Gül Kırtıl, 
Mehmet Şeneş, Doğan Yücel 
Health Sciences University, Ankara Health Research and Training Center, 
Department of Medical Biochemistry 
OBJECTIVES:Determination of reference intervals (RIs) by direct method is 
difficult and expensive. Therefore, many laboratories use the RIs recommended 
by the manufacturer. This may cause problems due to ethnic, genetic and 
environmental differences. In our study, we aimed to determine the RIs of the 
parameters measured in blood cell count (BCC) by using the patient data recorded 
in the Hospital Information Management System (HIMS) and to compare them 
with those used in our laboratory.
MATERIALS and METHODS:Between January-December 2017, 101071 
patients who applied to outpatient clinics of eye, ear nose and throat, physical 
therapy rehabilitation, urology, orthopedics, general surgery, plastic and 
reconstructive surgery, intact children, internal medicine and health board were 
included in the study. BCC parameters were analysed by Sysmex XN-3000 and 
XN-2000 instruments. The RIs were calculated separately for the female and 
male sexes for the 11-14, 15-20, 21-29, 30-39, 40-49, 50-64 and ≥65 age groups 
27-31 October 2019Turkish Journal of Biochemistry, 2019
XXVII. Balkan Clinical Laboratory Federation Meeting BCLF 2019 
XXX. National Congress of the Turkish Biochemical Society TBS 2019
Turk J Biochem, 2019; 44 (S3) http://www.TurkJBiochem.com106
and without discrimination of gender in the 1-10 age group by using indirect 
Bhattacharya method. IBM SPSS Statistics 22 program was used to exclude 
outliers and macros prepared in Microsoft Excel was used in calculations.
RESULTS:Most of the calculated RIs were consistent with the RIs that currently 
used in our laboratory. However, there were differences in the RIs of hemoglobin, 
RBC, MCH, MCHC, RDV-CV, PLT and HCT in different age and sex groups.
CONCLUSIONS:RIs can be determined by indirect method according to IFCC 
and CLSI recommendations from big data stored in HIMS. This approach may 
add value on patient safety.
Keywords: reference intervals, big data, bhattacharya analysis, blood cell count 
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OBJECTIVES:To decide for further testing, the percentages of mean/median 
enzyme activity of individuals, and cutoff are needed for biotinidase (BTD) 
deficiency and galactosemia (GALT), respectively. Each laboratory that performs 
screening tests should estimate these decision levels. The mean (263 Enzyme 
Unit-Eu) and the cut-off (3.5 U/g Hb) were determined for BTD and GALT, 
respectively. The reference intervals (RIs) are being estimated from big data. Our 
aim is to assess whether these values determined from small numbers of healthy 
newborns will be similar with the values estimated by the indirect methods for 
determination of RIs.
MATERIALS and METHODS:The histograms and Q-Q Plots of 33998 BTD, 
and 23438 GALT screening results generated in Tanyalçın Laboratory from 
2004 were evaluated. The RIs were estimated according to the Hoffmann and 
Bhattacharya Methods. The Microsoft Excel and SPSS Statistical Package were 
used.
RESULTS:Hoffmann METHOD: The data was separated into two sets according 
to the Q-Q Plots. The outliers were removed using the Tukey’s Method. The 
mean (SD), median, 2.5-97.5 percentiles are estimated as 247(81), 254, and 80-
384 Eu (N=33226) for BTD; and 8.29(2.21), 8.36, 3.75-12.79 U/g Hb (N=21309) 
for GALT, respectively. Bhattacharya Method: The center (SD), lower-upper 
limits were found as 270(84) and 102-438 Eu (N=33 364) for BTD (h=30), and 
9.5(3.09), 3.30-15.69 U/g Hb (N=22862) for GALT (h=2), respectively. The 
values determined were compatible with the decision levels estimated before.
CONCLUSIONS:The indirect methods for RI determination from big data can 
be helpful for verification of decision levels for the screening tests.
Keywords: Indirect methods, reference interval, big data, biotinidase 
deficiency, galactosemia 
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Reference values of neutrophil-lymphocyte, lymphocyte-monoctye,
platelet-lymphocyte ratio and mean platelet volume in healthy adults
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OBJECTIVES:This study was designed to evaluate the gender and age-specific 
reference values of neutrophil-lymphocyte ratio (NLR), lymphocyte-monocyte 
ratio (LMR), platelet-lymphocyte ratio (PLR) and mean platelet volume (MPV) 
which are indicative of systemic inflammation.
MATERIALS and METHODS:The results of the patients admitted to the 
outpatient clinics of our hospital were collected between January 2017 and July 
2019. Total number of patients was 249 829; 100 195 (40.1%) were male and 149 
634 (59.9%) were female. Parameters were measured by Sysmex XN 2000 and 
3000 analyzers. The patients were classified according to gender and age groups. 
In the total population and in each subgroup, the healthy group was selected by 
Bhattacharya procedure and the reference ranges of NLR, LMR, PLR and MPV 
were determined.
RESULTS:Patients were divided into 8 groups according to age (1-10, 11-14, 
15-20, 21-29, 30-39, 40-49, 50-64,and over 65 years). In the total population 
reference ranges were found as1.12-6.21, 8.71-11.97,0.30-2.41,39.9-156 for 
LMR,MPV,NLR and PLR, respectively. Reference ranges for each age range 
and sex were also evaluated. NLR was higher in females than males except for 
patients over 65 years of age. Similar results were found for MPV in both sexes 
and in all age groups. LMR was found to be higher in females in all age groups, 
but this difference was increased between 15-20 years and over 50 years. PLR 
was found to be higher in females than males in most age groups.
CONCLUSIONS:Different reference intervals may be used according to gender 
and different age groups for LMR,MPV,NLR and PLR.
Keywords: Neutrophil, Lymphocyte, Monocyte, Platelet, Inflammation 
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OBJECTIVES:The aim of this study was to establish reference intervals 
according to laboratory data in a population and to assess the vitamin B12 (B12) 
and folate status related to reference intervals for all age and sex groups.
MATERIALS and METHODS:The results were obtained retrospectively from 
the laboratory information system of Balıkesir State Hospital. The 20318 patients 
(70.2 % for female, 29.8% for male) between 18- 80 ages were selected. The ages 
groups of the patient was separated into six subgroups (18–30, 31–40, 41–50, 
51–60, 61–70 and 71-80 years). B12 and folate concentrations were measured by 
ARCHITECT i2000sr (Abbott Diagnostics, Abbott Park, IL, USA) autoanalyzer. 
Extreme values were excluded by using IBM SPSS. The central %95 reference 
intervals were calculated using non-parametric method.
RESULTS:The results of 20850 patients for B12 and 14183 for folate were 
evaluated. The mean+SD years of patients for B12 and folate were 48.9±16.3 
and 49.7±16.6, respectively. Mean+SD concentrations of B12 and folate were 
298±108 pg/mL and 6.15±2.78 ng/mL, respectively. 95% reference intervals 
were calculated to 144-536 pg/mL for vitamin B12 and 2.3-14.6 ng/mL for 
folate. There are statistically significant differences between female and male 
for B12 and folate. There is a significant difference between the age groups for 
folate, but there is not a significant difference for B12 concentrations.
CONCLUSIONS:In this study was found differences between the reference 
ranges recommended by the manufacturer and the reference ranges of our own 
population. Our results indicate that is important to determine the true reference 
range.
Keywords: Vitamin B12, Folate, Reference range, Laboratory data, Turkiye 
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Review of repeated anti-TPO test requests
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İzmir, Turkey 
OBJECTIVES:Serum anti-TPO measurements are useful in the diagnosis of 
autoimmune thyroid diseases and are often sufficient by themselves. Elevated 
levels are seen in postpartum thyroiditis and Graves’ disease as well as 
Hashimoto’s thyroiditis. There isn’t any relationship between anti-TPO levels 
and thyroid function. In the follow-up of patients with Hashimoto’s thyroiditis 
who had high anti-TPO levels, we aimed to compare whether the frequency of 
recurrent anti-TPO requests decreases with the measures taken.
MATERIALS and METHODS:Anti-TPO test is performed by chemiluminescence 
method on Advia Centaur XPT (Siemens) analyzer in our laboratory. The anti-
TPO tests that were studied in 2017 and 2018 from the LIS were examined. 
RESULTS:16,060 anti-TPO tests were conducted in 2017 and 14,130 in 2018. 
The number of patients who underwent 3 or more anti-TPO tests in 2017 was 
223 (789 tests), while in 2018 there were 59 patients (181 tests). While anti-TPO 
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levels were high in 98 (44%) of the patients who underwent titer monitoring in 
2017, it was found to be high in 40 patients (68%) in 2018.
CONCLUSIONS:The necessity of antibody titer monitoring is controversial in 
patients who have high anti-TPO levels with Hashimoto thyroiditis. Repetitive 
anti-TPO orderings in diagnosed autoimmune thyroid patients are examples of 
unnecessary testing. We think that it would be beneficial to display a warning 
message during the test request in patients with a high anti-TPO level, as well as 
a time limit test. The collaboration with the clinics that want this test the most has 
led to a reduction in unnecessary anti-TPO orderings.
Keywords: anti-TPO, Hashimoto tiroiditis, unnecessary test request 
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OBJECTIVES:To evaluate laboratory data of subclinical hypothyroidism 
(S-HYPO) and subclinical hyperthyroidism (S-HYPER) on outpatients, 
frequencies, gender and age distribution and causes.
MATERIALS and METHODS:We performed an epidemiologic study including 
144 outpatients, 21 men and 123 women, mean age 50.11yr, for 4 months, with 
thyroid-stimulating hormone (TSH) outside reference range. Serums of these 
patients were stored in freezing and tested for anti-thyroglobulin antibodies by 
ELISA.
RESULTS:We have done 599 TSH tests, 144 cases had TSH outside reference 
range and 415had normal levels. S-HYPO has a frequency of 12.5% while 
S-HYPER has a frequency of 8.4%. Subclinical thyroid diseases are found more 
often in females with 87% to 13% males. Aged <65yr has a frequency of 84% 
in S-HYPO and 62% in S-HYPER, while the age group ≥65yr has a frequency 
of 16% and 38% respectively. We measured 91 outpatients for anti-TG and got 
21 positive tests, including 11 tests positive for anti-TPO, autoimmune disease is 
present on 27.4% of patients, multinodular goiter on 9.4%, iatrogenic cause on 
9.4% and for 53.8% of patients we don’t have a given cause.
CONCLUSIONS:S-HYPO is more frequent than S-HYPER. The gender 
distribution gives female dominance, the ratio male/female is 1/6.8. In S-HYPO 
dominate young ages and in S-HYPER dominate older ages. The mild form of 
S-HYPO is much more frequent than severe form, approximately 8 times more 
common. The mild form of S-HYPER is 2 times more frequent than its severe 
form, on both diseases dominate mild forms respectively with 88.6% and 68%.
Keywords: Thyroid stimulating hormone, anti-TG, hypothyroidism, 
hyperthyroidism, subclinical 
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OBJECTIVES:In this study, neutrophil to lymphocyte ratio (NLR), platelet to 
lymphocyte ratio (PLR) and mean platelet volume (MPV) were investigated in 
adult patients with hypothyroidism.
MATERIALS and METHODS:The records of 496 hypothyroid patients and 5677 
euthyroid healthy individuals were compared from the laboratory information 
system between 10 July 2018 and 09 April 2019.
RESULTS:In the hypothyroid group, free triiodothyronine (f T3), leukocyte, 
neutrophil and NLR values were lower, thyrotropin (TSH), platelet, PLR, MPV 
values were higher, free thyroxine (f T4) and lymphocyte values were similar 
when compared with the euthyroid healthy group.
CONCLUSIONS:In adults with hypothyroidism, platelet count, PLR and MPV 
values are higher than euthyroid healthy individuals, while leukocyte, neutrophil 
and NLR levels are low and lymphocyte count is similar.
Keywords: Hypothyroidism, neutrophil to lymphocyte ratio, platelet to 
lymphocyte ratio, mean platelet volume 
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OBJECTIVES:Drugs that inhibit histone deacetylase (HDAC) activity show 
anti-tumor effect in many studies.Vorinostat (SAHA) has numerous applications, 
including inhibition of malignant cells growth.Curcumin, naturally occurring 
polyphenol thought to be the newest member of HDAC with potential pro-
apoptotic properties.The purpose of the presented study was to investigate the 
apoptotic effects of Curcumin in combination with Vorinostat on the Papillary 
Thyroid Cancer (PCT) cells.
MATERIALS and METHODS:Experimental study performed with cell culture 
from BCPAP cell line.Firstly, Cell viability was assessed using MTT assay 
following treatment with Curcumin and/or SAHA for 24, 48h.Calcusyn assay 
used for determination of synergistic dosages of the agents.Apoptotic effects of 
these agents were marked by Annexin V apoptosis assay and detected by Flow 
Cytometry.Data were analyzed by the GraphpadPrism statistical program.Values 
represent the mean ± SD (n = 3).
RESULTS:According to MTT assay, IC50 values at 48 hour was found 20.97µM 
and 0.91 µM for Curcumin and SAHA, respectively.Combination treatment 
of the agents showed markedly synergistic effects (CI = 0.891).Synergistic 
concentrations (9.33 µM for Curcumin, 0.40 µM for (SAHA) were used for later 
experiments.Curcumin and SAHA alone induced apoptosis at IC50 values while 
their combination at lower dosages induced synergistic effects.
CONCLUSIONS:The experimental evidence from this study suggests that 
combination of Vorinostat and polyphenol Curcumin shows synergistic effect 
which induces apoptosis on PCT cells.Combination of Curcumin and SAHA may 
be the subject of further study in animal models to determine doses which can 
exert significant effects in PCT cells and can enhance the therapeutic effect.
Keywords: Curcumin, Vorinostat, BCPAP, Synergism, Apoptosis 
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OBJECTIVES:Cell based cytotoxicity studies aim to investigate the cellular 
effects of various chemicals. Dose efficiency may change according to the 
cell type and also the test chosen. DMSO (dimethy sulfoxide) is a widely used 
compound that cause cellular death. We aimed to compare 4 different cell 
cytotoxicity tests for their sensibility in the L929 fibroblast cell line.
MATERIALS and METHODS:L929 cells were maintained in Dulbecco’s 
Modified Eagle Medium Supplemented with 10 % fetal bovine serum at 37 °C 
and 5 % CO2 in a humidified incubator. DMSO concentrations were 0.05%, 
0.5%, 1%, 2 % and cells were incubated for 24 h and 48 h. Cytotoxicity was 
determined with lactate dehydrogenase leakage assay (LDH), neutral red assay 
(NR), methyl tetrazolium (MTT) assay and crystal violet assay (CV).
RESULTS:Most sensitive result was obtained from CV test but the results were 
compatible with MTT and LDH assay results. In the comparison of MTT and 
LDH, LDH results showed higher selectivity for membrane damaged cells. On 
the contrary, NR assay results showed low sensitivity when compared to other 
test for all concentrations.
CONCLUSIONS:In the present study, we analyzed four different test for their 
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efficiency in the evaluation of cytotoxicity according to their mode of action. For 
L929 cells, CV is most convenient method for evaluating DMSO toxicity. For 
each cell line it is necessary to begin with the determination of chosing suitable 
cytotoxicity test in order to increase the accuracy of the work.
Keywords: Cytotoxicity, DMSO, MTT, LDH, NR
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OBJECTIVES:Flusilazole is an organosilicon compound, a triazole fungucide 
which is used for protection of crops. Its presence was reported in cereals and 
cereal based products. Flusilazole was reported to cause leydig cell tumor 
in mice for 2 weeks exposure, and testosterone and androstenedione levels of 
leydig cells decreased in response to flusilazole doses. However no report was 
exist on Sertoli cells. Sertoli cells have important role in spermatogenesis, two 
adjacent Sertoli cells compose Sertoli cell barrier. The aim of the study is to 
reveal possible cytotoxic effects of flusilazole on SerW3 cells mimicking in vitro 
Sertoli cell.
MATERIALS and METHODS:SerW3 cells (17 days old rat Sertoli cell) were 
cultured and flusilazole was exposed at concentrations of 0, 25, 100 and 200 µM 
for 24 hours. MTT and acridine orange/propidium iodide cell viability assays 
were performed in response to flusilazole in SerW3 cells. Additionally, Sudan 
Black B staining was performed for lipid droplet detection quantitatively and 
also examined under light microscope.
RESULTS:Flusilazole treatment caused decreases in cell viability in a dose-
dependent manner according to MTT assay results. Acridine orange/Propidium 
iodide cell viability assay revealed that flusilazole induced apoptotic cell death 
at high doses. Sudan Black B staining results showed that lipid droplets of the 
SerW3 cells decreased in response to flusilazole concentrations.
CONCLUSIONS:Results of the study revealed that azole based fungucide 
flusilazole induced cytotoxicity as well as it caused decreases in lipid droplet 
accumulation which is essential for Sertoli cell function. This research was 
financially supported by Hacettepe University, Scientific Research Projects 
Coordination Unit (Project No: FHD-2018-17594).
Keywords: Flusilazole, cytotoxicity, SerW3 cells
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Investigation of combine effects of propylparaben and methylparaben on 
pituitary-adrenal axis in male rats
Nurhayat Barlas, Eda Nur Inkaya, Nilüfer Coşkun 
Department of Biology, Hacettepe University, Ankara, Turkey 
OBJECTIVES:Propyl paraben and methyl paraben, which are generally 
preferred in combination, are chemicals that are used as preservatives in many 
pharmaceutical, food and cosmetic products. Therefore, we are frequently 
exposed to parabens known to have endocrine disrupting effects in our daily 
lives. The purpose of the study is to investigate the endocrine disrupting effect of 
methyl paraben and propyl paraben on the pituitary-adrenal axis.
MATERIALS and METHODS:In this study, 6 experimental groups were 
designed as 3 control groups (negative, oil and positive control 50 mg/kg bw/day 
Bisphenol A) and 3 treatment groups (10, 100 and 500 mg/kg bw/day) by mixing 
1:1 ratio of methyl paraben and propyl paraben. Doses were administered to the 
42-day-old male rats by oral gavage for 30 days.
RESULTS:At the end of the experiment, adrenocorticotrophic hormone, cortisol, 
aldosterone, androsterone, dihydrotestosterone hormone levels and biochemical 
values were measured in serum samples. Histopathological effects of pituitary, 
adrenal glands and liver, kidney tissues which are important in metabolism of 
toxic substances were investigated.
CONCLUSIONS:In histopathological findings, degeneration, congestion 
and edema were detected in the tissues. Also, serum cortisol, aldosterone, 
adrenocorticotrophic hormone and androsterone levels increased in 100 mg/kg 
bw/day MP+PP and 50 mg/kg bw/day BPA, serum dihydrotestosterone hormone 
increased in 10 mg/kg bw/day MP+PP, 500 mg/kg bw/day MP+PP and 50 mg/
kg bw/day BPA and serum triglyceride levels increased in 100 mg / kg bw/day 
MP+PP dose group, results showed that propyl paraben and methyl paraben have 
an effect on HPA axis hormonal activity.
The authors thank to Scientific Research Unit of Hacettepe University (Project 
No: FHD-2018-17085).
Keywords: Propyl paraben, methyl paraben, endocrine disruptors, male rats 
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Şeyma Nur Yıldız1 
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OBJECTIVES:Trace elements are defined as chemicals present in minimal 
quantities.Some of these elements including iodine, iron, and selenium are 
also entitled to micronutrients.Iodine is an essential component of the thyroid 
hormones.Therefore, various metabolic and neurologic disorders have been 
associated with iodine deficiency (ID).ID is a threat throughout the lifecycle. The 
effects of inadequate iodine intake change according to the stage of lifecycle.
The study aimed to assess the iodine status and maternal thyroid function in the 
pregnant women in Sivas that is a city in central Turkey.
MATERIALS and METHODS:This study was performed with the collaboration 
of Cumhuriyet University Department of Biochemistry and Department 
of Obstetrics and Gynecology and Sivas Numune Hospital Department of 
Obstetrics and Gynecology between 2015 and 2016.One Hundred-ninety-
three pregnant women in their second trimester who attended the hospital for 
routine antenatal care were included this study.Morning spot urine samples 
were collected in deiodized test tubes.Urine iodine levels were determined by 
colorimetric modified Sandell Kolthoff method.
RESULTS:The range of gestation week was 5th-13th in all locations. Median 
gestation weeks were 8 weeks 2 day, 8 weeks, 8 weeks 4 day,10 weeks, 7 
weeks 2 day and 8 weeks in Sivas Centre,Şarkışla,Suşehri,Gürün,Divriği, 
and Kangal,respectively.Median ID levels of pregnant women living in 
Şarkışla,Suşehri,Gürün,Divriği,and Kangal indicated inadequate iodine intake.
CONCLUSIONS:Our results indicated that iodine deficiency is a significant 
problem in Sivas. Therefore, there is a need policy such as iodine prophylaxis for 
women living in Sivas to eliminate this problem. Finally, these are only 
preliminary findings, and further investigations with larger samples are 
warranted.
Keywords: Urine iodine, Sivas, Pregnant women 
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Changed iron homeostasis in sleeping apnea patients
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OBJECTIVES:Obstructive sleep apnea syndrome (OSA) is defined as a 
combination of symptoms as a result of intermittent, recurrent constraint and 
/ or complete airway overhead airway overflow (sleep disturbance). OSA is 
associated with the development of insulin resistance, arterial hypertension, 
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metabolic syndrome, systemic atherosclerosis and increased cardiovascular risk.
MATERIALS and METHODS:40 patients with OSA were included. Their 
results were compared to sex and age matched healthy control. CBC, serum iron, 
ferritin, hsCRP, hepcidin, homocysteine and vitamin B12 were measured in the 
included groups. Intima media thickness (IMT) and Flow mediated dilatation 
(FMD) were used for atherosclerotic changes evaluation.
RESULTS:We found increased serum hepcidin levels in OSA patients with 
IMT and FMD changes (121.7 ± 11.9 μg/L) compared to control group (20.4 
± 1.8 μg/L); P<0.005. A positive correlation was found in OSA patients with 
atherosclerotic changes between IMT and FMD to serum hepcidin levels 
(r=0.859, r=0.871, resp.; P<0.05). Serum hepcidin correlates positively to 
homocysteine and vitamin B12 in OSA patients (r=0.902, r=0.911, resp.; 
P<0.005).
CONCLUSIONS:Brain-vascular disease risk factors are connected to 
obstructive sleep apnea syndrome. Disregulation of iron homeostasis is one of 
the main risk atherogenesis factors. Early hepcidin quantification might predict 
an atherosclerosis occurrence in OSA patients, which might be very important 
for better clinical diagnosis and practice. 
Acknowledgements: This project is sponsored by MU-Sofia, as part of Grant 
Д-52/2018.
Keywords: sleep apnea, iron, hepcidin 
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Comparison of urine analyzers LabUMat2-with-UriSed2 and Sysmex UC-
3500/UF-5000
Çağatay Hasip, Tuğba Öncel, Serap Çuhadar, Huriye Erbak Yılmaz, 
Ayşenur Atay, Figen Narin 
Department of Biochemistry, Izmir Katip Çelebi University, Atatürk Training 
and Research Hospital, Izmir, Turkey 
OBJECTIVES:Instrument method comparison experiments are based on the 
comparison of the results obtained by analyzing the samples with the new test 
method and the previously accepted method. In this study, we aimed to compare 
LabUMat2-with-UriSed2 and Sysmex UC-3500/UF-5000 analyzers in urine 
examination.
MATERIALS and METHODS:The urine samples of thirty patients were studied 
on LabUMat2-with-UriSed2 and Sysmex UC-3500/UF-5000 analyzers. Density, 
pH, RBC, WBC, hyaline casts, yeast, squamous epithelial cells, non-squamous 
epithelial cells were recorded for each patient. The distribution of the data was 
examined and the correlations were checked.
RESULTS:LabUMat2-with-UriSed2 and Sysmex UC-3500/UF-5000 analyzers 
showed that the density, pH, RBC, WBC, squamous epithelial cells and non- 
squamous epithelial cells correlated significantly (r = 0.803, p = <0.001; r = 
0.950, p = < 0.001; r = 0.730, p = <0.001; r = 0.695, p = <0.001; r = 0.437, p 
= 0.016; r = 0.377, p = 0.040, respectively), but hyaline casts and yeast cells 
showed no correlation (p> 0.05) statistically.
CONCLUSIONS:The results obtained for density, pH, RBC, WBC, squamous 
epithelial cells and non-squamous epithelial cells were compatible with each 
other, however hyaline casts and yeast cells were not. Hence, it maybe considered 
that manual microscobic confirmation can be beneficial for pathological urine 
samples.
Keywords: urinalysis,correlation,analyzer comparison 
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University, Trabzon, Turkey 
OBJECTIVES:Urinalysis is a chemical and microscopic analysis of urine and 
is frequently performed in clinical laboratories. Urinalysis is often required for 
evaluation of hematuria and urinary tract infections. Autoverification is a process 
of using an algorithm-based program where criteria are defined and approving 
the samples that meet all criteria without user intervention. The aim of this study 
is to evaluate the results with the use of autoverification in urine autoanalyzer in 
our laboratory.
MATERIALS and METHODS:This study was performed between May and 
August 2019 in Beckman Coulter IQ 200 Elite urine autoanalyser. The rules 
were defined by the iware program to the urine autoanalyzer. While the results 
that were in compliance with all the rules were automatically verified, the test 
results that did not follow the rules were taken to perform manual operation on 
the analyzer.
RESULTS:When the three-month period was examined, it was observed that 
28113 samples analyzed in total and 11371 of these samples were autoverified. 
The rate of autoverified results was 40.4%.
CONCLUSIONS:With the use of the autoverification, it was observed that 
a significant part of the results did not require user intervention so laboratory 
technicians can spend more time on incompatible results of chemical and 
microscopic analysis. Thus, it is obvious that Turn Around Time will be reduced. 
We believe that the autoverification will alleviate the increased workload of 
clinical laboratories and save the energy and time that laboratory experts can 
allow time to other clinical studies.
Keywords: Autoverification, Urinanalysis 
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Comparison of Iris iQ200 urine analyzer performance and manual 
microscopy in examination of urine sediments
Ismet Gamze Kutluay, Iclal Geyikli Çimenci, Mustafa Örkmez, 
Mehmet Tarakçıoğlu 
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OBJECTIVES:Complete urinalysis is one of the most widely used tests in clinical 
laboratories today. Urine analysis is an inexpensive, time-saving, easily applicable 
diagnostic tool that provides important information about kidney function. 
Although manual analysis applications are standardized, conventional 
microscopy of urine sediment is labor intensive, time-consuming, uncertain, 
and varies widely. Automated urine analysis saves time and labor. 
The aim of this study was to evaluate the performance of urine analyzer Iris 
iQ200, which has an image-based analysis system using a video camera, by 
comparing it with manual microscopy.
MATERIALS and METHODS:Freshly collected urines of 30 patients 
who presented to Gaziantep University Medical Faculty and whose urine 
examinations were requested by the physicians were studied. After chemical 
analysis and microscopic examination with the Iris iQ200 autoanalyzer, the 
remaining urine sample was centrifuged at 1500 rpm (400g) for 5 minutes, and 
the resulting sediment was evaluated for erythrocytes, leukocytes and crystals 
using manual microscopy.
RESULTS:The consistence between Iris iQ200 analyzer and Pearson correlation 
analysis was used to assess manual microscopic results. In the comparison of 
the two methods, the erythrocyte correlation coefficient was r=0.999, the crystal 
correlation coefficient was r=0.495, and the leukocyte correlation coefficient was 
r=0.725.
CONCLUSIONS:Between the two methods, high level of consistency in the 
erythrocyte analysis, moderate level of consistency in the crystal analysis, 
high level of consistency in the leukocyte analysis were observed. Compared 
to manual microscopy, the Iris iQ200 instrument tested in this study showed 
satisfactory analytical performances for erythrocytes and leukocytes.
Keywords: Iris Q200; automated urine sediment analyzer; urine microscopy; 
urine sediment 
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Istanbul,Turkey 
OBJECTIVES:Measurement of 24-h protein excretion is the reference method 
for determination of urinary protein excretion. Because of patient incompliance, 
protein/creatinin ratio (P/Cr) in spot urine is commonly used. In this study, 24-h 
urine specimen protein levels and P/Cr ratios in spot urine were compared.
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MATERIALS and METHODS:Retrospectively, datas of outpatients and 
inpatients included between 1st January 2018 and 1st May 2019. Urine protein 
was measured with colorimetric method by Beckman Coulter 5800 analyzer. 
Urine creatinine was measured with Jaffe method by Beckman Coulter 5800 
analyzer. Cases (n=157) were separated into 3 groups according to P/Cr ratios 
0-0.2 (n=71), 0.2-2 (n=56), >2 (n=30)). Kolmogorov-Smirnov test is used 
for homogenity of groups. Due to p<0.05 was applied Spearman correlation 
analysis. Descriptive statistics and correlation analysis were calculated by SPSS 
version 22 statistical programme.
RESULTS:In each group, we compared spot urine P/Cr ratios with 24-h 
urine protein levels. In first group, (P/Cr = 0-0.2) 24-h urine protein 
results (median:109.59; 25th-75thpercentil:71.2-143.0) and spot urine P/
Cr (median:0.09, 25th-75thpercentil:0.07-0.14) were calculated. Spearman 
(r=0.502, p=0.0001) test was applied. In second group, (P/Cr=0.2-2) 24-h urine 
protein results (median: 693.20, 25th-75thpercentil:293.91-1145.38) and spot 
urine P/Cr (median:0.67, 25th-75th:0.42- 1.13) were calculated. Spearman 
(r=0.705, p=0.0001) test was applied. In third group, (P/Cr = >2) 24-h urine 
protein results (median: 4504.66, 25th-75th percentil: 2259.40- 6192.90)and 
spot urine P/Cr(median: 4.50, 25th-75th percentil:3.00- 7.76) were calculated. 
Spearman (r=0.427, p=0.019) test was applied.
CONCLUSIONS:24-h urine protein levels are significantly correlated to spot 
urine P/Cr ratios.
Keywords: proteinuria, protein/creatinin ratio, 24-h urine protein 
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OBJECTIVES:It is known that light microscope (LM) used in 
routine studies in urine sediment analysis has some limitations. 
For example, some shaped elements with low refractive index in urine may not 
be distinguished from the ground.Therefore, as an alternative approach, phase 
contrast microscopes (FCM) can be used to better distinguish.The advantage 
of FCM is that it is sufficient to examine and evaluate the morphological and 
physical properties of living organisms.In this study, we aimed to compare the 
analytical performances of FCM and LM in routine urine analysis.
MATERIALS and METHODS:130 samples were studied, over 18 years of age. 
Samples prepared within 2 hours and examined under microscope. Intense and 
turbid urines with low amounts and excessive hematurics not included. Urine 
sedimentation tubes were collected in 10 mL samples and centrifuged at 400 g for 
4 minutes.Then 9 mL of the supernatant was carefully decanted and remaining 
amount examinated.
RESULTS:We found the differences in terms of image and noticed that some 
structures are more clearly seen in FCM and these structures can’t be selected 
under LM. FCM was found to be more advantageous in determining cell 
morphology and a positive correlation was found between the two methods in 
all parameters.
CONCLUSIONS:Some structures can’t be detected under LM. Therefore, 
examination of sediment with FCM increases the efficiency of diagnosis and 
treatment and can be used in clinical laboratories instead of LM,also can be 
incorporated into newly manufactured devices.Since there are no publications 
comparingLM and FCM in urine sediment, we recommend further studies.
Keywords: phase contrast microscopes (FCM),light microscope (LM),urine 
sediment 
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OBJECTIVES:Early diagnosis of renal abnormalities is essential to prevent the 
progression to irreversible phases. The earliest sign of the renal disease is the 
presence of microalbumin in the urine, which can detect via several methods. 
In this study, we compared the strip method with the immunonephelometric 
method. Our aim was to investigate the reliability of fast and low-cost first-step 
methods for microalbumin screening.
MATERIALS and METHODS:We analysed the urine samples with the albuminuria 
test request between June - July 2018. Firstly, urine samples were analysed 
quantitatively via an immunonephelometric method with the Roche Cobas 6000 
instrument, following a second semi-quantitative analyser with Sysmex UC-3500 
urine analyser. Results were compared using Spearman correlation analysis. 
RESULTS:A strong correlation was found between two analysers. Correlation 
was, r:0.831 (n: 86; p <0.01) and r:0.872 (n: 105; p <0.01) for albumin and 
creatinine, respectively. The coefficient of determination was detected r2=0.83 
and r2=0.738, for the levels of urine albumin and creatinine, respectively. As 
the clinical decision-making limit for albuminuria considered as 30 mg/dL, 
sensitivity, specificity, negative predictive value and positive predictive values 
for Sysmex UC-3500 were detected as 100%, 26%, 100%, and 57%, respectively. 
CONCLUSIONS:In this study, we showed that semi-quantitative systems may 
be an alternative for the first step screening with positive correlation and 100% 
NPV sensitivity, despite having a simpler technology. Urine strips may be a good 
option in clinical laboratories because of the low costs and rapid test results.
Keywords: Microalbumin, Sysmex UC-3500, strip, urinalysis, proteinuria 
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OBJECTIVES:In the general population, vitamin B12 deficiency is a relatively 
common finding. We aimed to investigate the possible difference in inflammation 
markers between three categories based on serum B12 level.
MATERIALS and METHODS:Male patients’ (18-60 years) one year data was 
classified according to serum vitamin B12 levels (DxI800, Beckman Coulter 
Inc.); Group-1: B12 < 146 ng/L, Group-2: 146-180 ng/L, Group-3: 181-348 
ng/L. Patients with white blood cell (WBC) over 15.0 × 10^9/L were excluded. 
We also excluded some clinics where test requests were made: intensive care 
units, oncology, emergency, infectious diseases, nephrology departments. After 
eliminating the extreme values (N=2,111) by Horn algorithm, backward linear 
regression analysis was performed for the remaining 2,485 patients.
RESULTS:In Group3, we had lower neutrophil/lymphocyte ratio than Group 
1 (p<0.05). Regression analysis revealed an independent relationship between 
vitamin B12 and WBC, neutrophil counts (standardized regression coefficients, 
βWBC = 0.108, p<0.010 and βNeutrophil = -0.101, p=0.016, respectively).
CONCLUSIONS:Recently, it was reported that the B vitamins are required for 
cytotoxic cellular immunity and modulating T cell responses. Our B12 levels are 
positively correlated with WBC (possibly lymphocyte-induced) and negatively 
correlated with neutrophil counts; this finding may support the role of Vitamin 
B12 as an immunomodulator. One of the major problems is knowing what the 
reference range of vitamin B12 is. Considering B12 levels in evaluation of 
immune status may be helpful for clinical approach.
Keywords: vitamin B12, neutrophil, lymphocyte, inflammation. 
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BorA-MeTiN composite sensors
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OBJECTIVES: Conventional glucometer strips are modified by glucose oxidase 
for glucose detection which is open to effects of by oxygen concentrations, pH, 
temperature and other physical parameters. Besides they are not reusable which 
limits their cost-effectiveness. In this study, we used molecularly (glucose) 
imprinted Boronic Acid (BorA) Mesoporous Titanium Nanoparticles (MeTiN) to 
achieve accurate and cost-effective results in blood sugar self-monitoring.
MATERIALS and METHODS: Glucose, Aminophenyl BorA (APBA) and 
MeTiN(1:1:1, w/w) solution was dropped (50uL) on screen printed platinium 
electrodes. Afterwards, 700 mV potential was applied for 20 minutes to 
polymerize BorA monomers electrochemically. Then, pH=3 HCl solution was 
applied to remove glucose from glucose-imprinted BorA-MeTiN composite 
sensor to reveal glucose imprinted cavities for rebinding. The sensor optimization 
was tested by electrochemical impedance spectroscopy (EIS).
RESULTS: According to the optimization studies, electrode LOD was calculated 
as 0.52 ng/mL glucose concentrations. Linearity of the electrode was between 
1-2000 ng/mL glucose levels. Regression coefficient value was obtained from 
18 calibration curves of the same electrode as R2=0.9873±0.0102. Electrodes 
were connected to a mobile phone via Arduino open circuit system to assess the 
compatibility of the sensor. With a software and mobile phone, we detected the 
100ng/mL glucose levels in serum samples with %12.44 error.
CONCLUSIONS: MeTiN supported APBA polymerization increased the 
sensitivity and selectivity of blood glucose determination. We used one electrode 
for 18 times. The stability of the MeTiN increased the molecularly imprinted 
polymer stability which enabled multiple usage. Thus, the novel sensor has the 
potential to be reusable and mobile phone integrated.
Keywords: glucose, molecular imprinting, boronic acid, titanium nanoparticle, 
impedance 
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OBJECTIVES:Prolactin (PRL) is a polypeptide hormone, mainly synthesized 
in anterior pituitary gland. Ferritin is a 24-subunit protein, which has a mainly 
function as an iron-storage protein. The purpose of this study was to classify 
high PRL and ferritin levels in patient with different disease, and to evaluate their 
values in such autoimmune disease.
MATERIALS and METHODS:The patients who applied to our university 
hospital, between Jan2018-Jul2019, and measured serum ferritin or PRL levels 
were included into the study. It was classified 2909 patients who had ferritin 
levels> 400 μg/L, and then they were divided into 5-subgroups between 400- 
>7000 μg/L. For PRL, 1048 patients were classified as PRL>19 ng/ml for males, 
and PRL>26 ng/ml for females, and then they were divided into 6-subgroups 
between 50->5000 ng/mL. Two-site Immunoenzymatic assay (Beckman Coulter, 
Inc) and chemiluminescent-microparticle immunoassay (CMIA) (Abbott, 
Diagnostics) were used for serum ferritin and prolactin assays, respectively.
RESULTS:Patients with hemophagocytic-lymphohistiocytosis had the highest 
ferritin levels (>20000 μg/L), followed by severe-combined-immunodeficiency 
(11544 μg/L). Such disease, systemic lupus erythematosus, polymyositis, 
Crohn’s disease, rheumatoid arthritis, Myasthenia Gravis, dermatomyositis was 
more likely to be hyper ferritin-affected diseases when compared with the general 
population. The highest serum PRL levels were observed in neoplasm(n=192), 
anemia(n=121) and psychiatric disorders(n=79). Serum PRL was also high in 
autoimmune thyroiditis and systemic-lupus-erythematosus.
CONCLUSIONS:Our results showed increased serum PRL and ferritin levels in 
autoimmune diseases. This may have clinical significance. Ferritin may induce 
complete activation of the immune response and PRL may play a role in the 
maturation of T lymphocytes.
Keywords: Autoimmune diseases, ferritin, prolactin 
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OBJECTIVES:Linuron is a widely used urea-based herbicide that has endocrine 
disruptor activity. This study aimed to further elucidate the potential effects of 
linuron on reproductive, biochemical and hematological biomarkers at different 
temperature conditions.
MATERIALS and METHODS:The combined effects of linuron and elevated 
temperature were studied on Cyprinus carpio. Carp were acclimated to two 
different temperatures (22 °C and 28 °C) for 15 days. Then, fish were exposed 
for 96 hours to linuron at environmentally relevant concentrations of 10 and 
100μg/L at 22 °C and at elevated water temperatures (28 °C).
RESULTS:We found that combined temperature increase and pesticide exposure 
affected the biological responses in C. carpio. Linuron caused an elevation in 
hematocrit level while it did not change hemoglobin concentration. An increase 
in the AST enzyme activity was determined. The herbicide caused persistent 
decrease in cortisol level and ALT enzyme activity. In addition, linuron exposure 
caused remarkable alterations in estrogen and testosterone levels.
CONCLUSIONS:This study indicates that the combined effects of linuron 
and elevated temperature induced the steroidogenesis, hematological and 
biochemical biomarkers. The results of this study could be used to assess the 
effects of environmentally relevant concentrations of pesticides.
Keywords: Pesticide toxicity, climate change, endocrine disruption
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OBJECTIVES: The circadian rhythm (CR) is the internal timing sytem which 
is considered to affect every biochemical, physiological, behavioral process 
and is affected by them. It is generated and controlled by positive (CLOCK (or 
NPAS2)-BMAL1/2) and negative (PERIOD (Per1/2/3)-CRYPTOCHROME 
(CRY1/2)) feedback loops. Another accessory negative loop involving NR1D1/2 
(REV-ERBα/β) has also been reported. Nucleotide excision repair (NER) is the 
most general repair mechanism for removing bulky lesions from the genome, and 
defective NER is implicated in various pathological conditions including cancer 
and neurodegenerative diseases. It is the sole pathway to repair UV induced 
pyrimidine dimers and [6,4]-photoproducts. It was shown that NER activity has 
a CR in mouse brain and the core NER protein XPA oscillates at the same phase 
with Bmal1 and anti-phase with Crytopchrome1, leading the hypothesis that there 
is a link between CR and NER. In this study, the effect of CRY1 on the repair of 
[6,4]-photoproducts in mouse embryonic cells lacking the negative loop of the 
CR was investigated.
MATERIALS and METHODS: Per1/2(-/-) cells were produced by using TALEN 
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genome editing, and nr1d1/2, Cry1/2(-/-) cells were prepared from them by 
the CRISPR/Cas9 system. CRY1(+/+) cells were the ancestor of Per1/2(-/-
),nr1d1/2(/-),Cry2(-/-) lines. Two cell lines (Cry1(+/+) and Cry1(-/-), both 
Cry2,Per1/2, nr1d1/2 KO) were exposed to ultraviolet-C (25 J/m2) radiation, 
and the NER was evaluated for each group by Immunoslot Blot. The data were 
analyzed with ImageQuant software.
RESULTS: Our data show that CRY1 expression does not have an effect on the 
repair of [6,4] photoproducts when cell lines were exposed to 25 J/m2 UV-C.
CONCLUSIONS: More studies are needed to clarify the possible role of specific 
circadian rhythm components on NER. 
This work was supported by National Institutes of Health Grant R01GM32833 
(to A.S.); the Scientific and
Technological Research Council of Turkey (TÜBİTAK) (G.K.-E.); and the 
Hacettepe University Scientific
Research Projects Coordination Unit (G.K.-E.) 
Keywords: CRY1, Circadian rhythm, Nucleotide excision repair, Immunoslot 
blot, Ultraviolet radiation
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Sutcu Imam University, Kahramanmaras, Turkey 
OBJECTIVES:The use of plants to cure several kinds of human diseases has 
a long history. Various parts of plants such as leaf, stem, bark, root, etc. are 
being used to prevent, allay symptoms or revert abnormalities back to normal. 
Although there are scientific studies about the antioxidant activities of some 
plants is limited. In this study, it was made to determine the antioxidant activities 
of different plants in commonly grown in Kahramanmaraş region which known 
to be used among the public. 
MATERIALS and METHODS:In our study, antioxidant activities of three 
different plants belonging to different families in Kahramanmaraş region were 
investigated. for this purpose, we studied menengiç (Pistacia terebinthus L.), 
ışgın (Rheum ribes L. ) and çiriş otu (Asphodelus aestivus). Firstly, the plants 
cut into small pieces with a knife. Then, the plants were homogenized with three 
volumes of ice-cold 1.15 % KCI. The activities of antioxidant enzymes and 
malondialdehyde (MDA) levels were measured in the supernatant obtained from 
centrifugation at 14.000 rpm. The activities of superoxide dismutase (SOD) and 
catalase (CAT) as antioxidant enzymes and MDA levels in plants were masured 
as spectrophotometric. 
RESULTS:While the highest CAT was found to be the maximum in Rheum ribes, 
It was found as lowest in Asphodelus aestivus (p<0.05). Also, SOD activity was 
found as highest in Rheum ribes (p<0.05). However, the lowest SOD activity 
was found in Pistacia terebinthus (p<0.05). While the levels of MDA were found 
as highest in Rheum ribes, the lowest MDA levels were found in Asphodelus 
aestivus (p<0.05). 
CONCLUSIONS:Our results indicated that Rheum ribes has the highest 
antioxidant enzyme capacity due to the highest metabolic activity of all them. 
Keywords: Rheum ribes. Asphodelus aestivus, Pistacia terebinthus. 
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injury in rats 
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OBJECTIVES:Oxidative stress mediators are believed to contribute to the liver 
ischemia/reperfusion (I/R) injury. Resveratrol, a polyphenol found in grapes, 
is shown to be a strong antioxidant in various tissues, with a property of an 
estrogen-receptor agonist. Therefore, we investigated the effects of resveratrol on 
oxidative injury in the liver. 
MATERIALS and METHODS:Female Wistar rats were randomly allocated into 
three groups (n = 8, each). The sham group (as control) was only subjected to 
surgical procedures, while other animals were subjected to liver ischemia (60 
min) and subsequent reperfusion (60 min). One group received resveratrol 
(15 mg/kg, 0.3 mL/day intraperitoneally) for both 5 days before surgery and 
15 min before ischemia (I/R+resveratrol group), while the other was treated 
intraperitoneally with 0.09 % saline as group (0.3 ml/day) (I/R group). At the end 
of this experimental, activities of catalase (CAT), superoxide dismutase (SOD) 
and the levels of malondialdehyde (MDA) were measured as spectrophotometric 
in liver tissues homogenates. 
RESULTS:In the I/R rat liver, we detected severe tissue injuries (p<0.001), the 
significant increases in the tissue levels of MDA (p<0.001), and the decrease in 
activities of SOD and CAT (p< 0.001), compared to the sham control. Resveratrol 
significantly ameliorated the liver injury, decreased MDA levels to the sham 
control levels (p<0.001). Resveratrol also restored the SOD and CAT activities. 
CONCLUSIONS:These results suggest that resveratrol could protect liver tissue 
against I/R injury with its potent antioxidant properties. 
Keywords: Resveratrol, liver ischemia/reperfusion, antioxidants
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ABSTRACT
BACKGROUND: Pancreatic ductal adenocarcinoma (PDAC) is the most 
common form of pancreatic cancer, which has the highest mortality rate of all 
solid tumors. The absence of an effective screening process and distinctive 
symptoms causes a delay in diagnosis. Traditional chemotherapy and curative 
surgery have limited benefits on patient survival. Enzymes are one of the most 
important groups of drug targets and are preferred markers for the detection of 
various diseases. 
OBJECTIVES: This study aims to identify up-regulated genes encoding 
enzymes in PDAC to suggest novel therapeutic targets for more effective 
treatments to be developed and diagnostic biomarkers for PDAC.
MATERIALS and METHODS: NCBI Gene Expression Omnibus (GEO) was 
searched for datasets using keywords ‘pancreatic ductal adenocarcinoma’. The 
inclusion criteria were i) Gene expression microarray data, ii) human-derived 
pancreatic ductal adenocarcinoma tissues and normal pancreatic tissue samples. 
All data processing and integration procedures were performed using ExAtlas. 
The false discovery rate is less than 0.05, and the change of gene expression 
is ≥ 10-fold were considered significant. The up-regulated enzyme-coding 
genes were detected in the differentially expressed gene list. The identified up-
regulation of enzyme-coding genes in PDAC was verified using datasets from 
TCGA and GTEx projects.
RESULTS: The random effect integrative meta-analysis of five submissions 
(GSE46234, GSE19280, GSE43795, GSE41368, and GSE71989) containing 24 
tumor-normal tissue pairs revealed 22 up-regulated genes, two of which encoding 
enzymes. The enzyme-coding genes with at least 10-fold differential expression 
compared to the controls were SULF1 (sulfatase, fold change=22.135) and 
KYNU (kynureninase, fold change=10.716), in consistence with the results from 
TCGA and GTEx data.
CONCLUSIONS: The results of this study suggest that sulfatase and 
kynureninase may have the potential to become diagnostic biomarkers and 
therapeutic targets for PDAC, which merits further investigation.
Keywords: Pancreatic Ductal Adenocarcinoma, microarray, meta-analysis, 
enzymes, gene expression
ÖZET
Genel Bilgi: Pankreatik duktal adenokarsinoma (PDA), en yaygın pankreas kan-
seri türü olup tüm solid tümörlerde en yüksek ölüm oranına sahiptir. Etkili bir 
tarama prosesinin ve ayırıcı semptomlarının bulunmayışı tanıda geç kalınmasına 
neden olmaktadır. Geleneksel tedavi yöntemleri ve küratif cerrahinin hastaların 
yaşam oranlarında sağladığı iyileşme oldukça kısıtlıdır. Enzimler, ilaç hedefleri-
nin önemli bir grubunu oluşturmakta olup aynı zamanda birçok hastalığın tanı-
sında tercih edilen belirteçlerdir.
Amaç: Bu çalışma, PDA’da daha etkili tedavi yöntemlerinin geliştirilmesi için 
yeni terapötik hedefler ve diagnostik biyobelirteçler önermek amacıyla en-
zim-kodlayan ve PDA’da yüksek eksprese olan genleri tanımlamayı amaçlamak-
tadır.
Gereç ve Yöntemler: NCBI Gene Expression Omnibus (GEO) veri bankası 
‘pankreatik duktal adenokarsinoma’ anahtar kelimesi kullanılarak tarandı. Çalış-
manın inklüzyon kriteri; i) Gen ekspresyon microarray datası, ii) insan kaynaklı 
PDA ve normal pankreatik doku örneklerini içeren çalışmalar olmasıdır. Tüm 
veri işleme ve entegrasyon prosedürleri ExAtlas kullanılarak yapıldı. Meta-ana-
liz, random effects metodu kullanılarak gerçekleştirildi. FDR oranının 0.05’ten az 
olması ve gen ifadesindeki değişimin ≥10 kat olması istatistiksel olarak anlamlı 
kabul edildi. Ekspresyonu yükselmiş olan enzim kodlayan genler ekspresyonları 
farklılaşmış gen listesinde tespit edildi. PDA’da tanımlanan enzim-kodlayan gen-
lerin yüksek ekspresyonu TCGA ve GTEx projelerinden elde edilen veri setleri 
kullanılarak doğrulandı.
Bulgular: Totalde beş GEO veri setinden 24 tümör-normal doku çiftinin dahil 
edildiği rastgele etki bütünleştirici meta-analizi, ile PDA’da 22 yüksek eksprese 
olan gen belirlenmiştir. Kontrollere kıyasla en az 10 kat diferansiyel ekspresyonu 
olan enzim kodlayan genler, TCGA ve GTEx verilerinin sonuçları ile uyumlu 
olduğu bulunan, SULF1 (sülfataz 1, kat değişimi = 22.135) ve KYNU (kinüreni-
naz, kat değişimi = 10.716) olarak belirlenmiştir.
Sonuç: Bu çalışmanın sonuçları, sülfataz 1 ve kinüreninazın PDA’da diagnostik 
biyobelirteç ve terapötik hedef olma potansiyellerine sahip olabileceğini göster-
mektedir. 
Anahtar Sözcükler: Pankreatik duktal adenokarsinoma, mikroarray, meta-ana-
liz, enzim, gen ekspresyonu
INTRODUCTION
Pancreatic cancer (PC) is a highly fatal malignancy and the fourth common 
cause of death from cancer within all types of tumors [1]. Pancreatic ductal 
adenocarcinoma (PDAC) and its variants are the most common types of 
pancreatic cancer and constitute more than 90% of all cases [2]. The overall 
5-year survival rate for patients with pancreatic cancer remains less than 8% 
and a one-year survival is around 18% when all stages are combined [1, 3]. 
Pancreatic cancer is asymptomatic in early stages; thus, the majority of patients 
with pancreatic cancer present at advanced stages. Besides, the absence of an 
effective screening process contributes to the resulting delayed diagnosis [4, 5]. 
Over 50% of patients with pancreatic cancer are diagnosed at the metastatic stage 
of the disease, and approximately 85% of these patients have a survival rate of 
less than one year [6]. Patients with metastatic state of the disease cannot benefit 
from surgical resection improving median overall survival to 11-23 months [7]. 
Even after radical resection, 60% of the patients experience local and systemic 
relapse within the first 12 months after curative resection [8], and more than 80% 
of the patients die of the disease due to local recurrence and/or distant metastasis 
[9]. Thus, early diagnosis of PDAC remains challenging and current therapeutic 
modalities are still inadequate in the treatment of the disease. There is an urgent 
need for the identification of diagnostic biomarkers and the development of novel 
and effective targeted therapies.
High transcriptome profiling is one of the most utilized approaches in the 
identification of novel prognostic or diagnostic biomarkers, and the development 
of more effective therapeutic targets. With the increasing number of studies using 
high transcriptome profiling, integration of transcriptome data by combining 
microarray raw data from several studies has become a preferred method to 
increase sample size, statistical power, and reliability for studies aiming to find 
novel biomarkers. Several meta-analyses have been conducted to determine 
molecular and clinical subtypes of pancreatic cancer [10], and to identify novel 
prognostic [11-14] or diagnostic biomarkers [15]. Using an integrative high 
transcriptome meta-analysis approach, this study aims to identify up-regulated 
enzyme-coding genes in PDAC and to suggest novel diagnostic biomarkers and 
therapeutic targets for the disease. 
MATERIAL and METHODS
Selection of Microarray Datasets
NCBI Gene Expression Omnibus (http://www.ncbi.nlm.nih.gov/geo/) was 
systematically searched for eligible datasets using the keywords ‘pancreatic 
ductal adenocarcinoma’. Inclusion criteria were: i) Gene expression microarray 
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data, ii) studies included human-derived pancreatic ductal adenocarcinoma 
tissues and normal pancreatic tissue samples. 
Generation of Gene Expression Matrix Files and Evaluation of Data Quality
All data processing and integration procedures were performed using ExAtlas 
according to the manual of the software [16]correlation matrix,gene set 
enrichment,ANOVA,PCA,expected proportion of false positives</keyword></
keywords><dates><year>2015</year></dates><accession-num>26223199</
accession-num><urls><related-urls><url>https://www.worldscientific.com/
doi/abs/10.1142/S0219720015500195</url></related-urls></urls><electronic-
resource-num>10.1142/s0219720015500195</electronic-resource-num></
record></Cite></EndNote>. The datasets that have been selected for meta-analysis 
were uploaded to ExAtlas and then gene expression matrix file was generated 
from each dataset separately. All the extracted data were pre-normalized with the 
RMA algorithm. Samples, where the correlation of expression of housekeeping 
genes in the range from 0.5 to 0.95, and the level of standard deviation from the 
global mean for each set of genes grouped by the average expression is less than 
0.3, were considered to be of good quality. Samples of low quality were removed 
from the dataset.  
Standard Meta-Analysis
The meta-analysis was performed using random-effects method [17], which takes 
into account the variance of heterogeneity between studies. The analysis was 
performed for each gene symbol and every tumor sample was compared with one 
of the normal pancreatic tissue samples selected randomly from the same dataset. 
False discovery rate is less than 0.05, and the change of gene expression is ≥ 
10-fold were considered significant. The enzyme-coding up-regulated genes in 
PDAC compared to the normal pancreatic tissues were reported. 
Verification of the results in another dataset
The Gene Expression Profiling Interactive Analysis (GEPIA) online database 
(http://gepia.cancer-pku.cn/index.html) is an interactive web server for analyzing 
RNA sequencing expression data of 9,736 tumors and 8,587 normal samples 
from the TCGA and the GTEx projects, using a standard processing pipeline 
[18]. It provides key interactive and customizable functions such as differential 
expression analysis between tumor and normal samples. Thus, to verify the results 
of this study, a boxplot was employed to visualize the expressions of up-regulated 
enzyme-coding genes identified in this study in pancreatic adenocarcinoma 
(n=179) and normal pancreatic tissue datasets (n=171) from TCGA and GTEx 
projects.
RESULTS
Microarray Datasets
A systematic search of the studies was carried out up to September 2019. Gene 
Expression Omnibus Datasets were searched with the term ‘pancreatic ductal 
adenocarcinoma’ and the search results were filtered by selecting organism as 
homo sapiens, study type as expression profiling by array and attribute name 
as tissue. As a result, 54 studies were found in GEO Database. It was carefully 
examined whether these studies met the inclusion criteria of this study. A to-
tal of 24 PDAC and 24 normal pancreatic tissue samples from five submissions 
(GSE46234, GSE19280, GSE43795, GSE41368, and GSE71989) were decided 
to be eligible for the meta-analysis (Table 1).  
Table 1. Eligible public datasets used in the meta-analysis.  
Public 
Datasets
Platform PDAC 
(n)
Healthy (n) PMID
GSE46234 HG-U133_Plus_2] Affymetrix Human 
Genome U133 Plus 2.0 Array
6 2 -
GSE19280 [HG-U133B] Affymetrix Human 
Genome U133B Array
4 3 23007696
GSE43795 Illumina HumanHT-12 V4.0 
expression beadchip
6 5 24072181
GSE41368 [HuGene-1_0-st] Affymetrix Human 
Gene 1.0 ST Array [transcript (gene) 
version]
6 6 24120476
GSE71989 [HG-U133_Plus_2] Affymetrix 
Human Genome U133 Plus 2.0 
Array
13 8 27363020
Up-regulated Enzyme-coding Genes in PDAC
The random effect meta-analysis resulted in 22 differentially over-expressed 
genes in PDAC compared to the healthy pancreatic tissue samples (Table 2).
The most significantly up-regulated gene in PDAC was POSTN (Periostin) with 
an approximately 45-fold differential expression compared to the controls. The 
up-regulated enzyme-coding genes in PDAC were SULF1 (sulfatase 1, fold 
change=22.135) and KYNU (kynureninase, fold change=10.716). 
Table 2: The differentially expressed genes with at least a 10-fold differential 
expression between pancreatic ductal adenocarcinoma and normal pancreatic 
tissues. *FDR:	False	discovery	rate 
Gene Symbol Gene Name Fold 
Change 
Combined
P-Value FDR*
POSTN periostin, osteoblast specific factor 45.239 0 0
SULF1 sulfatase 1 22.135 0 0
CEACAM6 carcinoembryonic antigen-related cell 
adhesion molecule 6 (non-specific 
cross reacting antigen)
20.215 0 0
S100P S100 calcium binding protein P 20.178 0 0
CEACAM5 carcinoembryonic antigen-related cell 
adhesion molecule 5
16.492 0 0
IGHV3-52 immunoglobulin heavy variable 3-52 
(pseudogene)
16.002 3.38e-06 0.00139
IGKV2D-26 immunoglobulin kappa variable 
2D-26
15.32 4.47e-06 0.001808
IGKV1D-33 immunoglobulin kappa variable 
1D-33
15.19 5.17e-06 0.002053
VCAN versican 13.152 0 0
SLC6A14 solute carrier family 6 (amino acid 
transporter), member 14
12.734 0 0
INHBA inhibin beta A 12.479 0 0
COL1A2 collagen, type I, alpha 2 12.331 0 0
LCN2 lipocalin 2 12.008 0 0
IGKV1OR2-3 immunoglobulin kappa variable 1/
OR2-3 (pseudogene)
11.591 4.51e-07 0.000189
FN1 fibronectin 1 11.484 1.50e-13 1.08e-10
KYNU kynureninase 10.716 0 0
CXCL5 chemokine (C-X-C motif) ligand 5 10.716 2.17e-10 1.09e-07
CTHRC1 collagen triple helix repeat containing 
1
10.701 4.44e-16 4.45e-13
ITGB6 integrin beta 6 10.61 0 0
TFF1 trefoil factor 1 10.307 1.87e-09 8.97e-07
COL3A1 collagen, type III, alpha 1 10.249 0 0
SEMA3C sema domain, immunoglobulin 
domain (Ig), short basic domain, 
secreted, (semaphorin) 3C
10.164 0 0
Validation based on TCGA and GTEx databases
To validate the results of this study, the GEPIA database was used to compare the 
expression levels of the identified enzyme-coding up-regulated genes between 
PDAC and normal pancreatic tissues. As shown in Figure 1 A and B, compared 
to normal pancreatic tissues, mRNA levels of kynureninase and sulfatase 1 
were 7-fold and 3.5-fold higher in PDAC respectively (p < 0.05). These data 
were consistent with the results above from the GEO data sets in the context of 
a statistically significant increase in the expressions of the two enzyme-coding 
genes in PDAC. 
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Figure 1. Expression levels of KYNU (A) and SULF1 (B) in cancer and normal 
tissues. PAAD: Pancreatic Adenocarcinoma, T: Tumor, N: Normal; *p < 0.05. 
  
DISCUSSION
In the present study, an integrated transcriptomic meta-analysis was performed to 
suggest novel therapeutic targets and diagnostic biomarkers for PDAC. Based on 
the gene expression profiles of five GEO datasets, a total of 22 significantly over-
expressed genes in PDAC were identified. Enzymes are preferred biomarkers 
for providing insight into the disease process by diagnosis, prognosis, and 
assessment of response therapy [19]. Besides, enzyme inhibitors constitute a 
significant portion of the druggable human proteome and the most important 
group of therapeutic agents that are in clinical use today [20, 21]. Thus, this study 
focuses on the identified up-regulated enzyme-coding genes in PDAC to suggest 
more effective therapeutic targets and diagnostic biomarkers for PDAC. Since the 
number of samples that met the stringent inclusion criteria of this study is small, 
only genes with at least ten-fold differential expression between PDAC and 
normal pancreatic tissues were considered as significant to increase reliability. 
Among the up-regulated genes identified in PDAC, two genes were found to 
encode enzymes. One of them was SULF1 (Sulfatase 1), which encodes an 
extracellular heparan sulfate endosulfatase that removes 6-O-sulfate groups from 
internal glucosamine residues in highly sulfated subdomains of heparin/HSPGs. 
The first study investigating the molecular function of SULF1 in pancreatic cancer 
was conducted in 2005 and reported a 22.5-fold increase in the mRNA level of 
SULF1 in pancreatic cancer compared to normal controls [22]. Later, two distinct 
studies showed that SULF1 protein level is significantly higher in pancreatic 
cancer tissues than in cancer-adjacent normal pancreatic tissues [23, 24]. In this 
study, a 22.31-fold increase in the mRNA level of SULF1 was detected in PDAC 
compared to normal pancreatic tissues, consistent with the results from TCGA 
and GTEx data, and previous reports. Overall findings suggest that sulfatase may 
have the potential to be an effective diagnostic biomarker for PDAC, which merits 
further investigation.  However, only two studies have evaluated whether SULF1 
inhibition has the potential to be an effective therapeutic strategy in pancreatic 
cancer. It has been reported that stable SULF1 expression resulted in reduced 
both anchorage-dependent and -independent cell growth; however, decreased 
FGF-2 mediated cell growth and invasion in SULF-1 negative Panc-1 pancreatic 
cancer cell line [22]. In 2007, Nawroth et al. reported that the expression of 
human extracellular sulfatases SULF1 and SULF2 enhances Wnt signaling in 
pancreatic cancer cells and contributes to the growth and tumorigenicity of these 
cells [25]. Thus, these divergent results above indicate a poor understanding of 
the complex molecular mechanism of SULF-1 in the pathogenesis of pancreatic 
cancer and underline the need for further studies in this field.
In the present study, the second significantly up-regulated enzyme-coding gene 
in PDAC was KYNU. It’s product, kynureninase or L-kynurenine hydrolase 
is involved in the biosynthesis of NAD cofactors from tryptophan through the 
kynurenine pathway [26]. KYNU expression has been demonstrated to be up 
regulated in cases with pediatric acute lymphoblastic leukemia [27] and lung 
adenocarcinoma [28] before. The results of these studies also suggested that the 
high expression of KYNU correlates with poor prognosis in patients. Moreover, 
it has been reported that inhibition of KYNU may represent a novel therapeutic 
approach for the treatment of glioma [29]. However, there are also studies that 
have reported a decrease in KYNU expression in highly aggressive osteosarcoma 
cell lines [30] and a negative association between KYNU expression and tumor 
grade in breast cancer [31]. The altered KYNU expression and thereby its 
molecular function may be associated with metabolic reprogramming in cancer 
development which could be easily affected by the specific metabolic demands 
of different cancer types. Since high expression of KYNU may give rise to 
higher NAD+ levels, it may also provide a selective advantage to cancer cells by 
increasing glycolysis via glyceraldehyde 3-phosphate dehydrogenase (GAPDH) 
and lactate dehydrogenase (LDH) that require NAD as a co-enzyme, and by 
fueling cancer cells [31]. However, the role of KYNU in pancreatic cancer and 
cancer metabolism is not yet known. Further studies addressing these issues may 
reveal therapeutic, diagnostic or prognostic values of altered KYNU expression 
in pancreatic cancer and its importance in pancreatic cancer metabolism. 
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Abstract:
In the Republic of North Macedonia the work of the diagnostic medical 
laboratories is regulated by the Law of Health Care. There is an urgent need 
for better development of an evidence-based, scientific, and sustainable national 
strategy for the improvement of health laboratory service. Clear indicators of 
improvement have to be established. A key indicator should be the number of 
laboratories that have achieved and can maintain accreditation.
The Macedonian Society of Medical Biochemistry and Laboratory Medicine 
(MSMBLM) recommends that the quality system established meets the 
requirements of the International Standard for medical laboratories (‘Medical 
laboratories: Requirements for quality and competence [EN ISO 15189:2012]. 
The accreditation of Macedonian medical laboratories is not mandatory; the 
decision for accreditation is voluntary. So far, nine medical laboratories have 
been accredited according the MKS EN ISO 15189:2013. Four of them are public 
sector laboratories. 
The small number of accredited laboratories could be the result of the shortage of 
financial resources, poor government attention to laboratory service, the shortage 
of qualified personnel and/or the lack of a national laboratory policy.
The experiences of laboratory professionals from accredited laboratories, who 
have a high level of knowledge, skills, and competence, are crucially important 
to the process of developing a competent laboratory service within the national 
health system.
Key words: Accreditation, Quality Management System, ISO 15189, medical 
laboratories, biochemistry
ISO 15189 akreditasyonuna giden yolun aydınlatılması: Kuzey Makedonya 
Cumhuriyeti’nden görüşler 
Özet
Kuzey Makedonya Cumhuriyeti’nde tıbbi laboratuvarların çalışmaları Sağlık 
Yasası ile düzenlenmiştir. Tıbbi laboratuvar hizmetinin iyileştirilmesi için kanıta 
dayalı, bilimsel ve sürdürülebilir bir ulusal stratejinin geliştirilmesine acil ihtiyaç 
vardır. Bu konuda açık iyileştirme göstergeleri tanımlanmalıdır. Temel bir 
gösterge, akreditasyon alan ve sürdüren laboratuvarların sayısı olmalıdır.
Makedonya Tıbbi Biyokimya ve Laboratuvar Tıbbı Derneği (MSMBLM), 
kurulan kalite sisteminin, tıp laboratuvarları için Uluslararası Standardın 
gerekliliklerini karşılamasını önermektedir (“Tıbbi laboratuvarlar: Kalite ve 
yeterlilik için şartlar” ”[EN ISO 15189: 2012]).
Kuzey Makedonya’da tıp laboratuvarlarının akreditasyonu zorunlu değildir; 
akreditasyon kararı isteğe bağlıdır. Bugüne kadar MKS EN ISO 15189: 2013 
uyarınca dokuz adet tıbbi laboratuvar akredite edilmiştir. Bunlardan dördü kamu 
sektörü laboratuvarıdır.
Kuzey Makedonya Cumhuriyeti’nde az sayıdaki akredite edilmiş laboratuvar 
bulunmasının nedenleri, finansal kaynakların yetersizliği, hükümetin laboratuvar 
hizmetine duyarsız kalması, kalifiye personel sıkıntısı ve / veya ulusal laboratuvar 
politikasının olmayışının sonucu olabilir.
Yeterli düzeyde bilgi, beceri ve yetkinliğe sahip olan akredite edilmiş 
laboratuvarlardaki laboratuvar uzmanlarının deneyimleri, ulusal sağlık sistemi 
içinde uzman bir laboratuvar hizmeti geliştirme süreci için çok önemlidir.
Anahtar kelimeler: Akreditasyon, Kalite Yönetim Sistemi, ISO 15189, tıbbi 
laboratuvarlar, biyokimya
INTRODUCTION
Laboratory medicine is a fundamental part of the modern healthcare system, and 
plays an important role in public health [1]. It is a very complex multidisciplinary 
diagnostic specialty with several interacting subdisciplines such as clinical 
biochemistry, hematology, immunology and others [2]. It depends on good 
knowledge of fundamental and applied sciences and the use of different 
technologies. Laboratory investigations are involved in every discipline of 
clinical medicine. Medical laboratories should ensure optimal test accuracy and 
precision, provide high quality laboratory test results, deliver test results in a 
timely manner and provide expert consultation to healthcare professionals [3]. 
However, legislators, clinicians, and patients are often unclear on the role of 
laboratory medicine as a specialty.
THE IMPLEMENTATION OF LABORATORY STANDARDS IN THE 
REPUBLIC OF NORTH MACEDONIA 
In the Republic of North Macedonia the work of the diagnostic medical 
laboratories is regulated by the Law of Health Care [4]. Specific requirements 
for the laboratory service regarding capacities, equipment, health personnel and 
diagnostic tests are defined in the Rule	Book	for	the	necessary	space,	equipment	
and personnel for founding, starting and performing healthcare procedures in a 
health care establishment [5]. This document is insufficient; there is an urgent 
need for better development of an evidence-based, scientific, and sustainable 
national strategy for the improvement of health laboratory service. Clear 
indicators of improvement must be established. A key indicator should be the 
number of laboratories that have achieved, and can maintain accreditation.
Accreditation is formal recognition that a body or person is competent to carry 
out specific tasks. Meeting the International Standard means the laboratory meets 
the technical competence requirements and the management requirements to 
consistently deliver technically valid results. 
Audit of Management System can be conducted by non-technical personnel. It 
includes assessment of management activities, such as:
• purchasing of consumable materials;
• management of calibration system;
• contracts / client interactions;
• document control and revision;
• training records.
Audit of Technical Competence must be conducted by someone familiar with 
test/methodology/performance of tests. The auditor assesses:
• sampling activities;
• preparation of reagents and/or samples;
• results / data analysis; 
• performance of test.
The role of scientific societies
The Macedonian Society of Medical Biochemistry and Laboratory Medicine 
(MSMBLM) recommends that the quality system established meets the 
requirements of the EN ISO 15189:2012 “Medical laboratories: Requirements 
for quality and competence” (EN ISO 15189:2012) [6], which has been accepted 
as the fundamental standard for the accreditation of medical laboratories in 
European countries. EN ISO 15189 was developed as a baseline standard for the 
Quality Management System (QMS) in medical laboratories and is recognized as 
the connecting standard for all disciplines in laboratory medicine. 
MSMBLM is a professional society of specialists in medical biochemistry. It is 
responsible for the translation of international guidelines into national guidelines. 
These guidelines have to be in agreement with the standard EN ISO 15189. For 
this purpose, cooperation between MSMBLM and the National Accreditation 
Body, Institute for Accreditation of the Republic of North Macedonia (IARM) 
[7] is essential. IARM, established in 2003, is a non-profit institution with a duty/
task to act in the public interest. It is a subject to peer evaluation. In 2008 IARM 
has become a member of the International Laboratory Accreditation Cooperation 
(ILAC), which is an umbrella organization for regional accreditation cooperation. 
The acceptance of accredited laboratory data is facilitated through mutual 
recognition arrangements among accreditation bodies. 
In Europe this is regulated by the European cooperation for Accreditation (EA) 
[8]. ISO 15189 is covered by the Health Care Committee (HCC) of EA, where, 
apart from almost all European Accreditation Bodies, European Federation of 
Clinical Chemistry and Laboratory Medicine and Medtech are represented [9-
12].  
The Law of accreditation was endorsed in 2009 (Official Journal of R.M. No. 
120/2009). In 2013, the Standardization Institute of the Republic of North 
Macedonia accepted the standard as the Macedonian norm for quality assessment 
of medical laboratories (MKS EN ISO 15189:2013). 
The accreditation of medical laboratories in Republic of North Macedonia is 
not mandatory; the decision for accreditation is voluntary. Accreditation is 
accessible to every client submitting an accreditation application to the National 
Accreditation Body. Assessment is performed every 4 years and surveillance is 
carried out annually. Flexible scope is not yet started but it is offered to accredited 
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laboratories that have already demonstrated that they have a verification/
validation procedure that justifies the trust that comes with a flexible scope [13].
In 2013, the first medical biochemistry laboratory was accredited in our country. 
So far, nine medical laboratories of 240 registered laboratories have been 
accredited according to the MKS EN ISO 15189:2013. Four of them are public 
sector laboratories. Research Center for Genetic Engineering and Biotechnology 
“Georgi D. Efremov”, which is a research unit of the Macedonian Academy 
of Sciences and Arts, and Diagnostic laboratories of the Institute of Pathology, 
Faculty of Medicine in Skopje are accredited according to MKS EN ISO 
17025:2006. 
The small number of accredited laboratories could be a result of the limited 
budget, especially for public medical laboratories, poor government attention to 
laboratory service, logistic and/or the lack of a national laboratory policy.
As the quality of laboratory service is a fundamental component of the healthcare 
system, the successful implementation of the accreditation process will bring 
a measurable quality improvement in laboratory service and, consequently, in 
the healthcare system [14-16]. Therefore, the Ministry of Health, professional 
associations, and other stakeholders should work together to make accreditation 
of medical laboratories a high priority and should undertake coordinated activities 
to integrate accreditation programs into national health policy and planning. 
Training by the Laboratory Quality Management system (LQMS) is a priority, 
with ISO 15189 accreditation as the ultimate goal [17].
Experience of implementing MK EN ISO 15189:2012 for accreditation of a 
university medical laboratory
Accreditation of a university laboratory is a difficult task, since teachers and 
teaching assistants have to coordinate different tasks, which makes the number of 
people involved in the process of accreditation quite variable. Implementation of 
a quality system on ISO 15189 and accreditation are completely achievable in this 
setting, in spite of the fact that this is a very demanding process. The experience 
of implementing a quality system on ISO 15189, and the accreditation of some 
tests for a university laboratory, is presented in the example of the Biochemical 
Analyses Laboratory (BAL), within the Institute of Medical and Experimental 
Biochemistry, the first public biochemical laboratory accredited according to 
MK EN ISO 15189:2013 in the Republic of North Macedonia. 
Application for accreditation
Application should contain:
1. General data about the organization 
1.1. Name and description of activities of the laboratory according to standard 
classification;
1.2. Legal identity of the organization;
1.3. Organizational structure of the laboratory and its position in the organization 
(with organizational scheme);
1.4. The names and position of key personnel with technical responsibility for 
testing and responsibility for quality assurance (head of laboratory, quality 
manager);
1.5. Personnel (technical staff);
1.6. Premises (locations where the tests are performed fоr the applied scope of 
accreditation);
1.7. When was the quality system according to standard МКС	EN ISO 15189: 
2013 implemented?
2. Scope of accreditation
Scope of accreditation identifies precisely the field of testing (classification 
according to IARM Regulation R 15). Scope of accreditation includes a listing 
of test methods, range of measurement, and biological material on which the 
testing is done.
The laboratory can claim accreditation only for the tests listed on the scope of 
accreditation.
3.	Short	description	of	the	equipment	
There has to be an appropriate equipment for realization of the respective 
laboratory tests. Equipment should be routinely calibrated and well-maintained.
The accreditation will be valid if:
1. Team members should have prior knowledge of the document
Document should be delivered to all staff members. They should be familiar with 
the technical and management requirements of the standard.
2. The accreditation team should be trained, competent and objective
The team is not going to be effective if it is composed solely of managers 
and leaders. Mutual trust and respect has to exist among the members of the 
team. The team has to promote safety and openness. If people feel that they are 
psychologically safe, they will be more open to share ideas, to say their opinion 
or to suggest new approaches. Dominance in the team should be avoided, but 
diversity is accepted, because diverse teams are much more productive. If there 
are opposite opinions in the team, people can overcome their way of thinking. 
Every team member should be trained and competent to perform different tasks in 
the laboratory. Team members should be people who are at the front line, people 
who are closest to the process, people who are experts in each step of the testing 
process, people who perform some tasks every day and know to perform them 
in the best possible way. Not all team members need to be involved in all phases 
of the work, but they should be included when decisions related to their area are 
being made.
3. The laboratory should improve its performance continuously
Accreditation requires that a lab has a quality management system that focuses 
on continuous improvement. Improvement should not be done to people, but it 
should be created with people. When people come to work every day, they should 
think not only to do their work but to improve it.  Continuous improvement is 
essential for success. 
Improvement should be a part of the culture of the organization and a natural part 
of how people perform their jobs. 
Key steps in the process of accreditation
1. Development of a Quality Manual 
The Quality manual is the key document describing the overall Quality 
Management System. It should provide an understanding of the laboratory 
management and organizational structure; it describes roles and responsibilities 
of Quality Manager and Laboratory Director; it gives framework for design and 
implementation of the quality management system in the lab. 
All staff members have to be familiar with the content and application of the 
quality manual and the referenced documents.
2. Development of process control 
In terms of process control, preparation of standard operational procedures 
(SOPs) and working instructions are necessary in the initial phase.
SOPs are documents with step-by-step written instructions for each procedure 
performed in the laboratory. The purpose of these documents is to make sure 
that all procedures are performed consistently (correctly and always in the same 
manner) by everyone in the laboratory. A well-known rule in the process of SOP 
creation is ‘write what you are doing and do what you’re writing’. 
3. Development of a management system for documented information
Every laboratory should have a control over the documented information. All 
relevant documents, records and policies have to be managed under controlled 
conditions and have to be reviewed and approved by authorized personnel prior 
to use. A written system of document preparation with declared responsibility 
for the documents.  Structured and organized control of documents allows the 
lab to function more efficiently. Managing and controlling of documents is an 
overwhelming process, but the time and effort put into improving the laboratory 
performance are well worth it.  
4.	Internal	quality	control	(IQC)	
IQC is a segment of the quality management system used to ensure the accuracy of 
the results. It involves the in-house procedures to ensure day-to-day consistency 
of an analytical (examination) process. All personnel should be trained for 
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implementation of IQC. If QC results are not acceptable, laboratory should not 
report patient results.
5. External Quality Assessment (EQA) 
EQASs are designed for the objective assessment of the laboratory’s performance 
using an external agency or facility. All laboratories should be enrolled in EQAS 
program, a process in which a laboratory receives an unknown sample to test 
and report the findings back to the EQAS provider. EQA should not be punitive. 
It should be used as a tool for improvement of laboratory performance. EQA 
programs will assist laboratories in improving analytical quality, inter-laboratory 
agreement, identify potential equipment or reagent failures, and identify any 
training deficiencies. Some EQA programs are voluntary while others are 
obligatory, either required by an accrediting body or by law. For laboratories that 
are accredited, or that plan to seek accreditation, EQA participation is usually 
required. 
6. Sample storage
Every laboratory should have written policies for types of samples that can 
be stored, correct sample labeling, location of stored samples, retention time, 
ambiental conditions for storage, maintenance and disposal of samples. 
The laboratory should have standard procedures for safety issues like disposal of 
all laboratory waste and patient samples in accordance with national regulations 
for disposal of medical waste.
7.	Reporting	of	results
Results should be reliable and accurate and reported in a timely manner. 
Every laboratory should have a procedure to ensure correctness of transcription 
of laboratory results. 
Each laboratory should have written procedure for reporting of critical results.
Comments on sample suitability with respect to acceptance/rejection criteria or 
sample quality that might compromise test results should be included. 
The content of the report should be according to the requirement of the standard 
EN ISO:15189:20112 (section 5.8.3).
8. Laboratory Information System (LIS)
An integrated Laboratory Information system (LIS) is crucial for the efficient 
management of work processes, quality control and financial planning. It is hard 
to imagine a modern diagnostic laboratory functioning without the use of a LIS. A 
good information management system will ensure that all data, including the final 
report is well managed; LIS should ensure the accessibility, accuracy, timeliness 
and security of data, as well as confidentiality and privacy of patient information.
Critical elements for improvement of the laboratory quality management 
system
In the 10-year-period as an accredited laboratory, we have identified critical 
elements for improvement of the laboratory quality management system.
Communication
Communication is essential for quality.  Each team member should be informed 
what was done in the past, what is in progress and which are future plans. 
Dissemination of information within the laboratory and between the laboratory 
and its customers is crucial for effective fulfillment of requirements and needs 
of customers.
Cause and effect diagram (Fishbone diagram)
One of the basic tools of quality improvement is the Fishbone diagram which 
identifies the possible causes of errors, called failure modes, and their effects. 
Failure modes effect analysis (FMEA) allows identification of the effects 
(criticality, severity and probability of occurrence). 
Root	Cause	analysis is a system of problem solving methods aimed at identifying 
the root cause of problems or incidents. By directing corrective measures at root 
causes, it is hoped that the likelihood of problem recurrence will be minimized.
Participation in EQAS
EQA is one of the critical elements for improvement of the laboratory quality 
management system because it represents a measure of laboratory performance.
A laboratory must develop a plan to demonstrate coverage of the test methods 
on its scope of accreditation over a 4-year-period. It is mandatory to demonstrate 
successful participation in EQAS. Acceptance criteria is +/- 2SD. Corrective 
action has to be taken for any outlying results.
As accredited laboratory, BAL has an obligation to fulfill two documents: plan 
for participation in EQAS/PT (document OB 05-18-2) and review of participation 
(document OB 05-18) and to present them to the lead assessor and technical 
assessor on annual basis during the on-site assessment of the laboratory. 
Some benefits of EQAS participation include:
- Discovering of sources of error,
- Systematic errors,
- Demonstration of effectiveness of changes,
- Common understanding of method differences,
- Discovery of method sensitivities,
- Comparison of laboratory’s internal methods against standard methods,
- It can be a source of method validation for new measurement techniques, 
methods, etc.
- EQAS also can lead to method/standard improvement.
Corrective and Preventive actions
Accreditation requires that a lab have a quality management system that focuses 
on continuous improvement. A critical part of that management system is 
identifying when the system doesn’t conform to the requirements and taking 
action to correct the problem and eliminate the root cause to avoid recurrence 
of the problem.  
Implemented corrective and preventive actions need to be periodically monitored 
to ensure that they were effective and resolve the problem or potential problem.  
Overall benefits of accreditation
• Increased confidence in data;
• Reduced uncertainties associated with decisions;
• Issues with methods, personnel, and equipment are identified and resolved more 
quickly;
• Customer satisfaction is improved;
• Business opportunities may increase.
Conclusions and future directions
The globalization of markets and migration of health professionals requires 
improving the laboratory diagnostic process. A quality laboratory system is the 
foundation of a strong national health system [18-21]. Laboratory workforce, 
infrastructure, and quality management system are vital for the delivery of quality 
laboratory services. Coordination with the Ministries of Education and Health is 
essential for maintaining standards of education and levels of knowledge. The 
competency of laboratory professionals has to be maintained through mandatory 
participation in continuous medical education (CME). Appropriate laboratory 
facilities, infrastructure, and equipment for each laboratory tier level are essential 
to enable safely and efficient performance. Strong programs supporting quality 
assurance, quality control, and quality improvement should exist. They are 
fundamental for the establishment, maintenance and improvement of laboratory 
quality systems. SOPs must be well-written, understood, and implemented; 
laboratory personnel should routinely perform IQCs; and laboratories must be 
required to participate in EQA or proficiency testing (PT) programmes. 
For Government, Ministry of Health, professional association(s) and 
stakeholders, accreditation of medical laboratories according to IS 15189:2012 
should be a high priority. They should act together and undertake coordinated 
efforts to integrate accreditation programs into national health policy, planning, 
and health development programmes.
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Induction of APAF-1 and TRAIL by bilberry tea in HCT-116 colon cancer 
cell line
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ABSTRACT
Objectives: In this study, we aimed to determine the effect of bilberry tea samples 
on the markers of the intrinsic and extrinsic pathways of apoptosis in the HCT-
116 colon cancer cell line.
Materials and Methods: Bilberry tea in different infusions and boiling periods 
(1 min, 3 min, 5 min, 10 min) were prepared and phenolic levels were determined 
by LC MS / MS technique. The highest phenolic content was determined in tea 
samples of dried shredded fruit for 5 min boiling, so this product was chosen 
for in vitro study. Cytotoxicity and viability tests were performed by adding 
WST-8 solution. Intrinsic and extrinsic pathways of apoptosis were assessed 
by determining the TNF-related apoptosis-inducing ligand (TRAIL), Apoptotic 
Protease Activating Factor-1 (APAF-1), Cytochrome-c, Caspase -3,-8,-9 levels in 
HCT-116 colon cancer cell line.
Results: Cytotoxicity studies in cell culture were conducted using 50-10 µg/ml 
of bilberry tea samples which was prepared at a concentration of 5 g/10 ml. The 
levels of Caspase 3, APAF-1, TRAIL and Cytochrome-c were significantly higher 
in bilberry added cell culture than the control cells. Other markers (caspase -8, -9 
levels) did not show any significant change compared to control cells.
Conclusions: It is concluded that bilberries induced TRAIL, APAF-1, Caspase-3, 
Cytochrome-c and consequently induced both intrinsic and extrinsic pathways 
of apoptosis.
Keywords: APAF-1, TRAIL, bilberry, HCT-116, colon cancer
ÖZET
Amaç: Bu çalışmada, yaban mersini çayı örneklerinin HCT-116 kolon kanseri 
hücresindeki apoptozun iç ve dış yolaklarında apoptoz belirteçleri üzerindeki 
etkisinin belirlenmesi amaçlandı.
Malzeme ve yöntemler: Yabanmersini çayı farklı infüzyonlarda ve kaynama 
sürelerinde (1 dak, 3 dak, 5 dak, 10 dak) hazırlandı ve fenolik seviyeler LC MS 
/ MS tekniği ile belirlendi. En yüksek fenolik içerik, 5 dakika kaynama için kuru 
paralanmış meyvelerin çay örneklerinde belirlendi, bu yüzden bu ürün in vitro 
çalışma için seçildi. Sitotoksisite ve canlılık testleri WST-8 çözeltisi ilave edilerek 
yapıldı. Apoptozun iç ve dış yolakları, HCT-116 kolon kanseri hücre hattında 
TNF-related apoptosis-inducing ligand (TRAIL), Apoptotic Protease Activating 
Factor-1 (APAF-1), Sitokrom-c, Kaspaz -3, -8, -9 seviyelerinin belirlenmesiyle 
değerlendirildi.
Bulgular: Hücre kültüründe sitotoksisite çalışmaları, 5 g / 10 ml konsantrasyon 
da hazırlanan 50-10 ug / ml yabanmersini çay numunesi kullanılarak 
gerçekleştirildi. Yabanmersini çay örnekleri eklenmiş hücre kültüründe kaspaz-3, 
APAF-1, TRAIL ve Sitokrom-c seviyeleri kontrol hücrelerine göre anlamlı 
derecede yüksek bulundu. Diğer belirteçler (kaspaz -8, -9 seviyeleri) kontrol 
hücrelerine kıyasla anlamlı bir değişiklik göstermedi.
Sonuç: Yabanmersininin TRAIL, APAF-1, kaspaz-3, sitokrom-c’yi indüklediği 
ve sonuç olarak apoptozun hem iç hem de dış yolaklarını indüklediği sonucuna 
varılmıştır.
Anahtar Sözcükler: APAF-1, TRAIL, yaban mersini, HCT-116, kolon kanseri
Introduction 
Cancer; is a pathological condition caused by disruption of the balance between 
cell proliferation and cell death due to excessive cell proliferation or decreased 
apoptosis. It has been reported that suppressed or decreased apoptosis plays an 
important role in cancer development (1). According to data from the American 
Cancer Society, 12.5% of annual deaths worldwide are caused by cancer and 
approximately 8,8 million people die annually from cancer (2).  The probability 
of lifetime cancer diagnosis is 39.7% for men and 37.6% for women. The most 
common cancers to be diagnosed in men are prostate, lung and colorectal cancers, 
which constitute 42% of all cases. In women, the most common cancers to be 
diagnosed are breast, lung and colorectal cancers, representing half of all cases 
(3).
Chemotherapy is one of the commonly used methods for cancer treatment. Two 
target mechanisms come into prominence in preventing the proliferation of 
cancer cells with chemotherapeutic drugs. These are inhibition of cell growth 
or activation of apoptosis. Stopping the cell cycle is an effective strategy in 
eliminating cancer cells. Apoptosis is regulated by the factors in intrinsic and 
extrinsic signaling pathways (4). 
In recent years, the use of natural sources as anticancer agents has become a 
popular research area, because of the resistance to anticancer drugs and cytotoxic 
effect of these anticancer agents against normal cells in long-term usage (5). 
Plants have been used for centuries to overcome human and animal diseases. 
Today, approximately 50% of the modern drugs used to suppress the proliferation 
of cancer cells in the clinic are obtained from natural products (6). According to 
the estimates of the World Health Organization, approximately 80% of the people 
living in developed countries use traditional treatment to solve their primary 
health problems (5). Therefore, natural products are considered as potential 
pharmaceutical raw materials (1).
The aim of this study was to investigate the effect of bilberry tea sample on the 
molecules of apoptosis pathways in HCT-116 colon cancer cell line.   
Material and method
Materials
McCoy’s 5A, Fetal Bovine Serum, Penicilin/Streptomycin, L-Glutamin were 
purchased from Capricorn Scientific (Ebsdorfergrud, Germany). All of the 
phenolic compound standards, Dimethyl sulphoxide (DMSO) and Trypan Blue 
were purchased from Sigma (USA). WST-8 Cell Proliferation Assay Kit were 
purchased from Cayman Chemical (Michigan, USA). Human (TRAIL) and 
Caspase (-3,-8-9 ELISA Kits were purchased from Genosis (USA). Human 
Apoptotic Protease Activating Factor-1 (APAF-1) ELISA Kit was purchased 
from Biosens (USA).
Bilberry Tea Preparation
Bilberries were harvested from Menderes region near to Izmir. Hand harvested 
fruits were destemmed and calibrated on the basis of equal sizes. Samples were 
stored at -20ºC before analyses. As study material, different forms of bilberry 
fruit and leaves were used: dried leaves, dried fruit, dried shredded raw fruit, 
frozen raw fruit, seedless fruit and fruit seeds. Dried leaves (DL) were separated 
manually from aerial parts in laboratory and dried at 600 C for 15 min in tray 
dryer. Processed leaves were finely ground with small home blender (Joyce home 
electrical accessory Co. Ltd). Dried fruits (DF) were obtained by similar drying 
processing procedure with different conditions:  400 C for 60 min. Dried shredded 
fruits (DSF) were processed in similar way to dried fruit and finely ground with 
small home blender (Joyce home electrical accessory Co. Ltd). Frozen fruits (FF) 
were obtained by freezing the fruits at -150 C for 24h. Seedless fruits (SF) were 
prepared by manual separation of seeds in laboratory. Fruit seeds (FS) were also 
obtained and used.
Tea processing was done by using two types of extraction procedures: infusion 
and boiling. Infusion was done by keeping the obtained products in previously 
boiled water 1000 C/ 5 min for different times (1 min, 3 min, 5 min, 10 min). 
Boiling was carried out by keeping the obtained products in continuously boiling 
water (1000 C)for different times (1 min, 3 min, 5 min, 10 min).
Determination of the amount of phenolic compounds by LC MS / MS Analysis
Quantitative analysis of the components was performed using the external 
standard method. The analysis were performed on Waters Xevo TQD system 
(Waters) containing automatic sample injection and UHPLC. Acquity UPLC 
BEH C18 (50 x 2.1 mm, 1.7 μm) column was used for the separation. The 
spectral range covered was from 190 to 360 nm. Column temperature of 45 ˚C 
and injection volume of 5 μL were selected. Based on the molecular spectrum of 
the standards, two wavelengths were used. The flow rate was 0.3 mL/min and 
the UV scan was carried out in the range of 254-280 nm. The optimum pH value 
for the separation efficiency was chosen between 2-3. The mobile phase was 
designated to be methanol + 0.1% formic acid (FA) and water + 0.1% formic 
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acid. A linear gradient defined was used for elution.
Cell culture
HCT-116 human colon cancer cell line was purchased from American Type 
Culture Collection (ATCC) and were multiplied in McCoy’s 5A medium 
supplemented with 10% fetal calf serum (FBS), 100 unit/ml penisilin, and 100 
μg/ml streptomycine and incubated at 37°C in a humid environment containing 
5% CO2. 
Determination of Apoptosis in Cell Culture
The highest phenolic content was determined in tea samples of DSF for 5 min 
boiling, so this product was chosen for in vitro study. After the HCT-116 colon 
cancer cells were plated in 6-well plates at 1 million/ mL, the tea sample was 
applied and the cells were collected following the incubation period of 48 
hours, centrifuged for 20 min at 2000-3000 rpm. Later, they were centrifuged 
at 2000-3000 rpm for 20 minutes again making icing-deicing application three 
times. Human TRAIL, Human APAF-1) Cytochrome-C, Caspase-3, Caspase-8, 
Caspase-9 were determined with commercially available ELISA kits.
Results  
The main phenolic contents of tea samples are presented in Table 1 and Table 2.
Table 1: LC MS/MS results of phenolic compounds (ng/ml) of different samples 
with different brewing times
Brewing Caffeic acid Kaempherol Ferulic acid Quercetin Vanilic acid Ellagic acid Delphinin Pelargonin
Dry Leaf 1 min 11,80 12,32 27,35 141,48 397,54 25,13 18,08 40,71
Dry Leaf  3 min 7,57 23,59 59,88 271,63 346,92 41,97 73,65 35,40
Dry Leaf  5 min 7,95 44,27 145,33 253,64 1079,18 31,85 56,88 184,28
Dry Leaf  10 min 6,52 20,76 41,06 165,03 225,82 30,11 45,88 13,38
Dry Fruit 1 min 8,92 80,10 218,04 732,54 1475,20 82,49 152,25 185,34
Dry Fruit 3 min 5,91 25,99 77,37 155,21 183,79 17,24 40,19 30,98
Dry Fruit 5 min 6,75 63,11 261,18 742,14 581,75 68,17 166,12 237,17
Dry Fruit 10 min 6,37 16,04 55,35 253,26 158,40 33,81 59,92 24,34
Dry shredded raw fruit 1 min 5,65 527,84 344,13 7087,67 128,29 689,70 1551,26 176,98
Dry shredded raw fruit 3 min 6,09 432,75 359,15 5222,89 286,45 511,49 1206,45 85,61
Dry shredded raw fruit 5 min 7,01 482,17 457,65 6091,25 537,68 567,81 1373,23 169,98
Dry shredded raw fruit 10 min 5,81 430,24 267,54 5341,57 314,43 501,16 1126,68 41,69
Frozen Raw Fruit  1 min 6,31 6,23 38,85 135,27 284,45 14,55 19,94 25,74
Frozen Raw Fruit  3 min 9,71 30,08 146,20 180,71 424,58 22,97 54,40 120,20
Frozen Raw Fruit  5 min 6,22 22,75 229,22 155,37 790,04 20,08 56,35 224,57
Frozen Raw Fruit  10 min 6,26 24,51 90,18 268,71 368,46 35,09 88,48 45,69
Seedless Raw Fruit 1 min 6,19 307,94 255,05 3126,47 473,41 314,31 738,73 32,30
Seedless Raw Fruit 3 min 8,93 376,44 352,40 3818,71 471,71 375,09 951,53 74,56
Seedless Raw Fruit 5 min 6,84 424,30 350,05 4471,08 615,41 423,11 1043,69 60,50
Seedless Raw Fruit 10 min 6,76 686,86 487,14 6751,40 635,44 628,97 1686,82 160,43
Seed 1 min 6,88 47,66 149,64 865,45 573,72 100,78 211,40 54,72
Seed 3 min 7,09 67,08 149,82 1196,82 361,10 135,89 235,47 70,07
Seed 5 min 6,66 76,59 145,41 1246,56 450,74 150,19 244,98 65,91
Seed 10 min 6,52 118,13 133,37 1697,29 513,23 192,09 361,44 40,07
Table 2: LC MS/MS results of phenolic compounds (ng/ml) of different samples 
with different boiling times 
Boiling Caffeic acid Kaempherol Ferulic acid Quercetin Vanilic acid Ellagic acid Delphinin Pelargonin
Dry Leaf 1 min 6,47 38,73 101,77 451,77 901,78 62,54 89,04 41,77
Dry Leaf  3 min 13,73 75,25 125,21 734,96 1213,75 97,03 182,43 45,40
Dry Leaf  5 min 6,02 35,30 50,42 433,42 301,02 52,62 99,26 20,54
Dry Leaf  10 min 10,85 66,94 169,24 770,76 1023,84 98,27 158,73 78,81
Dry Fruit 1 min 5,33 59,67 127,77 522,91 688,03 46,51 115,77 25,28
Dry Fruit 3 min 5,72 350,03 225,26 3256,67 461,12 308,18 748,29 50,41
Dry Fruit 5 min 4,43 382,02 252,89 3323,46 458,95 324,22 726,24 69,71
Dry Fruit 10 min 5,69 880,81 283,16 7582,45 634,29 703,52 1678,75 49,77
Dry shredded raw fruit 1 min 6,18 524,97 269,41 6087,00 246,92 576,74 1400,81 13,50
Dry shredded raw fruit 3 min 6,01 1164,79 387,65 11405,38 365,27 1064,93 2643,94 72,69
Dry shredded raw fruit 5 min 6,30 1305,19 496,37 12366,48 426,60 1155,62 2891,57 140,52
Dry shredded raw fruit 10 min 6,77 83,28 45,18 1177,79 51,91 137,49 234,83 8,83
Frozen Raw Fruit  1 min 7,57 128,18 163,74 1301,13 607,13 157,26 425,35 135,81
Frozen Raw Fruit  3 min 7,51 184,72 196,88 1692,92 499,54 193,74 448,80 74,97
Frozen Raw Fruit  5 min 8,12 296,59 284,84 2773,51 723,99 279,90 708,98 125,16
Frozen Raw Fruit  10 min 7,05 180,74 154,12 1634,45 479,02 172,85 412,49 42,74
Seedless Raw Fruit 1 min 7,35 546,77 386,58 4718,60 548,74 500,76 1141,49 106,55
Seedless Raw Fruit 3 min 6,41 936,90 395,29 7957,13 623,00 787,05 2129,66 65,90
Seedless Raw Fruit 5 min 8,47 1000,08 459,06 8336,39 681,25 799,32 2020,68 87,23
Seedless Raw Fruit 10 min 8,07 1044,13 498,43 8399,59 827,27 823,19 2152,48 126,79
Seed 1 min 6,80 115,72 185,85 1829,68 505,82 214,69 407,78 40,71
Seed 3 min 6,28 196,87 216,22 3161,61 445,67 340,53 698,16 84,59
Seed 5 min 6,18 240,38 186,29 3392,69 332,00 371,69 758,12 39,90
Seed 10 min 5,52 346,72 199,28 4427,19 236,86 442,46 992,95 78,81
When the above tables were examined, the infusion method with the highest 
phenolic molecule content was determined as 5 minutes boiling of DSF. Therefore 
5 min boiling DSF sample was used for cell culture studies. The IC50 values of 
bilberry extract was shown in Figure 1. 
 
Figure 1: IC50 concentrations for bilberry extract in HCT-116 colon cancer cell 
culture. It was calculated for 3 different periods: (0–24 h, 24–48 h and 48–72 h). 
The IC50 values were 101,680 μg/mL, 80.676 μg/mLand 106,180 μg/mL in 24th, 
48th and 72th hours, respectively.  As shown in Figure 1, the bilberry extract 
inhibited HCT-116 colon cancer cells proliferation in time-dependent manner 
with the highest IC50 (50% inhibitory concentration) value of 80.676 µg/ml after 
48 h treatment.
 
Figure 2: Effect of bilbery extract on apoptotic biomarkers in HCT-116 cell line; 
the levels of Caspase (-8, -9 -3), Cytochrome-c, TRAIL and APAF-1.
  
Cytotoxicity studies in cell culture were conducted using 50-10 µg/ml of bilberry 
tea samples which was prepared at a concentration of 5 g/10 ml. As it can be seen 
from the Figure.2. The levels of APAF-1, TRAIL, Cytochrome-c and Caspase 
3 were significantly higher in bilberry added cell culture than the control cells. 
Other markers (Caspase  -8, -9 levels) did not show any significant change 
compared to control cells.
DISCUSSION
It is proposed that many compounds derived from natural plants act like chemical 
inhibitors in human cancer treatments, thus may have chemotherapeutic activity 
(7, 8, 9).  Some studies have shown that bilberries manifest antioxidant (12), anti-
inflammatory (13), antibacterial (10, 14], hypoglycemic (15), antifungal (16), 
and antimutagenic (17) effects. In this study, the apoptotic effect of bilberry tea 
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on HCT-116 colon cancer cell line was assessed.
The studies with natural compunds have shown that the different solvents, and 
the methods used to dissolve the plant or the fruit affects the study results related 
to active compounds in the plant or fruit studied. In the studies of Yildiz et al. 
(2011) related to Vaccinium myrtillus L., the structure of the biological active 
components of Vaccinium myrtillus L. were clarified, and, the collected fruits 
were stored at -18˚C for 1 week, and then dried at 40˚C and pulverized. Dried 
fruits were extracted with methanol, ethanol, water and ethyl acetate, and left to 
stand in the stirrers with heater for 24 hours. The analyzes were performed by 
RC-HPLC. Researchers investigating the amount of phenolic compounds have 
found that the pehnolic content of plants show high variability due to the factors 
such as location, growing conditions, soil properties, irrigation, temperature 
and sunbathing. Previously, caffeic acid (6.29 ± 3.55 µg/g), epicatechin (8.35 ± 
5.04 µg/g), and myricetin (4.16 ± 1.81 µg/g), were found as the highest phenolic 
molecules in bilberry extracts (2.10 ± 0.64 µg/g) (19). The most promising 
anticarcinogenic agents in plants are these phenolic compounds, which are 
abundantly present in Bilberries (Vaccinium myrtillus) (20).  
In these studies, the bilberry fruits were extracted in the different types of 
solvents (water, ethanol and ethyl acetate), and their chemical compositions 
were identified using HPLC - DAD and HPLC-MS/MS method and the effects 
on antioxidant system were investigated using in-vitro analysis. In the result of 
these experimental studies, antiradical and antioxidant effects were found to be 
higher in ethanol, and ethyl acetate extracts, as well as high amounts of chemical 
compounds in these extracts. 
The healthiest way of using these plant extracts is to solve them in water. 
therefore, boiling and brewing   were used in our study. Since the studies have 
shown that brewing and boiling duration are effective in separating phenolic 
compounds from plants, we determined the phenolic content of bilberry fruits in 
different extraction times. Our data showed that the amount of obtained phenolic 
molecules vary depends on duration and extraction methods. Generally, the 
extracted amount was higher in boiling methods compared to those of brewing 
method and the highest phenolic molecule was quercetin both in two methods. 
In the study of León-González (2018), Anthocyanin- rich bilberry extract “Antho 
50” induced apoptosis and down-regulated the expression levels of different 
epigenetic proteins in human leukemia Jurkat cells. They observed that bilberry 
extract induced a redox-sensitive caspase-3- mediated apoptosis in chronic 
lymphocytic leukemia cells (21).  In consistent with the mentioned study, the 
bilberry tea which include of kaempherol, quercetin, myricetine and delphinin in 
high concentration induce caspase-3 levels.
In our study, the extrinsic pathway in the HCT-116 colon cancer cell line is 
stimulated, which was confirmed with an increase in the TRAIL levels. 
It has been suggested that ethanol extract of bilberry, rich in anthocyanins, 
inhibited the growth of HL60 human leukemia cells through the induction of 
apoptosis. When anthocyanidins and the anthocyanins isolated from bilberry 
extract were compared, the anthocyanins, mainly delphinidin- and malvidin-
glycosides caused apoptosis in the HL60 cells.  The bilberry ethanol extract and 
certain anthocyanins inhibited the growth of HCT116 human colon carcinoma 
cells (22).   In accordance with this study, bilberry tea sample having the high 
anthocyanins induced the apoptosis in our study.
In conclusion, the antioxidant and anticancer effect of natural products is related 
to its main phenolic content which are extracted by ethanol, water, methanol 
etc. The amount of extracted phenolic molecules might change due to extraction 
methods and extraction duration.  Bilberry tea may contribute to maintain plasma 
levels of anthocyanins, which possess antioxidant activity and inhibitory effects 
on cancer cell growth via inducing apoptosis.  Therefore, Bilberry tea might 
be suggested as a functional food for cancer treatment however further in vitro 
researchs need to clarify the required dose and effect of billberry tea. 
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Abstract
Objectives: Normal oxygen delivery is essential for survival. Hypoxia, which 
is a common feature of various pathological conditions, ranging from cancer to 
inflammatory diseases, occurs when normal oxygen delivery is altered by an im-
balance between cellular oxygen demand and tissue oxygen supply. Among the 
intricate mechanisms organisms have developed to maintain oxygen homeosta-
sis, a family of hypoxia-inducible transcription factors (HIFs), are found to be 
the main regulator adaptive cellular response to hypoxia. Although ELISA can 
be used for its measurement, the lability of the protein and length of the analysis 
(>5 hours) pose limitations. Thus, our aim is to develop an electrochemical impe-
dance spectroscopy (EIS) based biosensor system for quick and reliable measu-
rement of HIF-1α in serum.
Materials and Methods: HIF-1alpha antibodies have been used as a 
biorecognition receptor. For immobilization, the electrode was first modified 
with albumin, followed by PAMAM. The new biosensor was compared with the 
conventional ELISA method.
Results: Based on the chronoimpedance data, total analysis time for EIS was 
chosen as 15 minutes. Calibration curve was constructed by locating electron 
transfer resistance on y-axis and HIF1 concentration on x-axis, between 50-1000 
pg/mL. LOD and LOQ of the biosensor were calculated as 14.45 pg/mL and 
43.8 pg/mL, respectively. The new biosensor showed very good correlation when 
compared with the conventional ELISA method (R2= 0.99649).
Conclusion: We developed and analytically validated a biosensor system 
to measure HIF-1α in serum. This new biosensor promises more timely and 
accurate measurements in determining the tissue oxygenation in patients who 
have hypoxia related conditions such as diabetic foot.
Keywords: hypoxia inducible factor 1 alpha, biosensor, impedance, PAMAM
Özet
Amaç: Normal oksijen iletimi hayatta kalmak için esastır. Kanserden inflamatu-
var hastalıklara kadar çeşitli patolojik durumların ortak bir özelliği olan hipoksi, 
normal oksijen iletiminin hücresel oksijen talebi ile doku oksijen beslenmesi ara-
sındaki dengesizlik sonucu etkilenmesiyle meydana gelir. Organizmaların oksi-
jen homeostazını korumak için geliştirdiği kompleks mekanizmalar arasında, hi-
poksiye karşı ana düzenleyici hücresel uyum yanıtının hipoksi ile indüklenebilir 
transkripsiyon faktörleri ailesi (HIF) olduğu  bulunmuştur. Her ne kadar ELISA 
ölçümü bu belirteç için kullanılabilse de, proteinin labil doğası ve analiz süresinin 
uzunluğu (> 5 saat) bu ölçüme sınırlamalar getirir. Bu nedenle amacımız serumda 
HIF-1α’nın hızlı ve güvenilir ölçümü için elektrokimyasal empedans spektrosko-
pisi (EIS) bazlı biyosensör sistemi geliştirmektir.
Gereç ve Yöntem: HIF-1 alfa antikorları, biyotanıma reseptörü olarak 
kullanılmıştır. İmmobilizasyon için elektrot önce albümin, ardından PAMAM ile 
modifiye edilmiş ve geliştirilen yeni biyosensör, geleneksel ELISA yöntemiyle 
karşılaştırılmıştır.
Bulgular: Kronoimpedans verilerine dayanarak, EIS için toplam analiz süresi 
15 dakika olarak seçilmiştir. Kalibrasyon eğrisi, y-ekseni üzerindeki elektron 
transfer direnci, x ekseni üzerinde HIF-1 konsantrasyonu 50-1000 pg/mL arasında 
yerleştirilerek yapılmıştır. Biyosensörün LOD ve LOQ değerleri sırasıyla 14,45 
pg/mL ve 43,8 pg/mL olarak hesaplanmıştır. Yeni biyosensör, geleneksel ELISA 
yöntemiyle karşılaştırıldığında çok iyi bir korelasyon göstermiştir (R2 = 0,99649).
Sonuç: Bu çalışmayla, serumda HIF-la’yı ölçmek için bir biyosensör sistemi 
geliştirilmiş ve sistemin etkinliği analitik olarak doğrulanmıştır. Bu yeni 
biyosensör, diyabetik ayak gibi hipoksi ile ilişkili rahatsızlıkları bulunan 
hastalarda doku oksijenasyonunun belirlenmesinde daha kısa zamanda ve daha 
doğru ölçümler vermeyi vaat etmektedir.
Anahtar Sözcükler: hipoksi indüklenebilir faktör 1 alfa, biyosensör, empedans, 
PAMAM
Introduction
Normal oxygen delivery is essential for survival. Recently, 2019 the Nobel Prize in 
Medicine (or Physiology) was given to three scientists for their studies on adaptation 
of the organism in  hypoxic conditions [1]. There are different biomarkers that can 
show the level of hypoxic conditions and one of them is hypoxia-inducible factor-1 
(HIF-1). HIF-1 is a transcription factor that plays a key role in the development 
of adaptation response to hypoxia. The molecule  consists of the subunits HIF-1α 
and HIF-1β [2]. HIF-1α is the main regulator of oxygen homeostasis and adaptive 
cellular response to hypoxia to regulate cell survival [3]development, physiology, 
and pathobiology. The hypoxia-inducible factors (HIFs. It  is activated by a decrease 
in oxygen concentration of the cell and targets many genes in various pathways; 
erythropoiesis, iron metabolism, angiogenesis, glucose metabolism, vascular tonus, 
matrix metabolism, cell survival, proliferation and apoptosis. Studies have shown that 
HIF-1α dysfunction occurs in the hyperglycemic environment in diabetic individuals 
as a result of disruption of transactivation. The increased level of reactive oxygen 
radicals in the hypoxic environment inhibits HIF-1α gene expression. Interestingly, 
some HIF-1α polymorphisms were found to be significantly higher in diabetic foot 
ulcer patients when compared to that of healthy controls, so these mutations can be 
important in the pathogenesis of diabetic foot wound under hypoxic conditions [4]. 
The conventional method for HIF-1α analysis is the ELISA which has some 
limitations due to length of the analysis (>5 hours) and the lability of the protein. 
Besides matrix effects like hemolysis, hyperlipidemia can also alter the measurement 
accuracy in the ELISA system. Thus, our aim was to develop an electrochemical 
impedance spectroscopy (EIS) based biosensor system for quick and reliable 
measurement of HIF-1α in serum. 
Impedimetric biosensors are developed by immobilization of a receptor; an antibody, 
DNA or protein molecule, which show affinity only to the analyte molecule. The 
signals resulting from the interaction between this biological sensor and the analyte 
molecule are transmitted by the physicochemical transducer to the analysis system 
and measurement can be performed by analyzing the concentration-dependent 
response of these signals obtained through EIS [5]Biosensor technology has provided 
a number of benefits to detect both biological and chemical molecules. Abiosensor 
is a promising device, which is combination of sensitivity of electrochemistry and 
specificity of biological recognition, enables to detect any kind of molecules in a 
short time with selectively and sensitively. Likewise many analytical methods, it 
has also limitations, such as high oxidation potentials lead to detection of non-target 
molecules, furthermore non-electroactive species cannot show electroactive signal 
for measurement or some biomolecules cannot be transformed by enzymes, even 
if they can be transformed, they require secondary molecules such as mediators, 
coenzymes or labels. In order to detect molecules without electrochemical reaction, 
electrochemical impedance spectroscopy (EIS. In recent years, EIS has been 
able to make highly sensitive measurements as a sensing system especially in the 
development of biosensor technologies based on immunological based biomolecule 
interactions[6]. In EIS, the liquid interface properties and the binding parameters to 
the electrode surface can be measured. Since the EIS can measure the thickness or 
charge distribution (capacitance) of the electrode surface, it can be very sensitive 
to detect even very small changes that alter the electrical charge distribution on the 
electrode. Electrode surface resistance with EIS can be measured using potentiostat 
without any biochemical reactions. The color and turbidity properties of the measured 
fluid do not affect the measurement. 
In the light of the above background, we immobilized HIF-1 antibodies which are 
capable of recognizing HIF-1 on the screen printed electrode surface (the sensor 
system). Thus, the new electrodes we developed had a more specific and rapid 
measurement capacity since a direct affinity based bioreceptor was used for the 
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target molecule HIF-1. The measurement of the binding of HIF-1 to the anti-
HIF-1 on the electrode was performed by using surface-characterization EIS and 
the results were obtained with concentration-time-impedance function. In order 
to evaluate the validity of our measurement, results, procedure and performance 
characteristics were compared with the conventional ELISA technique.
Materials and Methods
Materials
All chemical materials were obtained from Sigma-Aldrich (USA). Electrochemical 
measurements were performed using the PalmSens3 potentiostat (Palmsens BV, 
The Netherlands). Screen printed gold electrodes (250 AT) were obtained from 
Dropsens (Spain). All chemicals were prepared using triple deionized water. 
Blood samples were taken from the control group and severe diabetic patients in 
whom amputation was planned. Serum were stored at -20°C until use. The study 
was approved by the Ethics Research Committee (16-9 /15) of
Ege University School of Medicine and supported by the Ege University 
Scientific Research Projects Commission (18-TIP-036).
Methods
This study included the archive blood of 30 patients between the ages of 18 and 
100 who participated in the Diabetic Foot Council which is being held every 
Wednesday at Ege University Faculty of Medicine Orthopedic Policlinic within 
the scope of approval of the ethics committee numbered 16-9/15. HIF-1α levels 
were measured by both ELISA and biosensor we developed in the Department of 
Medical Biochemistry. The basis of this study is based on the immobilization of 
antibodies, specific molecules, to the surface after modification of the transducer 
surface and subsequent electrochemical examination of the surface due to the 
affinity between the HIF-1 molecule and the antibody. The bonding result of 
this affinity changed the electrical properties of the surface and after the change 
of electrical properties acceptable signals were obtained and electrochemical 
measurement was performed by electrochemical impedance spectroscopy 
and chronoimpedance. The electron transfer resistance was measured in redox 
probe solution, this measurement was calculated Randless circuit model [7]. R2; 
represents the electron transfer resistance of the electrode surface. Since this 
resistance will change by binding of HIF-1α to the immobilized anti-HIF-1α on 
the electrode surface, the EIS values based on this have also changed. First of all, 
the gold nanoparticle modified electrode was placed in a cap containing water and 
ethanol (1:1) and left in a sonic bath for 2 minutes to remove impurities. Then, it 
was washed with pure water and dried under nitrogen gas. The gold nanoparticles 
were deposited on the surface by applying -200mV to the electrode immersed in 
a solution containing 200 ppm AuNPs. The electrode was then gently washed 
with distilled water and dried with nitrogen gas. AuNPs/BSA modification was 
carried out by the following modifications 50 µL of 1mg/mL BSA solution was 
placed on the surface of the gold nanoparticle coated electrode and incubated for 
1 hour. AuNPs/BSA/PAMAM modification was carried out as follows; BSA on 
AuNPs was activated with 5% glutaraldehyde for 30 minutes and 5 mM 50 µL of 
PAMAM was dropped onto the surface and incubated for 1 hour. The electrode 
was washed with distilled water and gently dried with nitrogen gas. AuNPs/
BSA/PAMAM/anti-HIF-1α modification was carried out via NH2 ends on the 
AuNPs/BSA/PAMAM electrode by activating 5 % gluaraldehyde and subsequent 
incubated by dropping anti-HIF-1α on electrode. After the electrode was washed, 
the unbonded anti-HIF-1α removed. All modification steps were investigated by 
electrochemical impedance spectroscopy.
Results
All EIS curves of the electrode modification are shown in Figure 1 (Figure 1). 
The GNP modified electrode is shown in green. The BSA coating was used for 
covalent PAMAM modification by immobilization and pH stabilization of the 
surface of the electrode. As can be seen, an increase in electron transfer resistance 
was observed with coating of the surface. This is an expected result. The red 
curve shows the BSA layer. BSA has been used because of the ability of gold 
nanoparticles to attract proteins to the surface. Glutarladehide was used for 
covalent bonding of the next immobilization material (PAMAM) by activating 
amine groups on BSA. PAMAM-G5 is the fifth generation demdrimer class 
for electrode surface. This molecule is formed by branching ethylenediamine 5 
times over the ethylene diamine nucleus and having amino groups at the end. 
This is also suitable for covalent bonding of BSA-PAMAM via glutaraldehyde. 
Since gold nanoparticles are nanomaterials, they are used in our biosensor 
system to facilitate electron transfer and increase surface area and provide active 
immobilization. PAMAM material was used to increase electrode surface area to 
immobilize more anti-HIF antibodies to increase sensitivity. In PAMAM bonding, 
because the surface is positively charged, it draws the negatively charged redox 
probe electrostatically to the surface, thereby increasing mass transfer, that is, 
Warburg impedance, increasing the electron transfer resistance on the electrode 
surface. The amino termini of PAMAM are reactivated with glutaraldehyde, 
making it suitable for anti-HIF binding. After activation of the PAMAM tips, 
anti-HIF was dropped onto the surface and covalently bonded to the surface. 
Since the anti-HIF immobilization increases the electron transfer resistance of 
the surface by forming an isolation layer, an increase in the impedance signal has 
occurred (Figure 1). 
Figure 1. Red curve GNPE, Yellow curve GNPE / BSA, green curve GNPE / 
BSA / PAMAM, Blue curve GNPE / BSA / PAMAM / Anti-HIF1alpha modified 
electrode EIS curves.
Figure 2 shows that the conductivity of the gold nanoparticle electrode is high 
and the Warburg impedance is dominant. An increase in impedance occurred 
when the surface was coated with BSA. Although PAMAM coating is expected to 
increase in flowing impedance, since the PAMAM layer is positively charged at 
pH=7, the electron transfer resistance is reduced by pulling the negatively charged 
redox probe and increasing the number of redox probes that are electrochemically 
transformed per unit time. Anti-HIF1 binding also increases the electron transfer 
resistance. These procedures show that immobilization procedures are performed 
very successfully. 
 
Figure 2. GNPE / BSA / PAMAM / AntiHIF1 a: 900mV 200Hz buffer and b: 
900mV 200Hz HIF1.
After 40 seconds, the impedance curve began to gain linearity and continued 
linearly, although the binding speed was low. Therefore, the detection time is 
optimized for 10 minutes.
For calibration curves, 13 calibration curves were prepared to evaluate electrode 
performance characteristics such as GNPE/BSA/PAMAM/Anti-HIF1 modified 
biosensor Repeatability, selectivity, repeatability, linear spacing, LOQ, and LOD 
were performed (Figure 3A and B).
Comparison of the newly developed biosensor with the conventional ELISA 
method is given in Table 1.
Max.Binding Rate: 40 Seconds
b
a
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Table 1. Comparison of the ELISA and the Biosensor
Parameters HIF 1 Biosensor ELISA
Sample Serum Serum
Linear Range 50 – 1000 pg/mL R2= 0,9964 81,92 – 20000 pg/mL
LOD 14,45pg/mL (3,3(S(Ret=50pg/mL)/m) <30pg/mL
LOQ 43,8 pg/mL (3,3(S(Ret=50pg/mL)/m) -
Reproducible R2 = 0.9964 ± 0.0024 (n=13) -
Repeatibility 1. (Serum n=3, 53,3): 51,6 ± 1,41 (pg/mL)
2. (Serum n=3,101,13) 100,3 ± 3,84 (pg/mL)
-
Detection Time 10 Minutes 5 Hours
Figure 3. A: Impedance curve of the calibration curve of the HIF1 biosensor from 
50 pg / mL to 1000 pg / mL. B: Calibration curve of the HIF1 biosensor (y-ΔRet, 
x-HIF (pg / mL.min)), R2 = 0.9964.
Supplementary Table 1 shows amputation and diabetes mellitus (DM) and 
amputation levels (Suppl. Table 1). HIF1 values (pg/mL) were also measured. 
HIF measurements using archive blood repeats from these patients in previous 
studies were performed using ELISA kit.
Conclusion
In this study, HIF1 alpha biosensor has been successfully developed for the 
first time in the literature. Our studies also include chrono-impedance studies 
to characterize the impedimetric detection time. The success of the biosensor in 
real serum samples also makes it possible to commercialize the biosensor after 
its development. The LOQ limit confirms that the calibration curve is close to 
the theoretical level. Selectivity studies using real serum samples and electrodes 
show good selectivity against serum samples. In the reproducibility study, when 
13 calibration curves were prepared and the standard deviation of R2 values 
were taken, extremely low standard deviation showed that the system was both 
reproducible and reproducible. As a result, we have successfully developed our 
biosensor system by achieving our goal.
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Supplementary Table 1. HIF-1a levels in DM and amputation samples
Patient DM 
Type
DM Duration (Year) Amputation Level HIF-1a (pg/mL)
Patient 1 Type-2 35 Finger 341.67
Patient 2 Type-2 6 Transmetatarsal 351.23
Patient 3 Type-2 1 Above Knee 673.77
Patient 4 Type-2 3 Transmetatarsal 64.23
Patient 5 Type-2 30 Finger 79.27
Patient 6 Type-2 32 Under the Knee 101.13
Patient 7 Type-2 25 Finger 54.67
Patient 8 Type-2 18 Finger 58.77
Patient 9 Type-2 45 Finger 43.73
Patient 10 Type-2 14 Under the Knee 60.13
Patient 11 Type-2 15 Chopart 57.4
Patient 12 Type-2 7 Under the Knee 53.3
Patient 13 Type-2 2 Finger 60.13
Patient 14 Type-2 22 Finger 102.5
Patient 15 Type-1 40 Under the Knee 639.6
Patient 16 Type-2 23 Under the Knee 49.2
Patient 17 Type-2 25 Transmetatarsal 82
Patient 18 Type-2 30 Finger 57.4
Patient 19 Type-2 20 Under the Knee 57.4
Patient 20 Type-2 40 Transmetatarsal 60.13
Patient 21 Type-2 27 Under the Knee 169.47
Patient 22 Type-2 2 Under the Knee 58.77
Patient 23 Type-2 16 Under the Knee 155.8
Patient 24 Type-2 20 Under the Knee 57.4
Patient 25 Type-2 4 Under the Knee 50.57
Patient 26 Type-2 15 Transmetatarsal 61.5
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Abstract
Background: Every year more than one million people commit suicide worl-
dwide. Suicide cases constitute 1-2% of the total global mortality. Reelin is an 
extracellular matrix glycoprotein and involved in the development of brain layers 
during embryogenesis. Reelin is linked with several psychiatric diseases but not 
investigated in the suicide cases.   
Objectives: We aimed to investigate reelin enzyme levels among suicide patients 
in comparison to the heathy controls.
Materials and Methods:  A total 86 suicide cases and 100 healthy controls were 
included in the study. Serum reelin levels were determined by using commercial 
Human ELISA kit. Demographic variables and clinic data were collected and 
analyzed.
Results: Body mass index and mean age among groups were significantly dif-
ferent. While the median reelin enzyme level of Suicide Group was 3038,31 
(IQR:212,46-8044,21) ng/L and that of Control Group was 2271,20 (IQR:77,67-
7647,83) ng/L. The difference was statistically significant (p <0.01).
Conclusions: According to the results of this study, reelin enzyme level of suici-
de patients was found to be significantly higher than normal cases. The importan-
ce and impact of our findings on suicide needs to be investigated across different 
populations.
Keywords: Suicide, Reelin, Emergency Service, ELISA, self-harm
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Özet
Giriş: Her yıl dünya çapında bir milyondan fazla insan intihar etmektedir ve 
intihar vakaları toplam küresel ölümlerin %1-2’sini oluşturmaktadır. Reelin hücre 
dışı bir matriks glikoproteinidir ve embriyojenez sırasında beyin tabakalarının 
gelişimine katılmaktadır. Reelin birçok psikiyatrik hastalıkla ilişkilendirilmesine 
rağmen intihar vakalarıyla ilişkilendirilmemiştir. 
Amaç: Bu çalışmada intihar girişiminde bulunan hastaların reelin enzim düzey-
lerinin sağlıklı kontrollerle kıyaslanması amaçlanmıştır.
Materyal ve Metot: Çalışmada toplam 86 intihar girişiminde bulunmuş hasta 
ile 100 sağlıklı kontrol kullanıldı. Serum örneklerinde reelin düzeyleri, Human 
ELISA kiti kullanılarak kit prosedürüne uygun olarak incelendi. Demografik de-
ğişkenler ve klinik veriler de toplandı ve karşılaştırıldı.
Bulgular: Gruplar arasındaki vücut kitle indeksi ve yaş ortalaması farklılıkları 
istatistiksel olarak anlamlı bulunmuştur. İntihar Grubu’nun ortanca reelin enzimi 
değeri 3038,31 (IQR: 212,46-8044,21) ng/L iken, Kontrol Grubunda bu değer 
2271,20 (IQR: 77,67-7647,83) ng/L olarak bulunmuş olup aradaki fark istatistik-
sel olarak anlamlıdır (p <0.01).
Sonuç: Bu çalışmanın sonuçlarına göre intihar hastalarında reelin enzim düzeyi 
normal vakalardan anlamlı derecede yüksek bulunmuştur. Bulgularımızın inti-
har üzerindeki önemi ve etkisi farklı popülasyonlarda da (daha yüksek veri ile) 
araştırılmalıdır.
Anahtar Sözcükler: İntihar, Reelin düzeyi, Acil Servis, ELISA, Kendine zarar 
verme
Introduction
Suicide is the self-injury with an aim to achieve death and is frequently encountered 
in emergency services and intensive care units [1]. Every year, more than one 
million people commit suicide worldwide and suicide cases constitute 1-2% of 
the total global mortality [2]. Most people who are on the verge of suicide tend 
to express their thoughts and intent. They use expressions that indicate desire to 
die and give signs that they feel worthless [3,4]. These are requests for assistance 
in suicidal cases. The thoughts and movements of people are limited just before 
the suicide as they consider suicide continuously and cannot perceive the other 
solutions for their problem(s) [3]. Suicide risk is increased 3-12 times among 
those with a history of psychiatric diseases compared to those without one [5]. 
Approximately 95% of people who have accomplished suicide have a history of 
psychiatric disease and the increase in frequency of suicide in some psychiatric 
diagnostic groups is noteworthy [4]. 
The gene encoding reelin is located on human chromosome 7 (7q22) and produces 
a protein with a molecular weight of 388 kDa. Reelin is an extracellular matrix 
glycoprotein involved in the development of brain layers during embryogenesis 
[6]. Reelin proteins are secreted from different regions of the brain, particularly 
Cajal-Retzius cells in the cortex and marginal zone of hippocampus. Reelin is 
not only secreted from the brain in the developmental process but is also secreted 
in adults from the glutamatergic granulated cells in the cortex and hippocampus 
GABAergic neurons in the cerebellum [7]. A number of studies indicated 
deficiency of the reelin in various neuropsychiatric diseases such as epilepsy, 
autism, major depression, lysencephaly, Alzheimer’s disease [8–10]. However, 
to the best of our knowledge, there is no study targeting the relationship between 
reelin and suicide.
Therefore, in the present study we aimed to test the relationship between suicide 
and reelin protein.
Materials and Methods
This study was conducted after the approval of Fırat University Faculty of 
Medicine Clinical Research Ethics Committee with the decision number 06-
06 dated 24/03/2015. A total of 86 patients who were suicide attempters and 
admitted to the Emergency Department of Firat University Medical School 
Hospital between March 2015 and November 2015 were included in the study 
and denoted as Suicide Group. In addition, a control group consisting of 100 
healthy volunteers was formed and denoted as Control Group.
We initially recorded demographic data from all the individuals in healthy controls 
(Control Group) and suicide attempters (Suicide Group). We also measured and 
recorded body mass index (BMI), pulse, and respiration rate of all the cases. 
We subsequently assayed blood serum reelin levels of all 186 individuals included 
in the present study. Reelin levels were assayed in serum samples according 
to the kit procedures using the Human ELISA kit (Rel Assay. Diagnostics, 
REF no1; E20160202016, LOT no1; 20160202, REF no2; E20160202017, 
LOT no2; 20160202). Samples were not diluted. Absorbances were read 
spectrophotometrically at 450 nm on ELX800 ELISA reader. In plate washing, 
Bio-tek ELX50 (BioTek Instruments, USA) was used as an automatic washer. 
Results were expressed as ng/L. The measuring range was 37 ng/L-7000 ng/L and 
the minimum measurable level was 15.23 ng/L.
After the data were collected, statistical analyses were performed using the 
statistical analyses program SPSS 21.0. Kolmogorov-Smirnov and Shapiro-
Wilk normality tests were employed to test the deviations from the normality. 
Numerical data were expressed as mean ± standard deviation and qualitative data 
were expressed as percentages. In addition, data that did not fit into the normal 
distribution were presented as Median (Interquartile range, IQR). Student t-test 
was used to test differences between means of two groups with the continuous 
variables that were normally distributed. Chi-Square test was used to test non-
random distribution of categorical data among groups. Man-Whitney-U test 
was used to compare non-parametric paired groups. A p-value of <0.05 was 
considered significant throughout the analyses.
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Results
Of the 186 patients included in our study, 86 were suicide attempters and 100 
were healthy controls. Among 86 suicide attempters, 52 (%60.5) were females 
and 34 (%39.5) were males. The control group consisted of 54 females and 46 
males. The mean age of Suicide Group was 28.14 (±10.04) years and that of 
Control group was 32.52 (±13.71) years. We conducted a Chi-square test was 
used to assess the gender distribution among groups and the results revealed that 
the difference was not significant (p=0.69) (Table 1). 
Although there was a statistically significant difference between the groups in 
the mean BMI (p = 0.001), age (p = 0.001), and respiratory rate (p <0.001), these 
values were within the limits accepted as clinically normal.
Table 1: Comparison of demographic and clinic data of Suicide Group and 
Control Group.
Parameters Suicide Group Control Group P
N (Female/Male) 86 (52/34) 100 (54/46) 0.690
Age (years) 28.14±10.04 32.52±13.71 0.001
BMI (kg/m2) 23.28±4.47 24.93±3.38 0.001
Pulse (beats per min) 90.65±21.76 84.92±14.78 0.112
Respiration Rate (breaths per min) 17.80±3.17 14.96±1.20 <0.001
In our study, the median reelin enzyme level was found to be 3038.31 ng/L (IQR: 
212.46-8044.21 ng/L) in Suicide Group and as 2271.20 ng/L (IQR: 77.67-7647.83 
ng/L) in Control Group. The difference in the reelin enzyme levels between the 
two groups was found to be significantly different (p <0.0001) (Table 2).
Table 2. Comparison of reelin levels in patients attempting suicide and healthy 
control group.
Parameters Suicide Group Control 
Group
P
N (Female/Male) 86 (52/34) 100 (54/46) 0.690
Reelin Enzyme Median (IQR ng/L) 3038.31 
(212.46-
8044.21)
2271.20 
(77.67-
7647.83)
0.001
Discussion 
Suicide is an increasing public health problem in our country as well as all over 
the world [11]. A number of earlier studies targeted the demographic data from the 
suicide cases in Turkey to deduce the general pattern. Önsüz et al. [12] evaluated 
1566 patients with suicide attempts in the emergency department and reported 
that 78.9% were women and 1109 of all patients were in the 15-34 age group. In a 
10-year retrospective study, 2988 out of 4569 patients admitted to the emergency 
department for suicide attempt were female (65.4%). The study also concluded 
that the mean age of females was 24.5±10.1 years and the mean age of males 
was 29.5±13.2 years [13]. Kara et al. [14] found that 74% of 1036 patients were 
females in their study on the evaluation of patients admitted to the emergency 
department due to intoxication. They also reported that 60% of all patients were 
in the 15-24 age group [14]. Ersoy et al. [15] found in their retrospective study 
that the female ratio was higher (72.8%) and the mean age of all patients was 
27±13.8 years. The demographic data reported here showed similar pattern to the 
aforementioned literature in terms of gender and age.
An intensive amount of research has been devoted to understanding the 
biochemical pattern in suicidal patients. However, the role of reelin in the suicide 
cases has not yet been investigated.  Here, we evaluated demographic data from 
the patients who attempted suicide in respect to reelin levels and found a negative 
correlation with age and body mass index. In a study on patients with autism, 
Camacho et al. [16] found that the reelin protein is expressed and stored in Cajal-
Retzius cells developing in the cereal cortex and cerebellum. While these cells are 
reported to be present in the developing cerebral cortex, most of these cells have 
been detected to have apoptosis and a very small group of them are alive in the 
progressed age groups. Therefore, as in our study, the level of reelin was found to 
be higher in individuals at younger ages [16].
The role of reelin in the innate psychiatric diseases have been investigated 
in depth. One of the most important mechanism of action of the reelin is 
synaptogenesis, structural and biochemical neuroplasticity in dendritic endings 
of axons in the hippocampus in the human brain [17]. Reelin level deficiency 
is attributed to disruption of neuroplasticity and regulation of gene expression 
from the endoplasmic reticulum, protein production and their posttranslational 
modification in peripheral tissues [17]. Similarly, in our study, an inverse 
relationship was found between the reelin level and body mass index, and it was 
found that the reelin level decreased as the body mass index increased.
More than 100 markers have been identified in the studies conducted to detect a 
possible biological marker in the brains of schizophrenia patients and reelin and 
glutamic acid decarboxylase (GAD) have been frequently studied in this context 
[18–20]. Both proteins are expressed in cortical GABAergic neurons. While GAD 
plays a role in GABA synthesis, the extracellular matrix protein, reelin, binds to 
dendrites and plays a role in long term potentialization, which is important in 
learning and memory. Low levels of both reelin and GAD1 mRNAs are among 
the most frequent findings in schizophrenia brains [8,19,21–24]. This suggests 
that the regulation of the GABAergic system is impaired in schizophrenia. This 
disorder has been reported to be associated with impaired working memory in 
patients with schizophrenia [25].
In the study of 10 male and 8 female patients diagnosed with the schizophrenia, 
Hornig et al. [26] investigated reelin enzyme level while comparing them to a 
total of 18 (9 females/ 9 males) healthy controls. ELISA and Western Blot were 
used in the study and both methods were compared. In both methods, it was found 
that reelin enzyme level increased significantly in schizophrenia patients. They 
claimed that the drugs patients had taken increased the level of the reelin [26]. 
Similarly, Fatemi et al. found that the concentration of blood reelin in patients 
with schizophrenia increased compared with the healthy control group [8].
Reelin levels were evaluated in a wide range of neurological and neuropsychiatric 
diseases such as depression, schizophrenia, Alzheimer’s and different results 
were obtained in each disease. The levels of reelin in postmortem brain tissues 
were investigated in schizophrenia patients and this enzyme was found to have 
decreased in patients with schizophrenia. In our study, the blood serum reelin 
levels were found to have elevated similar to Hornig et al. [26] and Fatemi et al. 
[8]. However, in both studies, it is stated that there is not enough data to explain 
the molecular mechanism of the increase.
There is a general lack of empirical information between suicide and reelin. 
We believe that more conclusive data could be conceived with a wider patient 
population. In addition, it was concluded that this study will be reference point 
for the future studies.
Conclusion
According to the results of this study, reelin enzyme level of suicide patients 
was found to be significant factor for suicide. The importance and impact of 
our findings on suicide needs to be investigated and targeting role of reelin in 
experimental animal studies will be an interesting research venue.
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